Novel saturation transfer difference (STD) NMR approaches to understand biologically relevant protein-carbohydrate interactions by Monaco, Serena
 Novel Saturation Transfer Difference 
(STD) NMR approaches to understand 
biologically relevant protein-
carbohydrate interactions 
 
 
 
Serena Monaco 
Faculty of Science 
School of Pharmacy 
 
 
Thesis submitted to the School of Pharmacy, University of East Anglia, in fulfilment of 
the requirement for the degree of Doctor of Philosophy 
 
Norwich, April 2018 
 
  
 
 
To Florent, 
the most beautiful discoveries are the ones we are making together 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This copy of the thesis has been supplied on condition that anyone who consults it is understood 
to recognise that its copyright rests with the author and that use of any information derived 
therefrom must be in accordance with the current UK Copyright Law. In addition, any quotation 
or extract must include the full attribution.
1 | P a g e  
 
Acknowledgements 
I will start these acknowledgements going straight to the point: I have had the biggest 
luck a young researcher in my field could have. I have learnt Saturation Transfer 
Difference NMR from the hands of one of its main developer, my supervisor, Jesùs 
Angulo, sitting at the spectrometer together, day after day, when I was the only (and 
very proud!) member of the Angulo’s Lab. My gratitude for this is immense, but this is 
not the only reason for thanking you, Jesùs: you have been more than a supervisor, you 
have been a mentor and an example of enthusiasm, perseverance and passion as few 
others. Thanks for your scientific and personal support through these years, for your 
positivity and empathy, for teaching me the concept of “tolerance to frustration” and 
the respect for my limits (while still pushing them further), lessons often disregarded in 
academy. Overall, you made my life possible, this made the difference. 
I am deeply thankful to Yaroslav Khimyak, my second supervisor. Thanks for your 
constant support, the fruitful and inspiring scientific conversations we had along the 
years, but also for your endless culture and the care you put in widening our horizons  
and keeping us together as a beautiful and cheerful group.  
A very special thank goes to Nathalie Juge and Louise Tailford at the Quadram Institute 
of Biotechnology. The chance to collaborate with you has been a real honour and the 
best intellectual fun for me. Thanks for your trust since the very early days of my PhD, 
and for your availability at any time. This has been so precious to me, and I really hope 
we can keep this going in the years to come. 
I am very grateful to the School of Pharmacy, the funding body of my 3 years here; and 
with it, I would like to thank Colin Macdonald for his help with the NMR instrumentation 
and Chris Morris, for giving me the chance of few years of enriching demonstration in 
the Physical Pharmacy module and for being always available (especially in these last 
few important months). A big thank also goes to the students I had the chance to 
supervise during my PhD: Aditya, Pani, Sham, Sarah, Ian, Tom and Agne. Thanks also to 
Joanne, Sharron, Kate and John for helping with every other aspect of the academic life. 
The NMR group has always been a big family for me, and there’s a  list of people I want 
to thank. First of all, Sam Walpole, thanks for being on my side since October ’15, and 
thanks for all your support every day since then. I think of you as my main partner in this 
academic adventure, and I feel so lucky I could work along such a brilliant mind and join 
2 | P a g e  
 
our efforts to produce some exciting science: it has been a pleasure and an honour. 
Susana Ramalhete and Karol Nartowski, made the days in the lab a constant source of 
enjoyment and mutual support. In the toughest days, your presence around made the 
whole difference. Thanks for all the personal and scientific support since day-one until 
today, throughout the distance: thanks for being real friends. The lab days would have 
not been the same without Franco, Francesc, Lucka, Martyna, Fabiana, Francesca, 
Cholpon, Elise, Remy and Teresa. It is so tough to endure so many goodbyes, but it has 
been truly enriching sharing a piece of the road together. Luckily some people stay, and 
I want to deeply thank Valeria, for being the most joyful and supportive mate, Vani and 
Juan Carlos for the enlightening “post-doc input” and for their precious help with this 
thesis, Alex, Matthew and Dani for making the NMR group as special as it is.  
I feel lucky to have found so many special people in Norwich, but I would like to add 
some personal acknowledgements, to the friends whom I painfully left somewhere else 
in Europe to start this beautiful experience. Thanks to Nando, Carlo and Marina for 
keeping being my Danish family, thanks to Lilli and Desi for being the corner of a big 
triangle across Europe together, for showing me that some things will never change. 
Clementine and Godot, thanks for being the closest to my soul, and the best friends I 
could ever whish for. A huge thank goes to my family is in UK: thanks to my uncle 
Matteo, for being there anytime and to my awesome brother, Ivan, for being “home” 
when I needed the most, I feel so lucky we got re-united in this corner of the world.  
These three years have been a challenging trip, but it was  worth the happiness and 
satisfaction I found through all my PhD and in my life in Norwich. This chance would 
never be real without the inspirations and the encouragement to discover which I had 
from my parents, two physicists, who only asked for one thing in my whole life: that I 
was happy. The sparkle that I saw in the eyes of my dad every night he came back from 
the lab since I was a child certainly played a hidden role in the choices I have made so 
far, and the multidisciplinary and curious mind of my mum, who always keeps learning 
and expanding her knowledge, was and is a great inspiration to never stop discovering. 
From the deepest point of my heart, my biggest thank goes to whom arrived 
serendipitously, who changed life and moved to a new country, to be by my side in this 
PhD adventure: my husband-to-be, Florent. Thanks for all the things we are learning 
from each other, for sharing success and defeat with me, for believing in me, for 
supporting my dreams, for the beautiful life we are choosing to build together.  
3 | P a g e  
 
Abstract 
Saturation transfer difference (STD) NMR spectroscopy is a powerful NMR technique 
extensively used to obtain epitope maps of ligands binding to biologically relevant 
protein receptors. This allows to reveal semi-quantitative structural details of the 
interaction, which is key to direct lead optimization efforts in drug discovery. However, 
it does not give information about the nature of the amino acids surrounding the ligand 
in the binding pocket. 
In this thesis, the main effort has been put to develop two novel implementations of 
STD NMR, aimed at elucidating the surroundings of the ligand (i.e., the amino acids lining 
the binding pocket, or an adjacent bound ligand) in biologically relevant complexes. 
First, we report the development of the novel “DiffErential EPitope mapping STD NMR” 
(DEEP‐STD NMR), a method producing differential epitope maps through i) differential 
frequency and/or ii) differential solvent (D2O/H2O) STD NMR experiments. These two 
approaches provide complementary information on the architecture of the binding 
pocket. The second novel method we propose is “Inter-ligand STD NMR” (IL-STD NMR), 
which relies on on-ligand differential frequency STD NMR to detect contacts between 
ligands bound to adjacent sites of a receptor. 
These novel STD NMR methodologies, in combination with traditional STD NMR and 
computational tools, have been applied to the study of two systems: the interactions of 
Cholera Toxin subunit B (CTB) with a set of promising inhibitors; and the interactions of 
an intramolecular trans-sialidase from Ruminococcus gnavus, a gut microbiota 
symbiont, with a set of mucin-related sialylated ligands. In the first study, we discovered 
the existence of a hitherto unknown binding subsite in the GM1 binding site of CTB. In 
the second study, we provided the first 3D molecular model of a Michaelis complex for 
an IT-sialidase.  
In both cases, we demonstrate that our newly developed approaches increase the level 
of resolution of STD NMR, widening its potential to impact the field of ligand design for 
biologically relevant receptors. 
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Chapter 1 
Introduction and objectives 
1.1 Carbohydrates as biological and pharmaceutical l igands  
At the beginning of the millennium, the result of the Human Genome Project (HGP) left 
the scientific world astonished: the entire human genome is composed of only about 
26,500 genes1. Previous predictions estimated this number to be ranging from 50,000 
to 140,000 genes, also considering that S. cerevisiae (baker yeast) and D. melanogaster 
(fruit fly) have respectively 6,000 and 16,000 genes 2,3. The existing biological diversity is 
then encoded in such a small number of genes. To explain this, the authors of the HGP 
reasoned  that “the finding that the human genome contains fewer genes than 
previously predicted might be compensated for by the combinatorial diversity 
generated at the level of post-translational modification of proteins”1. Among the post-
translational modifications, glycosylation is the second most frequent one, together 
with acetylation and after phosphorylation4. Glycosylation is the process of attaching an 
oligosaccharide, i.e. a glycan, to oxygen or nitrogen atoms of specific protein residues5. 
In this section, we will briefly introduce carbohydrates as a complex and charming class 
of biological molecules and functional ligands; also, we will explain why deepening our 
knowledge on protein-carbohydrate interactions can lead us to understand many 
physiological and pathological events in the human body, and to appreciate their 
beautiful complexity. 
1.1.1 From monosaccharides to complex glycans: the chemical perspective  
Carbohydrates are chemically defined as polyhydroxy ketones, aldehydes, alcohols and 
carboxylic acids. For most of them, the molar ratio of 1:2:1 between carbon, hydrogen 
and oxygen holds; hence, they have been historically defined as “hydrates of carbon”, 
i.e. “carbohydrates”. They are prime biological substances, metabolized as mono-, oligo- 
and polysaccharides6. In physiological conditions, monosaccharides form cyclic 
hemiacetals and hemiketals by intramolecular nucleophilic addition of one of their 
hydroxyl groups to the carbonyl function. The equilibrium is shifted towards the 5- or 6-
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membered heterocycles (called “furanose” and “pyranose” for their similarity to furan 
and pyran, respectively).  
Depending on the relative designation for the configuration of the stereogenic centre 
further from the carbonylic group, the stereochemistry of a sugar is designed by the use 
of prefixes “D-” or “L-”, of historical derivation (a “D-” and an “L-” sugars are enantiomers 
with respect to all the stereogenic centres of the molecule)7. Importantly, in solution, 
the rings are found in equilibrium between two epimeric forms. In D-sugars, these forms  
are called α if the hydroxyl on C1 is in axial position and β if it is in equatorial position 
(Figure 1.1a,b). The carbon C1 is also called “anomeric” carbon, due to its variable 
stereochemistry. 
 
Figure 1.1. The 9 fundamental monosaccharides found in vertebrates. (a) α-ᴅ-glucose (α-Glc), 
(b) β- ᴅ-glucose (β-Glc), (c) ᴅ-Galactose (Gal), (d) ᴅ-Mannose (Man), (e) ᴅ-Xylose (Xyl), (f) N-
acetyl-ᴅ-glucosamine (GlcNAc), (g) N-acetyl-ᴅ-galactosamine (GalNAc), (h) ᴅ-Glucuronic acid 
(GlcUA), (i) Sialic acid (Neu5Ac) and (j) ᴅ-Fucose (Fuc). In (a) and (b), the two anomeric 
configurations of Glucose are shown. For all the other sugars, the curly bonds indicate either 
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one or the other configuration. Carbon nomenclature is given for Glucose and applies from (a) 
to (h), and for Sialic acid, and applies for (i) and (j). 
The fundamental monosaccharides in vertebrates are 9 (Figure 1.1)8, and they are 
mainly found as D-sugars, in the same way as the fundamental amino acids are 21 
(mainly found in their “L-” form), and the fundamental nucleotides are 5. Glucose is the 
simplest of the fundamental monosaccharides and the other 8 can be metabolised 
starting from it. Enzymes called glycosyl-transferases can form glycosidic linkages 
between two or more monosaccharides. Due to the presence of two adjacent oxygens, 
the anomeric carbon is susceptible to nucleophilic attack from any hydroxyl groups6. If 
the attacking nucleophile is situated on a second monosaccharide unit, the new 
molecule is defined as a disaccharide7. The ring whose anomeric position is engaged in 
the glycosidic bond is called the non-reducing end, and the ring with a free anomeric 
hydroxyl is called the reducing end (Figure 1.2). It is easy to expand this scenario to the 
formation of consecutive glycosylic bonds yielding trisaccharides, oligosaccharides and 
eventually polysaccharides. 
The presence of nucleophilic donors on several carbons of each monosaccharide means 
that the regiochemistry of the linkage  can vary enormously and the opportunity for 
branching is very conspicuous8. Here it lies a substantial difference between 
carbohydrates and the two other main classes of bio-molecules: starting from the 9 basic 
aldo-pyranoses, the possible tetrasaccharides are 10 million; whereas, the possible 
tetramer formed by the 4 DNA nucleotides are 400, and 200,000 are the possible tetra-
peptides which we can obtain from the 21 fundamental amino acids (lipids have been 
excluded from this discussion). In this combinatorial calculation, we have not considered 
the fact that, additionally, glycosidic linkages are not only defined by the regiochemistry 
(e.g., (1-2), (1-3), (1-4) linkages, etc.), but also by the stereochemistry at the non-
reducing ring (e.g., α(1-2), β(1-2), α(1-3), β(1-3), linkages, etc.) . Thus, if a galactose is 
transferred onto the carbon C4 of a glucose, there are two possible outcomes, 
depending on whether the galactose is in α or in β configuration. In the first case, we 
will have the α-Gal(1-4)Glc disaccharide and in the second case we will have the β-Gal(1-
4)Glc disaccharide, which we commonly call lactose. Additionally, the glycosidic bond 
can be highly flexible, allowing rotation around the two dihedral angles φ and ψ7, 
defined in Figure 1.2. This means that linear, but even more branched, oligosaccharides 
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have the potential to explore a wide conformational space. The potential of glycans of 
assuming several “shapes” in solution adds a further layer of information-coding and it 
has been referred to as “the third dimension of the sugar code” 9. 
 
Figure 1.2. Example of a glycosidic bond in the disaccharide β-Gal(1-4)Glc (Lactose). The 
reducing and non-reducing ends are indicated, and the red curved arrows define the two 
dihedral angles: φ (O5’-C1’-O*-C4) and ψ (C1’-O*-C4-C3)10. 
The elements of glycan structural variability encountered so far are: 
i) Nature of the monomer units (i.e. composition); 
ii) Regiochemistry of the linkage; 
iii) Stereochemistry of the linkage (at the anomeric positions); 
iv) Conformational flexibility (of the glycosidic linkage). 
The enormous number of possible structural variation  is self-explanatory on the 
potential of information-storage of the totality of glycan structures in living organisms, 
which is what we call the “glycome”.  
1.1.2 The glycan code: exploring the social life of cells  
Having described the elements of structural complexity of glycans from a chemical point 
of view, we now want to highlight their fundamental role in biological contexts after 
post-translational modification (PTM) takes place.  
Biologically, glycans decorating proteins post-translationally modified can be divided 
into N- and O-glycans, depending on whether they are attached to an asparagine (Asn) 
or a threonine/serine (Thr, Ser), respectively8. N-glycans are biosynthesised in the 
endoplasmic reticulum (ER) on a lipid-like molecule termed dolichol phosphate, from 
which they are then transferred to the newly synthesised proteins in the lumen of the 
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ER. O-glycosylation takes place in the Golgi but is less frequent than N-glycosylation and 
less is known on how it works. Mucins are the class of glycoproteins carrying the greatest 
number of O-glycans.  
Going through the Golgi to reach the cytoplasm, glycoproteins undergo further 
modifications to allow distribution to their final destination: to specific cells 
compartments, to the cell surface or to the extracellular space10. Glycans in PTMs can 
be thought of as “tags” (exposed on the membranes of cellular organelles, of the cell 
itself or of free glycoproteins in the extracellular matrix) carrying specific information 
and allowing interactions with other entities, able to recognise and “read” the tags 
(Figure 1.3). Carbohydrate-recognising proteins are the counterpart of this 
“communication”. Protein-carbohydrate interactions are the processes to transduce the 
information delivered by PTMs. In another analogy, we can envision glycans as “keys”; 
then, the biological receptors, exposed on self-cells, guest-cells, viruses, or free 
receptors such as antibodies, toxins, carbohydrate binding modules etc., are the “locks”, 
as first postulated by Emil Fisher in 189411. The “keys” fit (almost always) uniquely in 
their “locks” allowing the information to be de-codified to start physiological or 
pathological processes12, in what has been defined as “the social life of cells”13. 
 
Figure 1.3. Cartoon representing five examples of biological host-guest recognition processes in 
which protein-carbohydrate interactions are involved. Toxins, bacteria, antibody, viruses or self-
cells recognise glycans exposed on the cell surface of a host cell. Figure from 14. 
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1.1.3 Medicinal glycochemistry: the pharmaceutical perspective  
In this thesis, we focus on two biologically relevant protein-carbohydrate interactions, 
involving bacterial proteins recognising glycans exposed on the intestinal lumen. In one 
case, the bacterial protein is the toxin from V. cholera (CT) which recognises a branched 
pentasaccharide (GM1) exposed on the epithelium of our gut. The GM1/CT interactions 
is one of the strongest protein-carbohydrate interactions (with a KD in the low nM 
range15) and mediates the internalisation of the toxin in the lumen of the epithelium 
cells, where the enzymatically active unit of the toxin triggers a cascade disrupting the 
ionic channels, and leading to strong dehydration16. In the second system, the bacterial 
protein is an intramolecular trans-sialidase from R. gnavus, a commensal bacterium in 
our gut17. Sialidases are carbohydrate active enzymes cleaving sialic acid units that are 
frequently capping the O-glycans which are present in high concentration on some 
glycoproteins such as mucins. By cleaving, and in some cases metabolising, sialic acid 
units they can adapt to mucin-rich niches of the intestine and colonise them18. In some 
cases, mucin degradation is associated to severe pathologies (such as inflammatory 
bowel disease in the gut, or cystic fibrosis in the lungs 19).  
These are only two examples of protein-carbohydrate interactions which became of 
interest in medicinal studies. Among other notorious examples of non-bacterial protein-
carbohydrate interactions we can mention the noxious interactions between 
hemagglutinin and neuraminidase expressed on the surface of the influenza virus with 
the sialic acid exposed on the epithelium of the host cells 20; or the leukocyte-endothelial  
initiating the leukocyte recruitment during acute and chronic inflammation, mediated 
by selectins, a glycan-binding class of adhesin proteins21. Protein-carbohydrate 
interactions also play a fundamental role in immunology processes and another 
remarkable example is the definition of blood types, first distinguished by Karl 
Landsteiner in 190022. To be blood type 0, A, B or AB simply refers to the type of glycan 
exposed on the blood cells of each individual, a piece of knowledge which allowed to 
safely perform blood transfusion already during WWII23. Glycochemistry is also in the 
spotlight of vaccinology for the development of carbohydrate-based vaccines (glycol-
vaccines). This was initially based on the idea of using bacterial polysaccharides as 
antigens, exploiting the unique glycan structure found on diverse pathogens 24. Starting 
from there, it has been possible to target the surface carbohydrates from protozoa to 
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cancer cells in the aim of developing always safer and more efficient vaccines25. 
Nevertheless, the main centre of interest in pharmaceutical research with respect to 
glycochemistry seems still to be the design and development of inhibitors of protein -
carbohydrates interaction26, which is the aim of the first of the two biological projects 
of this thesis (CTB). To do this in a knowledge-based fashion, a detailed understanding 
of how protein-carbohydrate interactions work is necessary, and we will try to cover the 
major features from a structural, thermodynamic and kinetic point of view in the 
following section.  
1.2 Protein-carbohydrate interactions: structural, thermodynamics and kinetics 
aspects  
1.2.1 Structural recognition patterns specific to protein-carbohydrate complexes  
Lectins are the main family of carbohydrate-binding proteins. Their sugar-binding 
capacity and their lack of enzymatic activity are the main common features to the 
components of this class of proteins, which otherwise differ largely in their binding site 
architectures, ranging from shallow grooves to deep pockets12. There are diverse classes 
of lectins: legume lectins, C-type lectins, galectins, viral proteins, toxins and so on14. 
When carbohydrate-binding proteins are associated to enzymatically active domains, 
unlike lectins, we define them as carbohydrate-binding modules (CBMs, CAZy, 
http://www.cazy.org27). Carbohydrate-active enzymes are another family of 
carbohydrate-recognising proteins, performing diverse enzymatic modification to their 
sugar substrates, once they bind. Among the enzymatic transformation they can 
perform there is hydrolysis and rearrangement of glycosidic bond (glycoside 
hydrolases), formation of new glycosidic bonds (glycoside transferases), non-hydrolytic 
cleavage of glycosidic bonds (polysaccharide lyases), just to name the most populated 
classes (CAZy, http://www.cazy.org27). Sugar-recognition is a prerogative of both active 
and non-active classes of proteins, regardless the destiny of the sugar substrate upon 
binding. For this reason, it is possible to generalise several recognition elements specific 
to protein-carbohydrate interactions. 
The slightly amphiphilic nature of carbohydrates is key to their specificity of interaction. 
The high density of hydroxyl groups makes the sugars suited as both H-bond donors and 
acceptors (Figure 1.4a,b)12. The most common side chains involved in the formation of 
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cooperative H-bonds are arginine, aspartate and asparagine28. In cases in which the 
hydroxyl groups are in a favourable geometry, they can coordinate Ca2+ ions inherent to 
the protein. Equatorial hydroxyl groups on carbons C3 and C4 are particularly suitable 
for Ca2+ complexation (this excludes galactoses), and mannose-binding C-type lectins are 
good examples of this recognition pattern (Figure 1.4c)12. In fact, most monosaccharides 
differ in the relative position of one or two hydroxyl groups. The different electron-
density profile for a pair of epimers (e.g. glucose and mannose, epimers at C2, or glucose 
and galactose, epimers at C4) determines different directionality of H-bond (or ion 
complexation), making each sugar uniquely recognised in its own binding pocket at 
incredible levels of specificity.  
 
Figure 1.4. Epimer selection by three types of lectins. Arrows indicate H-bonding and point from 
donor to acceptor. (a) Galactose binding by human galectin-1 engages the axial 4-hydroxyl 
group in three cooperative donor/acceptor H-bonds along with the hydroxyl on C6 (OH-6), and 
a CH/π- stacking interaction of the H1-H3-H5 plane with the central Trp residue of the lectin 
site; (b) by contrast, the equatorial OH-4 in mannose is reliably sensed by topologically fixed 
bidentate H-bonding and a second H-bond, shown here for the glucose/mannose-specific 
leguminous lectin concanavalin A; (c) mannose-binding C-type serum lectin (rat collectin) 
involves a strategically presented Ca2+ ion (sphere) to probe for the presence of the di-equatorial 
3- and 4-hydroxyl groups, along with two H-bonds. Figure adapted from 12. 
At the same time, the slight electron-depletion resulting on the CH bond (of carbons 
carrying hydroxyl or carboxylic groups) enables van der Waals and stacking interactions. 
The most recurrent example is the CH/π-stacking taking place with the aromatic 
moieties of tryptophan, tyrosine and phenylalanine. This recognition pattern is 
particularly favourable for β-sugars (β-glucose, -galactose, -mannose, -glucuronic acid) 
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due to the presence of 3 axial CH (at position 1, 3 and 5), which enhances the CH 
contribution to the π-stacking (Figure 1.4a)12,29.  
The group of Woolfson browsed all the X-Ray structures of protein-carbohydrate 
complexes available until 2015, checking for the occurrence of polar, aliphatic and 
aromatic amino acids proximal to the carbohydrates (normalising to their occurrence in 
all protein sequences). They reported that aspartic acid and asparagine (Asp, Asn) occurs 
approximatively twice as often as expected by chance; aliphatic residues were generally 
disfavoured; tryptophan, tyrosine and histidine (Trp, Tyr, His) occurred 9, 4 and 3 times 
more frequently than as expected by chance, respectively29. 
Additionally, clusters of arginine are regularly found in sialic acid recognising binding 
sites, where they multi-directionally complex the carboxylic group on C218, as we will 
see in Chapter 3 and 5; the same is true for heparin-recognising binding pockets which 
are rich in lysine and arginine, as heparin is a polysaccharide constituted of highly 
sulphated disaccharides units (they are regarded as the most negatively charged class 
of glycans)30. 
 
Figure 1.5. Differential conformer selection of the pentasaccharide of ganglioside GM1 by 
human galectin-1 and the cholera toxin B-subunit. The α2,3-sialylgalactose linkage at the branch 
site (a) can adopt three low-energy structures. Human galectin-1 (b) and the B-subunit of the 
cholera toxin (c) (PDB ID: 2CHB, 3CHB, respectively) bind different conformers (“keys”) so that 
the same pentasaccharide is bioactive in two distinct shapes 31. Figure from 12. 
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As we mentioned already, the conformational flexibility of the different glycosidic bonds 
also plays a fundamental role in protein-carbohydrate recognition. A remarkable 
example is found in the binding of the GM1 ganglioside to galectin-1 and to cholera toxin 
subunit B (CTB). GM1 (Figure 1.5a) is a branched pentasaccharide, whose non-reducing 
ends are a galactose and a sialic acid linked through a β-GalNAc(1-4)β-Gal unit.  
GM1 free conformation has been thoroughly studied, and the pentasaccharide has been 
found to adopt three major conformations in solution31. Most interestingly, the two 
lectins (galectin-1 and CTB) recognise two different “shapes” of the three most 
populated conformations (Figure 1.5b,c). Coming back to our previous analogy, the 
conformational behaviour of GM1 in solution resembles that of a “flexible key”, which 
can be recognised by different “locks”, selectively.  
Before concluding this discussion, it is also worth mentioning that the GM1/CTB complex 
has a 100-fold higher affinity than its GM1/galectin-1 counterpart (low nM vs. hundreds 
nM, respectively). This is to ascribe to the pentameric nature of CTB, which has a GM1 
binding pocket on each monomer, for a total of five32, in contrast to the homodimeric 
nature of galectin-133. The origin of the affinity enhancement associated to multivalent 
binding depends on the physiognomy of the multivalent receptor. In the case of the 
GM1/CTB interaction, the mechanism goes through the face-to-face binding of the 
pentameric lectin, orienting its multiple subsites in a common direction, to a 
carbohydrate or glycoprotein with clustered epitopes (GM1s are highly concentrated on 
the epithelial cell surface)34. Other multivalent interactions rely on so-called “bind and 
jump” mechanism, when the binding sites are at opposite ends of the molecule and the 
receptor “moves” on the carbohydrate-rich surface35. However charming, this 
discussion falls outside the field of interest of this thesis, and in the next sub-section we 
will focus on the discussion of thermodynamic aspects which will be essential to analyse 
every kind of mechanisms of binding (protein-carbohydrate, protein-ligand, 
monovalent, multivalent, etc.). 
1.2.2 The role of water and the enthalpy-entropy compensation effect   
So far, we described glycans as amphiphilic units, which are at the same time able to 
participate in cooperative H-bond (both as donors and acceptors) and in CH/π 
hydrophobic stacking in their amphiphilic binding sites. When we focus on the 
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thermodynamics of the interactions, we must consider the solvent as the third 
component of the mechanism of binding: water is the medium in which the interactions 
take place, water molecules are often intrinsic to amphiphilic binding sites and 
especially, the free ligands in solutions are surrounded by several layers of water 
molecules. 
In fact, the high density of hydroxyl groups on glycans poses interesting questions on 
the behaviour of these ligands when free in solution and surrounded by water 
molecules. Most interestingly, computational studies performed by the group of 
Vanderkooi gave an excellent answer to this question, showing how the possibility for 
intramolecular H-bond in monosaccharides strongly influences the structure of the 
water molecules constituting the first solvation layer36. For instance, an axial OH on C4 
(OH-4) can hydrogen bond to the OH-6 forming a network which reaches the O5 (OH-4 
→ OH-6 → O5). Alternatively, it can interact with an equatorial OH-3 creating an OH-6 → 
OH-4 → OH-3 network. An axial OH-2 can engage with OH-4 and OH-6, influencing the 
formation of an OH-2 → OH-4 → OH-6 network. Whatever the geometry, the presence 
of intramolecular H-bond networks themselves is associated to more nonpolar-like  
hydration around their hydroxyl. As we already mentioned, equatorial OH-3 and OH-1 
also contribute to the formation of a hydrophobic CH patch on the face of the sugar 
where the correspondent CH-3 and CH-1 are axial (e.g., favouring the interactions with 
aromatic π clouds).  
 
Figure 1.6. Positive (blue) and negative (red) electrostatic field iso-surface contours surrounding 
the hydrophobic patch of common biological sugars: β-glucose (b), β-mannose (c), and β-
galactose (d). The 3D structure of β-glucose (a) shows the CH groups present on the opposite 
face of these sugars. The figure is slightly offset from face-on view in order to show the vector 
orientation of these groups. Figure from 36. 
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The water structure surrounding this patch is relatively more polar-like than that 
observed when the OH-1 and OH-3 are in configurations that do not support patch 
formation. It is enlightening to notice that the monosaccharides common to biology are 
those containing both a hydrophobic patch and limited intramolecular H-bonding 
networks, namely, glucose, galactose, and mannose (as opposed as to allose and talose, 
for instance). The particular solvation properties deriving from these structural features 
makes these sugar units more prone to engage in molecular recognition events, 
arguably due to the different electrostatic potential surfaces observed on the two faces 
of the sugars (Figure 1.6)36. 
This brings us naturally to include into the discussion the hydrophobic effect, the 
tendency of nonpolar molecules (or part of molecules) to aggregate in aqueous media: 
a central aspect of biomolecular structure and recognition37. Some argue that the low 
occurrence of aliphatic residues in carbohydrate-recognising binding pockets is the 
proof that the hydrophobic effect does not play a fundamental role in protein -
carbohydrate recognition29, whereas some other may argue that already the CH/π 
interaction is a remarkable example of the hydrophobic effect38.  On the other hand, the 
hydrophobic effect plays a key role in accommodating the methyl groups of fucose or 
that of the amidic group of sialic acid, N-acetyl-glucosamine and N-acetyl-
galactosamine. The discussion is substantially controversial, as it is undeniable that the 
water molecules surrounding the apolar ligand and filling the active site of the protein 
are an important part of the mechanisms of binding.  
The entropic contribution to binding is another focal point of this discussion. Commonly, 
binding implies selection of one single conformation, among the many conformations  
the free ligand can assume when it is free, which will fit in the (more or less tight) binding 
site39. Unavoidably, the loss of conformational freedom, plus the loss of independent 
freedom of rotation and translation in solution, equates to an entropic loss (𝛥𝑆 < 0) 
which usually has a negative impact on the spontaneity of the process at physiological 
temperature (𝛥𝐺 =  𝛥𝐻 −𝑇𝛥𝑆). As a counterpart, the hydrogen bound water 
molecules which occupy the binding pocket of the protein are released upon binding, 
going back to a more “disordered” state in which they are free to tumble in the bulk 
solution. Clearly enough, based on what we just discussed in the previous paragraph, 
entropy and enthalpy go in opposite directions: the de-solvation of the free ligand and 
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of the apo binding pockets, which are enthalpically unfavourable, are entropically 
favourable; the loss of conformational freedom of the ligand, associated with the 
binding event, brings both: a gain in the enthalpic component (H-bond formation, 
hydrophobic effect, CH/π stacking), together with a loss of entropy of flexible ligands 
and proteins.  
Many thermodynamic studies have been carried out in the attempt of rationalising: i) 
the unfavourable entropy of binding caused by conformational restrictions of the ligand 
upon binding40; ii) the small conformational changes throughout the protein upon ligand 
binding41; iii) and the reorganization of solvent molecules within the active site of a 
protein after ligand binding42. The combination of these evidences has resulted in the 
proposal of the so-called enthalpy-entropy compensation, but the topic remains 
controversial. 
 
Figure 1.7. Enthalpy-entropy compensation in protein-ligand binding. Graphical abstract from 
37. Diagram of the thermodynamic results for 𝛥𝛥𝐽°𝑏𝑖𝑛𝑑, where 𝐽  stands for Gibbs energy 
(𝐺, blue), enthalpy (𝐻, green), and entropy (𝑆, red), respectively —obtained from ITC 
measurements at 298.15 K. The relative differences in the enthalpy and entropy of binding (i.e., 
mutual 𝐻/𝑆 compensation) result in indistinguishable values of 𝛥𝐺°𝑏𝑖𝑛𝑑  for 8 ligands with 
differential fluorinated patterns. The grey region demarcates the 95% confidence interval (i.e., 
two standard deviations) of 𝛥𝛥𝐺°𝑏𝑖𝑛𝑑  for the reference compound. The sketch of the 
association process is represented on the left panel.  
The term was coined in 1930 and discussed ever since. One of the latest comprehensive 
studies on the subject, a work from the group of Whitesides, brilliantly exemplified the 
effect of different fluorination pattern on a library of compounds interacting with 
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human carbonic anhydrase37. They showed that changes in the structure of the ligand 
often lead to opposite and compensating changes in the enthalpy and entropy of binding 
but result in surprisingly small changes in the free energy of binding, as it appears self-
explanatory in Figure 1.7. 
The most cautious authors still argue that, in fact, the enthalpy-entropy compensation 
in water prevents to accurately dissect out measured values of 𝛥𝐺 into contribution 
from enthalpy and entropy. Whereas we insist on the relevance of dissecting 𝛥𝐺 into its 
𝛥𝐻 and 𝛥𝑆 components (even by approximation) to discuss the mechanisms of binding, 
we agree that 𝛥𝐺 is the thermodynamic quantity most accurately accessible from 
measured binding constants in solution and the most relevant in calculations of 
equilibria. Therefore, in the next sub-section, we will present a simple model to describe 
protein-ligand interactions at the equilibrium and to treat them mathematically from a 
thermodynamics and kinetics point of view.  
1.2.3 One-site model for bimolecular association in solution: thermodynamic equilibrium 
and kinetics of exchange  
The framework that we are going to discuss does not only apply to protein-carbohydrate 
interactions but can describe any receptor-ligand system. The model is called “one-site 
model for bimolecular association in solution” (where no allosteric or cooperative effect 
is accounted for). Three distinct species are involved: a protein receptor (𝑃), a ligand (𝐿)  
and the complex of their association, the complex (𝑃𝐿). 
For the purposes of ligand-based NMR observation, the kinetics of the binding process 
is a determining parameter. In that context, we refer to it as the kinetics of exchange, as 
we observe the ligand exchanging between the free and the bound states. The 
unimolecular rate constant for the dissociation reaction (off-rate, 𝑘𝑜𝑓𝑓 , in s
-1) is inversely 
proportional to the half-life time of the receptor ligand complex. The bimolecular rate 
constant for the direct reaction, 𝑘𝑜𝑛 , measures the probability of productive encounters  
(i.e., encounters which directly lead to the formation of the complex). For simple 
systems, one normally can consider 𝑘𝑜𝑛  as invariable, under the main assumption that 
the association process of the interaction is controlled by molecular diffusion (in which 
𝑃 + 𝐿  𝑃𝐿  
𝑘𝑜𝑛  
𝑘𝑜𝑓𝑓 
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case, the best estimations give 𝑘𝑜𝑛  ≈ 10
8 – 109 M-1 s-1). However, if the interaction 
involves strong long-range forces (when electrostatic components are involved), 𝑘𝑜𝑛  
could be significantly larger; in contrast, it could be significantly lower if the interaction 
is coupled to large conformational changes.  
A key parameter in any binding equilibrium is the affinity, which can be expressed in 
terms of the dissociation equilibrium constant: 
𝐾𝐷 =  
[𝑃][𝐿]
[𝑃𝐿]
=  
𝑘𝑜𝑓𝑓
𝑘𝑜𝑛
 Equation 1.1 
where [𝑃] , [𝐿] and [𝑃𝐿]  correspond to the concentration of 𝑃 , 𝐿  (free state) and 𝑃𝐿  
(bound state) at the thermodynamic equilibrium. 𝐾𝐷  is also given by the ratio of 𝑘𝑜𝑓𝑓   
over 𝑘𝑜𝑛 . For systems in which we can assume 𝑘𝑜𝑛  diffusion-limited (so in absence of 
long range interactions or of large conformational rearrangements), the 𝐾𝐷  can be 
directly related to 𝑘𝑜𝑓𝑓 , i.e., measuring the affinity gives us direct information on the 
turnover of binding (or residence time in the binding pocket). For small 𝐾𝐷  values, 
corresponding to strong binding, 𝑘𝑜𝑓𝑓  will be small, indicating slow turnover of the 
ligand in the binding site, i.e., a long residence time. Vice versa, large 𝐾𝐷  values, 
corresponding to weak binding, will imply large 𝑘𝑜𝑓𝑓 , with a fast turnover and a short 
residence time.  
Changing perspective, if we consider that the fraction of bound receptor is given by 
𝑓𝐵
𝑃 =  
[𝑃𝐿]
[𝑃]𝑇
= 
[𝑃𝐿]
[𝑃]+[𝑃𝐿]
    Equation 1.2 
we can then combine this equation with the definition of 𝐾𝐷  and express the fraction of 
bound receptor as a function of the concentration of free ligand: 
𝑓𝐵
𝑃 =  
[𝐿]
𝐾𝐷+[𝐿]
   Equation 1.3 
This corresponds to the equation of a Langmuir isotherm for the saturation of a receptor 
site of interaction with the ligand (Figure 1.8).  
For low ligand concentration, [𝐿] << 𝐾𝐷, 𝑓𝐵
𝑃 is linearly proportional to [𝐿] ; on the other 
hand, for very large ligand concentration, [𝐿] >> 𝐾𝐷, the receptor is fully saturated with 
ligand molecules and 𝑓𝐵
𝑃 = 1. If we consider the particular situation in which the 
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receptor is half-saturated, i.e. when 𝑓𝐵
𝑃 = 0.5, the Langmuir isotherm equation predicts 
that the free ligand concentration is [𝐿] = 𝐾𝐷, which gives us a more practical definition 
of 𝐾𝐷, as “the concentration of ligand in the free state that leads to half saturation of 
the receptor”. At this point, it is important to highlight that, in the Langmuir isotherm, 
[𝐿]  represents the concentration of free ligand, and not the total added concentration, 
[𝐿]𝑇. 
 
Figure 1.8. Langmuir isotherm showing the fraction of bound receptor 𝑓𝐵
𝑃  as a function of the 
total ligand concentration [𝐿]𝑇 for three different affinities (in all cases [𝑃]𝑇=10μM). 
1.3 Theory of Solution State Nuclear Magnetic Resonance43 
The first Nuclear Magnetic Resonance signal was detected in bulk materials by Bloch and 
Purcell in 194544,45. As physicists, they thought to have found a precise method to 
measure magnetic moments of different nuclei. In the few following years, it became 
clear that the frequency of resonance of a given nucleus was affected by the chemical 
environment on the nucleus itself. The discovery of chemical shift, followed by the 
discovery of spin-spin coupling, disclosed the huge potential of the technique for 
chemical structural elucidation46. On these premises, the exponentially fast theoretical 
and technological developments of Nuclear Magnetic Resonance Spectroscopy 
started47. 
In 1953, the theory of the nuclear Overhauser effect (NOE) was published48, and in the 
same year the theory for exchange effects in NMR spectra was postulated49. In a few 
years, while the first commercial NMR magnets started to appears, the theory was  
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translated in routine practice, allowing extended structural and conformational 
studies50. As the first superconductive magnets were engineered and higher and higher 
magnetic fields could be reached and more sophisticated pulse sequences were 
developed (including multi-dimensional NMR), NMR started to be applied in the field of 
biology and in 1983 the first small protein was assigned51. In parallel, great progresses 
were made in the field of solid state NMR, with the discovery of the magic angle spin 
technology, and in the field of combined imaging and spectroscopy (bringing to MRI).  
Recently, the implementation of novel processing approaches, non-uniform sampling 
and non-Fourier signal processing methods in multidimensional NMR, enabled reducing 
experimental times considerably and allowed acquisition of up to 7D experiments 52, 
while the first 1.2 GHz magnet has been purchased by the University of Lille in France. 
NMR is thriving and without any doubt it can be considered as the most important and 
versatile of all the spectroscopies.  
1.3.1 Basic concepts53,54,55 
1.3.1.1 Spin number, spin angular momentum and magnetic moment 
Atoms are composed of nuclei and electrons. While many spectroscopy techniques rely 
on the observation of electron energy transitions, NMR focuses on nuclear spin energy 
transitions. Nuclei possess several properties through which we can define them: mass, 
electric charge, magnetism and spin. To discriminate between NMR “active” or “silent” 
nuclei, the nuclear spin quantum number (𝐼) is the most important parameter. Indeed, 
nuclei with 𝐼 = 0 do not exhibit NMR properties, while for all the other nuclei we can 
define a spin angular momentum P, also called the nuclear spin, and defined as: 
𝑃 = √𝐼(𝐼 + 1) ℏ   Equation 1.4 
where ℏ is the reduced Plank constant (ℏ = ℎ 2𝜋⁄ ) and 𝐼 =  
1
2
, 1,
3
2
, 2, etc. Classical 
angular momentum is associated to a rotating object. On the contrary, 𝑃 is an intrinsic 
property of the quantum particles. As in classical physics a charge in motion (e.g. 
associated to an angular momentum) generates a magnetic field, the intrinsic spin 
angular momentum leads to the generation of a magnetic moment, μ, which is 
proportional to 𝑃: 
𝜇 = 𝛾𝑃    Equation 1.5 
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where 𝛾 is the so-called gyromagnetic ratio, which shows a defining value for every 
different nuclide. 𝜇 and 𝑃 are vectors, with a defined magnitude and orientation. We 
can think of the individual magnetic moment of each spin in a sample as randomly 
oriented in normal conditions. However, when the sample is placed in a static magnetic 
field B0, the magnetic moments will show a tendency to align with the direction of the 
field, as little magnetic bars would do. In quantum terms, the observation of the system 
will lead to the detection of only a discrete number of different orientations of the spins, 
which is equal to 2𝐼 + 1.  
1.3.1.2 The differences in energetic state populations and the Larmor frequency  
For nuclei with 𝐼 =
1
2
 (such as 1H and 13C, the most commonly detected nuclei), there will 
be two possible orientations the spins can undertake. By convention, 𝐵0 is always 
applied in the z direction, therefore, nuclei with 𝐼 =
1
2
 will either align with z or with –z. 
We call these two energy states the 𝛼 and the 𝛽 state, respectively. Usually, the 
population of the 𝛼 state (𝑁𝛼) is slightly larger than the population in the 𝛽 state (𝑁𝛽) 
and the ratio between the two it increases exponentially with 𝛥𝐸 (therefore it depends  
on γ and 𝐵0): 
𝑁𝛼
𝑁𝛽
= 𝑒
𝛥𝐸
𝑘𝐵𝑇   Equation 1.6 
where 𝑘𝐵 is the Boltzmann constant and the difference in energy level between 𝛼 and 
𝛽, 𝛥𝐸, is given by: 
𝛥𝐸 =  ℏ 𝛾 𝐵0   Equation 1.7 
The quantum mechanics system we are trying to describe can become complex, but a 
very useful way to deal with it is to depict it in classical mechanics and vectorial terms, 
which is accurate up to a certain level. In particular, we can think of 𝐵0 imposing a torque 
on the magnetic moments 𝜇, which results in the precession of every one of the nuclear 
spins about the direction of the static field. The rate of the precession is expressed (in 
Hz) as follows: 
𝜈0 = 
−𝛾 𝐵0
2𝜋
    Equation 1.8 
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In NMR, this is called the Larmor frequency of the nucleus and it also corresponds to the 
frequency of the electromagnetic radiation required to the nuclei to change their spin 
state (from 𝛼 to 𝛽 or vice versa), by acquisition of a quantum of energy (𝛥𝐸 = ℎ𝜈).  
1.3.1.3 Bulk magnetisation and the perpendicular rf field B1 in the rotating frame 
Now, we can imagine summing up all the single μ components (precessing at the Larmor 
frequency and aligned with or against 𝐵0): the result will be a so-called “bulk” 
magnetisation vector 𝑀𝑧  aligned with 𝐵0 (Figure 1.9). The magnitude of 𝑀𝑧  will be given 
by the z projection of the sum of the magnetic moments 𝜇. Formally, we would then 
write that: 
𝑀𝑧 ∝ 𝑁𝛼 − 𝑁𝛽    Equation 1.9 
This implies the net magnetisation on the transverse (x-y) plane to be null. As 
mentioned, to induce an energy transition between the 𝛼 and the 𝛽 states, the Larmor 
frequency of the nucleus of interest must be matched by the electromagnetic wave 
employed for excitation of the sample.  
 
Figure 1.9. Bulk magnetisation as represented in the vector model. The single spin magnetic 
moments rotating at the Larmor frequency in their 𝛼 and 𝛽 states (pointing above and below 
the x-y plane, respectively) sum up to give the bulk magnetisation vector 𝑀𝑧 , whose direction is 
+z and whose intensity is the projection of the sum of the μs on z. Figure adapted from 54. 
Practically, as the frequencies typically associated with nuclear spin transitions fall in the 
range of radio waves (tens to hundreds of MHz), for typical magnets used in NMR 
spectroscopy, the excitation is done applying a radiofrequency pulse oscillating at 
around the Larmor frequency (passing current via a coil surrounding the sample). This 
produces a magnetic field, 𝐵1, perpendicular to 𝐵0 (the direction of 𝐵1 can be modulated 
by the coil properties). To help visualising the effects of the oscillating rf pulses on the 
bulk magnetisation rotating along z in the presence of 𝐵0, the formalism of the rotating 
frame of reference was introduced (Figure 1.10). 
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In the laboratory frame the x, y, z coordinates are viewed as static, while the rotating 
frame of reference uses coordinates x’, y’, z’ which are rotating with the frequency of 
the B1 field of the radiofrequency pulse . If the magnetic field introduced by the rf pulse 
oscillates in the x axis (x-pulse), it can formally be decomposed into two counter-rotating 
components oscillating in the transverse plane with frequencies ± 𝜈0  (Figure 1.10) 
(where 𝜈0  is expected to be the frequency for NMR condition to be satisfied). In the 
rotating frame of reference, one of the rf field vectors is then static and the second 
rotates with 2𝜈0  in opposite (-) direction. Being this now far from the Larmor frequency, 
it can be ignored. Therefore, in the rotating frame, time dependency of the rf field is 
removed and both 𝑀𝑧  and 𝐵1 are static and perpendicular to each other. 
 
Figure 1.10. Representation of laboratory and rotating frame of reference. Figure adapted from 
54.  
1.3.1.4 Chemical shift and the fundamental pulse-acquire NMR experiment 
We already argued that the resonance frequency of a given nucleus  depends on its 
gyromagnetic ratio (𝛾) and applied external field 𝐵0, and we mentioned that the local 
environment of the nuclei in the molecule (namely surrounding electrons of any 
neighbouring nucleus) has a large effect too. Electrons circulating in their orbitals can 
be seen as currents passing through wires and producing small (local) magnetic fields 
(𝐵’) in the opposite direction to 𝐵0. Hence, the effective (local) magnetic field (𝐵) felt by 
the nucleus is slightly smaller than the applied external magnetic field (𝐵0) and is given 
by the equation: 
𝐵 =  𝐵0 −𝐵
′ =  𝐵0(1 − 𝜌)   Equation 1.10 
where 𝜌 is the shielding constant. 
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The electron density surrounding the atoms in any molecule is typically rather complex 
and depends on several factors including formation of hydrogen bonds, presence of 
electronegative nuclei in close proximity, unpaired electrons or through-space 
interactions within molecular clusters. Experimentally, the chemical shift (𝛿) is 
measured as a frequency difference of the analysed nuclei (say resonating at 𝜈𝑖) with 
respect to one reference frequency. If we  imagine the reference frequency to be on-
resonance with the rotating frame (𝜈0 ), the other sets of nuclei can either move slower 
or faster, and consequently will have a smaller or larger δ. The chemical shift of each set 
of nuclei is defined in the ppm (part per million) scale as: 
𝛿𝑖 = 10
6 𝜈𝑖−𝜈0
𝜈0
   Equation 1.11 
and it is independent from the strength of the field 𝐵0. 
We have now all the tools to describe the fundamental pulse-acquire experiment, 
consisting in turning on an rf irradiation of given amplitude for a given time. As already 
𝐵0 did on 𝜇 (inducing precession), the rf field imposes a torque on 𝑀𝑧  rotating it 
perpendicularly to the direction of the 𝐵1. This drives the bulk magnetisation vector 
away from its equilibrium position (from the z-axis towards the x-y plane, according to 
the “motor rule”). The 90° pulse, bringing the magnetisation on to the x-y plane, 
equalises the spin populations of the 𝛼 and 𝛽 states, that is, it makes 𝑀𝑧  null. A 180° 
pulse, instead, which will bring 𝑀𝑧  to –z, does invert the populations. All these elements 
(and many more) are useful to manipulate the magnetisation in pulse sequences way 
more complicated than the pulse-acquire. For that purpose, it is also important to know 
that if the rf field is applied for a time 𝑡p, the flip or nutation angle of the pulse (𝜃) 
through which the magnetisation is rotated is found as: 
𝜃 = 
𝛾
2𝜋
𝐵1𝑡𝑝  degrees  Equation 1.12 
Far from its equilibrium state by any 𝜃 angle, the bulk magnetisation will tend to recover 
its +z position by precessing around z. As we have seen, different sets of nuclei will 
precess at different frequencies, each of them inducing a weak oscillating voltage in the 
coil (now acting as a receiver coil rather than a transmitter coil). This small signal will be 
amplified and processed (Fourier transformed from the detected time domain to the 
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frequency domain) and the result will be a frequency spectrum containing as many 
“peaks” as many are the sets of nuclei experimenting different electronic environment 
(i.e. having different chemical shifts). 
We have explained very briefly the use of rf pulses to perturb the equilibrium between 
the energy states of the nuclear spins (generating sets of signals on the receiver coil, and 
allowing to detect an NMR spectrum of the sample). Of deepest interest for the 
techniques used and developed in the present thesis, though, are the complicated 
processes of re-establishing the equilibrium state after perturbation. These processes 
are called relaxation, and to them we dedicate the following sub-section.    
1.3.2 Relaxation in one- and two-spin systems54,55 
Understanding relaxation is relevant from many points of view. In the first place, we 
need to know how much time the nuclei in our sample take to come back to equilibrium 
after a given pulse, to allow full recovery of the bulk magnetisation on the z axis, before 
pulsing again, i.e., before acquiring another scan (acquiring and accumulating more than 
one scan is the norm in NMR, to increase the S/N ratio). Nuclear relaxation is stimulated 
by a suitable fluctuating magnetic field to induce the necessary spin transitions that 
eventually will lead to re-establishing the equilibrium populations. These fluctuations 
act locally (as opposed as to the rf pulse, which is coherently applied to the whole 
sample) and they are modulated by the random molecular motions existing in the 
surrounding environment (mainly diffusional rotations). Therefore, understanding 
relaxation can also unveil information on the motional regimes in the sample. Among 
the mechanisms which can induce relaxation, the most relevant for us is the process of 
magnetic dipole-dipole interactions, which, in particular, is responsible for inducing the 
so-called “cross relaxation” process, which gives rise to one of the most relevant 
observables in NMR spectroscopy, the Nuclear Overhauser Effect (NOE). NOE allows to 
probe intermolecular distances and most (if not all) of the NMR techniques investigating 
intermolecular interactions are based on it.  
1.3.2.1 Spectral density function and correlation time 
To understand better the role of random fluctuations in relaxation processes and NOE, 
it is fundamental to introduce the concept of spectral density function and the related 
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notion of correlation time. Random fluctuations in the sample generate molecular 
motions with a distribution of frequencies that can be expressed by the so-called 
correlation function. The correlation function with respect to time (τ) for an isotropic 
rotational diffusion of a hard sphere is: 
𝐺(𝜏) =  𝐵𝑙𝑜𝑐
2̅̅ ̅̅ ̅𝑒
−
|𝜏|
𝜏𝑐    Equation 1.13 
where 𝐵𝑙𝑜𝑐  is the local field, |𝜏| is the modulus of the time and 𝜏𝑐  is the correlation time, 
dictating the rate of decay of the correlation function with time. By definition, 𝜏𝑐  is the 
time a molecule takes to rotate through one radian and it is a key NMR parameter 
because it enables to quantify molecular tumbling motions. It is affected by molecular 
size (or better by radial volume), solvent viscosity and temperature. Generally, it is in 
the order of picoseconds for small molecules in non-viscous solvents at room 
temperature (in the fast motion or extreme narrowing limit), and in the order of 
nanoseconds for macromolecules in aqueous solutions (in the slow motion or spin 
diffusion limit). 
The exponential part of the correlation function is independent from the source of the 
local fields; it is therefore possible to simplify the equation by defining a reduced 
correlation function, 𝑔(𝜏), which is independent of the size of the local fields: 
𝑔(𝜏) =  𝑒
−
|𝜏|
𝜏𝑐    Equation 1.14 
The Fourier transform (FT) of the correlation function is called the spectral density 
function, 𝐺(𝜏)
𝐹𝑇
→ 𝐽(𝜔), and translates the distribution of molecular motions at the 
angular frequency expressed in radian (𝜔 = 2𝜋𝜈):  
𝐽(𝜔) =  𝐵𝑙𝑜𝑐
2̅̅ ̅̅ ̅ 2𝜏𝑐
1+𝜔2𝜏𝑐
2   Equation 1.15 
The reduced spectra density, 𝑗(𝜔), does not depend on the size of local fields and it is expressed 
as: 
𝑗(𝜔) =  
2𝜏𝑐
1+𝜔2𝜏𝑐
2   Equation 1.16 
In both forms, what is crucial to highlight is that the amount of motion at the Larmor 
frequency is simply found by evaluating 𝐽(𝜔) at 𝜔 = 𝜔0 , as shown in Figure 1.11. The 
expressions also show that the dependence of the spectral density for a hard sphere 
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with frequency follows a Lorentzian function and highlights its dependence from the 
correlation time.  
In other words, as fluctuations lead to generation of pulsing local magnetic fields in the 
surroundings of the spins, the spectral density function represents the probability of 
finding a fluctuating magnetic component at any given frequency because of the 
motion. Therefore, the area under the three curves is equal (and does not dependent 
from 𝜏𝑐). 
 
Figure 1.11. Spectral density function 𝐽(𝜔) as a function of the frequency of molecular motions 
for different correlation times (from small 𝜏𝑐 for fast tumbling molecules to large 𝜏𝑐 for slow 
tumbling molecules). 𝜔𝜏 represents the frequency of spin transition. Figure from 54. 
Fast tumbling molecules (small molecules, non-viscous solvents or elevated 
temperatures) can probe a wide range of motional frequencies and therefore show a 
wide spectral density distribution varying with 𝜔 (fast motion in Figure 1.11). In contrast 
with the above, slowly tumbling molecules (large molecules, or medium-sized molecules 
in viscous solvents or low temperatures) can only experience lower frequencies of 
motion, having a narrower but more intense distribution of frequencies (slow motion in 
Figure 1.11). Hence, the spectral density function is sharply peaked around 𝜔 = 0.  
1.3.2.2 Longitudinal relaxation (T1) 
Hence, we can go back to the pathways of the magnetisation in our sample. We have 
already presented the rf pulse as an event perturbing the spin populations at equilibrium 
of the α and β states (𝑁𝛼 and 𝑁𝛽). In these terms, for the equilibrium to be restored 
transitions must take place, bringing the nuclei back to their original energy state (𝛼 to 
𝛽, or 𝛽 to 𝛼). We can start from the assumption that the rate of this transition process 
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is proportional to 𝑁𝛼, and it is a first order process with a proportionality constant 𝑊 
(Figure 1.12).  
 
Figure 1.12. A state transition from α to β decreases the α population, a state transition from β 
to α increased the α population. 
The rate of change of 𝑁𝛼 and 𝑁𝛽 can be written as: 
𝑑𝑁𝛼
𝑑𝑡
= −𝑊(𝑁𝛼 −𝑁𝛼
0) +𝑊(𝑁𝛽 −𝑁𝛽
0),   
𝑑𝑁𝛽
𝑑𝑡
= +𝑊(𝑁𝛼 −𝑁𝛼
0) −𝑊(𝑁𝛽 − 𝑁𝛽
0)  
Equation 1.17 
where 𝑁𝛼 − 𝑁𝛼
0  and 𝑁𝛽 −𝑁𝛽
0  indicate the deviation from the population in the α and β 
states at the equilibrium (𝑁0 ). Based on Equation 1.9, 𝑀𝑧 ∝  𝑁𝛼 − 𝑁𝛽 , we can write the 
dependency of 𝑀𝑧  with the time as: 
𝑑𝑀𝑧
𝑑𝑡
= 
𝑑(𝑁𝛼−𝑁𝛽) 
𝑑𝑡
=
𝑑𝑁𝛼  
𝑑𝑡
− 
𝑑𝑁𝛽  
𝑑𝑡
   Equation 1.18 
Combining Equation 1.17 and Equation 1.18, we find that: 
𝑑𝑀𝑧
𝑑𝑡
=
−𝑅𝑧 (𝑀𝑧−𝑀𝑧
0)
𝑑𝑡
    Equation 1.19 
where 𝑅𝑧 = 2𝑊 and 𝑀𝑧
0 = 𝑁𝛼
0 − 𝑁𝛽
0. When 𝑀𝑧 = 𝑀𝑧
0, the system is at the equilibrium 
and nothing happens, but when 𝑀𝑧  deviates from the equilibrium, the rate of change is 
proportional to the deviation. As for any other first order kinetics, solving the differential 
equation above shows that z-magnetization returns from 𝑀𝑧(0) to 𝑀𝑧
0 following an 
exponential law. The time constant of the exponential is 1/𝑅𝑧  (also called 1/𝑅1), and this 
is often referred to as 𝑇1, the longitudinal or spin-lattice relaxation time. It is important 
to specify that 𝑇1 is the “time constant” of the kinetics of longitudinal relaxation and not 
the effective time required for recovery. The term “spin-lattice” used to describe 
longitudinal relaxation refers to the fact that the energy is lost by the spins and 
transferred in the form of heat to the surroundings (the rigid “lattice” when we talk 
about crystalline solids, but the term has become of widespread use for any kind of 
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sample). The thermal energy involved is too small as to affect the temperature of the 
sample. 
As we mentioned already, the transfer of energy from the spin to the surrounding is not 
spontaneous, but it is mediated by the chaotic tumbling of molecules (reason for which, 
in solid samples, longitudinal relaxation can take up to minutes). Longitudinal relaxation 
only occurs when these molecular motions create a time-dependent magnetic field 
fluctuating around the Larmor frequency. Since 𝑇1 depends on the probability of 
components oscillating at the appropriate frequency, the curves in Figure 1.11 predicts 
how the longitudinal relaxation rate vary with correlation time. In Figure 1.11, 𝜔𝜏  
represents the frequency of spin transition. For a fast tumbling molecule, the spectral 
density would be most likely low (as many rotational frequencies are possible), and the 
relaxation will be slow (point “a” in Figure 1.11). Relaxation can fasten if the distribution 
changes towards a more intermediate motional regime, where the spectral  density at 
𝜔𝜏  would be higher (point “b” in Figure 1.11). The relaxation is again very slow for slow 
motion when the tumbling rate falls below 𝜔𝜏 . The maximum relaxation rate occurs 
when 𝜔0𝜏0 = 1, which corresponds to 𝐽(𝜔0) = 𝜔0
−1.  
1.3.2.3 Transverse relaxation (T2) 
At the same time as the longitudinal z-magnetisation returns to its equilibrium state 
through longitudinal relaxation, a second phenomenon is occurring: the decay of the 
transverse magnetisation to zero. This is brought about by mutual swapping of energy 
between spins, meaning simultaneous transition of one spin from α to β, while another 
spin transits from β to α, what we call a flip-flop process. This process does not 
contribute to restoration of the bulk magnetisation to the z plane, as the overall 
population does not change, but it contributes to the loss of net magnetisation in the 
transverse plane. Just at time zero after the 90° pulse, the bulk magnetisation in the x,y-
plane results from a coherent superposition of magnetic moments. The flip-flop process, 
brought about by the slightly different magnetic field that each spin experiences 
tumbling around, destroys that coherence of the bulk magnetisation, bringing it to zero 
(precessing spins are dephased). This process occurs until equilibrium (x,y magnetisation 
equals zero) is established with a rate characterised by the transverse relaxation time 
constant T2. Dephasing of spins is due then to magnetic field inhomogeneities, which 
are given by two factors: either intrinsic non-uniformity of the sample (un-optimised 
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shimming, turbidity of the sample, imperfection of the glass, etc.), or local magnetic field 
inhomogeneities arising from intra- and intermolecular interactions in the sample. The 
relaxation time constant for these two sources combined is designated 𝑇2*: 
1
𝑇2
∗ = 
1
𝑇2
+ 
1
𝑇2(𝛥𝐵0)
   Equation 1.20 
where 𝑇2 refers to the contribution from local relaxation processes and 𝑇2 (𝛥𝐵0) refers 
to that from field inhomogeneity. 
As when the longitudinal magnetisation is restored there is no transverse magnetisation 
to be destroyed on the x-y plane, it is clear that 𝑇2 can never be longer than 𝑇1 (in fact, 
longitudinal relaxation always contributes to dephasing of the spins in the transverse 
plane, whereas the opposite is not true). While 𝑇1 has a minimum for intermediate 
motion and then increases again for slow tumbling motion, 𝑇2 decreases steadily as the 
correlation time increases, as shown in Figure 1.13. Here, we do not enter the details of 
the effect of 𝑇2 on the width of the peaks (smaller 𝑇2 are associated with broader 
signals), but in Sub-section 1.3.5, we will see more in detail how this effect weights 
differently on protein-based and ligand-based methods for the investigation of 
intermolecular interactions. 
 
Figure 1.13. Motional dependence of longitudinal (𝑇1) and transverse (𝑇2) relaxation times. 
Figure from 54. 
1.3.2.4 Longitudinal cross relaxation  
In the same way as we treated the rate of changes in populations Nα and Nβ to derive 
the rate of longitudinal relaxation 𝑅𝑧  of a single spin returning to equilibrium after an rf 
pulse, we can derive relaxation rates of more complex processes. For instance, a sample 
containing two sets of spins, I and S. They will have between them four energy levels, 
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which can be labelled according to the spin states of the two spins, as shown in Figure 
1.14.  
In such systems, there are six possible pathways for relaxation, when we consider all the 
4 energy levels. 𝑊1
𝐼  and 𝑊1
𝑆  are the four allowed spin transitions that we already 
encountered, and which will be denoted as “single quantum transitions”. Transitions 
between the 𝛼𝛼 and the 𝛽𝛽 states are denoted as 𝑊2
𝐼𝑆  and are “double quantum 
transitions” and 𝑊0
𝐼𝑆  is the “zero quantum transition” going from 𝛼𝛽 to 𝛽𝛼, 
simultaneously. Double and zero quantum transitions are forbidden for nuclei with spin 
½ (in spectroscopy, the selections rules allow only transition with 𝛥𝐼 = 𝐼(𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑠𝑡𝑎𝑡𝑒) −
𝐼(𝑓𝑖𝑛𝑎𝑙 𝑠𝑡𝑎𝑡𝑒) = ±1). 
 
Figure 1.14. The six possible transitions in a two-spin system under the effect of an external 
magnetic field. Figure adapted from 55. 
As we have done before, we can write the rate equation for the flow of population for 
each level (which we now call 𝑁1 to 𝑁4, rather than 𝑁α,β). For level 1, for example, we 
would write: 
𝑑𝑁1
𝑑𝑡
= −𝑊1
𝑆𝑁1− 𝑊1
𝐼𝑁1− 𝑊2
𝐼𝑆𝑁1 + 𝑊1
𝑆𝑁2 + 𝑊1
𝐼𝑁3 + 𝑊2
𝐼𝑆𝑁4  Equation 1.22 
The same equation can be written for the other three energy levels. In the two-spin 
system in analysis, solving the differential equations for the population of each energy 
level as we have done for the longitudinal relaxation of a single spin system in Equation 
1.17 does not give us the required answers. Instead, the use of the product operator 
formalism is required. Although we have not included this approach in this dissertation, 
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we can define the two operators Iz and Sz, which plainly represent the magnetisations 
of spins I and S on the z-axis, respectively, which is what we want to follow from a 
practical point of view. The differential equations solving 𝑑𝐼𝑧/𝑑𝑡 and 𝑑𝑆𝑧/𝑑𝑡 are called 
the Solomon equations. To simplify them, we can write the two Solomon equations of 
main interest for us in the following form: 
𝑑(𝐼𝑧−𝐼𝑧
0 )
𝑑𝑡
= −𝑅𝑧𝐼(𝐼𝑧 − 𝐼𝑧
0) − 𝜎𝐼𝑆 (𝑆𝑧 −𝑆𝑧
0)   Equation 1.23 
𝑑(𝑆𝑧−𝑆𝑧
0 )
𝑑𝑡
= −𝑅𝑧𝑆(𝑆𝑧 − 𝑆𝑧
0) − 𝜎𝐼𝑆 (𝐼𝑧 − 𝐼𝑧
0)   Equation 1.24 
The combined rate constants are defined as: 
𝑅𝑧𝐼 = 𝑊0
𝐼𝑆 + 2𝑊1
𝐼 + 𝑊2
𝐼𝑆    Equation 1.25 
𝑅𝑧𝑆 = 𝑊0
𝐼𝑆 + 2𝑊1
𝑆 + 𝑊2
𝐼𝑆   Equation 1.26 
𝜎𝐼𝑆 = 𝑊2
𝐼𝑆 −𝑊0
𝐼𝑆    Equation 1.27 
where 𝑅𝑧𝐼 and 𝑅𝑧𝑆 are the auto-relaxation (longitudinal relaxation) rate constants, 
and 𝜎𝐼𝑆 is the rate at which the magnetisation is transferred from spin to spin by 
relaxation processes and is termed longitudinal cross relaxation rate constant. The main 
results springing from the Solomon equations is the definition of the concept of cross 
relaxation itself, showing that in a two-spin system the rate of recovery of I and S 
depends on each other (if the cross relaxation is not null). 
The corresponding transition probabilities are: 
𝑊1
𝑆 = 
3
40
𝑏2𝑗(𝜔0𝑆)   Equation 1.28 
𝑊1
𝐼 = 
3
40
𝑏2𝑗(𝜔0𝐼)    Equation 1.29 
𝑊0
𝐼𝑆 = 
1
20
𝑏2𝑗(𝜔0𝐼 − 𝜔0𝑆 ) =
1
20
𝑏2𝑗(0)   Equation 1.30 
𝑊2
𝐼𝑆 = 
3
10
𝑏2𝑗(𝜔0𝐼 + 𝜔0𝑆 ) =
3
10
𝑏2𝑗(2𝜔0𝐼)   Equation 1.31 
Where 𝑏 is the dipolar constant:  
𝑏 =
𝜇0  𝛾𝐼 𝛾𝑆 ℏ
4𝜋𝑟3
   Equation 1.32 
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with 𝛾 being the gyromagnetic ratio, 𝜇0 is the permeability of vacuum and 𝑟 is the inter-
nuclear distance. We assumed that the spins of interest are of the same type (e.g., 1H), 
with comparable Larmor frequencies. Hence, homonuclear cross relaxation in Equation 
1.27 can be re-written as: 
𝜎𝐼𝑆 = 𝑊2
𝐼𝑆 − 𝑊0
𝐼𝑆 =
3
10
𝑏2𝑗(2𝜔0𝐼) −
1
20
𝑏2𝑗(0)   Equation 1.33 
Since double and zero quantum transitions are not allowed by the conventional 
selection rules, these are not observable, but they can strongly influence the observable 
NMR intensities associated to the transitions of the spins involved in the process of cross 
relaxation. In the following sub-section, we will analyse the importance of cross 
relaxation in two-spin system with different motional regimes and understand its 
relationship with the Nuclear Overhauser Effect. 
1.3.3 Nuclear Overhauser Effect (NOE): from Steady state NOE to Transient NOE54,55,56 
The nuclear Overhauser effect (NOE) itself is a manifestation of cross relaxation, 
stimulated by dipolar coupling. If we imagine a little magnetic field associated to each 
nucleus in the sample, it is easy to imagine that the nuclei will affect each other, each 
generating its own field and sensing the others. The prerogative for cross relaxation to 
take place (so for 𝜎𝐼𝑆  to be non-zero), is that the set of nuclei I and S are close to each 
other, as from the previous equations we have seen that 𝜎𝐼𝑆  is inversely proportional to 
the sixth power of the distance between the nuclei. The NOE’s dependence on the 
distance between sets of nuclei is what makes this technique essential in structural 
studies, as we will show. 
1.3.3.1 NOE enhancement in the slow and fast motion regime 
In the two-spin homo-nuclear system which we are considering, we can envisage the 
situation in which we apply a continuous selective rf pulse on a frequency corresponding 
to the single transition of one of the nuclei (say S), saturating the populations across 
energy levels 1-2 and 3-4 in Figure 1.14. In this new condition, the allowed relaxation 
pathways are 𝑊2
𝐼𝑆  and 𝑊0
𝐼𝑆 , as the single quantum transitions of spin S are saturated 
(Figure 1.15). 𝑊2
𝐼𝑆  and 𝑊0
𝐼𝑆  are not single quantum transitions, so that they cannot be 
detected, but their effects are observable on the signals of spin I in a 1H 1D spectrum 
acquired under the selective saturation of spin S.  
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Figure 1.15. Energy levels for a two-spin system upon saturation of spin S. Figure adapted from 
55. 
This results from a change in the spin I magnetisation that will manifest as a modification 
of the NMR signal intensity of I. This modification resulting from selective saturation of 
the spin S transitions is termed NOE enhancement (Figure 1.16).  
 
Figure 1.16. Examples of the effects of cross relaxation on 1D 1H NMR spectra of spins I and S 
(a) upon selective saturation of spin S. When spin S is irradiated (b), the S populations are 
equalised, and we do not observe any signal (in the irradiated spectrum the situation after 
instantaneous saturation is depicted). If cross relaxation between S and I is taking place, the 
peak intensity of spin I is affected. When relaxation takes place via 𝑊2 processes, a positive 
enhancement is observed (c); when relaxation takes place via 𝑊0 processes, a negative 
enhancement is observed (d). Figure adapted from 54. 
When spin S is irradiated, the S populations are equalised, and we do not observe any 
signal for that spin. At the same time, the peak intensity of spin I is affected due to cross 
relaxation with spin S. When cross relaxation takes place preferentially via 𝑊2  processes, 
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a positive enhancement is observed; in contrast, if the dominant mechanism for cross 
relaxation involves 𝑊0  processes, a negative enhancement is observed (Figure 1.16c,d). 
The NOE enhancement is indicated as 𝜂, and its sign and magnitude are proportional to 
the cross relaxation rate 𝜎𝐼𝑆 : 
𝜂 ∝ 𝜎𝐼𝑆 =  𝑊2
𝐼𝑆 −𝑊0
𝐼𝑆   Equation 1.34 
The magnitude of the NOE on spin I varies according to how the NOE experiment is 
performed (and it can depend on other variables), but the sign of the enhancement will 
be dictated by which process is more favourable between 𝑊2
𝐼𝑆  and 𝑊0
𝐼𝑆 , for the system 
in analysis. 
We have already introduced the definition for fast motion or extreme narrowing limit, 
defined as 𝜔0𝜏𝑐 ≪ 1 and characterised by very short correlation times; and the slow 
motion or spin diffusion limit, when 𝜔0𝜏𝑐 ≫ 1 and characterised by very large 
correlation times.  
Thus, in the extreme narrowing limit, 
𝑗(2𝜔0) =  2𝜏𝑐 =  𝑗(0)    Equation 1.35 
and Equation 1.33 simplifies to  
𝜎𝐼𝑆 =
1
2
𝑏2𝜏𝑐    Equation 1.36 
Under this condition, the sign of 𝜎𝐼𝑆  is positive since 𝑊2𝐼𝑆 >𝑊0𝐼𝑆 , resulting in a positive 
NOE enhancement. 
In the spin diffusion limit, 
𝑗(2𝜔0) =  
2
𝜔0
2𝜏𝑐
= 
𝑗(0)
𝜔0
2𝜏𝑐
2    Equation 1.37 
and Equation 1.33 simplifies to  
𝜎𝐼𝑆 = −
1
10
𝑏2𝜏𝑐    Equation 1.38 
as 𝑗(2𝜔0) is negligible relative to 𝑗(0). Under this condition, the sign of 𝜎𝐼𝑆  is negative 
since 𝜏𝑐 > 0, resulting in a negative NOE enhancement.  
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In concluding this discussion, it is important to stress that if 𝑟 is too large (usually above 
5 Å), 𝑏 will tend to 0,  𝜎𝐼𝑆  will be null and there will not be NOE effect whatsoever. That 
is, in essence, the relevance of NOE experiments for determination of 3D structures of 
molecules: it is observable only for short spin-spin distances, reporting through-space 
connectivity associated to the 3D architecture of the molecule. 
1.3.3.2 Steady state NOE 
The experiment schematised in Figure 1.16, in which spin S was saturated selectively by 
a weak continuous wave (CW) rf irradiation, is called “steady state” NOE (ss -NOE). We 
define a long low power continuous wave rf as a “saturating pulse”, which ensures full 
saturation of the populations of spin S, and hence results in the disappearance of the 
peak corresponding to S, and in an enhancement in the peak corresponding to I, 
proportional to 𝜎𝐼𝑆 .  
The pulse sequence to perform this experiment is shown in Figure 1.17: in a first 
experiment, a continuous wave is on spin S for a time long enough to allow 
homogeneous saturation across the sample (long rectangle in Figure 1.17); as soon as 
the CW is switched off, a hard 90° pulse is given (short and tall rectangle in Figure 1.17), 
and acquisition follows. 
 
Figure 1.17. Pulse sequence for steady state (SS) NOE experiments. The saturation on spin S is 
obtained using a continuous wave rf irradiation, immediately followed by a hard 90 ° pulse and 
acquisition. The reference spectrum, in which the intensities are unperturbed, is a simple pulse-
acquisition experiment. The difference spectrum is obtained by subtraction of the saturated 
spectrum from the reference spectrum. Figure adapted from 55. 
Treating this with the product operator formalism, 𝑆𝑧 = 0, i.e. the steady state has been 
reached as an effect of the CW (when this is on for long enough). This means that 𝐼𝑧  is 
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not changing either (𝑑𝐼𝑧/𝑑𝑡 = 0). Including these two conditions, we can rewrite 
Equation 1.23 as it follows: 
𝑑(𝐼𝑧−𝐼𝑧
0 )
𝑑𝑡
|
𝑆𝑆
= −𝑅𝑧𝐼(𝐼𝑧,𝑆𝑆 − 𝐼𝑧
0) − 𝜎𝐼𝑆  (0 − 𝑆𝑧
0) = 0   Equation 1.39 
therefore: 
𝐼𝑧,𝑆𝑆 = 
𝜎𝐼𝑆
𝑅𝑧𝐼
𝑆𝑧
0 + 𝐼𝑧
0   Equation 1.40 
Hence, the enhancement 𝜂 is given by: 
𝜂𝑆𝑆 = 
𝐼𝑧,𝑆𝑆−𝐼𝑧,𝑟𝑒𝑓
𝐼𝑧,𝑟𝑒𝑓
=  
𝜎𝐼𝑆
𝑅𝑧𝐼
𝑆𝑧
0
𝐼𝑧
0    Equation 1.41 
where 𝐼𝑧,𝑟𝑒𝑓  is the magnetisation of spin I in the reference spectrum. The element to 
stress here is that the enhancement on spin I, when spin S is saturated to the steady 
state, does not only depend on 𝜎𝐼𝑆  alone, but the longitudinal relaxation of I itself, 𝑅𝑧𝐼, 
plays a role too.  
1.3.3.3 Transient NOE  
Equation 1.41 implies that the enhancement measured on spin I, in a steady state 
experiment saturating spin S, is not only proportional to 𝑟𝐼𝑆
−6, so it can only give a 
qualitative measure of the distances. This is not the case for the transient NOE 
experiment, which relies on a shaped and selective 180° pulse on S to invert its 
population (rather than equalising it).  
The pulse sequence to perform this experiment is shown in Figure 1.18. Again, in the 
first experiment, inversion of population is achieved by a shaped short pulse; a mixing 
time, 𝜏𝑚 , is then allowed for the magnetisation to evolve, before a hard 90° pulse is 
given, and acquisition follows. 
This means that, after the pulse (time 0), 𝐼𝑧(0) = 𝐼𝑧
0 and 𝑆𝑧 (0) = −𝑆𝑧
0. Dealing with a 
transient process means that in this case the differential equations for 𝑑𝐼𝑧/𝑑𝑡 and 
𝑑𝑆𝑧/𝑑𝑡 must be solved. If we want to know what happens to spin I when the population 
on spin S is inverted, we must solve Equation 1.23 again: 
𝑑𝐼𝑧
𝑑𝑡
= −𝑅𝑧𝐼(𝐼𝑧(𝑡) − 𝐼𝑧
0) − 𝜎𝐼𝑆  (𝑆𝑧(𝑡) − 𝑆𝑧
0)   Equation 1.42 
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where the dependence of the magnetisation of both spins with the time has been 
highlighted, as we are dealing with a transient phenomenon. In the initial rate 
approximation (in the first instance after the shaped pulse, i.e., for very short mixing 
times), we can re-write: 
𝑑𝐼𝑧
𝑑𝑡
|
𝑖𝑛𝑖𝑡
= −𝑅𝑧𝐼(𝐼𝑧
0 − 𝐼𝑧
0) − 𝜎𝐼𝑆  (−𝑆𝑧
0− 𝑆𝑧
0) =  2𝜎𝐼𝑆𝑆𝑧
0
  Equation 1.43 
 
Figure 1.18. Pulse sequence for transient NOE experiments. The inversion on spin S is obtained 
using a shaped 180° pulse, followed by a mixing time, 𝜏𝑚, a hard 90° pulse and acquisition. The 
reference spectrum, in which the intensities are unperturbed, i s a simple pulse-acquisition 
experiment. Figure adapted from 55. 
It is easy to integrate this equation for the length of the mixing time (that is from time 0 
to 𝜏𝑚 ), to find that: 
𝐼𝑧(𝜏𝑚) = 2𝜎𝐼𝑆𝜏𝑚𝑆𝑧
0 + 𝐼𝑧
0
   Equation 1.44 
where the NOE enhancement is given by: 
𝜂(𝜏𝑚) = 
𝐼𝑧(𝜏𝑚)−𝐼𝑧,𝑟𝑒𝑓
𝐼𝑧,𝑟𝑒𝑓
=  
2𝜎𝐼𝑆 𝜏𝑚𝑆𝑧
0
𝐼𝑧
0    Equation 1.45 
Unlike the steady state experiment, the behaviour of spin I does not depend on its 
longitudinal relaxation properties, but only on the cross relaxation rate and on the 
mixing time, which we can set experimentally. This make transient NOE an excellent tool 
for correlating NOE enhancements coming from transient NOE experiments with inter-
nuclear distances between the two spins based on the inverse proportionality of 𝜎𝐼𝑆  and 
𝑟𝐼𝑆
6 . 
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1.3.3.4 Truncated driven NOE (TOE) 
If we apply short shaped selective pulses in a train, increasing the overall length of the 
irradiation period, we can measure the rate at which the steady state is reached; but in 
the first points of this experiment we are still in transient NOE condition. We call this 
approach the truncated driven NOE, abbreviated to TOE. As we will see in more detail  
in Chapter 2, Section 2.1, TOE is the key element for Saturation Transfer Difference NMR 
(STD NMR), which relies on saturation on the nuclei of a large molecule receptor 
(generally a protein) leading to intermolecular NOEs with the closest nuclei of the l igand. 
Whereas the NOE enhancement at the steady state is strongly dependent on the 
relaxation properties of the nuclei (in this case the ligand nuclei, which is what we 
observe), the rate at which the steady state is reached is affected by inter-nuclear 
distances. Before entering into the details concerning STD NMR, which is the core 
technique of the different systems studied in this thesis, in the following sub-section, 
we will introduce the concept of spin diffusion and give a brief overview on the wide 
range of NOE- or relaxation-based methods to study intermolecular interactions by 
NMR. 
1.3.4 NOE in multi-spin systems: spin diffusion54,56 
NOE is a direct consequence of the contributions to relaxation of the double- and zero-
quantum transitions (𝑊2
𝐼𝑆  and 𝑊0
𝐼𝑆 ) processes, while any mechanism inducing single 
quantum transitions (𝑊1s broadly) can be considered as a competing mechanism 
reducing the observed NOE enhancement. The discussion so far has covered the 
relaxation effects in one- and two-spin systems. It goes without saying that real systems 
are never so simple, and many are the factors influencing the longitudinal relaxation 
behaviour of a molecule in a complex system. This goes from the small contribution of 
other relaxation effects (chemical shift anisotropy, quadrupolar interactions, etc.), to 
the presence of paramagnetic species in solution, such as dissolved O 2. We group 
together all these terms and call them 𝜌𝐼
∗, or the “leakage” of the system. 
𝜌𝐼
∗ is not the only factor which can affect the detection of NOE enhancement, and a key 
role is played be the relayed-NOE: the so-called spin diffusion. This arises from the 
presence of nuclei N, neighbouring S and I, and themselves in position to cross-relax 
with S and I, with the ultimate effect of diluting the NOE.  
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Mathematically, the NOE enhancement on I, upon irradiation of S, is affected by the 
presence of a third set of nuclei N in the following way: 
𝜂𝐼{𝑆} = 𝜂𝐼,𝑚𝑎𝑥  
𝑟𝐼𝑆
−6
𝑟𝐼𝑆
−6+𝑟𝐼𝑁
−6   Equation 1.46 
Therefore, the closest N is to I, the least is the chance to measure distances accurately. 
But diluting the NOE enhancement is not the only thing that a neighbouring nucleus can 
do; in fact, if N is close enough to I, it can even sense the effect of the irradiation on S 
through I. This is what we call a relayed-NOE. For small molecules, for which direct NOE 
is positive (SI), the relayed NOE (IN), is negative. This is because a decrease in the 
population difference of I from the NOE between S and I results in an increase of the 
difference in population between I and N. If the direct effect is positive, the indirect 
effect will be, in turn, negative. The same is not true for large molecules, for which both 
the direct and the indirect NOE are negative. Therefore, the presence of relayed NOE in 
the structural study of fast tumbling molecule is not a dramatic problem, as the negative 
sign of the relayed NOEs makes it easier to distinguish direct effect from indirect effects. 
For slow tumbling molecules, the problem is more conspicuous, as both direct and 
indirect effects exhibit a negative enhancement. Additionally, for larger, slow tumbling 
molecules the NOE grows more rapidly because of the long correlation time (the same 
reason why the NOE for large molecules are larger in absolute values than the NOE for 
small molecules). In such systems, extended saturation times selective to one spin can 
end up being spread throughout the (large) molecule until all the nuclei experience 
roughly the same saturation level. This extreme manifestation of relayed-NOE is called 
spin diffusion (noticeably, the limit of slow tumbling is also referred to as spin diffusion 
limit). In fact, this terminology has been extended to indirect NOE in general, whereas 
its use in general contexts is controversial.   
1.3.5 NMR approaches to investigate intermolecular interactions 
The NMR techniques to study intermolecular interactions divide into i) ligand-based, 
whether we put ourselves in the conditions of observing the response of a small 
molecule in the presence of its receptor; or ii) receptor-based techniques, observing the 
receptor itself. The two are schematised in Figure 1.19. 
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Figure 1.19. Cartoon schematising the two approaches to receptor ligand interactions: ligand-
based and receptor-based point of view. 
1.3.5.1 Ligand-based methods for intermolecular interactions investigation57 
Ligand-based NMR methods imply observing intermolecular systems composed of a 
small molecule binding to a much larger receptor, which we monitor through NMR 
experiments focusing only on the signals from the small molecule (in the free state). 
These ligands are characterized by large relaxation time constants 𝑇1 and 𝑇2, vanishing 
or weakly positive NOE enhancements (short correlation times), and large translational 
diffusion coefficients. Bound compounds share the NMR relaxation properties of the 
receptor, and have short 𝑇2, large and negative NOE enhancements with efficient spin-
diffusion, and slower molecular diffusion. These significant differences make possible 
the detection of the interactions, as, when bound, the ligand will transiently assume the 
properties of the receptor, and it will behave differently in the free and the bound state. 
For the kinetics reasons which we have seen in Sub-section 1.2.3, large excess of ligand 
over the receptor is required for saturating the binding site of the protein receptor when 
dealing with weak binders ([𝐿]𝑇 ≫ [𝑃]𝑇  and [𝐿]𝑇≫ 𝐾𝐷). In these conditions, though, 
𝑓𝐹
𝐿 ≫ 𝑓𝐵
𝐿. For this reason, in ligand-based techniques, the difference in the property 
under observation between the free and the bound state, which we generally call 𝑄𝐹  
and 𝑄𝐵  should be such that 𝑓𝐵
𝐿Q𝐵  is significant relative to 𝑓𝐹
𝐿Q𝐹. One advantage of this 
is the fact that in a sample containing ligand in large excess to the receptor, the signals 
of the small molecules will be predominant, and the protein envelope will be on the 
baseline. 
The plainest example of how the properties of the receptor can be transferred to the 
ligand and detected in a 1D 1H NMR spectrum is the 𝑇2 broadening experiment. Short 
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𝑇2 is associated to broad signals, whereas long 𝑇2 is associated to sharp signals. In a 
solution containing a large receptor with two molecules, say one binder and one non-
binder, conditions can be optimised to determine, just from the simple 1D 1H NMR 
spectrum which of the two molecules is the ligand, as only its signals will transiently be 
affected by a 𝑇2 typical of the large receptor and will be much broader than the signals 
of the molecule which does not interact with the receptor (Figure 1.20a). 
The same mechanism can be exploited in a more elegant way applying the Carr-Purcell-
Meiboom-Gill sequence (CPMG), also called 𝑇2-filter experiment. This relies on the 
repetition of spin-echo building blocks, applied after the usual 90° pulse. The spin-echo 
building block consists of a 180° pulse, anticipated and followed by a fixed interval τ. As 
we know, the 180° pulse inverts the spin populations, therefore the x,y-magnetisations 
which were defocused according to their different chemical shifts during the first period 
τ, will be inverted and then refocused after the second interval τ. This will only be true 
for the magnetisation which has not been lost already by loss of coherence in the x-y 
plane due to intrinsic transverse relaxation (𝑇2). Hence, in a CPMG experiment, after 
several spin-echo building blocks, the transverse magnetisation of molecules with short 
T2 will quickly disappear, whereas that from molecules with long  𝑇2 will survive. This is 
very useful for removing the interfering signals of proteins in samples to study protein -
small molecule interactions, clearing up the spectra of the large molecule, and showing 
only the small molecule signals (this is called a 𝑇2-filter). But, what is more relevant, it 
can be applied to detect protein-ligand binding. Thus, applying a CPMG sequence to the 
one-receptor-and-two-ligand system described before, only the signal of the non-binder 
will survive the spin-echo loop, while the signals of the molecules interacting with the 
protein will disappear completely (as well as any visible protein signal)58. 
Introducing a paramagnetic element in the protein-ligand system and inducing 
paramagnetic relaxation is another possibility to detect intermolecular interactions. The 
transverse relaxation rate constants, R2, are proportional to the product of the squares 
of gyromagnetic ratios of the two interacting spins. Considering that the electron 
gyromagnetic ratio is 658 times higher than that of the proton, the presence of one 
unpaired electron in one molecule, will induce a relaxation effect onto a nearby proton 
significantly more efficient than other proton located at that position. A first approach 
to study intermolecular interactions is to employ a first ligand of the receptor carrying a 
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“spin label”, i.e., a functional chemical group containing an unpaired electron (e.g., the 
radical TEMPO). We then study the interactions of secondary ligands binding in an 
adjacent binding pocket, in the presence of saturating amounts of the first spin-labelled 
ligand. The unpaired electron will act as a transverse magnetization sink for all molecules 
that bind in the secondary binding site, an effect that will strongly depend on the 
distance between the adjacent site and the spin-label of the first ligand. If we carry out 
𝑇2-filter experiments on this system, the ligand signals will be dramatically reduced due 
to the 𝑅2 relaxation enhanced by the presence of the spin-label
59. 
The CPMG and the paramagnetic relaxation experiments, together with 19F relaxation 
experiments for fluorinated compounds, are quick methods relying on the large 
difference between the relaxation properties of the large and the small molecule to 
detect binding. In drug discovery, these are routinely used to screen large libraries 
obtaining an immediate answer about the potential to bind.  
 
Figure 1.20. Cartoon representation of (a) the 𝑇2-filter experiment and (b) the WaterLOGSY 
experiment in the situation where multiple fragments (represented by geometric 
shapes) and one receptor (represented by a yellow oval) are in solution. The schematic 
representation of the appearance of the spectra in the presence and the absence of the 
receptor is shown below each experiment. Figure from 60. 
Another very widespread technique in pharmaceutical research is WaterLOGSY, which 
relies on the transfer of magnetisation by intermolecular NOE between the ligand and 
the bulk or bound water. This experiment can be considered as a variant of the STD NMR 
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experiment, in which we employ the water molecules present at the receptor-ligand 
interface to produce the perturbation in the magnetization of the protein and eventually 
of the ligand protons.20 These water molecules show characteristic features of large-
sized molecules, as they are bound to the macromolecular receptor, and hence give rise 
to strong negative NOEs with both the protons at the surface of the protein and the 
ligand protons in the bound state. In contrast, water molecules in the solvation shell of 
the ligand in the free state show characteristic features of small or medium-sized 
molecules (small 𝜏𝐶) and hence give rise to small positive NOEs with the ligand protons. 
In practice, we use steady state NOE-like pulse sequences in which we selectively 
saturate the water signal (light water must then be used). In this experiment, the ligand 
signals are affected by strong negative NOEs with both, water and receptor protons, and 
hence have opposite sign to the signals of the non-binding molecules in the sample 
(Figure 1.20b)61.  
The ligand-based methods described so far, albeit reliable and very easy to run, cannot 
give any information on the binding mode of the potential ligands. We have to resort to 
STD NMR and transfer-NOESY (tr-NOESY) to know more on the epitope of binding of a 
small molecule and on its bound conformation, respectively. Being the studies proposed 
in this thesis strictly structural, STD NMR and tr-NOESY are the key techniques used, 
therefore Section 2.1 of Chapter 2 will be devoted to them.  
1.3.5.2 Receptor-based methods for intermolecular interactions investigation62 
Ligand-based techniques have on their side the ease of employment, the lack of upper 
limit in the size of the receptor, and the fact that no previous information on the 
receptor is required upon analysis (no need of assignment and therefore no need of 
isotopic labelling). 
In turn, this means that it is not possible to know what is going on at the receptor level 
and to establish directly the location of binding on the surface of the receptor 
(competition experiments are required). Also, interactions with slow kinetics (strong 
affinity) are hard to detect with ligand-based methods, and small receptors do not 
guarantee reliable results. 
Therefore, receptor-based methods are highly complementary and can answer many 
questions that ligand-based methods cannot. To this purpose, the chemical shift 
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assignment of the protein is almost always required. Protein assignment requires 13C 
and/or 15N isotopic labelling (as well as 2H in some cases) and poses an upper limit on 
the size of the protein (fast transverse relaxation precludes detection of signals from 
very large proteins). Additionally, for large proteins, signal overlapping becomes too 
conspicuous for the protein to be resolved. In this regard, advanced multi-dimensional 
experiments, together with powerful non-uniform sampling techniques, which help 
reducing the experimental times, and higher magnetic fields are pushing this limit higher 
and higher. 
Once the chemical shifts of each residue (or most of them) are known, and the structure 
of the protein is determined, changes in chemical shifts of the amide protons of the 
receptor can be easily followed upon ligand addition (e.g. in a titration experiment) by 
carrying out simple 1H,15N-HSQC experiments. This technique is called chemical shift 
perturbation (Figure 1.21) and allows to identify the binding site and/or any allosteric 
effect, if present.  
 
Figure 1.21. General example of a CSP experiment. (a) Detail of a 1H-15N HSQC experiment 
showing significant variations of peak positions after successive additions of the ligand. (b) Map 
of the residues that determine the interaction interface (amino acids suffering large 
perturbations in chemical shifts).  Figure from 63. 
For protein-protein complexes, a selective subunit isotopic labelling can be used to 
remove the signals of the non-isotopically enriched subunits from the spectra, and again 
follow the chemical shift perturbation of the non-deuterated protein during the 
interaction. For high molecular weight proteins, the non-labelled protein can be per-
deuterated (i.e., all the the non-labile 1H spins are substituted by 2H spins), to reduce 
the broadening of the labelled protein under observation. A more efficient methodology 
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consists in selectively introducing protons in a per-deuterated protein. Particularly 
effective is the introduction of protonated methyl groups. Very recently, there has been 
an increased interest in 13C direct observation NMR methods, allowing the development 
of new schemes for specific 13C labelling, allowing selective visualisation of given 
residues in the protein. 
Other methods to characterise the interfaces between species are: intermolecular, 
inter-subunit or inter-domain NOEs and paramagnetic relaxation enhancements (PREs). 
Subsequently, distances and relative orientations of the subunits can be restrained by 
using NOEs, residual dipolar couplings (RDCs), and pseudo-contact chemical shifts 
(PCSs). 
1.4 Motivation and objectives of this thesis 
1.4.1 Why high-field NMR in combination to computational tools is an ideal tool for 
protein-carbohydrate investigation 
In the previous sections we have set the theoretical framework of this thesis, introducing 
the world of glycobiology and intermolecular interactions, on one hand, and the field of 
Nuclear Magnetic Resonance, with an eye on the phenomenon of NOE and its extensive 
application in structural studies, on the other hand.  
Before stating the aims of the current work, it is worth emphasising the vast potential 
of NMR to study biologically relevant protein-ligand interactions. More than any other 
class of ligands, carbohydrates are complex and flexible entities with a high degree of 
stereochemistry which make them interesting subjects for NMR observation. 
Nevertheless, the chemical similarity of carbohydrate monomers, and of the protons  
within each ring, poses the problem of chemical shift overlapping: the proton chemical 
shift dispersion of carbohydrates is generally low, with chemical shifts concentrated 
between 3.2 ppm and 4.1 ppm for the ring protons H2 to H6, and between 4.4 ppm and 
5.2 ppm for the anomeric ones64. Thus, to study carbohydrates at atomic detail, high-
field spectrometers are necessary. The 800 MHz Bruker spectrometer available at the 
School of Pharmacy at UEA is an optimal tool to investigate the protein-carbohydrate 
interactions.  
A proficient level of expertise in the field of computational analysis is also required to 
model the 3D structure of the interactions in solution, on the bases of the structural 
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experimental data. Molecular docking is a good starting point for providing 3D models 
for protein-ligand interactions and the suite Maestro Schrodinger has been reported to 
be the most efficient tool to model flexible carbohydrates in relatively shallow binding 
pockets65 (still, Molecular Dynamics is always the method of choice to account for the 
full flexibility of the system). As we will see in the following chapter, validation of STD 
NMR data against the simulated 3D models is necessary, and the best available tool for 
this is a program called CORCEMA-ST (COmplete Relaxation and Conformational 
Exchange Matrix for Saturation Transfer), a MatLab code released in 2002 by the group 
of Rama Krishna66. 
In our research group, the coexistence of these three fields of expertise, the availability 
of the 800 MHz Bruker spectrometer and the Maestro suite, as well as the expertise in 
the use of the CORCEMA-ST script (under licence) provided the perfect environment for 
undertaking the development of novel STD NMR approaches for the structural 
investigation of a number of biologically relevant protein-carbohydrate interactions at 
atomic detail.  
In this environment and over the three years of this doctoral project, it has been very 
frequent to be in touch with research groups inside and outside the UK and to take small 
or large part into several collaborations. Only the two biggest (and most successful) 
works of biological relevance are included in this thesis: namely, a drug discovery project 
on the structural study of cholera toxin inhibitors; and the fundamental structural 
investigation of an intramolecular trans-sialidase from the gut microbiota. Still, the fact 
that many other side projects kept coming and going was an exceptional training and 
inspiration. This allowed us to study and observe many different biological systems from 
any natural kingdom, what constantly encouraged us to experiment further. 
1.4.2 Our initial intentions of novel STD NMR methodology development 
Investigating such a wide range of protein-ligand interactions was a strong stimulus to 
experiment with STD NMR, as we were pushed to tailor the technique to the features of 
every different system.  
The initial aim of the present thesis was to expand the potential of Saturation Transfer 
Difference NMR, exploiting some novel conceptual ideas. 
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Specifically, we wanted to answer the following questions:   
1. It was known that different irradiation frequencies slightly affect the outcome of 
the STD NMR results. Can these differences be exploited? Can the 
inhomogeneity of spin diffusion help tracking the different pathways for direct 
and indirect saturation transfer, to get information on the architecture of the 
binding pocket? 
2. Does the presence of protons from water affect the saturation transfer from the 
polar residues containing exchangeable protons?  
3. Can we extract further information from STD NMR experiments with direct 
irradiation on the proton frequencies of the ligand? Can we observe 
intramolecular NOEs across the bound ligand on STD NMR experiments? Can we 
observe inter-ligand NOEs on STD NMR experiments, in a system containing two 
ligands bound to adjacent subsites? 
4. In the case of positively answering those questions, can we provide a 
standardised protocol for the scientific community to implement our findings in 
their research? 
The answers to these questions are reported in Chapter 3. 
1.4.3 Cholera toxin inhibition: investigation of a novel class of GM1 antagonists 
The first of the biological investigations undertaken involved the structural elucidation 
of the binding of a promising lead and its fragments to the GM1 binding subsite of the 
Cholera Toxin subunit B (CTB), coming from the research group of Inmaculada Robina 
(University of Seville). 
In the wake of a long history of drug discovery studies aimed at designing GM1 
antagonist to serve as CTB inhibitors and prevent the onset of the cholera infection, the 
particularity of the CTB binders investigated by us was their limited carbohydrate 
nature, making them more “drug-like” than many of the ligands proposed before.  
Namely, the main lead was based on a scaffold containing a thio-galactose and a 
polyhydroxyalkylfuroate-aromatic moiety, designed to bind in the GM1 binding pocket, 
to the two well-characterised galactose and sialic acid subsites, respectively. In a 
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previous work, on the bases of the STD NMR binding epitopes of the three ligands, a 
qualitative bidentate binding mode was postulated67.  
Hence, the main question we wanted to answer was: 
1. Can we determine the binding mode of the main lead and its fragments, 
quantitatively? Does the binding actually involve the two known binding 
subsites? 
Our finding that the polyhydroxy moiety did not occupy the sialic acid binding subsite, 
but a novel groove adjacent to it, opened new questions: 
2. Do the sialic acid and the novel sub-sites exclude each other, or do they coexist? 
Can they both be occupied at the same time? 
3. Where is the source of the specificity of the novel class of ligands (the 
polyhydroxyalkylfuroate binding to the novel binding sub-site or the galactose 
binding to the galactose subsite)? 
4. What is the impact of structural variations of the scaffold on the affinity of 
binding? How can penalties associated to the flexibility of the polyhydroxy chain 
be reduced? 
The answers to these questions are reported in Chapter 4. 
1.4.4 Investigating the specificity of an IT-sialidase from gut microbiota: structural study 
on the binding mode of syaloglycans 
The research group of Nathalie Juge at the Quadram Institute of Biotechnology is 
strongly focused on the investigation of the gut symbiont Ruminococcus gnavus (R. 
gnavus), a mucin degrader with the ability of binding, hydrolysing and metabolising the 
sialic acid capping the glycans exposed on the mucus. The recently discovered link 
between R. gnavus and the inflammatory bowel disease brought renewed attention to 
this organism68. 
In particular, we have studied a sialidase from R. gnavus, RgNanH. The enzyme consists 
of i) a carbohydrate binding module recognising sialic acid (CBM40), and ii) an 
enzymatically active domain (GH33), which converts the α2/3 sialic acid domain capping 
59 | P a g e  
 
the mucins into a tricyclic derivative of sialic acid itself: 2,7-anhydro-Neu5Ac. For this 
feature of its enzymatic domain, RgNanH is defined as an intramolecular trans-sialidase 
(IT-sialidase), a class of enzymes currently containing three members in total.  
We undertook two sub-projects, focusing on the enzymatic domain and on the 
carbohydrate binding module, with the aim of investigating the domains in terms of 
affinity, specificity and mechanism of recognition towards a library of α2/3 and α2/6 
sialoglycans.  
For GH33, our target questions were: 
1. Which are the main elements of the ligands for molecular recognition? 
2. Does GH33 select α2/3 sialoglygans over α2/6 s sialoglygans? 
The finding that GH33 binds to both 3’-sialyllactose (3’SL) and 6’-sialyllactose (6’SL), 
despite the fact that only 3’SL is the hydrolysable substrate, opened more questions: 
3. Do 3’SL and 6’SL bind to the same subsite? Which are their relative affinities? 
4. What is the 3D structure of the complexes? 
5. Which are the key elements of the interactions? 
6. How to explain the specificity of the reaction for α2/3 sugars? 
7. How to explain the prevalence of the intramolecular trans-reaction over the 
intermolecular trans-reaction? 
For CBM40, our target questions were: 
1. Which are the main elements of the ligands for molecular recognition? 
2. Which is the minimum sugar entity recognised by CBM40? 
3. What is the selectivity of CBM40 towards sialoglycan linkages? 
4. How do sugar decorations (e.g., the presence of a glycolylic group in the place 
of the acetamide group on the sialic acid, the N-acetylation of the galactose and 
glucose moieties) affect the binding? 
The answers to these questions are reported in Chapter 5. 
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Chapter 2 
Techniques and tools 
2.1 Saturation Transfer Difference NMR and Exchange-transferred-NOE 
2.1.1 Effect of chemical exchange on chemical shift54 
Rarely, if ever, we can consider the system in our samples static from an NMR point of 
view.  Some phenomena, such as the internal bond vibrations for the molecules in our 
tube (in the frequency range of 1013-1014 Hz), are too fast to be noticeable in the NMR 
time scale. Still, many interesting dynamic processes are in a suitable time scale for NMR 
observation in the frequency range between 10 and 1010 Hz69 and we call them chemical 
exchange processes. These include restricted bond rotation, group interconversion or 
tautomerism, as examples of intramolecular processes of great interest for organic and 
structural chemists. In our spotlight are the intermolecular chemical exchange processes 
involving ligand-protein binding events.  
Any process of chemical exchange can be written as an equilibrium between two  states 
𝐴 and 𝐵:  
 
As already mentioned in Chapter 1, Sub-section 1.2.3, the biomolecular association in 
solution between a protein (𝑃) and a ligand (𝐿) to form a protein-ligand complex (𝑃𝐿) 
can be written as: 
 
In the context of ligand-based NMR techniques in which we have framed our work, we 
can formalise the chemical exchange process as: 
 
Where 𝐿𝐹  and 𝐿𝐵are the free and bound ligand, respectively. 
𝐴 𝐵 
𝑘𝑒𝑥 
𝑘𝑒𝑥 
𝑃 +  𝐿 𝑃𝐿 
𝑘𝑜𝑛 
𝑘𝑜𝑓𝑓 
𝐿𝐹 𝐿𝐵 
 
𝑘𝑜𝑛  
𝑘𝑜𝑓𝑓  
61 | P a g e  
 
In many cases, the chemical exchange will influence the appearance of the spectra. This 
will be most obvious when the chemical shift of one or more protons of the ligands is 
affected by the chemical exchange (in this case the appearance of the spectra will 
depend on the kinetics of the exchange). For simplicity, let’s imagine a two-site 
exchange between equal populations, for example an amide with a methyl group sitting 
on the amidic nitrogen (Figure 2.1a). The semi-rigidity of the amidic bond is such that 
the methyl group can rotate from a cis to a trans configuration relative to the amidic 
oxygen, undergoing the equilibrium shown in Figure 2.1a. In each configuration, the 
methyl group would experience a different chemical environment and therefore have 
different chemical shift. If the rate of exchange between the cis and the trans 
configuration is slow enough in the chemical shift time scale (𝑘𝑒𝑥  << 𝛥𝜈), each species 
(A and B) will have a lifetime long enough and we will be able to clearly distinguish two 
sharp separated peaks (one coming from the methyl group in A and one coming from 
the methyl group in B, Figure 2.1b left).  
 
Figure 2.1. (a) Restricted rotation around the amidic bond. The methyl group is in chemical 
exchange between a cis and a trans configuration relative to the amidic oxygen. (b) Schematic 
classification of the dynamic exchange regimes observed in NMR spectra, with approximate 
rates (𝑘) or life time (τ) associated with these regimes. Figure adapted from 54. 
If we started to steadily increase the temperature of the system, i.e. to steadily increase 
the exchange rate of the process, we will see the peaks “moving” toward each other. 
Eventually, when the chemical exchange rate is so fast relative to the chemical shift time 
62 | P a g e  
 
scale (𝑘𝑒𝑥  >> 𝛥𝜈) that the two species cannot be distinguished anymore, we will observe 
one single sharp peak, resulting from an “average” between the two species (Figure 2.1b 
right).  
The transition between the slow and fast motion regimes is called intermediate motion 
and goes through broadening of the two peaks until a point, called coalescence point, in 
which the signals “flatten out” seeming to disappear (𝑘𝑒𝑥  ≈ 𝛥𝜈). As the exchange rate 
increases, one broad signal at the average chemical shift among the two starts to be 
visible and becomes sharper as the kinetics fastens (𝑘𝑒𝑥  >> 𝛥𝜈).  
The broadening effect arises as the same spin (e.g. the methyl protons in Figure 2.1a) 
will experience two different precession frequencies while they transition from the A to 
be B form and vice versa. In the intermediate regime, the precession frequency changes 
within the scale of the acquisition time, leading to a net dephasing of the bulk 
magnetisation vector (the exchange does not happen coherently for all the molecules 
at the same time). This will lead to short FIDs (faster loss of net magnetisation) which 
are associated to broad signals. If the exchange rate is very fast, little net dephasing of 
transverse magnetisation can occur and the FID records the average frequency between 
the two species, producing a sharp single signal. 
2.1.2 Effect of chemical exchange on other NMR parameters: slow and fast motion54 
When the system under study is either in the slow or in the fast regime of chemical 
exchange, we will obtain sharp signals (two in slow exchange conditions and one in fast 
exchange conditions) which we can analyse to obtain useful information on the 
dynamics of the system. For instance, in Figure 2.1, the presence of one or two signals 
alone informs us on the rate of exchange around the semi-rigid bond. But the chemical 
shift is not the only NMR parameter influenced by chemical exchange processes (albeit 
it is the most promptly observed). Other NMR parameters, such as longitudinal or 
transverse relaxation rate constants, scalar couplings, and residual dipolar couplings are 
sensitive to various types of chemical exchange and can assume different values when 
experiencing transitions between different environments.  
In the case of ligand-receptor binding processes, in particular, the ligand transiently 
adopts NMR parameters typical of the much larger receptor (we will generally refer to 
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any of these parameters as 𝑄), and, at the same time transiently perturbs the binding 
site microenvironment in the receptor. In both cases, 𝑄𝐹  ≠  𝑄𝐵 , i.e. 𝛥𝑄 ≠ 0 (where the 
subscripts F and B refer to the parameters in the free and the bound state, respectively). 
Therefore, monitoring 𝛥𝑄 upon binding can provide precious information on the nature 
of the process. When we consider both 𝜈 and 𝑄 for a given system, three scenarios are 
possible69: 
1) 𝑘𝑒𝑥  << 𝛥𝑄 and 𝑘𝑒𝑥  << 𝛥𝜈; 
2) 𝛥𝜈 >> 𝑘𝑒𝑥>> 𝛥𝑄; 
3) 𝑘𝑒𝑥  >> 𝛥𝑄 and 𝑘𝑒𝑥>> 𝛥𝜈. 
In case 1), the exchange is slow relative to both time scales, therefore we observe two 
resonances and can measure both 𝑄𝐹  and 𝑄𝐵 . In case 2), the exchange is slow relative 
to the chemical shift time scale and fast relative to 𝑄, so we observe two signals on 
which we can measure an average observed 𝑄, as follows: 
𝑄𝑜𝑏𝑠 = 𝑓𝐹
𝐿𝑄𝐹
𝐿 + 𝑓𝐵
𝐿𝑄𝐵
𝐿   Equation 2.1 
Where 𝑓𝐹
𝐿 and 𝑓𝐵
𝐿 are the fractions of free and bound ligand, respectively. In case 3), the 
exchange is fast relative to both time scales, and we have a single signal on which we 
can equally measure the average observed 𝑄𝑜𝑏𝑠 , as in Equation 2.1 (the same three 
cases and equations apply to any chemical exchange process, involving A and B rather 
than 𝑄𝐹  and 𝑄𝐵 ).   
2.1.3 Saturation transfer by chemical exchange. Saturation Transfer Difference (STD) 
NMR70 
For any system under chemical exchange in which we can see relatively sharp NMR 
signals in the spectrum from the molecule/s involved in the exchange, we can apply 
saturation transfer methods. Intuitively, this involves a “transfer” of magnetisation from 
a state A to another state B (e.g., from bound to free state, in our protein-ligand 
interaction system), and vice versa. This is implemented by perturbing (or saturating) 
the resonance of given protons in one state and observing how it is transferred to the 
other state. For the magnetisation to be transferred, the transfer process must occur at 
a faster or at least comparable rate relative to the spin relaxation; else, the effect of the 
spin perturbation is lost before the exchange is completed (i.e., it must be true that 𝛥𝑅1 
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<< 𝑘𝑒𝑥 , where 𝛥𝑅1 is the difference between the 𝑅1s of the ligand in the free and the 
bound state).  
Let us now focus again on the ligand-receptor interaction, as observed from the ligand 
perspective. Also, let us imagine that the exchange rate is fast relative to the chemical 
shift exchange rate and relative to both relaxation time scales (𝑘𝑒𝑥>> 𝛥𝜈 and 𝑘𝑒𝑥>> 𝛥𝑅1,
𝛥𝑅2). 
These are the optimal conditions for ligand-based NMR methods for characterising 
molecular interactions. It is worth emphasising again that for such fast kinetics, large 
excesses of ligands are necessary to saturate the protein sites. Due to the fast exchange 
and to the large excess of ligand, which means that the chemical exchange is taking place 
with highly unequal populations, the observed signals of the ligand will mostly 
correspond to those of the free form, with the very weak broad protein signals on the 
baseline. That means that, under these conditions, the bound state is not directly 
accessible (not observable), and hence, it would not be possible to directly perturb the 
ligand signals selectively in the bound state, with the aim of transferring that 
perturbation to the free state. Indeed, in STD NMR we resort to protein saturation, 
followed by one first step of intermolecular saturation transfer (by NOE), and then, the 
chemical exchange will eventually carry that saturation from the bound to the free state 
of the ligand. For a large protein, selective saturation of a single amino acid resonance 
will result in a rapid spread of the magnetisation over the entire macromolecule. This is 
the spin diffusion effect which we described in Chapter 1, Sub-section 1.3.4. When a 
ligand binds to the saturated receptor, it will receive part of this saturation by 
intermolecular NOE. The assumption that 𝛥𝑅1 << 𝑘𝑒𝑥  means that the ligand will have 
time go back in the bulk solution before losing the transferred magnetisation. As NOE is 
negative slow-tumbling molecules, the sign of the NOE acquired by the ligand upon 
contacting the saturated protein will be negative too, resulting in a decrease of the 
ligand signals upon protein irradiation70a. The amount of saturation transferred to the 
binder depends on the macromolecular mobility, the lifetime of the complex (saturation 
transfer is only detected for complexes with dissociation constant 𝐾𝐷  in the range of 10
-
3 to 10-8 M) and the geometry of binding (binding mode, which depends on the bioactive 
conformation of the ligand, and the intrinsic architecture of the binding pocket), as we 
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will see in more detail in the following sub-sections dedicated to the practical aspects of 
STD NMR. 
2.1.4 Technical aspects of STD NMR and pulse sequence70 
Based on saturation transfer from the protein to ligands in fast chemical exchange, the 
technical implementation of Saturation Transfer Difference NMR (STD NMR) is very 
simple. On a sample containing the receptor (large molecule with MW > 15 kDa) at low 
concentration (10-5 to 10-6 M) and a large molar excess (1:10 up to 1:1000) of a pool of 
small test compounds, two experiments are recorded (Figure 2.2 top): i) 1D 1H-NMR 
under conditions of thermal equilibrium, the so-called reference spectrum or off-
resonance experiment, and ii) a second 1D 1H-NMR experiment, the on-resonance  
experiment, in which some protons of the receptor are selectively irradiated with low 
power radiofrequency during a certain period (saturation time) that can be varied 
typically in the range of several seconds.  
 
Figure 2.2. Illustration of the 1D STD NMR experiment (top) applied to a sample containing a 
protein receptor in the presence of a mixture of two small test compounds in molar excess 
(bottom). Two 1D NMR spectra are recorded: i) a standard 1D 1H NMR (off-resonance or 
reference spectrum), and ii) a 1D 1H NMR spectrum with selective saturation of receptor proton 
signals. Saturation of protein proton polarisation can be transferred to a small molecule by 
intermolecular NOE if protein-ligand 1H-1H distances are short enough (< 4-5 Å). Thus, saturation 
transfer will only take place to molecules that transiently bind to the receptor. The difference 
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spectrum (𝐼0 − 𝐼𝑠𝑎𝑡, top right) will show only signals corresponding to the ligand, while signals 
of non-binders cancel out. Figure from 70c. See also Figure 3.1. 
During the on-resonance experiment, the existence of non-equilibrium magnetisation 
(saturation) on 1H nuclei of the receptor leads to intermolecular NOEs with 1H nuclei of 
the ligand, in the bound state, as the ligand most likely will have at least some of their 
1H nuclei at very short distances (r < 4-5 Å) from those 1H nuclei of the receptor.  
This process results in the macroscopic detection of (transferred) s aturation on the 
ligand NMR signals (𝐼𝑠𝑎𝑡 ). Since signals are reduced in the corresponding off-resonance 
experiment (𝐼0), subtraction of both experiments (𝐼0 − 𝐼𝑠𝑎𝑡) leads to positive difference 
signals allowing the identification of the binding compounds. The intensities of non-
binding molecules remain the same in both spectra and the difference spectrum cancels 
them out (dark blue signals in Figure 2.2).  
As we can see in the pulse program (Figure 2.3), the key element is the saturating 
irradiation selective to the protein. This could be achieved by a low power continous  
wave saturating pulse, as in the pulse sequence of the steady state NOE (as in Figure 
1.16), but to avoid undesirable spillover of the saturating field, this is replaced by a train 
of Gaussian-shaped selective pulses of 50 ms each (the filled half oval in Figure 2.3). The 
power is set to cover a bandwidth of about 100 Hz, while the number of pulses in the 
train (n) is adjusted to obtain the desired length of total saturation time.  
 
Figure 2.3. Pulse sequence for STD NMR . The narrow and wide-open bars correspond to trim 
pulses with a length of 2.5 and 5 ms, respectively, performed at the power level for spin-lock. 
The narrow-filled bar is a 90° hard pulse. A series of selective pulses (50 ms duration, 4 ms inter-
pulse delay, frequency switched for on-resonance and off-resonance spectrum) is applied for 
saturation. The first two pulses as well as the gradient are applied to destroy residual 
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magnetization. Phase cycling: φ1=x; φ2=y; φ3=x; φ4= φR=x, 2(−x), x, y, 2(−y), y; φ5=4(y), 4(−x), 
4(−y), 4(x). Figure from 71. 
Hence, a hard 90° pulse (the filled bar with phase φ4) is applied, followed by a spin lock 
purge pulse (usually between 10 and 40 ms), to remove the broad protein signals. Any 
other unwanted residual magnetisation can be cancelled by using trim pulses with a 
length of 2.5 and 5 ms (the empty bars with phase φ1 and φ2, respectively), performed 
at a power level for spin-lock. The use of a gradient in correspondence of the trim pulses 
can help this process71. 
Due to the variable length of the saturating Gaussian train (which can go from 0.1 s to 
20 s, depending on the system and the purpose), the STD NMR experiment can be 
regarded as a truncated driven NOE (TOE) experiment, as described in Chapter 1, Sub-
section 1.3.3. The usual saturation time for STD NMR in screening experiments is 2-3 s, 
as a compromise between sensitivity and reasonable experimental time.  
2.1.5 Ligand epitope mapping by STD NMR70c, 72 
The potential of STD NMR goes well beyond simple screening, as not all the signals of 
the ligand in a STD NMR spectrum show the same amount of saturation. Theoretically, 
the magnetization transferred from receptor to ligand protons by intermolecular NOE 
in the bound state depends on the inverse of the sixth power of their distances 56. Thus, 
the observed differences in saturation transferred among the different ligand protons  
indicates different spatial proximities between the distinct parts of the ligand molecule 
and the protein in the bound state. Qualitatively, stronger ligand STD intensities reflect 
closer inter-proton distances between the corresponding ligand protons and the 
receptor surface in the bound state.   
This means that we can map the protons of the ligand closer to the protein surface, and 
get semi-quantitative structural information about the binding, by comparing the 
relative STD intensities of the different protons of the ligand at a given saturation time. 
This is done by normalizing all the measured STD factors (𝐼0 − 𝐼𝑠𝑎𝑡 /𝐼0) against the most 
intense one, which is arbitrarily assumed to be 100%. Thus, the resulting percentage STD 
values represent a map of the ligand–protein contacts delineating which ligand moieties 
are key for recognition by the receptor. This is what we call ligand epitope mapping, an 
example of which is shown in the left panel of Figure 2.4.  
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In this process, the choice of the saturation time is crucial. The STD intensity of any given 
proton of a ligand typically increases at increasing protein saturation time, until reaching 
a plateau, the 𝑆𝑇𝐷𝑚𝑎𝑥, which depends on the relaxation properties of the ligand (for 
fast-tumbling small molecules we usually expect around 5-6 s). The plateau is affected 
by the longitudinal relaxation (𝑅1) of the ligand in the free state. This means that 
𝑅1 plays a more relevant role the closer we get to the 𝑆𝑇𝐷𝑚𝑎𝑥. It is worth considering 
that, ideally, the group epitope mapping information should not depend on the chosen 
saturation time. However, significantly different 𝑅𝑧  relaxation rates of the different 
protons of the ligand can produce artefacts in the epitope definition. 
 
Figure 2.4. Ligand epitope mapping by STD NMR. Left: group epitope mapping of a 
tetramannoside binding to the human anti-HIV-1 antibody 2G12 by normalization of the STD 
initial slopes from the experimental curves (right). In this example, the distribution of saturation 
transfer indicates binding through the non-reducing mannose residue (mannose A). Figure 
adapted from 70c. 
Specifically, protons with slower 𝑅1 relaxation will accumulate more efficiently 
saturation in solution. Thus, their relative STD intensity will be enhanced in comparison 
to other ligand protons, and, thus, their proximity to the binding pocket may be largely 
overestimated at long saturation times. Since all these artefacts are consequence of 
differences in the ability to accumulate saturation in the free state, a way to cancel them 
out is to derive STD intensities for a saturation times tending to zero, when virtually no 
accumulation of saturated ligand takes place. To that aim, Mayer and James 72 proposed 
measuring STD intensities at increasing saturation times, as opposed as to a single 
saturation time experiment, and fitting the experimental build-up curves to the mono-
exponential function: 
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𝑆𝑇𝐷(𝑡𝑠𝑎𝑡) =  𝑆𝑇𝐷𝑚𝑎𝑥(1− 𝑒
𝑘𝑠𝑎𝑡∗𝑡𝑠𝑎𝑡 )   Equation 2.2 
where 𝑆𝑇𝐷(𝑡𝑠𝑎𝑡) is the observed STD intensity at a given saturation time, 𝑡𝑠𝑎𝑡  , 𝑆𝑇𝐷𝑚𝑎𝑥 
is the asymptotic maximum of the build-up curve, and 𝑘𝑠𝑎𝑡  is a rate constant that 
measures the speed of STD build-up. An example of the resulting build-up curves is 
reported in the right panel of Figure 2.4. 𝑘𝑠𝑎𝑡and 𝑆𝑇𝐷𝑚𝑎𝑥 are derived by least-squares 
fitting, and the initial slope of the curve is obtained as: 
𝑑𝑆𝑇𝐷(𝑡𝑠𝑎𝑡) 𝑑𝑡𝑠𝑎𝑡⁄ |𝑡𝑠𝑎𝑡→0 = 𝑆𝑇𝐷𝑚𝑎𝑥  𝑘𝑠𝑎𝑡    Equation 2.3. 
The group epitope mapping of the ligand is obtained by normalisation of the relative 
values of the set of initial slopes obtained, relatively to an arbitrarily chosen proton of 
the set, usually the one with highest initial slope.  
2.1.6 Exchange-transferred-NOESY: bio-active conformation of the ligand54,56 
STD NMR is not the only ligand-based technique with the potential of elucidating 
structurally the binding mode in protein-ligand interactions. Exchange-transferred 
NOESY (tr-NOESY) is a 2D NMR technique enabling us to study the conformation of the 
bound ligand in solution. From the technical point of view, tr-NOESY is purely a NOESY 
experiment applied to a sample containing a receptor and ligand in an appropriate ratio 
(which relates to the affinity of the interaction). The basic pulse program for any NOESY 
experiment is shown in Figure 2.5. 
So far, we have not entered the details of 2D experiments. Simplistically, any 2D 
experiment consists of the following steps: preparation, evolution, mixing and 
detection. In the pulse sequence in Figure 2.5, the preparation is the 90° hard pulse with 
phase φ1 and the evolution time is the time interval t1. The evolution time is the key 
element here, as it allows to generate the second dimension of the spectra. Let us 
imagine, for a sample containing a single signal, that t1 is set to 0; then, the sum of the 
first two 90° hard pulse is a hard 180° pulse, which would simply invert the 
magnetisation from z to -z. 
The net transverse magnetisation would be null, and no signal would be detected. If we 
started to increment the length of t1, we would let the magnetisation vector evolve by 
a given angle, so that, when we pulse again with phase φ2, a small signal would be 
detected. As we increase t1 by regular intervals, the detected signal will increase, until 
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reaching a maximum when the magnetisation vector had time to evolve by a 90° angle; 
for larger t1 the magnetisation would then decrease, pass through a null, then through 
a negative minimum, and so on according to the sinus, until the signal entirely decays 
due to relaxation. 
 
Figure 2.5. Pulse sequence for the 2D NOESY experiment. Narrow filled bars correspond to 90° 
hard pulses. Phase cycling: φ1=x, −x (incremented according to time-proportional phase 
incrementation (TPPI)); φ2= φ3=x; φR=x, −x. Figure from 71. 
 The resulting set of FIDs constitutes a pseudo-FID itself, which defines the evolution of 
magnetisations in what we call the indirect dimension (as it is indirectly generated). A 
2D Fourier transform of this data, on the one-signal sample imagined, would yield a 
signal with the same frequency in both dimensions. The situation becomes more 
interesting when more than one set of protons is present in the sample, as we can 
observe correlations between the signals (or peaks) in some fashion (e.g., through bond 
or through space), leading to the appearance of the so-called cross peaks. In the case of 
NOESY, the cross peaks indicate correlation through space, meaning that the two 
protons linked by that correlation are spatially close.  
Thus, the resulting spectra will show diagonal peaks with identical frequency in both 
dimensions (large blue dots in the spectra in Figure 2.6), and cross peaks featuring the 
two frequencies of the correlating protons (small dots in the scheme in Figure 2.6). It is 
important to highlight that cross peaks only exist when the cross relaxation 𝜎𝐼𝑆  is not 
null. Therefore, it is important to choose mixing times such that the cross relaxation of 
the nuclei of interest is at its maximum. As we have seen profusely, the sign of 𝜎𝐼𝑆  
depends on the correlation time of the molecules under investigation. Thus, the sign of 
the cross peaks will be the same or the opposite relative to the diagonal peaks (assumed 
to be positive), depending on the correlation time of the analytes, and their intensi ty 
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will be modulated as a function of the mixing time 𝜏𝑚  of the experiment (among other 
things), as shown in Figure 2.7. 
 
Figure 2.6. Schematic representation of the exchange-transferred NOESY. The existence of 
receptor-ligand interaction can be proved by the change in sign of the NOESY cross peaks 
comparing samples in the absence and in the presence of the receptor.   
From Chapter 1, Sub-sections 1.3.2 and 1.3.3, we are also aware that low molecular 
weight molecules typically show small NOEs and reach their maximum in NOESY 
experiments at mixing times in the range of seconds. In contrast, large molecules (e.g., 
proteins) show strong NOEs and reach their maximum magnitude for much shorter 
mixing times (in the range of tens or hundreds of milliseconds). 
Exchange-transferred NOE experiments take advantage of the fact that a small ligand 
in the presence of a high molecular weight receptor will also show negative NOEs if the 
kinetics of the binding is within the fast exchange condition, and the ligand-to-protein 
ratio is carefully selected73.  
In this experiment, the chemical exchange can transfer to the free state the 
perturbations in the populations of the protons of the ligand due to the intra-ligand 
longitudinal 1H-1H cross relaxation processes in the bound state. These processes lead 
to strong negative NOEs in the bound state that can be transferred to the bulk solution 
72 | P a g e  
 
if the kinetics is fast enough. In the free state, those populations (bound state NOEs) 
survive long enough (due to the smaller 𝑅𝑍  of small molecules) as to produce an 
accumulation in the bulk solution, allowing the observation of strong NOEs in the NMR 
signals of the free ligand (Figure 2.6).  
Under these conditions, the observed longitudinal cross relaxation rate or NOE 
(𝜎𝑇𝑟−𝑁𝑂𝐸 ) is given by the population-weighted average of the NOEs in the free and the 
bound state: 
𝜎𝑇𝑟−𝑁𝑂𝐸 = 𝑓𝐹
𝐿𝜎𝐹
𝑁𝑂𝐸 + 𝑓𝐵
𝐿𝜎𝐵
𝑁𝑂𝐸   Equation 2.4 
where 𝑓𝐹
𝐿and 𝑓𝐵
𝐿 are the fraction of free and bound ligand, and 𝜎𝐹
𝑁𝑂𝐸and 𝜎𝐵
𝑁𝑂𝐸, the NOEs 
in the corresponding free and bound states. To detect NOEs from the bound state, we 
must assure that |𝑓𝐵
𝐿𝜎𝐵
𝑁𝑂𝐸| ≫ |𝑓𝐹
𝐿𝜎𝐹
𝑁𝑂𝐸|. If the ligand : protein ratio is too high, 𝑓𝐹
𝐿 ≫
𝑓𝐵
𝐿, we will enhance the properties of the free state, detecting the NOEs of the small 
molecule (𝜎𝐹
𝑁𝑂𝐸). In fact, the ligand-to-protein ratios for transferred NOE observation 
are within a much narrower range than in the case of STD NMR experiments (typically 
between 10:1 to 50:1).  
From the observation of transferred NOEs, we can determine the bioactive 
conformation of the ligand in the binding site of the receptor. Nevertheless, those 
protons of the receptor close to the ligand in the bound state can produce relay NOEs 
that can affect the intra-ligand NOEs. This phenomenon is called protein mediated spin 
diffusion, and to avoid its effect on structural calculations we must resort again to initial 
slopes analysis, or, if feasible, the use of a per-deuterated receptor74. 
2.2 Molecular modelling  
2.2.1 Molecular Mechanics75 
Molecular modelling is a broad field ranging from orbital-based quantum mechanical ab 
initio calculations to predict small system interactions (e.g., in the water dimer) or more 
ordered interactions (e.g., lattice and solid states studies) to empirical and semi-
empirical methods. Indeed, most of the interesting systems in chemistry and biology are 
too big to be considered purely through quantum mechanics. To simplify the problem, 
some assumptions and approximations should be made. 
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In molecular mechanics, the essential assumption is the Born-Oppenheimer 
approximation, stating that: the motions of the nuclei and of the electrons can be treated 
separately. Due to the minuscule size of the electrons relative to the nuclei, indeed, their 
motion can be neglected, and the molecular system can be regarded as an ensemble of 
spherical masses, bringing the problem back to a classical mechanics one. The masses 
are given coordinates and interact with each other through processes of bond 
stretching, dihedrals distortion, angles opening and closing according to classical 
mechanical rules. The method based on these assumptions is indeed called “force field” 
approach and has huge applications, despite the apparent oversimplification on which 
it is based. 
In fact, the potential energy 𝑈 is expressed as a function of the internal coordinates ?⃗?  
of the N particles constituting the system (Equation 2.5). The nature of each particle and 
bond must be specified and the parameters relative to them, e.g., the atoms mass and 
volume. The constants 𝑘𝑏 ,𝑘𝜃  and 𝑘𝜒, as well as the bonds and angles reference values 
𝑏0 and 𝜃0   in Equation 2.5, are extracted from experimental data (hence these methods  
are called semi-empirical). In solving this equation, penalties are associated with 
distortion from these reference values. To find the optimal molecular geometry, the 
values of the coordinates of each atom are searched by minimizing the force field 
equation, which follows in its simplest form: 
𝑈(?⃗? ) =  ∑ 𝑘𝑏
𝑏𝑜𝑛𝑑𝑠
(𝑏 − 𝑏0)
2 + ∑ 𝑘𝜃
𝑎𝑛𝑔𝑙𝑒𝑠
(𝜃 − 𝜃0)
2 + ∑ 𝑘𝜒
𝑑𝑖ℎ𝑒𝑑𝑟𝑎𝑙𝑠
(1 + cos(𝜂𝜒 − 𝛿))
+ ∑
𝑞𝑖𝑞𝑗
𝜀 𝑟𝑖𝑗
𝐶𝑜𝑢𝑙 𝑖,𝑗
 +  ∑(
𝐴𝑖𝑗
𝑟𝑖𝑗
12  +
𝐿𝐽 𝑖,𝑗
 
𝐵𝑖𝑗
𝑟𝑖𝑗
6 
)  
   Equation 2.5 
where the contribution of bond stretching, angles and dihedrals re-arrangement are 
considered. In the second line of the equation, the non-bond terms are also taken into 
account, namely the electrostatic interactions (𝐶𝑜𝑢𝑙 𝑖, 𝑗) and the Lennard-Jones (𝐿𝐽 𝑖, 𝑗) 
repulsion-dispersion potential energy terms, where 𝑞𝑖 and 𝑞𝑗 are the charges of the 
interacting particles, 𝜀 is the permittivity of the material, 𝐴𝑖𝑗 and 𝐵𝑖𝑗 are the Lennard-
Jones coefficients and 𝑟𝑖𝑗 is the distance between the particles. 
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2.2.2 Protein-ligand docking calculations76,77 
Based on the force field theory, molecular docking is a computational procedure that 
aims at predicting the preferred orientation and conformation of a ligand bound to its 
target protein (protein-ligand docking). Each docking program operates slightly 
differently, but they share common features that enable them to search for the 
locations on the protein surface that lead to favourable interactions with the ligand, 
sample the conformational space of the ligand and compute the interaction energy 
between the protein and ligand. 
In classic protein-ligand docking, the receptor is considered as a rigid body, while the 
ligand can be set free to rotate, translate and change conformation (or it can be treated 
as a rigid body only able to rotate and translate). More computationally demanding 
techniques allow some degree of flexibility of the receptor as well, and they are referred 
to as induced fit docking techniques. 
In both cases, the practical steps to follow to perform docking calculations are: 
o Protein preparation and ligand conformational minimisation; 
o Grid generation; 
o Docking calculations; 
o Scoring function. 
Here, we will shortly describe them one by one. 
o Protein preparation and ligand conformational minimisation 
Most often, the receptor structure comes from X-ray crystallography data, but it can be 
derived from NMR studies or homology modelling. Thus, the protein structure need to 
be checked and prepared, to ensure that all the atoms and bonds are correctly specified, 
that no hydrogen atom is missing, and that all the residues in the binding pocket have 
unique orientation (in some cases, amino acid side chains can present several 
conformations in the X-ray structure). At this point, it is also possible to select the 
number and type of water molecules to keep in the binding pocket, and finally a round 
of minimisation is performed. 
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For the ligand, a round of conformational search minimisations is frequently performed. 
This allows to start from a conformation which is a low relative minimum, representative 
of the free molecule in solution (keeping in mind that the ligand conformation will be 
explored during the docking steps as well). 
o Grid generation 
The space of the receptor in which one wants to fit the ligand must be defined, by 
generating a grid. Its main feature are its centre and its shape and dimension. To centre 
the grid, one generally uses the reference ligand in the binding pocket, but it is possible 
to centre the grid in any position, simply by choosing the residues of interest.  
The dimension and the shape of the grid are arbitrary: by default, the grid has cubic 
shape, but the three sides can be set to have different length. In Glide, one can define 
an inner and an outer grid: the inner grid will enclose the centre of the ligand (defined 
as the midpoint of the longest segment which can be drawn between any two atoms of 
the molecule), while the outer grid will contain the whole ligand, as shown in Figure 2.7. 
The size of the grid strongly affects the outcome of the docking calculations: larger grids 
will allow to probe unusual and asymmetric binding pocket, exploring a wider space; on 
the other hand, smaller grids will limit the number of results, excluding odd poses and 
saving calculation time (therefore, ideally, the smaller the better). 
 
Figure 2.7. Example of grid generation in the case of cholera toxin subunit B with its natural 
ligand GM1 (from PDB ID: 3CHB). The inner grid is lined in green and the outer grid is lined in 
purple. 
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o Docking calculations 
The main objectives of the actual calculations are: i) to define the best location for the 
ligand on the surface (within the grid), ii) to sample the conformational space of the 
ligand and iii) to compute the energy relative to the interaction, giving a higher score to 
the most favourable ones. To this purpose, different minimization and filtering steps 
may be implemented in the docking protocol from software to software. Generally, the 
starting point is a conformational search on the ligand, from which the lowest energy 
conformations are then minimized in the field of the receptor, using a force field which 
can be chosen (usually the Optimised Potential for Liquid Simulations for All Atoms, 
shortened to OPLS-AA). Finally, the resulting poses are subjected to a Monte Carlo 
procedure that examines torsional minima, before providing the final solution. This must 
be considered as a “funnel” process, where the number of poses decreases stepwise.  
 
Figure 2.8. Glide docking “funnel” showing the protocol followed to generate docked poses. 
Figure from 76. 
The algorithm shown in Figure 2.8 refers to the Glide docking method, which is the main 
programme used in the current project, but the general procedure is similar among the 
different software available on the market (e.g., DOCK, FlexX, AutoDock, AutoDock Vina, 
etc.). An interesting study published by the group of Imberty reported a comparison of 
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three software (DOCK, AutoDock and Glide) to predict the binding mode of flexible 
carbohydrates in shallow lectins binding site. They found that Glide is the most 
successful to account for the flexibility of the oligosaccharides and to represent the 
complexity of their binding modes65. 
o Scoring functions 
The scoring of the poses after the calculation is crucial to rank the solutions according 
to energy and to compare one another. Ideally, one would require assessing the relative 
free energy of binding (ΔG) of the ligand-receptor interactions generated, which is a 
computationally demanding task. Thus, empirical scoring function approximating ΔG 
have been developed to enable ranking77. They consider mainly solvation, ionic 
interactions and hydrogen bonds to yield reliable approximations. Several functions are 
available, and they serve diverse needs. “Glide gscore” in Glide, for example, is 
particularly suitable to compare binding of different ligands to one receptor (e.g., to 
define the best binder among many); on the other hand, “Glide emodel”, weighting 
more significantly the force fields component such as electrostatic and van der Waals 
energies, is more convenient to compare conformations of the same ligand to its 
receptor. 
2.3 Model validation. COmplete Relaxation and Conformational Exchange MAtrix 
approach: CORCEMA-ST66,78 
A quantitative assessment of the goodness of a 3D molecular model of a protein-ligand 
complex in relation to the experimental STD NMR data requires a tool able to 
theoretically predict STD intensities from the Cartesian atomic coordinates of the 3D 
molecular model. The theoretical framework for this quantitative validation of STD NMR 
experiments is CORCEMA-ST (Complete Relaxation and Conformational Exchange 
Matrix for Saturation Transfer), developed by Rama Krishna in 2002. Written as a MatLab 
code, CORCEMA-ST can predict the STD intensities for the protons of a ligand at different 
saturation times, upon input of the Cartesian co-ordinates of the structure of the ligand-
receptor complex obtained by any experimental or computational method (e.g., X-ray 
crystallography, NMR, docking simulations ) (Figure 2.9).  
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Figure 2.9. Cartoon representation of the CORCEMA-ST protocol. Figure from 78. 
CORCEMA-ST calculates the observable magnetization transferred in the protein-ligand 
NOE occurring when the protons of the protein are irradiated to saturation. This is 
achieved by solving the matrix differential equation which describes the intensity of 
magnetization (𝐼𝑧) as a function of the saturation time (𝑡𝑠𝑎𝑡 ), including the kinetics of 
the magnetization transfer (motion of magnetisation 𝑄) combined with the kinetics of 
chemical exchange (𝐾) and that of relaxation 𝑅1 (𝑅). The matrix equation is of the form: 
𝐼𝑧(𝑡𝑠𝑎𝑡) = 𝐼𝑧(0) +
[1−𝑒−
(𝑅+𝐾)∗𝑡𝑠𝑎𝑡 ] 𝑄
𝑅+𝐾
   Equation 2.6 
Hence, the transferred magnetisation is translated into STD factors and build-up curves 
can be plotted for the different ligand protons and compared with the experimental 
ones to prove whether the 3D model fits with the STD NMR data. 
The goodness of the fit between the molecular model and the experimental NMR data 
can be quantified by the so-called NOE R-factor: 
𝑁𝑂𝐸 𝑅 − 𝐹𝑎𝑐𝑡𝑜𝑟 =  √
∑(𝑆𝑇𝐷 𝑒𝑥𝑝,𝑖− 𝑆𝑇𝐷 𝑐𝑎𝑙𝑐 ,𝑖)
2
∑(𝑆𝑇𝐷 𝑒𝑥𝑝,𝑖)
2   Equation 2.7 
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where 𝑆𝑇𝐷𝑒𝑥𝑝,𝑖  and 𝑆𝑇𝐷𝑐𝑎𝑙,𝑖  are the experimental and calculated STD intensities of each 
proton i, respectively. By its definition, the NOE R-factor can assume any positive value, 
with lower values corresponding to better fit between experimental and theoretical 
data. Thus, different theoretical structural models derived, e.g., from different docking 
runs, can be ranked according to how well they explain the experimental STD NMR data. 
NOE R-factors below 0.3 are regarded as satisfactory to validate the 3D structure79. 
The preparatory steps to run CORCEMA-ST calculations are:  
o preparation of the files containing the structure of the complex, ligand, and 
protein; 
o preparation of a text file containing the NMR chemical shifts (simulated from 
ShiftX (www.shiftx2.ca) or experimentally available) for all the protein protons; 
o definition of the parameters relative to the system in analysis in the MatLab 
script. 
To limit the size of the matrix on which to make calculations, one defines a cut-off 
around the ligand. 5 Å is usually the lowest limit to be used, but 8-10 Å give more 
accurate results. To account for the kinetics of the chemical exchange, the equilibrium 
constant of the interaction must be entered; the concentration of protein and ligand 
must also be specified in order to calculate the distribution of the species in solution. To 
represent the spin diffusion and relaxation effect, it is important to specify the 
correlation times of the free ligand and of the complex. Relaxation can be also affected 
by non-specific relaxing agents present in the sample, such as traces of paramagnetic 
elements in solution: this is described by the parameter 𝜌 (expressed in Hz), for which 
higher values corresponds to the stronger relaxation effect on all the nuclei in solution 
(resulting in a lower overall intensities of the signals). These parameters are used to 
simulate the 𝑇1 values for the relaxation of the ligand's protons, which can also be input 
manually, if they are experimentally available80. Finally, the experimental conditions  
relative to the spectrometer and to the acquisition must be specified ( i.e., the field 
strength of the instrument, the frequency range of irradiation and the saturation times 
used). 
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Chapter 3  
Novel Saturation Transfer Difference (STD) NMR 
approaches: DEEP-STD NMR and IL-STD NMR 
Parts of the findings from this Chapter are published as: 
Monaco, S.; Tailford, L. E.; Juge, N.; Angulo, J., Differential Epitope Mapping by STD NMR 
Spectroscopy To Reveal the Nature of Protein–Ligand Contacts. Angewandte Chemie 
International Edition 2017, 56, 15289-93. 
3.1 Introduction  
3.1.1 From bulk magnetisation to NOE in protein-ligand systems  
As discussed in Chapter 1, Sub-section 1.3, we can think of macroscopic magnetisation 
as resulting from the difference in population (𝑁) between 2𝐼 + 1 states, which 
generates a bulk magnetisation vector 𝑀𝑧  aligned with 𝐵0, i.e. along the z axis. The 
acquisition of NMR experiments relies on a perturbing event (application of a 
radiofrequency) misaligning the bulk magnetisation from its position of equilibrium. 
Thereafter, recovery of the equilibrium conditions occurs, which is a universal driving 
force in all natural systems. In the case of nuclear spin perturbation, the rate of this 
recovery (d𝑀𝑧/dt), i.e. relaxation, is of paramount importance. Relaxation is favoured 
by physical phenomena inducing transitions. Among them, if two nuclei called I and S 
are close enough through space, then cross relaxation -induced by dipole-dipole 
interactions- is particularly of interest for us, as i) its rate is dictated by the motional 
regime of rotational diffusion, and ii) the kinetics of cross relaxation, or the rate constant 
of cross-relaxation 𝜎𝐼𝑆  is (inversely) dependent to the distance between the interesting 
nuclei. As already derived from the Solomon equations (in Chapter 1, Sub-section 1.3.3, 
Equation 1.32 and 33): 
 𝜎𝐼𝑆 = 𝑏
2 3
10
𝑗(2𝜔0) − 𝑏
2 1
20
𝑗(0)      Equation 3.1 
where:  
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𝑏 =
𝜇0  𝛾𝐼 𝛾𝑆 ℏ
4𝜋𝑟3
   Equation 3.2 
and τC is the correlation time, 𝛾 is the gyromagnetic ratio of each nuclei, 𝜇0 is the 
permeability of vacuum and r is the inter-nuclear distance. In fact, cross relaxation is 
responsible for the Nuclear Overhauser Effect (NOE)55. Detecting NOEs is crucial for 
structural studies by NMR, allowing complicated assignments of natural products, 
distance measurements (if reference distances are available) and hence obtaining 
constraints definitions for protein structural calculations. Moreover, it plays an 
irreplaceable role in the investigation of chemical exchange processes, such as the 
protein-ligand recognition processes which are our objects of study. We already 
described our protein-ligand system in exchange as follow: 
𝑃 + 𝐿 ⇋ 𝑃𝐿   Equation 3.3 
Which, from the ligand perspective rewrites as: 
𝐿𝑓  ⇋ 𝐿𝑏   Equation 3.4 
To observe the ligand in its bound state, we must look at NMR variables which vary 
dramatically when the ligand interacts with the protein. It should be clear at this point 
that the correlation time τC is an ideal variable for this purpose. Therefore, a profound 
understanding of the NOE phenomena, the process/es leading to “spin diffusion” and 
their modulation in systems under fast exchange conditions is essential to be able to 
optimise ligand-based techniques and to generate new developments. Based on this 
theoretical knowledge, the work presented in this chapter aims at expanding the already 
brilliant potentialities of Saturation Transfer Difference (STD) NMR, beyond its current 
limits. 
3.1.2 The process of protein-ligand saturation transfer and the long-standing question of 
protein spin diffusion homogeneity  
We can define the STD NMR experiment as a truncated driven NOE (TOE) experiment71. 
It thus relies on the generation of non-equilibrium magnetisation (selective irradiation) 
on a small group of receptor nuclei, followed by transfer of non-equilibrium population 
all over the nuclear spins of the protein, and eventually leading to intermolecular NOEs 
with the closest nuclei of the ligand in the bound state70a. For the purpose of this 
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discussion, we can outline the STD NMR experiment in four processes at the atomic 
level, as cartooned in Figure 3.1: i) a selective shaped pulse of variable length is applied 
to a given set of protein protons to perturb the equilibrium, long enough as to induce 
saturation; ii) by dipole-dipole direct NOE, the irradiated protons transfer magnetisation 
to the adjacent protons (which can belong to the protein or to the ligand); iii) by dipole-
dipole relayed NOE (spin diffusion), the protein nuclei transfer magnetisation to the 
whole network of nuclei in an intramolecular process; iv) if a small molecule binds to the 
surface of the protein, the magnetisation is transferred to the interacting ligand nuclei 
via an intermolecular process. Quantification of the relative distribution of saturation 
transferred among the different ligand protons yields the binding epitope mapping of 
the ligand, which allows to identify the main contacts of the ligand with the protein 
residues in the complex70b.  
 
Figure 3.1. Cartoon of the sequence of events taking place during an STD NMR experiment. The 
outcome is the binding epitope mapping of the ligand constituted by the three different moieties 
A-B-C, reporting on its binding mode.  
However, this approach fails to provide distinctive information about the ligand location 
or orientation in the bound state; and on the presence of ligands bound in adjacent 
subsites. Additional experiments are required for these aims: to characterize the 
location of binding, competitive STD NMR experiments with “spy” ligands of known 
binding location must be carried out81,82; while to identify the orientation of binding in 
relation to other bound fragments, ILOE tr-NOESY experiments must be performed83,84.  
Importantly, STD relies on the efficacy of spin diffusion to homogeneously spread the 
saturation over the receptor, but this is not always ensured and, indeed, differences in 
ligand binding epitope mappings can be observed if STDs are acquired at different 
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saturating frequencies66. Here, we will try to show the fact that small inhomogeneities  
in saturation, under appropriate experimental setup, can deliver more specific 
information on the intermolecular interactions than just simply the ligand epitope, but 
it can reveal the nature of the protein amino acids where the saturation comes from.  
3.1.3 Protein spin diffusion inhomogeneity: can it be exploited to get structural 
information? 
Our idea is to exploit the differences in ligand epitope mappings arising from acquiring 
sets of two experiments under different conditions (e.g., different irradiation 
frequencies or different solvent composition). The differences in the resulting epitopes, 
albeit expected to be small, can be magnified and mapped into the ligand to provide 
additional layers of structural information on the architecture of the binding site 
compared to the standard STD NMR experiments. We then devised two independent 
approaches:  
 Approach 1: Exploring the nature of the protein residues around the ligand in the 
bound state (lining the binding pocket). Elucidating their nature should facilitate 
the determination of the orientation of the ligand relative to them (Figure 3.2), 
if the 3D structure of the binding pocket is known; 
 Approach 2: Exploring the presence of different bound ligands in proximity to 
each other, in the cases of ternary protein-ligands complexes. This approach 
should facilitate elucidating the relative orientation of the ligands in the ternary 
complex (Figure 3.3). 
Approach 1, which we call DiffErential EPitope mapping STD NMR (DEEP-STD NMR), 
consists of two implementations a) differential irradiation frequencies and b) 
differential solvent composition. These are based on the following hypotheses, 
respectively: 
 Hypothesis A: Ligand protons will receive larger amounts of saturation if the 
protein protons in their proximity are “directly irradiated” instead of being 
“relayed-NOE” saturated (Figure 3.2a).  
 Hypothesis B: Ligand protons close to slow-exchanging protein exchangeable 
protons will receive less saturation if the latter are exchanged to deuterium, i.e. 
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running the experiments in D2O, instead of proton, i.e. running them in H2O 
(Figure 3.2b). 
Implementation of these two hypotheses is expected to provide distinctive information 
on the nature of the protein protons (aromatic, polar, or apolar) the ligand is in contact 
with in the bound state, allowing to get some information on the pharmacophore of the 
protein, as we discuss more in detail in Section 3.3. It is worth to highlight that, with this 
approach, we might get access to information on the pharmacophore of the protein 
using a single ligand experiment, in contrast with the considerable number of active 
molecules that are required for classic ligand-based determination of a protein 
pharmacophore85,86. 
 
Figure 3.2. Cartoon representing the two implementations of the DEEP-STD NMR protocol. (a) 
Different irradiation frequencies: (i) STD NMR with selective irradiation (1) on protein protons 
close to ligand proton B. (ii) STD NMR with selective irradiation (2) on protein protons close to 
ligand proton A; the distinct binding epitopes of the ligand are sketched in the free state. (b)  
Different solvent composition: (i) STD NMR experiment in D2O. (ii) STD NMR experiment in H2O.  
Figure adapted from 87. 
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Approach 2, which we call Inter-Ligand STD NMR (IL-STD NMR), is a variation of the 
differential irradiation DEEP-STD NMR approach applicable to ternary complexes (one 
protein and two or more ligands), where ligand protons and protein protons are directly 
irradiated alternatively (on-ligand vs. off-ligand irradiation). We postulate the following: 
 Hypothesis C: In a ternary complex composed of one protein and two ligands X 
and Y, protons of ligand X close to protons of ligand Y will receive larger 
saturation when adjacent Y (and protein) protons are directly irradiated (or vice-
versa), compared to when only the protein is irradiated (Figure 3.3). 
It must be considered that the magnetization can be transferred from one ligand to the 
other either directly (intermolecular through space direct NOE) or through an 
intermediate protein proton placed close to both (intermolecular relayed NOE, or 
protein-mediated spin diffusion). Nevertheless, in both cases, the observation of IL-STD 
necessarily originates from proximity in the space between those protons from different 
ligands. In this way, detection of IL-STDs is expected to deliver information facilitating 
the determination of the relative orientation of ligands bound in adjacent binding 
subsite. 
 
Figure 3.3. Cartoon representing the IL-STD NMR approach. (i) STD NMR with selective 
irradiation (1) on protein protons. (ii) STD NMR with selective irradiation (2) on ligand proton 
γ (close to proton C of the adjacent fragment) as well as on protein protons.  
This is because an STD increase on a given proton (or set of protons) of ligand X when a 
given proton (or set of protons) of ligand Y is directly irradiated (or vice-versa) would 
arise when these “regions” of the two ligands are closer in space than any other region 
of the molecules. This is discussed in detail in Section 3.4. 
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3.1.4 Model systems: brief introduction  
To validate our hypotheses, we chose three biologically relevant protein-ligand model 
systems for which high resolution 3D structures of the complexes from X-ray diffraction 
data were available. The two DEEP-STD NMR approaches (differential irradiation and 
differential solvent composition) have been applied to:  
i) The complex between 2,7-anhydro-Neu5Ac and GH33, the glycosyl hydrolase 
domain of the intramolecular (IT) trans-sialidase from Ruminococcus gnavus 
(IT-sialidase from RgNanH, PDB ID: 4X4A)17. The compound 2,7-anhydro-
Neu5Ac is a Neu5Ac derivative, resulting from the intramolecular trans -
glycosilating activity of GH33. So far, only three IT-sialidases have been 
discovered, and their role of mucin-degraders make them a subject of great 
interest in gut microbiota fundamental research. 
ii) The complex between 3-nitrophenyl-α-D-galactopyranoside (3NPG) and 
Cholera Toxin Subunit B (CTB, PDB ID: 1EEI). 3NPG is a well-known CTB 
inhibitor that occupies the galactose binding subsite of the GM1 pocket, 
mimicking the galactose of the natural binder88. As one of the first and 
simplest CTB ligands developed, it is frequently chosen as a reference (and/or 
starting material) in CTB inhibitor drug design projects 89,90,91,92.  
The IL-STD approach has been tested on: 
iii) The complex of Naproxen with Bovine Serum Albumin (BSA, PDB ID: 4OR0). 
The physiological importance of Serum Albumin and its remarkable ability of 
binding endogenous and exogenous compounds determined the usefulness 
of this protein as a model for the study of ligand protein interactions 93. In 
complex with Naproxen, a non-steroidal anti-inflammatory, and analogous 
small molecules have been used for optimisation of many experimental 
techniques, like ligand-based NMR experiments94,95. BSA has three Naproxen 
binding sites, two of which adjacent to each other and with affinities 
compatible with strong STD detection96. 
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3.2 Structural information from protein spin diffusion inhomogeneity - Preliminary 
data  
3.2.1 Binding epitope anomalies and “on-resonance scanning”  
Serendipitously, during our studies of the interactions of the Carbohydrate Binding 
Module domain of RgNanH (CBM40) with Neu5Acα6Lac (6’SL, Figure 3.4a,b), we 
obtained the first results that indicated that relevant structural information can indeed 
be encrypted in the spin diffusion inhomogeneity. CBMs are small carbohydrate 
recognising domains associated to glycosidases. We were analysing the ligand specificity 
of CBM40 (21 kDa) through STD NMR investigation of a library of 15 sialic acid-containing 
ligands, leading to the structural elucidation of key features of their binding to CBM40 
(whole study reported in Chapter 5, Section 5.3)97. The binding pocket of CBM40 is quite 
shallow (Figure 3.4b) and the main element of recognition for all the ligands is the non-
reducing sialic acid capping (Figure 3.4a). The binding of CBM40 to 6’SL (and to all the 
other ligands studied) can be considered weak (transient), with 𝐾𝐷  in the mM range, as 
quantified by ITC.  
 
Figure 3.4. (a) Chemical structure of Neu5Acα6Lac (6’SL). (b) Crystal structure of the complex 
6’SL/CBM40 (PDB ID: 6ER497): the binding site is shallow and the Neu5Ac is the main recognition 
element. Ile95 is coloured in turquoise and indicated by an arrow (see Figure 3.5c for more 
details). (c) STD NMR experiment at 0.60 ppm and 2 s saturation time: reference spectra (x 1) in 
red and difference spectra (x 4) in black. (d) STD NMR experiment at 6.77 ppm and 2 s saturation 
time: same colouring scheme and scaling as (c). The signals coming from the sialic acid (main 
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element of recognition) are labelled. The relative ratio between the signal from the methyl 
group and the rest of the sialic acid signals is visibly higher when irradiating at 0.60 ppm.  
The binding of 6’SL to CBM40 could be detected by STD NMR, with STD (%) signals for 
the sialic acid protons in the range of 10% when CBM40 was irradiated at a frequency 
of 0.60 ppm (where most of aliphatic resonances are found) and 2 s saturation time. STD 
signals from the lactose moiety where weaker as this part of the ligand is loosely bound. 
Interestingly, the methyl group of the sialic acid moiety showed a significantly higher 
STD % (60%, Figure 3.4c). The over 5-fold difference observed between the strongest 
STD signals of the methyl group and the signal of the rest of the protons lead us to name 
this effect the “STD incremental effect”. However, when the same sample was irradiated 
at 6.77 ppm (in the aromatic region of the protein) the result was a stark drop in the STD 
intensity of the methyl group, relative to the rest of the signals (Figure 3.4d). The same 
behaviour of the STD intensity of the methyl group in STD NMR experiments at two 
different frequencies (0.60 ppm and 6.77 ppm) was observed for all the other sialic-acid 
containing binders (as reported in Chapter 5, Section 5.3).  
To exclude the likelihood of direct ligand irradiation during irradiation at the aliphatic 
region, i.e. at 0.60 ppm (the methyl group resonates at 1.74 ppm), STD NMR 
experiments at 2 s saturation time were performed at increasing irradiation frequencies 
with 0.20 ppm increments. This meant scanning the spectral region from -0.20 ppm to 
1.40 ppm, in what we call “on-resonance scanning” (Figure 3.5a). The STD intensities for 
the methyl protons and for H6 of the sialic acid (as a reporter signal) were recorded, 
showing a very interesting trend: after an increase of the STD signal of the methyl group 
from 60% to 80% moving from 0.60 ppm to 0.80 ppm, there was a drop between 1.00 
ppm and 1.20 ppm. The signal then slightly increased at 1.40 ppm, where we were only 
0.40 ppm away from the methyl resonance frequency itself and direct irradiation was 
certainly playing a role. On the contrary, the control peak H6 stayed almost steady along 
the spectral window (Figure 3.5a). This suggests that the Neu5Ac methyl group reaches 
a maximum STD intensity between 0.80 ppm and 1.00 ppm.  
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Figure 3.5. (a) “On-resonance scanning” from -0.2 ppm to 1.4 ppm for the CBM40/6’SL complex. 
For each experiment, the absolute STD intensity is recorded at 2 s saturation time. (b) Predicted 
distribution of protein protons resonating at each 0.20 ppm interval, as obtained from ShiftX2 
on the crystal structure of CBM40 at the experimental conditions. (c) Detail of the crystal 
structure showing the relative orientation of the sialic acid of 6’SL and Ile95 (PDB ID: 6ER497). 
The turquoise surface encloses the directly irradiated protein protons and the ligand methyl 
group object of the analysis. 
We identified the two methyl groups of Ile95 at the binding pocket of CBM40 as having 
predicted resonance frequencies (by ShiftX2) at 0.84 ppm and 0.58 ppm. Ile95 is pointing 
the two methyl protons towards the ligand methyl group in the bound state (Figure 
3.5c), and thus, potentially direct irradiation of those Ile95 protons along the scanning 
were responsible for the behaviour of the Neu5Ac methyl group. 
This data helps ruling out that the “STD incremental effect” observed for the methyl 
group of Neu5Ac is given by direct irradiation (further evidence to this argument is 
provided in Chapter 5, Sub-section 5.3.2). More importantly, this data gave ground to 
formulate Hypothesis A: arguably, as the isoleucine methyl protons are being directly 
irradiated, thus they can transfer an enlarged amount of saturation to the Neu5Ac’s 
methyl group, very close in space in the bound state, in comparison to other 
frequencies, hence boosting its STD intensity (Figure 3.5c). In this case, central 
irradiation of the isoleucine seemed to be achieved at 0.80 ppm in agreement with the 
ShiftX2 prediction (at 0.60 ppm the effect is also appreciable). 
To our best knowledge, the data shown in Figure 3.5a is the first reported evidence that 
selective irradiation of residues lining the binding pocket and contacting the ligand can 
help identify which part of the ligand is closer to those amino acids. 
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This was a preliminary result of paramount importance for us, as it paved the way to 
carry out differential frequency irradiation experiments, which, applied to the optimal 
systems, lead to the formulation of DiffErential EPitope mapping STD NMR (DEEP-STD 
NMR), object of Section 3.3. 
3.2.2 Further considerations on the “STD incremental effect” observed on the 
6’SL/CBM40 complex  
The “STD incremental effect” observed on the methyl group of 6’SL as bound to CBM40 
can be considered as an anomalous STD outcome. To fully justify such a large effect, a 
few additional considerations seem necessary before moving to more standard 
situations (where 5-fold STD differences between the first and the second strong signal 
are rarely observed). First, it must be considered that CBM40 is a relatively small protein 
(21 kDa) whose 1D 1H NMR peaks look not as broad as larger-sized proteins, due to its 
shorter τc (estimated to be circa 20 ns). For comparison, Figure 3.6 shows the 1D 1H NMR 
spectra of a larger protein (GH33, τc estimated to 50 ns, Figure 3.6a), whose peaks look 
more like a so-called “protein envelope” (Figure 3.6b).  Arguably, sharper protein peaks 
allow more intense direct irradiation and stronger saturation transfer, magnifying the 
effect of inhomogeneous spin diffusion for small proteins as compared as large proteins, 
as sketched in Figure 3.6c,d. The chemical shift dispersion of the protein protons under 
the effect of T2 broadening have already been reported by Kang et al. to affect strongly 
the STD outcome (for a large antibody they had to correct CORCEMA-ST calculations to 
account for line broadening)98. Furthermore, the low affinity, the shallow geometry of 
the subsite and most likely a very fast kinetics of interaction intensify the intensity gap 
between the saturation received by the methyl group, which is the only one buried in 
the hydrophobic pocket (containing Ile95, Tyr116 and Tyr210), and the other Neu5Ac 
protons. Low affinity typically involves short residence time, which could explain the fact 
that the rest of the Neu5Ac protons receive a considerably lower saturation. This effect 
is partially cancelled out when irradiation at 6.77 ppm is performed, where a more 
homogeneous protein saturation is achieved, so there are no “hot spots” in the binding 
pocket close to ligand protons (like the “hot” methyl groups of Ile95 when irradiating at 
0.60 ppm). 
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Figure 3.6. Left panel: 1H NMR spectral region (0.10 ppm‐1.40 ppm) of the proteins GH33 (52 
kDa) (a) and CBM40 (21 kDa) (b) Fourier transformed with the same line broadening factor of 
the window function. Due to its smaller size (and τc), the peaks of CBM40 look sharper and less 
“envelope‐like”. Right panel: cartoon representing the T2 broadening effect on the protein 
signals. Sharp signals receive much more magnetization when primarily irradiated (and thus 
transfer it more efficiently to the close ligand protons). Ideally isolating a single protein signal, 
irradiation pulse of the same width will saturate a much higher percentage of the sharp signal 
(c) than on the broad one (d). 
3.3 DiffErential EPitope Mapping STD NMR (DEEP-STD NMR)  
3.3.1 Significance and potential of Differential Epitope Mapping by STD NMR 
The potential of the preliminary data discussed above is that, in favourable cases, we 
can tailor the STD NMR experiments to take advantage of the inhomogeneity of the spin 
diffusion process within the protein, i.e. we can select which types of protein protons  
will be directly irradiated. Thus, the differences in binding epitopes will highlight those 
parts of the ligand contacting a given type of irradiated protein residues (Hypothesis A, 
Figure 3.2a).  
Additionally, as pointed out in Hypothesis B, another source of minor differences in 
epitope maps is the solvent. In D2O, the polar side chains of amino acid in the binding 
pocket have their exchangeable protons replaced by deuterium, which is inefficient for 
transferring saturation56. In contrast, in H2O, these protons would be available to receive 
saturation through intra-protein spin diffusion, and hence be able contribute to an 
additional transfer of saturation to ligand protons, compared to the STD NMR 
experiments carried out in D2O99. The efficiency of this process depends on exchange 
rate of those polar protons with bulk water, with slow exchanging protons in the binding 
pocket being expected to produce the largest variations 99. We can exploit this effect to 
detect clusters of slow exchanging residues (arginine, in particular, as we will explain in 
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detail in Sub-section 3.3.6) in close contact to the bound ligand, as increases in relative 
STD intensities of protons located in one part of the ligand, when the STD NMR 
experiment is carried out in water, will indicate contacts with protons in slow exchange 
with water.  
To detect and quantify these differences we resort to experimentally determining a 
“Differential Epitope Map” of a ligand under two differential conditions (which might be 
either two different frequencies, or two different solvents, D2O or H2O). As we will 
describe in the following subsection, this is a map of the differences in relative ligand 
STDs (i.e., epitope differences) from each pair of STD NMR experiments reflecting 
contacts to specific types of amino acids.  
Potentially, if the 3D structure of the protein is unknown, this approach would spread 
light on the nature and architecture of the binding site, allowing to identify possible 
“patches” (aliphatic, aromatic, polar, etc.) within the pocket. In cases for which the 3D 
structure of the protein is known, this approach could provide the orientation of the 
ligand in the binding pocket and/or help discriminating where a ligand binds between 
two alternative binding sites. 
3.3.2 Definition of DEEP-STD factor (ΔDEEP-STD) and protocol for acquisition and 
processing DEEP-STD NMR experiments  
The DEEP-STD NMR protocol then consists of running pairs of STD NMR experiments 
under two different experimental conditions (Figure 3.2), and quantifying their 
differences in relative STDs. Each pair comprises experiment-1 (exp1) and experiment-
2 (exp2), performed under differential conditions. The “Differential Epitope Map” of a 
ligand under two experimental conditions (exp1 and exp2) is determined through the 
DEEP-STD factor (ΔSTD𝑖) for each proton i as:  
ΔDEEP− STD𝑖 = 
𝑆𝑇𝐷 𝑒𝑥𝑝1,𝑖
𝑆𝑇𝐷 𝑒𝑥𝑝2,𝑖
− 
1
𝑛
∑ (
𝑆𝑇𝐷 𝑒𝑥𝑝1,𝑖
𝑆𝑇𝐷 𝑒𝑥𝑝2,𝑖
)𝑛𝑖     Equation 3.5 
The first step in the analysis of DEEP-STD NMR data consists in determining which of the 
two experimental conditions, exp1 or exp2, produced stronger STD intensities 
(comparing their total sum of STD values). The experiment with the largest total sum 
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will be called exp1. Next, the ratio of STD intensities (
𝑆𝑇𝐷 %𝑒𝑥𝑝1,𝑖
𝑆𝑇𝐷 %𝑒𝑥𝑝2,𝑖
) is calculated for each 
proton of the ligand. These ratios report not only on differences in the epitopes but also 
on the different global level of protein saturation achieved in both experiments (e.g., 
protein saturation on the aromatics leads to a reduced global saturation, as the number 
of aromatic residues is normally much lower than the number of aliphatic ones). For that 
reason, to obtain the differential epitope, the intrinsic differences in protein saturation 
must be removed. To that aim, the average ratio of STDs over all protons must be 
calculated [
1
𝑛
∑ (
𝑆𝑇𝐷 %𝑒𝑥𝑝1,𝑖
𝑆𝑇𝐷 %𝑒𝑥𝑝2,𝑖
)𝑛𝑖 ]. To remove the contribution from differences in 
saturation level, and to establish a “zero” in the scale for analysis of the differential 
epitope, this average factor must be subtracted to each of the individual STD ratios. This 
assures that the ΔDEEP− STD𝑖 s reveal only those differences arising from the distinct 
types of amino acids hit by the saturating radiofrequency. If the change in conditions is 
affecting the residues lining the binding pocket, we will observe positive values for 
protons experiencing a relative increase in STD values in exp1 and negative values for 
protons experiencing a relative increase in STD values in exp2. It is important to highlight 
that the increase/decrease of STD values is "relative”, as it comes from the comparison 
of the binding epitopes under the two conditions, as expressed in Equation 3.5, and not 
from the comparison of absolute STD values.  
3.3.3 Differential irradiation DEEP-STD NMR experiments 
We first tested the protocol by analysing the effect of different irradiation frequencies 
on the binding of 2,7-anhydro-Neu5Ac to GH3317. We ran two STD NMR experiments  
irradiating (0.5 s) at 0.60 ppm (exp1) and 6.55 ppm (exp2). These frequencies are known 
to be centred in the aliphatic and aromatic protein proton spectral regions, 
respectively100. It is worth noticing that the selection of frequencies to irradiate different 
types of protein protons can be based on either known NMR spectral properties of the 
protein (if chemical shifts are assigned), on NMR databases (e.g., BMRB101), or on 
predictions if a 3D model of the protein is available (as in this study, Table 3.3101). 
The DEEP-STD factors (0.60 ppm/6.55 ppm) are shown in Figure 3.7a. Positive DEEP-STD 
factors report relative STD increases when irradiation was at 0.60 ppm (aliphatics); 
negative ones indicate increases when irradiation was at 6.55 ppm (aromatics). The 
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resulting differential epitope map is shown in Figure 3.7b. The results clearly show how 
different protons of the ligand occupy distinct areas of the GH33 binding pocket lined 
by either aliphatic or aromatic residues. The positive ΔDEEP-STD for CH3 and H3a suggest 
vicinity to aliphatic side chains, whereas negative ΔDEEP-STDs for H8, H9 and H9’ 
suggest vicinity to aromatic protons.  
The DEEP-STD NMR results shown in Figure 3.7a are in excellent agreement with the 
published crystal structure of the complex between 2,7-anhydro-sialic acid and GH33 
(Figure 3.7c), where the ligand sits between aliphatic (Ile258, Ile338, and Val502) and 
opposite aromatic patches (Tyr667 and Trp698). The ligand protons CH3 and H3a point 
towards the aliphatic residues, while H8, H9, and H9’ are projected towards the aromatic 
side chains. Protons H3e, H4, H5, H6 and H7 sit in between these two regions in 
agreement with their negligible ΔDEEP-STD factors.  
 
Figure 3.7. Left panel: Differential Epitope Mapping (0.60 ppm/6.55 ppm) of 2,7-anhydro-
Neu5Ac in complex with GH33. (a) ΔDEEP-STD histogram: positive ΔDEEP-STD (above the limit 
of +0.75) after aliphatic irradiation (0.60 ppm) are in cyan, and negative ΔDEEP -STD (below -
0.75) after aromatic irradiation (6.55 ppm) are in magenta. (b) Differential Epitope: ΔDEEP-STD 
map of the ligand. Cyan surfaces highlights ligand contacts with aliphatic side chains; magenta, 
contacts with aromatic side chains. The ligand polar protons have been omitted. (c) Crystal 
structure of the complex (PDB ID: 4X4A17). Protein protons are coloured as a function of their 
NMR frequencies: directly irradiated at 0.60 ppm (aliphatics) in cyan and directly irradiated at 
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6.55 ppm (aromatics) in magenta (Table 3.3). Right panel: differential Epitope Mapping (2.25 
ppm/0.60 ppm) of 3-nitrophenyl-α-D-galactopyranoside (3NPG) in complex with Cholera Toxin 
Subunit B (CTB). (d) ΔDEEP-STD histogram: protons with positive ΔDEEP-STD (above the limit of 
+0.75) after irradiation at 2.25 ppm are in orange. (e) Differential Epitope: ΔDEEP-STD map of 
the ligand. Orange surfaces indicate ligand contacts with protein side chains directly irradiated 
at 2.25 ppm. The ligand polar protons have been omitted.  (f) Crystal structure of the complex 
(PDB ID: 1EEI88). Protein protons directly irradiated at 2.25 ppm are enclosed in orange surface. 
For both systems, protons were added using Schrodinger software102. Comparison of (b) and (c) 
highlights the excellent match of the differential epitope map of the ligand with the distribution 
of the residues in the binding pocket. Figure adapted from 87. 
Further, we applied the novel protocol to the complex of CTB, a larger receptor (65 kDa), 
with 3NPG88. Unfortunately, the ligand contains an aromatic moiety, which precludes 
protein irradiation in this spectral region. However, in DEEP-STD NMR, it is possible to 
select other groups of protein protons for irradiation, providing that they are in spectral 
regions devoid of ligand signals. For CTB, we targeted protein resonances at 2.25 ppm, 
where no ligand protons showed signals, and protein signals were available for 
saturation. We predicted the chemical shifts of protons of CTB within 4 Å of the ligand 
in the X-ray structure, and the results indicated Glu51 and Gln56 protons as the ones 
likely to be directly irradiated (Figure 3.7f, and Table 3.3). Experiments conducted with 
differential frequencies (2.25 ppm/0.60 ppm), resulted in positive ΔSTD values for 
protons H4, H5, H6 and H6’ on the galactose, indicating an increase in relative STDs 
when irradiating at 2.25 ppm (Figure 3.7d). In contrast, negligible ΔSTD factors were 
observed for H1, H2, H3, and the aromatic protons at the opposite end of the molecule.  
The differential epitope map of 3NPG (Figure 3.7e) was found to be in perfect agreement 
with the published crystal structure of the complex between 3NPG and CTB (Figure 
3.7f),[10] in which the galactose ring area of H4 to H6 is surrounded by the side chains of 
Glu51 and Gln56. In contrast, H1, H2, H3 and aromatic carbons are pointing far from 
those side chains in the binding pocket (Figure 3.7f). These results confirm that it is 
possible to identify the nature of the ligand-receptor contacts by means of differential 
protein irradiation. The spectra and the raw and processed data are shown in Figure 3.8, 
Tables 3.1 and 3.2. 
96 | P a g e  
 
 
Figure 3.8. Left panel: 1 mM of 2,7-anhydro-Neu5Ac in the presence of 50 M GH33 in 
deuterated tris-d11 buffer, 293 K. (a) Reference spectra (x 1); (b) STD NMR spectrum with on-
resonance irradiation at 6.55 ppm (x 64); (c) STD NMR spectrum with on-resonance irradiation 
at 0.60 ppm (x 32). Right panel: 1 mM of 3NPG in the presence of 10 M CTB (50 M binding 
pockets) in deuterated Phosphate Buffer Saline (PBS buffer), 278 K. (a) Reference spectra (x 1); 
(b) STD NMR spectrum with on-resonance irradiation at 2.25 ppm (x 8); (c) STD NMR spectrum 
with on-resonance irradiation at 0.60 ppm (x 16). Figure from 87. 
It is worth mentioning here that, which ΔSTD values should be considered significant will 
depend on the sizes of the STD factors for the protein-ligand system under study. Based 
on the results of the systems analysed here, we experimentally determined that ΔSTD 
greater than 0.75 in magnitude were significant. 
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Proton 
1H   
(ppm)[a] 
STD %  
0.60 ppm 
STD %  
6.55 ppm 
Ratio STD 
0.60 ppm/6.55 ppm 
ΔDEEP-
STD 
CH3 1.90 3.66 0.94 3.89 1.68 
H3a 1.89 2.87 0.91 3.15 0.94 
H3e 2.04 2.42 1.05 2.30 0.09 
H4 3.82 2.84 1.38 2.06 -0.16 
H5 3.79 2.58 0.94 2.74 0.53 
H6 4.41 2.68 1.18 2.27 0.06 
H7 4.30 2.61 1.29 2.02 -0.19 
H8 3.41 1.41 1.24 1.14 -1.08 
H9 3.46 1.03 0.89 1.16 -1.06 
H9' 3.63 1.15 0.82 1.40 -0.81 
  Sum Sum STD average  
  23.25 10.64 2.21  
Table 3.1. DEEP-STD NMR using Differential Irradiation (0.60 ppm/6.55 ppm) of the GH33/2,7-
anhydro-Neu5Ac complex. [a] Spectra for assignment acquired at 293 K. Table from 87. 
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Proton 
1H   
(ppm)[a] 
STD %  
2.25 ppm 
STD %  
0.60 ppm 
Ratio STD 
 2.25 ppm/0.60 
ppm 
ΔDEEP-
STD 
H1 5.50 6.73 3.66 1.84 -0.68 
H2 3.73 12.51 4.95 2.53 0.01 
H3 3.81 10.81 4.72 2.29 -0.23 
H4 3.75 21.82 5.9 3.70 1.18 
H5 3.73 15.21 4.6 3.31 0.78 
H6/H6' 3.40 19.79 5.84 3.39 0.87 
H cd 7.27 2.81 1.46 1.92 -0.60 
Hb 7.69 5.24 2.9 1.81 -0.71 
Ha 7.75 12.21 6.38 1.91 -0.61 
  Sum Sum STD average  
  107.13 40.41 2.52  
Table 3.2. DEEP-STD NMR using Differential Irradiation (2.25 ppm/0.60 ppm) CTB/3NPG. [a] 
Spectra for assignment acquired at 278 K. Table from 87. 
3.3.4 Selection of irradiation frequencies and identification of directly irradiated residues 
in the binding pocket  
For proteins of known 3D structure, directly irradiated protons can be easily identified 
in the binding pocket if their chemical shift assignments are known. In many cases, 
however, the protein chemical shifts are not available. Then, statistical averages of 
chemical shifts of the residues present in the binding pocket (from existing NMR 
databases) can be used.  
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GH33 Binding Pocket Residues 
CTB Binding Pocket 
Residues 
258 ILE HA 4.11  12 TYR HA 4.63 
  HB 2.01    HB2 2.73 
  HD1 0.49    HB3 2.90 
  HG2 0.98    HD1 7.07 
  HG12 1.48    HD2 7.01 
  HG13 1.29    HE1 6.8 
338 ILE HA 4.71    HE2 6.83 
  HB 1.69  32 ALA H 8.29 
  HD1 0.60    HA 4.16 
  HG2 0.84    HB 1.37 
  HG12 1.25    HB2 1.73 
  HG13 1.14    HB3 1.51 
502 VAL HA 4.70  33 GLY HA 3.89 
  HB 1.74    HA2 3.87 
  HG1 0.70    HA3 3.88 
  HG2 0.36  51 GLU HA 4.35 
557 THR HA 3.62    HB2 2.02 
  HB 4.10    HB3 2.08 
  HG2 0.97    HG2 2.28 
525 TYR HA 5.98    HG3 2.30 
  HB2 2.95  56 GLN HA 4.05 
  HB3 2.84    HB2 1.81 
  HD1 7.02    HB3 1.93 
  HD2 6.93    HE21 7.08 
  HE1 6.64    HE22 6.87 
  HE2 6.64    HG2 1.94 
677 TYR HA 4.66    HG3 2.02 
  HB2 3.05  90 ASN HA 4.83 
  HB3 2.76    HB2 3.02 
  HD1 6.82    HB3 2.82 
  HD2 6.83    HD21 7.44 
  HE1 6.68    HD22 6.97 
  HE2 6.63  91 LYS HA 4.62 
698 TRP HA 4.47    HB2 1.85 
  HB2 3.18    HB3 1.72 
  HB3 3.01    HD2 1.62 
  HD1 6.63    HD3 1.62 
  HE1 9.89    HE2 2.96 
  HE3 7.25    HE3 2.94 
Table 3.3. 1H chemical shifts of amino acid residues in the binding pocket (within 4 Å from the 
ligand) of GH33 (left) and CTB (right) as simulated by Shiftx2 (http://www.shiftx2.ca). 
Resonances within 0.4 ppm from the directly irradiated frequencies ( i.e., 0.60 ppm and 6.55 ppm 
in the case of the differential irradiation DEEP-STD studies of the GH33/2,7-anhydro-Neu5Ac 
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complex, and 2.25 ppm in the case of the CTB/3NPG complex,) are highlighted in the same colour 
scale as in Figure 3.7. Table from 87. 
Alternatively, the 3D structure of the protein can be used to predict the chemical shifts 
using existing software. Here, we selected the irradiation frequencies based on 
predictions of chemical shifts using the available 3D structures of the proteins by using 
ShiftX2 (http://www.shiftx2.ca100), as we report in Table 3.3.  
Additionally, the chemical shifts of selected protons on the proteins were also checked 
against average chemical shift histograms from the Biological Magnetic Resonance Data 
Bank (http://www.bmrb.wisc.edu). All molecular graphics were generated with 
Schrodinger Maestro 11 version 2016-4. Hydrogen atoms were added to the ligand and 
to the protein using the Protein Preparation Wizard and LigPrep, and protonated 
residues within 4 Å from the ligand where selected as shown in Figure 3.7. 
3.3.5 Differential solvent D2O/H2O DEEP-STD NMR 
We next studied 2,7-anhydro-Neu5Ac in complex with GH33 under two different solvent 
conditions: D2O (exp1), or H2O (exp2). The irradiation frequency was set at 0.60 ppm. In 
H2O, the large pool of solvent protons acts as a magnetization sink 103, resulting in a 
global saturation lower than in D2O. For this reason, we set exp1 in Equation 3.5 to be 
the experiment in D2O.  
Thus, negative DEEP-STD factors correspond to ligand protons with reduced relative 
STDs in D2O, that is, being adjacent to slow exchanging polar residues in the bound state. 
We recorded negative DEEP-STD factors from differential D2O/H2O experiments at 
protons H3a, H3e, H9, and H9’ (Figure 3.9a). Here again, the DEEP-STD NMR results were 
in line with the crystal structure (Figure 3.9c), where the ligand protons H3a, H3e, H9, 
and H9’ point towards a highly polar patch in the GH33 binding pocket (Arg257, Arg276, 
Arg575, and Arg637).  
This is in excellent agreement with the known slow exchanging behaviour of the  
protons of arginine residues in H2O99. Interestingly, the ligand methyl group showed a 
positive DEEP-STD factor (Figure 3.9a), which is explained by the presence of a fast 
exchanging hydroxyl group (Y525) close in space to the methyl groups of V502 (Figure 
3.7c and 3.11)99. 
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Finally, we conducted DEEP-STD NMR experiments with differential D2O/H2O conditions 
on the 3NPG/CTB complex. The ΔDEEP-STDs of 3NPG were negligible, and no differential 
epitope was obtained, indicating that changing solvent did not significantly affect the 
STD pattern (Figure 3.9d). This is in agreement with the lack of slow exchanging polar 
residues in the CTB binding pocket (Figure 3.9f)88. This suggests that when no differential 
epitope is obtained after a change from D2O to H2O, the protein binding pocket is likely 
to lack slow exchanging polar side chains (e.g. Arg)99. The spectra and the raw and 
processed data are shown in Figure 3.10, Tables 3.4 and 3.5.  
 
Figure 3.9. Left panel: differential Epitope Mapping (D2O/H2O) of 2,7-anhydro-Neu5Ac in 
complex with GH33. (a) DEEP-STD histogram: protons with DEEP-STD factor < -0.75 are in green. 
Protons H6 and H7 were excluded from the analysis, due to their proximity to the water peak, 
and the use of solvent suppression. (b) Differential Epitope: DEEP-STD map of the ligand. Green 
surfaces indicate ligand contacts with the protein side chains carrying slow exchanging protons. 
(c) Crystal structure of the complex (PDB ID: 4X4A17). The slow exchangeable protons in the 
binding pocket are enclosed in a green surface. Right panel: differential Epitope Mapping 
(D2O/H2O) of 3NPG in complex with CTB. (d) DEEP-STD histogram: all the protons showed values 
close to 0, indicating that none of the residues in the binding pocket is affected by the change 
in conditions. (e) Differential Epitope: no DEEP-STD map of the ligand was obtained. (f) Crystal 
structure of the complex (PDB ID: 1EEI88). The slow exchangeable protons in the binding pocket 
are enclosed in a green surface. Figure adapted from 87. 
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Figure 3.10. Left panel: 1 mM of 2,7-anhydro-Neu5Ac in the presence of 50 M GH33 50 uM in 
PBS buffer, 298 K. (a) Reference spectra (x 1); (b) STD NMR spectrum in D2O (on-resonance at 
0.60 ppm; off-resonance at 40 ppm) (x 32); (c) STD NMR spectrum in H2O:D2O 90:10 (x 128). 
Right panel: 1 mM of 3NPG in the presence of 10 M CTB (50 M binding pockets), 278 K. (a) 
Reference spectra (x 1); (b) STD NMR spectrum in D2O (on-resonance at 0.60 ppm; off-resonance 
at 40 ppm) (x 16); (c) STD NMR spectrum in in H2O:D2O 90:10 (x 32). Figure from 87. 
Proton[a] 
STD % 
D2O 
STD % 
H2O 
Ratio STD 
D2O/H2O 
ΔDEEP-STD 
CH3 3.66 0.51 7.18 1.75 
H3a 2.87 0.69 4.16 -1.26 
H3e 2.42 0.59 4.10 -1.32 
H4 2.84 0.45 6.31 0.89 
H5 2.58 0.46 5.61 0.19 
H8 1.41 0.27 5.22 -0.20 
H9 1.03 0.3 3.43 -1.99 
H9' 1.15 0.31 3.71 -1.71 
 Sum Sum STD ratio average  
 17.96 3.65 5.42  
Table 3.3. DEEP-STD NMR using Differential Solvent (D2O/H2O) of the 2,7-anhydro-
Neu5Ac/GH33 complex. Table from 87. [a] For ass ignment see Table 3.1. 
103 | P a g e  
 
Proton[a] 
STD % 
D2O 
STD % 
H2O 
Ratio STD   
D2O/H2O 
ΔDEEP-STD 
H1 3.66 1.4 2.61 -0.62 
H2 4.95 1.51 3.28 0.05 
H3 4.72 1.51 3.13 -0.10 
H4 5.9 1.83 3.22 -0.01 
H5 4.6 1.24 3.71 0.48 
H6/H6' 5.84 1.6 3.65 0.42 
H cd 1.46 0.51 2.86 -0.37 
Hb 2.9 1.1 2.64 -0.59 
Ha 6.38 2.02 3.16 -0.07 
 Sum Sum STD ratio average  
 40.41 12.72 3.14  
Table 3.5. DEEP-STD NMR using Differential Solvent (D2O/H2O) of the 3NPG/CTB complex. Table 
from 87. [a] For ass ignment see Table 3.2. 
3.3.6 The exchange rate of polar protons and Differential D2O/H2O Epitope Mapping  
In H2O, the exchange rate of exchangeable polar protons on amino acid side chains of 
the protein in the ligand binding pocket has a strong influence on the ability of these 
protons (and their adjacent non-exchangeable ones) to transfer magnetization to a 
bound ligand. In H2O, slow exchanging protons will contribute to transfer the 
magnetization from the binding site to the ligand. In contrast, in the case of fast 
exchanging protons, their exchange with the bulk water will be too fast for them to take 
part efficiently in the protein-ligand saturation transfer process. In addition, the 
magnetization of non-exchangeable protein protons in the binding pocket close in space 
to fast exchanging protein protons will be lost in the bulk water due to an efficient 
exchange-mediated magnetization leakage (Figure 3.11)99.  
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Based on these premises, the presence of slow exchanging protons in the binding pocket 
will enhance the STD response of ligands protons in close contact with them, if the 
experiment is performed in H2O as opposed to D2O (a red “+” in Figure 3.11). It is worth 
noting that the enhancement of STD signal is "relative"; that is, after comparison of the 
“binding epitopes” (relative normalized STDs) under the two conditions (H2O and D2O), 
and not by comparing the absolute STD values (Equation 3.5).  
The presence of “isolated” fast exchanging protons will not have a significant effect on 
the STD of the ligand protons when increasing the percentage of protonated sites over 
deuterated ones (in light water they will exchange fast and they will be “invisible” in 
terms of magnetization transfer). However, as mentioned above, the presence of fast 
exchanging protons near to non-exchangeable protein protons leads to leakage of the 
magnetization of the latter. 
 
Figure 3.11. Cartoon representing the different pathways for saturation transfer from slow and 
fast exchanging polar protons of the binding pocket to the bound ligand in H2O. Slow exchanging 
protein polar protons contribute to additional STD intensities on the ligand (plus signs). Fast 
exchanging protons either do not contribute or can lead to ligand STD reduction due to 
exchange mediated leakage (minus sign). This figure can be considered as a modified version of 
Figure 1 in 99, adapted to explain DEEP-STD NMR experiments with differential solvent 
conditions (D2O/H2O). Figure from 87. 
What is more, if the latter is/are in close contact with ligand protons (X’H-H in Figure 
3.11), the result will be a relative reduction of the STD intensities of the closest ligand 
protons (a purple “-” in Figure 3.11). This explains the positive DEEP-STD factor D2O/H2O 
observed for the methyl group of 2,7-anhydro-Neu5Ac (>+0.75) in our study. In the X-
ray structure (PDB ID: 4X4A), the methyl group of V502, which is contributing 
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significantly to the transfer of magnetization in the STD NMR experiments (Figure 3.9), 
points toward the hydroxyl group of Y525, which is known to have a very fast kinetics of 
exchange99. This induces an efficient exchange-mediated leak of magnetization from 
V502 to the bulk water, having the overall effect of decreasing the STD intensity on the 
methyl group in H2O (when compared to the same sample in D2O). 
3.3.7 CORCEMA-ST validation of the DEEP-STD data for 2,7-anhydro-Neu5Ac/GH33  
To validate the DEEP-STD NMR approach, we tried to reproduce the differential epitope 
mapping at 0.5 s for the complex 2,7-anhydro-Neu5Ac with GH33, running the 
CORCEMA-ST calculations simulating the two approaches experimentally followed: i) 
differential frequency STD (0.60 ppm/6.55ppm), and ii) differential solvent (D2O/H2O). 
Even when no optimization of the parameters needed for the calculations was pursued, 
the theoretical results produced a pattern of positive and negative ΔDEEP-STDs (Figure 
3.12) very similar to what observed experimentally (Figure 3.7a and 3.9a).  
 
Figure 3.12. ΔDEEP-STD histograms for 2,7-anhydro-Neu5Ac in complex with GH33 calculated 
on the STD (%) at 0.5 s predicted by CORCEMA-ST: (a) differential irradiation ΔDEEP-STD (0.60 
ppm/6.55 ppm) and (b) differential solvent ΔDEEP-STD (D2O/H2O).  
These theoretical results further strongly support the proposed DEEP-STD NMR 
approach, highlighting how depending on the architecture and chemical nature of the 
amino acids at the binding pocket, as well as depending on the protonation of polar side 
chains, the transfer of saturation to the ligand is different, and we can pick up those 
differences.  
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3.4 Inter-Ligand STD NMR (IL-STD)  
3.4.1 Significance of the IL-STD approach and its potential limitations in comparison to 
the ILOE approach  
In Sections 3.2 and 3.3, we demonstrated the validity of Hypotheses A and B and 
established the DEEP-STD NMR protocol, as a tool to investigate the nature of the 
intermolecular contacts in protein-ligand complexes, getting information otherwise 
inaccessible by traditional STD NMR. The technique relies on harnessing the 
inhomogeneity of spin diffusion on the receptor to “localise” the source of strongest 
magnetisation from the protein.  
Based on Hypothesis C, Inter-Ligand STD NMR (IL-STD NMR) can be thought as a 
reintroduction of the intra- and inter-ligand NOEs in ternary protein-ligand systems 
(Figure 3.3). The idea is to “directly” irradiate ligand proton(s) and to measure the effect 
on the neighbouring-ligand protons. Whereas changes in saturation of the “self” protons  
(of the irradiated molecule) are not structurally useful, variations in saturation of the 
protons of the other ligand in the ternary complex can reflect spatial vicinity of the two 
ligands (which here can as well be thought as “fragments”, to use a common 
terminology in drug discovery). Notably, this is the same information available from tr-
NOESY experiments carried out on the ternary complexes, an elegant approach 
developed by the group of Pellecchia and named “ILOE” (Inter-Ligand NOE) 84. 
Compared to ILOE, IL-STD NMR is less time-consuming (the long experimental time of 
tr-NOESY and the complication arising from the acquisition of 2D experiments make 
ILOE the least popular among ligand based NMR methods in pharmaceutical 
companies104). The disadvantage is the risk of direct irradiation in the spectra, intrinsic 
to the act of irradiating a single proton within a crowded spectrum.  
IL-STD NMR is a valuable tool to validate 3D molecular models of ternary complexes (e.g. 
generated by multiple ligand docking), as it provides information on how the two 
fragments are located relative to each other. On the other hand, if the 3D structure of  
the ternary complex is unknown, the experiment must be repeated for each proton of 
each ligand to obtain thorough information (as one could not know where to irradiate a 
priori). In both cases, to mitigate the risk of direct irradiation, each set of experiments 
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must be repeated for each ligand in the absence of the other (i.e. on the binary complex). 
This allows to assess the genuine inter-ligand nature of the relative STD increments 
observed upon irradiation of one of the two ligands (such controls must a lso be run in 
the ILOE approach, to verify that the inter-ligand cross peak does not come from protein-
protein or protein-ligand contacts).  
3.4.2 Definition of IL-STD factor (ΔIL-STD) and data processing protocol  
Like differential irradiation DEEP-STD NMR, IL-STD NMR relies on acquiring pairs of STD 
NMR experiments at two irradiation frequencies and quantifying their differences in 
relative STD intensities. We call these frequencies on-ligand, when we irradiate on 
resonance of ligands protons (keeping well in mind that we are at the same time hitting 
the protein too), and off-ligand, when we irradiate on the protein solely. 
To obtain positive values for the protons receiving inter-ligand saturation, here the 
“experiment-1” will always be the on-ligand and the “experiment-2” will always be the 
off-ligand. Thus, the value of interest for the IL-STD data processing is 
𝑆𝑇𝐷 𝑜𝑛−𝑙𝑖𝑔𝑎𝑛𝑑
𝑆𝑇𝐷 𝑜𝑓𝑓−𝑙𝑖𝑔𝑎𝑛𝑑
. 
The unavoidable presence of some effects of direct irradiation, intra- and inter-ligand, 
leads to values of 
𝑆𝑇𝐷 𝑜𝑛−𝑙𝑖𝑔𝑎𝑛𝑑 ,𝑖
𝑆𝑇𝐷 𝑜𝑓𝑓−𝑙𝑖𝑔𝑎𝑛𝑑,𝑖
 much larger and non-homogeneous than what observed 
for the calculation of the DEEP-STD factor. This makes the term  [
1
𝑛
∑ (
𝑆𝑇𝐷 %𝑒𝑥𝑝1 ,𝑖
𝑆𝑇𝐷 %𝑒𝑥𝑝2 ,𝑖
)𝑛𝑖 ] not 
relevant for the IL-STD data processing. This is because it would strongly depend on the 
number of directly irradiated protons, which varies from situation to situation, therefore 
subtracting this value to each  
𝑆𝑇𝐷 𝑜𝑛−𝑙𝑖𝑔𝑎𝑛𝑑
𝑆𝑇𝐷 𝑜𝑓𝑓−𝑙𝑖𝑔𝑎𝑛𝑑
 would not be generally informative. The 
term [
1
𝑛
∑ (
𝑆𝑇𝐷 %𝑒𝑥𝑝1,𝑖
𝑆𝑇𝐷 %𝑒𝑥𝑝2,𝑖
)𝑛𝑖 ] was introduced in the ΔDEEP-STD calculation to remove the 
contribution from differences in saturation level, and to establish a “zero”, as the final 
aim was the definition of a differential epitope. Changing irradiation from on to off 
causes differences in saturation level which are not possible to attenuate.  
On the other hand, to detect inter-ligand contacts, our aim is merely to distinguish 
relative STD increments arising from the irradiation of a neighbouring ligand proton. 
Based on this argument, for a ternary complex formed of a protein and two ligands X 
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and Y, we can define an IL-STD factor for each proton i of X when a given proton of Y is 
irradiated (or vice-versa) as: 
ΔIL − STD𝑖 ,𝑡𝑒𝑟𝑛𝑎𝑟𝑦 = 
𝑆𝑇𝐷 𝑜𝑛−𝑙𝑖𝑔𝑎𝑛𝑑,𝑖
𝑆𝑇𝐷 𝑜𝑓𝑓−𝑙𝑖𝑔𝑎𝑛𝑑 ,𝑖
−  𝑁   Equation 3.6 
Where N is an entire number, defined as the composite function mode of the population 
of ⌊
𝑆𝑇𝐷 𝑜𝑛−𝑙𝑖𝑔𝑎𝑛𝑑,𝑖
𝑆𝑇𝐷 𝑜𝑓𝑓−𝑙𝑖𝑔𝑎𝑛𝑑 ,𝑖
⌋ (⌊𝑥⌋ or floor function of x is the integer part of any number x). If two 
modes are present, we recommend choosing the lowest value. N will in most cases be 
equal to 1, unless there are factors which increase the  
𝑆𝑇𝐷 𝑜𝑛−𝑙𝑖𝑔𝑎𝑛𝑑
𝑆𝑇𝐷 𝑜𝑓𝑓−𝑙𝑖𝑔𝑎𝑛𝑑
 to higher values, as 
in the example reported in this section. This allows to establish a baseline against which 
assessing the increase or decrease of each proton (which is similar to what one would 
do equalising by-eye the intensity of the difference spectra, on-ligand and off-ligand, 
against the protons not affected by direct irradiation). Most importantly, each 
ΔIL − STD𝑖 ,𝑡𝑒𝑟𝑛𝑎𝑟𝑦  must be compared to the correspondent ΔIL − STD𝑖 ,𝑏𝑖𝑛𝑎𝑟𝑦  
calculated under the same on-ligand and off-ligand irradiation conditions but in the 
absence of the irradiated ligand (X if we are analysing Y or vice-versa). The protons 
affected by direct irradiation (or intra-ligand effects) will show a positive ΔIL − STD𝑖   in 
both experiments (ternary and binary); the protons which will have a positive 
ΔIL − STD𝑖 ,𝑡𝑒𝑟𝑛𝑎𝑟𝑦  and a negative ΔIL − STD𝑖,𝑏𝑖𝑛𝑎𝑟𝑦  can safely be considered at NOE 
distance from the directly irradiated proton of the adjacent ligand. 
3.4.3 BSA/Naproxen as a “pseudo-ternary” complex of the type X-X’  
Ternary fragment complexes of a protein and two fragment X and Y are very common 
in fragment-based drug design (FBDD) projects in the developing stage. Obtaining such 
confidential systems from a pharma company or a FBDD group involves complications, 
in terms of IP issues, therefore we tested the approach on the complex of commercially 
available BSA with Naproxen, which we consider as a “pseudo-ternary” complex, for the 
purposes of our proof of concept. Naproxen occupies three well characterised binding 
sites of BSA: “drug site 2”, “drug site 1” and “fatty acid site 6”. The latter two being 
adjacent to each other (Figure 3.13a)96,105. 
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Figure 3.13. (a) Distribution of Naproxen (NPS) binding sites in bovine (BSA), equine (ESA), 
leporine (LSA) and human (HSA) serum albumin complexes, from 96. The three BSA binding sites 
of relevance for us are highlighted in red. (b) STD NMR build-up curves for Naproxen in complex 
with BSA. (c) STD NMR binding epitope mapping. 
Defining binding affinities to the three sites is controversial, “drug site 2” is reported to 
be the one with strongest affinities and many 𝐾𝐷  values for this system have been 
published, ranging from 0.034 µm to 0.82 µm94,106,107. 
STD analysis of this complex shows very high STD intensities and very steep build up 
curves, already plateauing at 2 s (Figure 3.13b). This can be ascribed to the high binding 
affinities, the peculiar relaxation properties of Naproxen and the strong contribution of 
rebinding (from the three subsites). Compatibly, the binding epitope map is rather 
homogeneous with the lowest value of relative STD intensities on the three non-
aromatic sets of protons (the methoxy group, the proton in α and the methyl in β to the 
carboxylic group, between 70% and 74%) and the strongest value on a1, the aromatic 
proton in ortho to the methoxy group (Figure 3.13c). It is important to underline that 
the observed STD signals arise from the combination of Naproxen binding in the three 
different sites, most likely with different kinetics and affinities. This makes very 
cumbersome to accurately interpret the STD NMR binding epitope. Nevertheless , based 
on the observed epitope pattern, we can speculate that the major contribution for the 
observed STD intensities comes from the Naproxen occupying the fatty acid site 6 
(Naproxen NPS2 in Figure 3.13a). Naproxen NPS2 seems the ligand most 
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homogeneously buried in the protein, and the one which leaves the non-aromatic ends 
slightly more solvent exposed, while the binding mode of Naproxen NPS1 and NPS3 
looks less compatible with the observed binding epitope. 
On the other hand, if drug site 2 is the one with highest affinity, and the lowest 𝐾𝐷  
measured is 0.034 µM, it makes the interaction of Naproxen NPS1 in that site too strong 
to be detected by STD NMR. 𝐾𝐷s in the range of units of µM, instead, are compatible 
with the very strong STD signals observed. On these assumptions, we can consider the 
BSA/Naproxen system a “pseudo-ternary” complex formed of a protein and two ligands 
X and X’. 
3.4.4 IL-STD NMR on Naproxen allows to confirm the binding of Naproxen NPS2 and NPS3 
to adjacent BSA subsites  
We irradiated the methyl group in α to the carboxylic group (1.46 ppm) and observed 
the response on the methoxy group (3.71 ppm), as from the crystal structure the methyl 
group of NPS3 is remarkably close to the methoxy group of NPS2. We acquired two 
build-up curves (0.1 s to 2 s) irradiating at 1.464 ppm (on-ligand) and 0.60 ppm (off-
ligand).  The spectra at 1 s saturation time are shown in Figure 3.14. 
 
Figure 3.14. 4 mM of Naproxen in the presence of 50 M BSA in deuterated PBS buffer, pH 7.4, 
303 K, saturation time 1 s. (a) Reference spectra (x 1); (b) STD NMR spectrum with on-resonance 
irradiation at 1.46 ppm (x 32); (c) STD NMR spectrum with irradiation at 0.60 ppm (x 32).  
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The ΔIL − STD𝑖 ,𝑡𝑒𝑟𝑛𝑎𝑟𝑦  were calculated using the initial slopes (non-normalised) 
extrapolated from the build-up curves at the two frequencies (
𝑖𝑛𝑖𝑡𝑖𝑎𝑙  𝑠𝑙𝑜𝑝𝑒 𝑜𝑛−𝑙𝑖𝑔𝑎𝑛𝑑,𝑖
𝑖𝑛𝑖𝑡𝑖𝑎𝑡𝑙  𝑠𝑙𝑜𝑝𝑒 𝑜𝑓𝑓−𝑙𝑖𝑔𝑎𝑛𝑑,𝑖
), 
rather than on the STD values at a given saturation time (
𝑆𝑇𝐷 𝑜𝑛−𝑙𝑖𝑔𝑎𝑛𝑑,𝑖
𝑆𝑇𝐷 𝑜𝑓𝑓−𝑙𝑖𝑔𝑎𝑛𝑑 ,𝑖
) (Figure 3.15a). 
This looked necessary for such steep build up curves. Not surprisingly, a very similar 
pattern of ΔIL-STDs was obtained when the calculations were repeated with the STD 
intensities at 0.1 s, as we discuss in the following sub-section. The raw and processed 
data are found in Table 3.6. 
 
Figure 3.15. (a)  ΔIL-STD histogram for the system Naproxen/BSA calculated using the initial 
slopes of the build-up curves acquired at 1.46 ppm (on-ligand, methyl group irradiation) and 
0.60 ppm (off-ligand). Intra-ligand NOE is the main effect, with ΔIL-STDs decreasing from the 
methyl group towards the other end of the molecule: the trend is broken at the ΔIL-STD of the 
methoxy group, which is larger than the ΔIL-STD of a1 and a3. This reports on the proximity of 
the two bound Naproxen NPS2 and NPS3, as observed in (b) the crystal structure of the complex 
(PDB ID: 4OR0). 
For a X-X’ ternary complex, running the experiment on the binary system is not possible. 
Nevertheless, the ΔIL-STD patterns obtained were self-consistent and in good 
agreement with the crystal structure (Figure 3.14b). Naproxen is a small and rigid 
molecule, and it is clear from the ΔIL-STD (Figure 3.14a) that the main effect of 
irradiating on-ligand is an increase of the neighbouring aromatic groups due to intra -
ligand NOE.  
The IL-STD factors decrease along the molecule going from the carboxylic to the 
methoxy end (Figure 3.14a). Remarkably, the IL-STD factor on the methoxy group is 
higher than the one for a1, a3 and a2. Considering the rigidity of the molecule, this can 
solely be explained by the inter-ligand transfer of magnetisation from Naproxen NPS3 
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to Naproxen NPS2 (also confirming our assumption of observing Naproxen NPS2 
mainly). 
Due to the multiple-binding modes, the steep build-up curves and the “pseudo-ternary” 
X-X’ nature of the complex, the BSA/Naproxen complex was a very hard system on which 
to detect IL-STD signals. The fact that we do see them, gives us ground to propose that 
IL-STD NMR can be detected and has the potential to be useful for assessing the relative 
orientation of two bound ligands, or of two binding subsites (when one of the two is 
known) as we report in Chapter 4, Section 4.2 on a X-Y ternary complex. 
Proton 
1H   (ppm) 
[a] 
Initial slope  
1.46 ppm 
(s-1) 
Initial slope  
0.60 ppm 
(s-1) 
Ratio initial slope 
1.46 ppm/0.60 
ppm 
ΔIL-STD 
OCH3 3.71 43.27 4.83 8.96 0.96 
a1 6.98 59.32 6.93 8.57 0.57 
a3 7.13 56.97 6.22 9.16 1.16 
a2 7.61 48.78 5.61 8.70 0.70 
a4 7.53 64.33 5.27 12.20 4.20 
a5 7.59 54.59 5.69 9.60 1.60 
a6 7.24 61.55 4.76 12.94 4.94 
Hα 3.55 71.29 4.56 15.64 7.64 
 
   
N 
 
 
   
8 
 
Table 3.6. ΔIL-STD calculated using the initial slopes of the STD NMR build-up curves (1.46 
ppm/0.60 ppm) for the Naproxen/BSA complex. [a] Spectra  for ass ignment acquired at 298 K. 
 3.4.5 Selection of the saturation time for ΔDEEP-STD and ΔIL-STD studies 
The interpretation of the data obtained on the Naproxen/BSA system triggered some 
reflection on using a single saturation time, as opposed to a whole build-up curve, to 
calculate IL-STD factors. The IL-STD factors (1.46 ppm/0.60 ppm) of Naproxen NPS2 at 
three different saturation times are reported in Figure 3.16. It is interesting to observe 
how the information present at 0.1 s gets lost at increasing saturation times; and how 
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the absolute intensities of ΔIL-STD become lower at longer saturation times. This 
“flattening” is due to the role of longitudinal relaxation. Not surprisingly, the pattern 
observed at 0.1 s is very similar the one observed when the ΔIL-STD are calculated using 
the initial slopes obtained from the build-up curves in Figure 3.14a (the initial slope 
extrapolates the STD (%) when the saturation time approaches zero).  
 
Figure 3.16. ΔIL-STD factors (1.46 ppm/0.60 ppm) for Naproxen (NPS2) in complex with BSA at 
increasing saturation times (0.1 s, 0.3 s, 0.5s). The pattern observed at 0.1 s (very similar to the 
one obtained with the initial slopes in Figure 3.14a) is lost as the saturation time increases (at 
0.5 s the IL-STD factors for protons Methoxy, a1, a3 and a2 are similar). 
In Figure 3.17, the same comparison is drawn for differential irradiation DEEP-STD study 
on 2,7-anhydro-Neu5Ac/GH33 from Figure 3.7a, left panel. In this case, the stark 
differences observed at 0.5 s disappear at 2 s, where all the ΔDEEP-STD are below |0.5|.  
It is interesting to observe that, at longer saturation times, the pattern of the ΔDEEP-
STD map is retained (H3a and CH3 are still the highest positive values and H8, H9 and H9’ 
still the lowest negative values), but the overall map is “flattened” around 0.  
STD NMR can be considered as a truncated NOE (TOE) experiment, where the rate at 
which the steady state is reached carries the information on spatial proximity. This 
means that the ligand longitudinal relaxation (𝑅1) starts playing a role the closer we get 
to the steady state (at longer saturation times). In the binding epitope mapping 
approach, eliminating the 𝑅1 contribution is crucial to retain the spatial information. 
𝑆𝑇𝐷𝑚𝑎𝑥 (reached at the steady state, when the curve plateaus) is dependent on both 
cross relaxation (𝜎𝐼𝑆 ) and longitudinal relaxation (Equation 1.40, in Chapter 1). For this 
reason, the binding epitope of ligands containing protons with different relaxation 
properties could be misleading if calculated at a single time point too close to the 
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𝑆𝑇𝐷𝑚𝑎𝑥
70c,108. Therefore, for determining STD NMR binding epitope mappings, relying 
on the initial slope is unavoidable, albeit time-consuming to acquire and process.  
 
Figure 3.17. ΔDEEP-STD factors (0.60 ppm/6.55 ppm) for 2,7-anhydro-Neu5Ac in complex with 
GH33 at increasing saturation times (0.5 s, 1 s, 2 s). As observed for the IL-STD data (Figure 3.16), 
the starker differences among the protons are observed at the shorter saturation times. 
For the DEEP- and IL-STD NMR, comparison of a single saturation time at two different 
frequencies is shown to be reliable and allows to keep the protocol simple enough (STD 
NMR build-up curves can always be run in particularly problematic systems or in case of 
doubt). The condition for the choice of the saturation time is that it is short enough in 
the relaxation time scale of the system in analysis (far from the plateau of the build-up 
curve). Thus, the choice of the saturation time is system-dependent. Seemingly, analysis 
at long saturation times can cause loss of information (flatter histograms), not its 
mismatching. In defining the saturation time at which to perform the analysis, it is also 
fundamental to consider the absolute intensities of the signals for each complex. If the 
signal intensities are too small, the experimental error could invalidate the approach 
(e.g., for most protein-ligand systems, the STD signals at 0.1 s would be within the noise). 
For very low affinity systems, or in situations where many experiment needs to be 
performed, one can consider increasing the saturation time to 1 s or 2 s, upon making 
sure that the information is not lost.  
Based on this, to extract the maximal information coming from spin diffusion 
inhomogeneity using DEEP-STD and IL-STD approaches, we recommend to always 
choose the shortest saturation time that the system and the situation allow. 
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3.5 Conclusions  
In this chapter, we proposed two novel and versatile approaches to exploit 
inhomogeneity of spin diffusion to obtain information on the molecular space 
surrounding the ligand (Figure 3.18).  
Firstly, the information coming from IL-STD NMR (spatial vicinity of two adjacently 
bound fragments in a binding pocket) could already be obtained by other ligand-based 
techniques (tr-NOESY under ILOE conditions). Thus, we propose IL-STD NMR rather as a 
proof of concept that inter- (and intra-) ligand STD can be observed: to the best of our 
knowledge, this had never been reported before. For favourable cases, IL-STD NMR 
looks like a promising and time-efficient technique to help the process of knowledge-
based drug design. Together with ILOE, it allows to explore the orientation of binding 
sub-sites and bound fragments in known and unknown binding pockets, or to validate 
ternary complex models in fundamental research projects, as we report in Chapter 4, 
Section 4.2. 
 
Figure 3.18. Cartoon schematising the information obtained on protein-ligand interactions by 
traditional STD NMR and by the two approaches proposed by us (DEEP-STD NMR and IL-STD 
NMR). 
Secondly and more importantly, we propose DEEP-STD NMR as an original approach, 
which gives access to a layer of structural information previously inaccessible through 
ligand-based NMR techniques: exploring the nature of the amino acid residues 
surrounding the ligand in the binding site, and hence assessing the pharmacophore of 
the protein. We designed a simple and robust protocol relying on differential irradiation 
or differential deuteration of the polar residues in the binding site; and we envision that 
DEEP-STD NMR, in combination with classical STD NMR, will become a popular approach 
to characterize intermolecular interactions revealing the nature of the protein-ligand 
contacts. Given the amphiphilic nature of many ligand-receptor interactions (both 
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synthetic and natural ligands), the approach is advantageous both in fragment-based 
drug discovery and in fundamental biological research.  
If the 3D structure of the protein is known, the protocol allows for the first time to gain 
information from STD NMR on the orientation of the ligand. We have demonstrated this 
here for small ligands, which are more difficult to orient than larger ones. DEEP-STD 
NMR combined with the 3D structure of the protein is expected to define the orientation 
of larger ligands in the bound state even more easily. As we will show in Chapter 4 and 
5, if different ligands of a well characterized protein are studied, DEEP-STD NMR will 
provide different fingerprints to readily obtain their different binding orientations  
(Section 5.2). From there, the technique can be expanded by performing “on-resonance 
scanning” and detailing even more in depth the nature of the contacts (Section 4.3). 
Noticeably, DEEP-STD NMR is applicable even when the 3D structure of the protein is 
unknown; in this case, the nature and architecture of the binding site could be unveiled, 
as the technique allows to identify possible “patches” (aliphatic, aromatic, polar, etc.) 
within the unknown pocket. 
The possibility of detecting “polar patches” is especially appealing in the investigation 
of protein-carbohydrate interactions, as carbohydrate-recognising binding pockets are 
often lined with arginine, histidine and asparagine109 (promoting cooperative H-bonds, 
bidentate interactions and other stabilizing contacts 12). GH33, among the many 
sialidases, is a remarkable example, with its arginine triad complexing the carboxylate 
group to keep the sialic acid in place12; but it is also true for heparin-binding proteins 
and other targets110. 
IL-STD NMR and DEEP-STD NMR should be regarded as versatile tools providing 
structural information at the atomic level on the binding pocket environment in which 
the ligand resides. 
3.6 Materials and Methods  
3.6.1 Chemicals, ligands and proteins  
Compounds 3-nitro-phenyl -ᴅ-galactopyranoside (3NPG) and Naproxen > 98.8%, 
cholera toxin subunit B (CTB), bovine serum albumin (BSA), deuterium oxide (99.9% 2H), 
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tris-(hydroxymethyl-d3)amino-d2-methane (Tris-d11, 98% 2H), disodium hydrogen 
phosphate (Na2HPO4), potassium dihydrogen phosphate (KH2PO4), sodium chloride 
(NaCl) and potassium chloride (KCl) were purchased from Sigma. Sugar Neu5Acα6Lac 
(6’SL) was purchased by Glycom. Sugar 2,7-anhydro-Neu5Ac was prepared from our 
collaborators in the group of Nathalie Juge (Quadram Institute) as previously described 
in 111. [Briefly, the compound was enzymatically synthetised by incubating 4-
Methylumbelliferyl-Neu5Ac with RgNanH in ammonium formate buffer (100 mM) at 
37°C, pH 6.5 overnight. The reaction was terminated by the addition of an equal volume 
of ethanol and the precipitate removed by centrifugation (4000 g for 20 min).  The 
mixture was evaporated to dryness and the 2,7-anhydro-Neu5Ac was purified by Folch 
partitioning.] 
CBM40 and GH33 were also expressed by our collaborators at the Quadram Institute as 
well. CBM40 was expressed in Escherichia coli BL21 Rosetta (DE3) (Novagen) with a six-
histidine tag and purified on a nickel-Sepharose column, as described in 97. GH33 was 
expressed in Escherichia coli BL21 cells (New England Biolabs, Boston, USA) and purified 
by immobilized metal anion chromatography (IMAC) as described17, where this domain 
is denoted “RgNanH NI-domain”. 
3.6.2 NMR measurements and processing  
 1H and 13C resonance assignment for the ligands was performed on the bases of 1D 1H, 
2D 1H-1H DQF-COSY, 1H-13C HSQC and 1H-1H NOESY experiments run on the free ligands 
in deuterium oxide. For STD NMR experiments, all the samples consisted of 50 μM in 
binding sites (CBM40 and GH33 and BSA have a single binding site per protein, whereas 
CTB is a pentamer with five identical binding sites) and 1 mM ligand (except for 
Naproxen which was at 4 mM). 6’SL/CBM40 sample was analysed at 288 K and 2,7-
anhydro-Neu5Ac/GH33 samples were analysed at 293 K, both buffered in 10 mM Tris -
d11 pH 7.8 and 100 mM NaCl; 3NPG/CTB samples were analysed at 278 K and 
Naproxen/BSA sample was analysed at 303 K, both buffered in 10 mM PBS buffer, 137 
mM NaCl and 2.7 mM KCl pH 7.4. For the experiments in light water, buffers and ligands 
were freeze dried and dissolved in Milli Q and the H2O:D2O ratio adjusted to 90:10 (10% 
D2O for locking purposes). An STD pulse sequence that included 2.5 ms and 5 ms trim 
pulses and a 3 ms spoil gradient was used. Saturation was achieved by applying a train 
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of 50 ms Gaussian pulses (0.40 mW) on the f2 channel, at the variable frequencies 
indicated in the text (on-resonance experiments) and 40 ppm (off-resonance 
experiments). The broad protein signals were removed using a 40 ms spinlock (𝑇1𝜌) 
filter (stddiff.3). When required, water suppression was achieved by excitation sculpting 
with gradient (stddiffesgp.3). Saturation times ranging from 0.1 s to 2 s as indicated in 
the text and 5 s relaxation delay were used. 6’SL/CBM40 experiments were run with 256 
scans; DEEP-STD experiments (2,7-anhydro-Neu5Ac/GH33 and 3NPG/CTB) were run 
with 256 scans for samples in D2O and 512 scans for samples with H2O:D2O 90:10; 
Naproxen/BSA were run with 32 scans.  All the experiments were recorded at 1H 
frequency of 800.23 MHz on a Bruker Avance III spectrometer equipped with a 5-mm 
probe TXI 800 MHz H-C/N-D-05 Z BTO. For Naproxen/BSA, the build-up curves (0.1 s to 
2 s) for each proton were fitted mathematically to a mono-exponential equation 
(y=a*[1-exp(b*x)]), from which the initial slopes (a*b) were obtained. The binding 
epitope mapping was obtained by dividing the initial slopes by the one proton a1, to 
which an arbitrary value of 100% was assigned.  
3.6.3 CORCEMA-ST66  
For CORCEMA-ST calculation in Sub-section 3.3.7, the cut-off distance around the 
binding pocket was 8 Å. The concentration of ligand and protein used was respectively 
2 mM and 45 μM. 𝑘𝑜𝑛  was set to 1 × 10
-8 M-1 s-1. The bound ligand correlation time was 
50 ns, whereas the free correlation time was 1 ns. The equilibrium constant used was 
2000 M-1 (𝐾𝐷  = 0.5 mM). The ρ leak used was 0.4 Hz, except for the simulation of the 
experiment in H2O, where the ρ leak was put at 6 Hz. The irradiation frequency was set 
to the range 0.1 ppm to 1.1 ppm to simulate the conditions of irradiation at 0.60 ppm; 
and to the range 5.1 ppm to 7.0 ppm to simulate the conditions of irradiation at 6.55 
ppm. To simulate the presence of H2O as a solvent, the “i4” (“indata11”) was set to 0 (1 
is for measurement in D2O, 0 for measurement in H2O). In these conditions, the STD 
intensities were simulated for a saturation time of 0.5 s. 
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Chapter 4  
New avenues for Cholera Toxin B (CTB) inhibition 
4.1 Introduction 
4.1.1 Cholera: onset and treatment of a neglected tropical disease  
Cholera is a bacterial infection classified within the group of “neglected tropical 
diseases”112. It is considered endemic in 50 countries, but it manifests as epidemic in 
association with natural disasters and emergency situations characterised by poor 
hygienic conditions113. The World Health Organization estimates 3-5 million people 
affected by cholera and 100.000 to 130.000 deaths, every year114. The infection is spread 
by ingestion of the bacteria Vibrio cholera O1 or O139112. Once the microorganism 
reaches the small intestine and colonises it, it secretes an enterotoxin called cholera 
toxin (CT), which triggers disruption of the ion channels of the epithelial cells of the 
guest. This leads to severe water and salt loss, resulting in strong de-hydration and 
death115.  
At the molecular level, the ion channel disruption pathway is initiated by the interaction 
of cholera toxin with the glycosphingolipid ganglioside-monosialylated GM1 exposed on 
the membranes of the mucosal cells of the hosts intestines. GM1 is a branched 
pentasaccharide of structure β-Gal(1-3)β-GalNAc(1-4)-[αNeuAc(2-3)-]β-Gal(1-4)Glc 
(Figure 4.1a). CT belongs to the lectin family and is an 84 kDa AB5 protein, composed of 
a monomeric A and a pentameric B5 subunit (Figure 4.1b)116. CTA is the enzymatically 
active domain responsible for the toxic effects; CTB is responsible for complexing GM1 
in a multivalent fashion and mediating entry into the cell115.  
The mechanism of penetration of CT through the membrane to reach the Golgi 
apparatus has been extensively investigated through a range of methods but some parts 
of the mechanisms are still unclear117,118,119. CTA triggers a signalling cascade that 
disrupts the normal biochemical pathway of the regulatory enzyme adenyl cyclase (AC). 
The outcome is the continuous activation of AC, and thus, the uninterrupted hydrolysis 
of ATP to AMP. The high concentration of AMP up-regulates the chloride channel 
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proteins in the lumen; therefore, an excess of Cl- ions is expelled. To maintain the 
electrochemical balance, an equal amount of Na+ is excreted, followed by water due to 
osmosis, thus causing severe de-hydration115. 
 
Figure 4.1. (a) Structure of the GM1 pentasaccharide with residues labelled in red; the main 
recognition elements for binding to CTB are enclosed in blue curves. (b) Crystal structure of CT 
(PDB ID: 1XTC120): CTB pentamer in green to yellow and CTA in cyan and blue, as shown by the 
curly brackets.  
The first treatment for cholera consist of re-hydration of the infected individuals with 
clean water. This becomes very challenging when cholera occurs in areas with 
contaminated water sources. For severe cases, antibiotics are used, mainly tetracyclines 
and doxycyclines112; however, antibiotic resistance is a growing concern and multidrug 
resistant strains of Vibrio cholera have been observed worldwide121,122,123. This evidence 
has boosted i) research towards vaccine development (the oral administration of CTB 
vaccine is widespread and there are many other options available on the market114); and 
ii) the design of CTB antagonists, to inhibit the formation of the GM1/CTB complex.  
4.1.2 Dissecting the Cholera Toxin B/GM1 interaction  
The present work pursues the optimisation of inhibitors of cholera toxin internalisation, 
by impeding the molecular recognition of GM1 by the cholera toxin subunit B (CTB). 
Remarkably, the GM1/CTB interaction is one of the strongest observed for protein -
carbohydrate complexes, with a 𝐾𝐷  in the nM range
124. Thus, a profound knowledge of 
the structural features that govern the molecular recognition between CTB and GM1 is 
key to the design of strong inhibitors. High-resolution crystallography studies 120,125,126,   
and one thorough thermodynamic analysis127 of the native GM1/CTB complex are the 
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germinal works which allowed to unravel the mechanism of molecular recognition. The 
X-ray structure of the GM1/CTB complex (PDB ID: 3CHB126) shows that the main 
elements of recognition of GM1 are the non-reducing galactose (IV) and sialic acid (V) 
residues (Figure 4.1 left and 4.2), so that the binding mode can be considered as bi -
dentate.  
The research group of Homans investigated the GM1/CTB interaction in solution by 
isothermal titration calorimetry (ITC), detailing the thermodynamic contribution of each 
monosaccharide of GM1127. The study showed that residues (III), (IV) and (V) contribute 
for 17%, 39% and 43%, respectively, of the buried surface area of the intermolecular 
interaction. On the other hand, residues (IV) and (V) account for 54% and 44% of the 
intrinsic binding energy, respectively, thus indicating that the galactose binding subsite 
is more specific and shielded from the solvent than the sialic acid one.  
 
Figure 4.2. 3D representation of the binding site of GM1 bound to CTB (PDB ID: 3CHB126). CTB is 
shown as a surface coloured in blue and orange to identify the sialic acid and galactose subsites, 
respectively. GM1 is shown as sticks and labelled as in Figure 4.1a. The protons of GM1 are 
omitted for clarity.  
Two valid arguments to account for the high monovalent affinity of the interaction 
are127:  
 the conformational pre-organization of the pentasaccharide (i.e., free 
conformation is similar to the bound conformation); 
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 the key-residues for recognition, galactose (IV) and sialic acid (V), being spaced 
by residues (II) and (III), which prevents any corresponding couple of fragments 
of GM1 from achieving interaction of comparable efficiency (i .e., preventing 
multiple binding modes). 
Based on these fundamental works, the research groups of Jimenez-Barbero and 
Bernardi used NMR (tr-NOESY and ROESY) and computational techniques to analyse the 
binding of GM1 analogues to CTB128.  
Firstly, they demonstrated that substituting GM1 residues (II) and (I) with 
cyclohexanediol does not affect its binding affinity. Hence, they synthetised a small 
library of glycomimetcs, in couple of stereoisomers (Figure 4.3), in which the sia lic acid 
(V) of GM1 was replaced with an α-decorated carboxylic group, meant to mimic the less 
Neu5Ac specific interaction.  
Ligand 5 (R configuration) was found to be 10 times more active than its stereoisomer 
Ligand 4 (𝐾𝐷s 190 μM and 1000 μM, respectively). Hence, Ligands 6 and 7 were 
synthesised in the R configuration and gave binding affinities to CTB of 45 μM and 10 
μM, respectively. 
 
Figure 4.3: Synthetic glycomimetics based on the scaffold of a non-reducing β-Gal(1-3)β-GalNAc 
O-glycosilated to a substituted cyclohexanediol, from the work of Jimenez-Barbero and 
Bernardi128.  
Tr-NOESY experiments showed that, while Ligand 6 rearranged upon binding, the free 
and bound conformations of Ligand 7 was identical. Specifically, the non-reducing 
galactose and aromatic ring of Ligand 7 seemed to interact through a stabilizing stacking 
where the phenyl ring is sandwiched between the GlcNAc and the protein surface, as 
shown by MD and tr-NOESY. Ligand 7 inspired many of the following GM1 antagonists 
which we will cover in the following sub-section, and the observation of a 
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“conformational lock” within the ligand marked a milestone in the research on GM1 
glycomimetics128. 
4.1.3 Overview of CTB inhibitors: from cyclohexanediol scaffolds to polyvalent ligands 
The group of Bernardi built on the cyclohexanediol scaffold modifying systematically 
different fragments of the structure without succeeding to improve the affinity relative 
to Ligand 7129,130. Thereafter, they designed a new class of ligands based on a galactose 
linked to a sialic acid moiety through a non-hydrolysable spacer, in the attempt to 
reproduce the bidentate binding mode of GM1. While bioavailability increased due to 
insertion of the non-hydrolysable linker, the affinity decreased (𝐾𝐷  in the low mM 
range). Among them, Ligands 58 and 59 in Figure 4.4 showed the best affinities90. 
 
Figure 4.4. Scaffold of the non-hydrolysable ligands, from the work of Bernardi90. 
Pieters and co-workers conjugated a lactose moiety to aryl residues through a thiourea 
(Ligands 23 and 24 in Figure 4.5)131: the galactose served as an anchor to the galactose 
binding subsite, and the phenyl groups was conceived to occupy the sialic acid subsite. 
The strongest binder of this library showed a 𝐾𝐷  of 23 μM by weak affinity 
chromatography, while no 3D structural information was provided on the binding of this 
library in the study. 
 
Figure 4.5. The lactose-based ligands, form the work of Pieters131. 
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A great research effort has also been put in the field of multivalent binding, which is 
known to enhance the affinity by 100- to 1000-fold relative to monovalent binding28. 
Jointly, the groups of Bernardi and Pieters proposed a class of glycodendrimeric ligands 
composed of 3,5-d-(2-aminoethoxy)-benzoic acid repeating units, substituted with 
lactose moieties (𝐾𝐷=10 μM). Conjugating the dendrimer core with Ligand 5 (Figure 4.3) 
via a spacer yielded a 𝐾𝐷  of 0.5 μM, showing the validity of the approach
132. Other 
solutions resorted to α-cyclodextrins133 or poly-(N-acryloylmorpholine) polymers as 
bivalent ligands (that is, consisting of two galactose moieties connected through a 
linker)134. The group of Gibson specifically focused on the investigation of galactose-
functional polymers. First they showed how the length of the polymeric linker is a key 
element for binding to such a deep binding site (most lectins present much shallower 
clefts of interaction)135. More recently, they introduced a secondary binding motif on 
the linker, branched relative to the original galactose one (Figure 4.6a). Whereas the 
installed “side chains” were simple organic residues, based on benzylic groups 
decorated with halogens in different patterns (Figure 4.6b), they showed that their 
presence increased the efficiency of binding relative to the previous galactose-only-
functional polymers136.  
 
Figure 4.6. (a) The glycopolymers with secondary branched binding motifs approach proposed 
by the group of Gibson; (b) some of the small organic residues used as the second unit in the 
study. Figure from 136. 
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In this study, the authors highlighted two very important points: i) resorting to glycan 
branching, trying to mimic the binding mode of GM1 as we know it from the available 
structural biology information, achieved improved results; ii) complicated glycan-
synthesis is not the only way to reach powerful lectins inhibition.  
The lowest 𝐾𝐷  reported so far, with affinity in the picomolar range, was achieved by 
means of an elegant approach using an engineered neoglyco-CTB equipped with five 
GM1 units attached through linkers to each monomer of the engineered CTB (Figure 
4.7). This design allowed to match the geometrical requirements of the wild type toxin 
and deactivate it in multivalent fashion with optimal spacing137. 
 
Figure 4.7. Engineered CTB W88E (in orange), carrying five GM1s (blues points) to bind wild-type 
CT (in red). Figure from 137. 
4.1.4 CTB ligands based on polyhydroxyalkylfuroate scaffolds92 
Drawing from the knowledge acquired in the previous decade of research on GM1-
mimicking molecules, Robina and co-workers, our collaborators at the University of 
Seville (Spain), designed four new generations of compounds as potential inhibitors of 
CTB92. The novel underlying idea was to promote bi-dentate monovalent binding while 
reducing the number of carbohydrate units in the antagonists, to ease synthetic efforts.  
The rationale behind this scaffold (Figure 4.8a) is the presence of a β-thio-galactose: this, 
on one hand, anchors the ligand into the specific galactose subsite and, on the other 
hand, prevents hydrolysis when compared to an O-glycosidic linkage. The thio-galactose 
is linked to a polyhydroxyalkylfuroate chain (PHF chain), meant to mimic sialic acid and 
to occupy its subsite. The pharmacophores are there connected by a non-hydrolysable 
click chemistry spacer, synthetically convenient and chemically stable. The polyhydroxy 
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chain, together with the triazole linker, helps increasing the solubility and offers 
possibilities for further decoration of the chain or assembly of multivalent binders.  
The affinity of the four libraries towards CTB were assessed by weak affinity 
chromatography (WAC), using a dedicated approach developed by Ohlson and co-
workers in 200991. In this approach, 3-nitrophenyl-α-ᴅ-galactopyranoside (3NPG), a 
well-known CTB binder, was used as reference (𝐾𝐷=1.10 mM). The results pointed at 
Ligand 30 as the main lead from Generation II, with a 𝐾𝐷  of 1.05 mM (Figure 4.8b).  
Ligand 30, together with its constituent binding Ligand 20 and Ligand 33 (Figure 4.9), 
were analysed by 1H STD NMR to determine the epitope mapping of their interactions 
to CTB, and to elucidate the role of the polyhydroxyalkylfuroate chain in the interaction.  
 
Figure 4.8. (a) Schematic representation of Generation II of S-linked galactosides (E=1,2,3 
triazole), in 92; (b) Chemical structure of Ligand 30, the best performing CTB binder from 
Generation II.  
The STD NMR analysis showed the thio-galactose moiety and the furoate-aromatic 
region of Ligand 30 to be the closest contact points to the CTB surface. This qualitatively 
confirmed the hypothesis of a bi-dentate binding mode adopted by Ligand 30. The fact 
that the two fragments (Ligand 20 and 33) show relative STD intensity patterns very 
similar to that of the parent compound (Figure 4.9) supported the case of specific 
binding to the same binding subsites, although it did no shed light on the location of the 
subsites, particularly in the case of the polyhydroxyalkylfuroate chain. 
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Figure 4.9. 1H STD NMR binding epitope mapping of Ligand 30, Ligand 20 and Ligand 33 (data 
from 92). The normalised STD values from the initial slope of each proton, relative to the most 
intense one (for which a 100% is arbitrarily assigned), is shown next to it.  
4.2 Discovery of a novel binding subsite in the GM1 binding pocket of CTB  
4.2.1 Crystallisation trials of the Ligand 33/CTB complex 
Based on the work of Robina and co-workers, we first attempted to define the location 
of binding of the polyhydroxyalkylfuroate ligands by trying to co-crystallise the Ligand 
33/CTB complex. In the first place, the complex solution (1 : 1 ligand  to protein ratio at 
4% DMSO) was plated in phosphate buffer pH 7.4 at variable concentration of PEGs of 
variable sizes (4x4 in triplicates), incubated at 16 °C and followed over two weeks. 
Despite these being the favourable conditions for crystallisation of CTB in the apo 
form116,88, the few crystals observed were too small for X-Ray diffraction. Therefore, 48 
x 8 conditions were tried in duplicate with commercially available screening kits, namely 
Structure Screen 1 Eco Screen (MD1-01-ECO and MD2-02-ECO), PACT Premier Eco 
Screen (MD1-29-ECO), JCSG-plus Eco Screen (MD1-37-ECO) and Morpheus® (MD1-48). 
About ten crystals were fished after 2 weeks of incubation at 16 °C, and analysed at the 
Diamond Light Source synchrotron from our collaborators at the School of Biology (Dr. 
Andrew Hemmings and MSc Isabella Acquistapace). Unfortunately, none of the resulting 
structures contained the ligand and only a blurry fit of the CTB in apo form was obtained 
(resolution > 3 Ȧ). This could be explained by the presence of DMSO in the drops 
(necessary to solubilise the ligand but probably disturbing the crystallisation process), 
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but also and especially by the flexible nature of the ligand and by its low affinity (1.35 
mM).  
4.2.2 STD NMR competition experiments: probing the fragments specificity to the CTB 
subsites within the GM1 binding pocket  
Among ligand-based NMR techniques, STD NMR competition is a powerful approach to 
probe the location of binding of unknown ligands82,81. To this aim, STD-active probe 
ligands known to occupy the subsites of interest are needed. Ligand 3-nitro-phenyl α-ᴅ-
galactopyranoside (3NPG) was chosen as a probe-ligand for the galactose sub-site (as in 
PDB ID: 1EEI88); and 3’-syalillactose (3’SL), the Neu5Ac-containing branch of GM1, was 
chosen as probe-ligand for the sialic acid subsite (Figure 4.10). 
 
Figure 4.10. Chemical structures of 3-nitrophenyl-α-ᴅ-galactopyranoside (3NPG) and 
3’-sialyllactose (3’SL). The numbering of 3NPG and the residue names of 3’SL are shown.  
Four STD NMR competition experiments were carried out. The results are summarised 
in Table 4.1 and the spectra are shown in Figure 4.11 and in Figure A.1 of the Appendix.  
Experiment 
Reference 
Binder 
Competitor Displacement 
(a) Ligand 30 3NPG Y 
(b) Ligand 30 Ligand 33 Y 
(c) Ligand 33 3NPG N 
(d) Ligand 33 3’SL N 
Table 4.1. Table of results of the competition experiments. The column “Displacement” shows 
whether the competitor displaced (Y) or not (N) the reference binder.  
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In experiment (a), Ligand 30 was observed competing with 3NPG. When an equimolar 
fraction of 3NPG was added to the solution containing the Ligand 30/CTB complex, some 
displacement of Ligand 30 was observed. In particular, the STD intensities of Ligand 30 
were halved, a result compatible with both compounds presenting a similar 𝐾𝐷  for CTB 
(1.10 mM for 3NPG and 1.05 mM for Ligand 30). This confirms that the thio-galactose 
moiety of Ligand 30 binds to the galactose subsite, previously occupied by 3NPG. 
 
Figure 4.11. STD NMR spectra of competition experiments (a), (b), (c) and (d) (as labelled in 
Table 4.1). For each panel, the superposition of the reference spectra and the STD difference 
spectra is shown on the top and bottom, respectively. The spectra of the reference binder alone 
are shown in red and the spectra upon addition of the competitor are shown in black. Protons 
nomenclature is given in Figure 4.8b and 4.10. Red arrows on the difference spectra highlight 
the decrease of STD signals of the reference binders upon addition of the competitor. (d) The 
small 3’SL STD signals on the baseline of the difference spectra are indicated by a blue circle. A 
line broadening factor of 3 Hz was applied to the FID before FT. Ligand 30 signals are highlighted 
by red triangles, 3NPG signals are highlighted by red hexagons, Ligand 33 signals are highlighted 
by black circles and 3’SL signals are highlighted by black diamonds. Full spectra of competitions 
130 | P a g e  
 
(a) and (b), and the STD NMR spectra of the 3’SL/CTB complex alone are reported in the 
Appendix (Figure A.1 and A.2). 
In the competition between Ligand 30 and Ligand 33, experiment (b), only protons H1, 
H2, and H5 of ligand 30 could be monitored due to complete overlapping of the 
non-galactose peaks of the two ligands. The STD signals of these protons dropped upon 
addition of Ligand 33 (𝐾𝐷= 1.35 mM), thus showing that both Ligand 30 and Ligand 33 
occupy a common subsite, most likely via the polyhydroxyalkylfuroate moiety. This 
could be expected based on the similar binding epitopes of the PHF region of both 
ligands, as reported in Figure 4.9. 
In experiment (c), Ligand 33 was tested in competition with 3NPG. No competition was 
observed in this experiment, showing that the binding of Ligand 33 does not involve the 
galactose subsite.   
Finally, to investigate the binding location of the PHF moiety, competition between 
Ligand 33 and 3'SL was carried out (experiment (d)). The 1H STD intensities of Ligand 33 
were not affected upon addition of 3’SL. Despite being of low intensity, the STD signals 
corresponding to 3’SL can be seen in the baseline of both difference spectra (the STD 
NMR experiment on the complex 3’SL/CTB is shown in Figure A.2 of the Appendix). This 
suggests that the binding of Ligands 30 and 33 does not involve the sialic acid subsite 
but may require the presence of an unknown subsite able to accommodate the PHF 
moiety of both ligands. 
4.2.3 ILOE experiments: exploring proximity of the binding subsites  
The scenario depicted by the STD NMR competition experiments did not exclude that 
Ligand 30 and Ligand 33 could compete for a subsite outside the GM1 binding pocket. 
In fact, the binding of Ligand 30 to the galactose subsite is compatible with binding to a 
second binding pocket, located elsewhere on the protein surface, and where Ligand 33 
would bind too. To shed light on this, the proximity of the galactose subsite and the 
unknown subsite accommodating the PHF chain of both ligands must be probed. 
Following an ILOE approach84, we ran tr-NOESY experiment on the potential ternary 
complex 3NPG/CTB/Ligand 33 to explore the vicinity of the two binding subsites. As 
observed in experiment (c) in Table 4.1, 3NPG and Ligand 33 bind independently from 
each other. Therefore, if they were bound in proximity to each other, i.e. their binding 
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subsites were adjacent, there would be chances of protons of both ligands getting close 
in space in the bound state, and then significant possibilities of observing inter-ligand 
cross peaks on the ILOE spectra. Expansions of the ILOE experiment are reported in 
Figure 4.12. 
 
Figure 4.12. Left, expansion of the tr-NOESY experiments of the ternary complex 
3NPG/CTB/Ligand 33 (in black) and the control 3NPG/CTB (in red). Diagonal and cross peaks are 
assigned and the ILOE signal between Hc,d of 3NPG and Htriazole of Ligand 33 is squared in 
turquoise and magnified on the right. 3NPG frequencies are highlighted by red hexagons, and 
Ligand 33 frequencies are highlighted by black circles. The structure and nomenclature of the 
two ligands is reported here again for clarity.  
In addition to the expected intra-ligand cross peaks from both ligands, we did observe a 
single inter-ligand cross peak between the triazole proton (Htriazole) of Ligand 33 (7.67 
ppm) and the Hc,d protons of 3NPG (positions meta and para to the nitro group, both 
at 7.27 ppm). As a control, the same experiment was performed on the binary 3NPG/CTB 
and Ligand 33/CTB complexes and on CTB alone (the control spectra and the full width 
spectra of the ternary complex are shown in the Section A.3 of the Appendix). The 7.67 
ppm/7.27 ppm cross peak, which we interpret as an intermolecular contact between 
3NPG and Ligand 33, was absent in the three control spectra. This confirmed that the 
cross peak genuinely comes from a close proximity between the two “fragments” Ligand 
33 and 3NPG in the bound state.  
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Albeit, arguably, the inter-ligand NOE could be mediated by the presence of an 
intermediate relay protein proton, the information encoded in the inter-ligand cross 
peak is that the Htriazole of Ligand 33 and the Hc and Hd of 3NPG are closer to each 
other than any other pair of protons of the two molecules. This is a qualitative result of 
paramount importance in our study, proving: 
i)  that the subsite accommodating the PHF chain is adjacent to the galactose 
subsite (excluding unspecific interactions),  
ii)  that the experiment provided information on the binding orientation of 
Ligand 33, such that the triazole end is the part pointing towards the galactose 
subsite. 
4.2.4 Molecular docking failed to provide a satisfactory model of the binding mode of the 
PHF chain  
Translating the experimental data available from STD NMR competitions experiments  
and ILOE is into a quantitative binding model requires the construction of a 3D model 
compatible with the whole set of experimental data.  
This is usually accomplished by molecular docking calculations. The available X-Ray 
structures of CTB bound to GM1 and 3NPG (PDB ID: 3CHB126 and 1EEI88) were good 
starting points to model our thio-galactose ligands.  
 
Figure 4.13. (a) Front view of GM1 (dark grey) and 3NPG (white) as bound to CTB (PDB ID: 
3CHB126 and 1EEI88). CTB is shown as a surface representation, with Ile58 and Lys34 coloured in 
green (these residues turned out to be fundamental for PHF binding, as reported in the following 
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sub-section). The galactose and sialic acid subsites are coloured in orange and blue, respectively. 
All ligand protons are omitted for clarity. 
Figure 4.13 shows the front view of the GM1 binding pocket from the X-Ray structures  
of GM1/CTB and 3NPG/CTB, to visualise the relative orientation of the two binding 
subsites. It is interesting to pinpoint how the galactose of GM1 and of 3NPG fit the 
galactose subsite in the very same orientation, despite the different glyosidic linkage, in 
accordance to the specificity of the interaction. 
Firstly, we carried out classic molecular docking (flexible ligand onto a rigid receptor). 
The coordinates of CTB from the X-Ray structure with GM1 (PDB ID: 3CHB) were used to 
generate the receptor grid and the docking parameters were optimised by re-docking 
GM1 to it with the aim of obtaining the complex as reported from the crystal structure 
(Figure 4.14a). With this optimised setting, docking of Ligand 20 (Figure 4.9) showed 
that the thio-galactoside moiety fits in the galactose subsite with the same orientation 
as the galactose of GM1 and 3NPG (Figure 4.14b). The CORCEMA-ST calculations 
validated the model with an NOE R-factor of 0.21 (Figure 4.15). 
Ligand 30 docked consistently and fit the thio-galactose in the expected subsite, as 
3NPG, Ligand 20 and GM1 (Figure 4.16a). Superposition of the galactose moiety of the 
lowest energy solution with the validated structure of Ligand 20 showed good 
convergence for the orientation of the thio-galactosidic linkage, and the triazole of 
Ligand 30 seemed to fit similarly to the acetamide group of Ligand 20.  
 
 
Figure 4.14. (a) Best docking solution of GM1 (cyan) in complex with CTB, superposed to the X-
ray structure of GM1/CTB (grey), PDB ID: 3CHB126. (b) Best docking solution of Ligand 20 (violet) 
in complex with CTB, superposed to the X-ray structure of 3NPG/CTB (white), PDB ID: 1EEI88. 
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Figure 4.15. CORCEMA-ST calculations for the best docking solutions of Ligand 20 with CTB. (a) 
Experimental STD NMR build-up curves for Ligand 20 in complex with CTB92. (b) CORCEMA-ST 
derived STD NMR build-up curves for the lowest energy docking solution of the complex. For 
clarity, the molecule atoms are divided in two columns (i) and (ii).  
However, it should be noted that CORCEMA-ST did only validate the mode of binding of 
protons belonging to the thio-galactose moiety (Figure 4.17 (i, ii)). In the docking 
calculations, the PHF moiety failed to converge to a highly populated solution, sampling 
instead the whole surface around the galactose subsite and entirely hindering the sialic 
acid subsite, in disagreement with the competition experiments (Figure 4.16b). 
Accordingly, the CORCEMA-ST calculations for protons from the PHF chain to the 
aromatic moiety did not match the experimental build-up curves (Figure 4.17 (iii, iv)).  
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Figure 4.16. (a) Zoom in of the galactose subsite: the 15 lowest energy docking solution for 
Ligand 30 (yellow) as superimposed to the lowest energy docking solution of Ligand 20 (violet); 
(b) zoom out of (a) to the entire GM1 binding pocket. (c) The 15 lowest energy docking solution 
for Ligand 33 (light red); (d) superimposition of (b) and (c). 
On the other hand, the docking solutions for Ligand 33 failed to converge at all, neither 
among them nor with the PHF moiety of Ligand 30 (Figure 4.16c and d). Most solutions 
occupied both the galactose and sialic acid subsites, and CORCEMA-ST calculations failed 
to validate the model (Figure 4.18). 
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Figure 4.17. CORCEMA-ST calculations for the best docking solutions of Ligand 30 with CTB. (a) 
Experimental STD NMR build-up curves for Ligand 30 in complex with CTB92. (b) CORCEMA-ST 
derived STD NMR build-up curves for the lowest energy docking solution of the complex. For 
clarity, the molecule atoms are divided in four columns (i), (ii), (iii) and (iv). 
 
Figure 4.18. CORCEMA-ST calculations for the best docking solution of Ligand 33 with CTB. (a) 
Experimental STD NMR build-up curves for Ligand 33 in complex with CTB92. (b) CORCEMA-ST 
derived STD NMR build-up curves for the lowest energy docking solution of the complex. For 
clarity, the molecule atoms are divided in four columns (i), (ii) and (iii). 
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4.2.5 MD and CORCEMA-ST validation of a novel subsite accommodating the PHF moiety  
One of the main weaknesses of considering the receptor as rigid in docking calculations 
is that potential conformational rearrangements of the receptor are not considered. To 
account for the flexibility of the ligand and the receptor, a thorough molecular dynamics 
(MD) of the system was performed by MSc Samuel Walpole in our group.  
In the first place, to enhance sampling of the free state of the receptor, a Hamiltonian 
Replica Exchange Molecular Dynamics (HREMD) method was applied to the apo CTB. 
HRMED approaches have previously been shown to be effective in identifying druggable 
transient binding sites138. Analysis of the trajectory over all five subunits consistently 
revealed the presence of a transient groove close to the known galactose and sialic acid 
subsites. While this groove is closed in the crystal structure of CTB, opening is facilitated 
by rotation of the Ile58 and Lys34 sidechains (Figure 4.19a), both in the presence and in 
the absence of the native ligand GM1.  
  
Figure 4.19. (a) Top: novel CTB subsite in the open (turquoise) and closed (green) conformations 
overlaid. The red arrows indicate the χ1 torsional rotation from closed to open states for the 
two residues involved (χ1 values reported for both). Bottom: top view of the closed and open 
conformations in surface representation, showing the initial and final frames of the HRMED 
simulation of apo CTB. (b) Representative frames of the most populated clusters of Ligand 30 
(pale yellow) and Ligand 33 (light red) with CTB (“open” conformation). In both panels, the 
residues forming the galactose binding subsite are shown as orange surface. The residues 
constituting the sialic acid binding subsite are shown as blue surface. Ile58 and Lys34, which 
constitute the novel groove, are shown as green surface and labelled.  
Since no large chain rearrangement is observed, the energy barrier between the 
“closed” and “open” conformations is expected to be very small. Furthermore, 
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repeating the simulation with the receptor bound to GM1 revealed that opening of this 
groove still takes place in the presence of the native ligand. This shows that this subsite 
is accessible even when the galactose and sialic acid sites are engaged, which represents 
a structural feature of crucial importance for further inhibitors design.  
 
Figure 4.20. (a) Experimental STD NMR build-up curves for Ligand 30 in complex with CTB92. (b) 
CORCEMA-ST calculated STD NMR build-up curves averaged over the 100 most representative 
frames from MD of Ligand 30 with CTB.  
Docking of Ligand 30 to this “open” conformation again showed good convergence of 
the galactose residue to the galactose subsite, with the PHF moiety consistently 
occupying the novel subsite, suggesting that it acts as specific subsite for the non-
carbohydrate part of the ligand. Starting from the best solution of the open 
conformation docking calculations, a 100 ns molecular dynamics simulation of this 
complex demonstrated that this conformation is dynamically stable, and the novel 
subsite is occupied for most of the simulation (Figure 4.19b). 
The same approach was applied to Ligand 33, which docked consistently in the “open 
conformation” occupying the novel subsite, as opposed as when docked in the “closed 
onformation”. A 100 ns dynamics simulation of the Ligand 33 docking solution in the 
open conformation of CTB revealed an even greater dynamic stability when compared 
to the Ligand 30/CTB complex, with the PHF chain of Ligand 33 exclusively occupying 
the novel subsite throughout the simulation. Without a galactose moiety to act as an 
anchor, Ligand 33 can bury itself further into the hydrophobic binding subsite (Figure 
4.19b). To validate the MD data, we performed CORCEMA-ST calculations on the 100 
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most populated frames from each of the MD simulations of the CTB complexes with 
Ligand 30 and Ligand 33. In this case, the agreement with the experimental data was 
very satisfying, with an NOE R-factor of 0.25 and 0.31, respectively (Figure 4.20 and 
4.21). 
 
Figure 4.21. Experimental STD NMR build-up curves for Ligand 33 in complex with CTB92. (b) 
CORCEMA-ST calculated STD NMR build-up curves averaged over the 100 most representative 
frames from MD of Ligand 33 with CTB. 
The binding mode of Ligand 33 as validated by CORCEMA-ST in the novel binding subsite 
is compatible with the presence of 3NPG in the galactose binding subsite (as suggested 
by experiment (c) in Table 4.1 and by the ILOE data). To investigate this hypothesis, we 
superposed the structure of 3NPG/CTB available by X-Ray (PDB ID: 1EEI88) and the most 
representative frame from the MD simulations of the Ligand 33/CTB and we proposed 
it as a qualitative model for the ternary complex (Figure 4.22). In the resulting model 
containing the two ligands, indeed, the Htriazole of Ligand 33 and the aromatic protons 
Hc and Hd of 3NPG are at a distance close enough as to be compatible with generation 
of inter-ligand NOE. 
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Figure 4.22. Top view of the superposition of 3NPG from PDB ID: 1EEI88 (dark grey) with the most 
representative MD frame of Ligand 33 (light red) in the CTB open binding site (homogenous 
surface colouring). All protons are omitted, but the Htriaz of Ligand 33 and the aromatic protons 
of 3NPG, while the turquoise double-point arrows shows the inter-ligand NOE observed in the 
ILOE tr-NOESY in Figure 4.12. 
4.2.6 Inter-Ligand-STD NMR (IL-STD NMR): an additional tool to detect adjacent binding 
subsites  
Even without being quantitative, the model proposed for the ternary complex in Figure 
4.22 agrees with the ILOE results. This gave us ground to approach the system by IL-STD 
NMR, as introduced in Chapter 3, Section 3.4. The ternary complex at a 1 to 40 protein 
to ligand ratio was analysed by STD NMR, first at the standard irradiation frequency of 
0.60 ppm (aliphatic region) and then at 7.27 ppm, on resonance with the protons Hc and 
Hd of 3NPG.  
By simple visual analysis of the STD difference spectra acquired at 0.60 ppm and 7.27 
ppm, an overall decrease of the STD signals when irradiating at the aromatic region (7.27 
ppm) rather than at the aliphatic region (0.60 ppm) was evident. This evidence is easily 
explained by the generally lower occurrence of aromatic residues relative to aliphatic 
residues, meaning that a lower number of directly irradiated protein protons is 
irradiated at 7.27 ppm than at 0.60 ppm. This translate into less overall available 
magnetization and lower STD intensities upon irradiation in the aromatic region. An 
expected increase was observed for the STD intensities of the peak coming from Hc and 
Hd (7.27 ppm, directly irradiated) and for the aromatic signals of Ligand 33, as an effect 
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of direct irradiation (these resonate within 0.15 ppm high-field from it, respectively 7.21 
ppm, 7.16 ppm, 7.12 ppm). Also, the intensity of the Hb proton (7.69 ppm) increased 
when irradiating the adjacent Hc,d, due to intra-ligand NOE.  
Interestingly, we observed an increase in the STD intensity of proton Htriazole of Ligand 
33 (7.67 ppm) upon irradiation of proton Hc and Hd of 3NPG (7.27 ppm) (Figure 4.23). 
This STD increase cannot be due to direct irradiation (the signal is 0.40 ppm apart from 
the source of irradiation) or intra-ligand NOE (as the directly irradiated aromatic protons  
of Ligand 33 are far in space from the triazole); hence, the signal increment can only be 
explained by the inter-ligand transfer of magnetization between Hc and d and Htriazole, 
which is only possible if those protons from the two ligands established a close contact 
in the bound state. This is in perfect agreement with the ILOE data (Figure 4.12).  
As argued in Chapter 3, Section 3.4, the risk of direct irradiation is the main limitation of 
this approach. For example, the inter-ligand correlation Hc and Hd/Htriazole observed 
by ILOE could be detected by IL-STD only via irradiation on the Hc and Hd signal of 3NPG. 
This is because the irradiation of Htriazole would have implied the direct irradiation of 
the 3PNG, due to the proximity of Htriazole to Hb of 3NPG, thus leading to spurious 
results. 
 
Figure 4.23. IL-STD difference spectra of the ternary complex 3NPG/CTB/Ligand 33 with 
irradiation at 0.60 ppm (in black) and at 7.27 ppm, on resonance with Hc and Hd of 3NPG (in 
red). The spectra are zoomed on the single protons for space optimization purposes. The 
assignment of all peaks is given and the peak of Htriazole is squared in turqouise and magnified, 
showing increased intensity when irradiating at 7.27 ppm, whereas all the other protons (with 
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the exceptions discussed in the main text) decrease. A saturation time of 2 s and line broadening 
factor of 1 Hz were employed. 
To exclude any possible artefacts, acquisition of control experiments under the same 
experimental conditions on the two binary complexes was necessary. The control 
experiment carried out on the binary complexes Ligand 33/CTB showed that, in the 
absence of 3NPG, the intensity of the triazole proton (as well as the rest of protons of 
Ligand 33) decreased when irradiating at 7.27 ppm, ruling out that the observed IL-STD 
was due to direct irradiation. An increase was observed for the aromatic protons  
between 7.24 and 7.04 ppm, which experience direct irradiation as indicated above 
(Figure 4.24a).  
 
Figure 4.24. IL-STD control experiments on (a) 3NPG and (b) Ligand 33 in a complex with CTB. 
Difference spectra with irradiation frequency of 0.60 ppm are shown in black, and difference 
spectra with direct irradiation at 7.27 ppm are shown in red. Same experimental conditions as 
for the spectra in Figure 4.23. 
The control experiment on the binary complex 3NPG/CTB is shown in Figure 4.24b. 
Expectedly, all the STD intensities decreased when irradiated at 7.27 ppm, except for 
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the directly irradiated protons Hc and Hd and the Hb, which received direct intra-ligand 
NOE from the adjacent Hc and Hd. 
Quantitatively, these data can be better analysed by determining the IL-STD factor for 
each proton of the ligands constituting the ternary complex, and by comparing them 
with the IL-STD factor obtained in the binary complexes used as control samples (Figure 
4.25). The equation for IL-STD calculation is described in Sub-section 3.4.2 (Equation 
3.6). In our case, N = 1, therefore the equation simplifies to: 
ΔIL − STD𝑖 ,𝑡𝑒𝑟𝑛𝑎𝑟𝑦 = 
𝑆𝑇𝐷 𝑜𝑛−𝑙𝑖𝑔𝑎𝑛𝑑,𝑖
𝑆𝑇𝐷 𝑜𝑓𝑓−𝑙𝑖𝑔𝑎𝑛𝑑,𝑖
−  1 
By definition, the IL-STD factor will only be positive for protons receiving inter-ligand 
saturation from the irradiated proton of the adjacent fragment (if we are able to exclude 
the protons receiving extra saturation by intra-ligand NOE or direct irradiation excluded 
from the analysis).  
 
Figure 4.25. ΔIL-STD histograms of the 3NPG/CTB/Ligand 33 ternary complex, and the two 
control complexes Ligand 33/CTB and 3NPG/CTB (and controls), represented individually for 
Ligand 33 (a) or 3NPG (b). The values relative to the Htriazole of Ligand 33 are squared in 
turquoise. The bar chart is cut at 3.0. Raw and processed data in Table 4.2.  
In fact, protons presenting positive ΔIL-STD in both the experiment and the control are 
subject to either intra-ligand NOE or direct irradiation (this is easily determined by 
looking at the spectra), while protons presenting negative values in both the experiment 
and the control are too far in space from the irradiated proton(s) to be affected. By 
looking at the histogram representation in Figure 4.25a we can easily appreciate how 
the Htriazole from Ligand 33 is the only proton with a positive IL-STD only in the ternary 
complex experiment (and a negative ΔIL-STD in the control experiment). The IL-STD data 
are reported in Table 4.2.  
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  Ligand 33/CTB/3NPG Ligand 33/CTB 
1H δ Atom ID 
STD% off 
ligand 
STD% on 
ligand 
ΔIL-STD 
STD% off 
ligand 
STD% on 
ligand 
ΔIL-STD 
2.24 Me 11.46 5.02 -0.56 10.91 4.54 -0.58 
3.48 H-2'' 4.19 3.69 -0.12 5.62 2.28 -0.59 
3.79 H-3'' 4.95 4.26 -0.14 5.99 2.33 -0.61 
4.23 H-4''b 2.9 2.41 -0.17 3.28 1.67 -0.49 
5.03 CH2(Bn) 6.97 3.29 -0.53 6.14 3.45 -0.44 
6.36 H-3''' 10.61 5.68 -0.46 10.7 5.73 -0.46 
7.12 H para 9.16 42 3.59 11.57 52 3.49 
7.16 H meta 11.13 54 3.85 10.5 57 4.43 
7.21 H orto 9.25 65 6.03 10.15 73 6.19 
7.68 Htriazol 7.83 9.71 0.24 5.84 3.48 -0.40 
     3NPG/CTB 
5.50 H1 12.27 1.42 -0.88 12.51 13.43 0.11 
3.73 H2 16.6 12.27 -0.26 18.49 11.92 -0.38 
3.76 H3 18.13 11.69 -0.36 19.79 11.69 -0.42 
3.81 H4 16.77 10.5 -0.37 17.44 11.24 -0.32 
3.73 H5 17.1 11.02 -0.36 18.31 11.24 -0.38 
3.40 H6/H6' 12.27 7.68 -0.37 15.81 6.7 -0.55 
7.27 H cd 6.9 99 13.35 7.68 94.31 11.65 
7.69 Hb 12.63 36.96 1.93 13.27 36.25 1.68 
7.75 Ha 21.61 15.36 -0.29 23.59 15.81 -0.34 
Table 4.2. Raw STD intensities for the ternary complex (3NPG/CTB/Ligand 33) and the two 
controls. The STDoff ligand at 0.60 ppm and STDon ligand at 7.27 ppm, as well as the calculated ΔIL-STD 
are shown. The ΔIL-STD relative to Htriazole are highlighted in red. 
4.2.7 Relevance of the discovery of a novel binding subsite and the IL-STD approach from 
a drug design perspective  
The work presented in this section can be regarded as an example of the strong potential 
of NMR when combined to molecular modelling approaches, in drug discovery contexts. 
The combination of both techniques becomes particularly precious when studying 
systems unsuitable for crystallisation, a recurrent situation for highly flexible and low 
affinity ligands. In this project, the combination of these methods allowed to establish a 
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milestone in cholera toxin inhibitors design: the discovery of a hitherto unknown binding 
subsite in the GM1 binding pocket of CTB (Figure 4.26). For the first time here, we used 
MD to obtain a 3D model of CTB-inhibitors as bound to the GM1 binding pocket, strongly 
supported by high resolution STD NMR data, as confirmed by CORCEMA-ST. Importantly, 
the flexibility of the ligands in solution was taken into account by simulating build-up 
curves for the complexes (Ligand 30/CTB and Ligand 33/CTB) over the 100 most 
representative frames obtained by MD simulations, with excellent outcomes. The NOE 
information extracted by both ILOE and IL-STD was also crucial to establish the relative 
orientation of the subsites. 
 
Figure 4.26. Representative frames of the most populated clusters of Ligand 30 (pale yellow) 
and Ligand 33 (light red) with CTB (“open” conformation). Zoom on the furoate-benzyl moieties: 
residues forming a slightly lipophilic cleft are represented in thin sticks.  
Whereas the traditional Fragment Based Drug Discovery (FBDD) approach relies on 
combinations of simple fragments to construct effective leads, we decomposed a good-
performing lead (Ligand 30) to understand its binding mode and explore the 
surroundings of the two well-characterised binding subsites, finding a new groove with 
good specificity for the non-carbohydrate and non-hydrolysable PHF moiety. 
To the purpose of the exploration of the binding pocket, the flexibility of the ligands was 
an advantage (Ligand 30 contains 10 rotatable bonds). Although, comparing the 𝐾𝐷  of 
Ligand 30 (1.05 mM), Ligand 33 (1.35 mM) and 3NPG (1.10 mM), one can argue that the 
flexibility of the PHF chain provides a considerable entropic disadvantage to the binding 
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event. The similar 𝐾𝐷s of 3NPG and Ligand 30 suggest that the enthalpic gain due to the 
fit of the furoate and aromatic ring in the novel binding subsite is compensated by the 
negative entropy associated with the binding of the flexible ring. It is also interesting to 
remark that Ligand 33, even lacking the galactose moiety and leaving the galactose 
subsite free, has an almost comparable 𝐾𝐷  to Ligand 30. This could be justified by the 
lack of “galactose-anchor”, which allows Ligand 33 to bury the aromatic moiety deeper 
in the slightly lipophilic novel subsite (Figure 4.26).  
The furoate ring of Ligand 33 fits tightly between Lys34 and Ile58, and its benzyl ring 
interacts closely with Lys34, Val156 and Pro157. On the other hand, Ligand 30 seems to 
be slightly more solvent exposed, for not being able to reach the same depth of Ligand 
33. It is interesting to point out that the residues Lys34 and Ile58 had already been noted 
as a lipophilic patch with the potential of interacting with hydrophobic ligands by Fan 
and co-workers, when they provided the X-Ray structure of 3NPG and three aromatic 
derivatives with CTB88. As in the X-Ray structure of GM1 with CTB, the two residues were 
modelled in the close conformation. With the HREMD approach, we clearly showed that 
the intuition of Fan and co-workers was well-grounded. 
We believe that our findings pave the path for the design of three-finger ligands, to be 
tuned to an optimal degree of rigidity allowing the simultaneous occupation of the three 
subsites with minimal loss of entropy.  
4.3 Exploring the three-subsite GM1 binding pocket of CTB: NMR structural 
investigation of small analogues of Ligand 30  
4.3.1 A novel set of small of “small CTB ligands”  
The route to three-finger CTB inhibitors design based on Ligand 30 requires a further 
dissection of the thio-galactose/PHF scaffold. In this way we can: i) understand the 
contribution of each fragment to the binding specificity, and ii) probe the potential 
offered by the thio-glycosidic linkage (which can be decorated, as opposed to the O-
glycosidic linkage). 
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Figure 4.27. Chemical structures of the six analogues of Ligand 30 analysed in this section. The 
𝐾𝐷  values measured by weak affinity chromatography (WAC) are given for each ligand 
(unpublished). 
To this aim, our collaborators from the University of Seville provided us with a set of 
“small” Ligand 30 analogues, that we call the “SCJ set”, in reference to MSc Sebastian 
Carrion Jimenez who synthesised them. The novel compounds lack the triazole-
polyhydroxy linker and have the thio-galactose residue directly connected to the 
furoate-benzyl moiety. The variability across the set is given by the anomeric 
configuration (α or β), and the oxidation state of the glycosidic sulphur (present as a 
thioether, sulphone or sulphoxide functional group), for a total of 6 compounds (Figure 
4.27).  
The ligands are named numerically as Ligands 93, 97, 98 (β-thioether, -sulphone, and -
sulphoxide respectively) and Ligands 105, 108 and 109 (α- thioether, -sulphone, and -
sulphoxide respectively). The 𝐾𝐷  values of the ligands were determined by weak affinity 
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chromatography (WAC) in the group of Maria Bergstrom at Linneus University (Sweden), 
following an approach developed by Ohlson and co-workers in 200991. Interestingly, 
these ligands showed higher affinities (𝐾𝐷  values ranging from 0.35 mM to 0.55 mM), as 
compared to Ligands 20, 30 and 33, whose 𝐾𝐷  was above 1 mM
92. 
In the SCJ set, the presence of the two main elements of recognition of Ligand 30, i.e., 
the thio-galactose and the fuorate-benzyl moieties, linked through one single carbon 
atom, poses interesting questions. The smaller size of the ligands does not possibly allow 
them to occupy the galactose subsites and the novel binding subsite at the same time, 
as Ligand 30 does. Therefore, we concentrated our efforts in finding out the subsite(s) 
where the smaller ligands bind to. In addition, we aimed to gain insights on the relative 
specificities of the two pharmacophores, in particular, whether the affinity of the 
furoate-benzyl moiety for the non-carbohydrate novel subsite is significant enough as 
to direct the ligands to bind to the novel groove rather than to the galactose subsite. To 
that aim, we combined STD binding epitope determination, DEEP-STD NMR, DEEP-STD 
on-resonance scanning, STD competition experiments and tr-NOESY experiments. 
4.3.2 STD NMR binding epitope mappings: larger impact of sulphur oxidation state on the 
binding mode in comparison to the effect of anomeric configuration  
First, we acquired the STD NMR build-up curves for the SCJ set in complex with CTB. The 
six binding epitopes looked rather different (Figure 4.28). The galactose moiety seemed 
to be the main recognition element across the set of ligands, with Ligand 93 and Ligand 
97 showing strong contacts from H2 to H6 of the sugar ring, while the other four ligands 
have a less uniform STD pattern, where alternatively H3, H4 or H5 and H6 are the closest 
protons to the surface. It is also interesting to highlight that the protons sitting on the 
carbons adjacent to the sulphur show the weakest contact to the protein surface, while 
the furoate and the benzyl group always show from medium to strong contacts. 
Particularly, Ligand 98 showed a binding epitope indicating that the whole ligand is 
intimately contacting the binding pocket surface in the bound state. 
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Figure 4.28. STD NMR binding epitope mapping of the “small” ligands, based on the normalised 
STD values from the initial slope of each proton, relative to the most intense one (for which a 
100% is arbitrarily assigned). Legend indicates weak (blue), medium (yellow) and strong (red) 
contacts. The proton assignment of the ligands, the raw build-up curves data and the normalised 
STD values are reported in Section A.4 of the Appendix. 
Albeit the many differences, some analogies were observed between pairs of ligands 
with the same sulphur oxidation state, especially between the two thioethers (Ligand 
93 and 105) and the two sulphoxides (Ligand 98 and 109). Interestingly, more significant 
differences were observed between the two sulphones (Ligand 97 and 108) and among 
the triplets of ligands in the same anomeric configuration. This suggests that the 
oxidation state of the sulphur in the thio-glycosidic linkage is a key determinant of the 
ligand binding mode, showing a larger effect than the anomeric configuration. 
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4.3.3 DEEP-STD fingerprint: zoom on the galactose subsite 
In Chapter 3, Section 3.3, we described the DEEP-STD approach and validated it against 
two complexes with high-resolution crystal structures87. Here, we show how we can use 
DEEP-STD NMR to obtain a “fingerprint” of the binding pocket, thus aiding to 
discriminate whether different ligands bind to the same subsite. This implies comparing 
the differential epitope map of a complex of known 3D structure with the differential 
epitope maps of unknown ligands (with the same protein and under the same 
differential conditions). If the unknown ligands respond to the differential conditions 
similarly to how the known ligand responds, i.e. their DEEP-STD maps are comparable, 
it means that they are exposed to the same residues (or the same kind of residues) and 
they most likely occupy the same binding pocket (or highly similar binding pockets).  
Unfortunately, at this stage, the two sulphoxides, Ligand 98 and 109, had to be excluded 
from the analysis, for the following reasons. Firstly, they had the lowest affinities (𝐾𝐷  
0.48 mM and 0.49 mM), but, more importantly, they showed a significant degree of 
hydrolysis in the sample over time. As a result, some of the peaks coming from the 
hydrolysis overlapped with the peaks of the parent ligand, and although the sub-
products did not give STDs, their presence complicated the STD analysis and 
interpretation.  
Hence, to elucidate the location of binding of these four ligands (Ligand 93, 97, 105, 
108), we compared the differential irradiation DEEP-STD maps (2.25 ppm/0.60 ppm) 
with the DEEP-STD map (2.25 ppm/0.60ppm) of the 3NPG/CTB complex, of known 3D 
structure from X-ray diffraction. For an optimal signal-to-noise ratio and a reduced 
experimental time, the DEEP-STD NMR experiments for these systems were performed 
with 2 s saturation time (rather than 0.5 s as in the proof of concept study; the effect of 
the saturation time in DEEP-STD studies has been discussed in Sub-section 3.4.5). The 
DEEP-STD maps (2.25 ppm/0.60 ppm, Figure 4.29) showed a stark increase of the STD 
intensities of the galactose protons (from H3 to H6) upon irradiation at 2.25 ppm, similar 
to what was observed for 3NPG. The raw DEEP-STD data are reported in the Section A.5 
of the Appendix. 
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Figure 4.29. Differential Epitope Mapping (2.25 ppm/0.60 ppm) of (a) Ligands 93, 97, 105, 108 
and (b) 3NPG in complex with CTB, obtained at 2 s saturation time. For each ligand, the three 
largest positive ΔDEEP-STD values are shown as orange bars. (c) Crystal structure of the complex 
3NPG/CTB (PDB ID: 1EEI88). Protein protons directly irradiated at 2.25 ppm are enclosed in 
orange surface. 
The increase in galactose STDs at 2.25 ppm is already evident by simple inspection of 
the resulting 1D STD NMR spectra comparing the two irradiation frequencies (Figure 
4.30). As shown in Chapter 3, Section 3.3, 2.25 ppm is the predicted frequency around 
which the β and γ protons of Gln56 and Glu51 resonate. The proximity of Gln56 and 
Glu51 to H4, H5 and H6 of the galactose moiety is appreciable in the crystal structure of 
the 3NPG/CTB complex (PDB ID: 1EEI88, Figure 4.29c). Overall, the positive ΔDEEP-STDs 
observed for the galactose protons of the four ligands confirm that the thio-galactose 
moiety occupies the galactose binding site. 
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It is interesting to think about the type of information obtained by DEEP-STD NMR in 
comparison with the information we would obtain by STD NMR competition. That is, the 
STD competition experiments of the four ligands with 3NPG could demonstrate that the 
small ligands compete with 3NPG. Strictly, however, this finding would purely inform us 
that the galactose subsite is involved in the binding of the small ligands, without 
clarifying whether it is the thio-galactose moiety of the small ligands which occupies the 
galactose subsite (although that would be expectable from structural reasons, no 
evidence would be available to rule out binding through the other end of the molecule). 
Thus, the nature of the information disclosed by the DEEP-STD NMR fingerprint 
approach is not accessible by either simple STD NMR competition experiments or by STD 
binding epitope mappings (as already shown). 
It should be noted that DEEP-STD NMR experiments work on standard STD sample 
conditions, thus allowing to perform the experiments on the same sample used for STD 
binding epitope mapping (saving protein and synthetic ligands). In addition, DEEP-STD 
NMR can be carried out in a relatively short time (about 15 minutes for each of the 
ligands discussed above, using 2 s of saturation time). 
It is also important to mention that irradiation at 2.25 ppm does hit the furoate methyl 
group directly (resonating between 2.30 and 2.40 ppm), but due to the spatial isolation 
of this group of protons and relative distance from the galactose ring, this does not 
affect the STD intensities observed for the thio-galactose protons (as shown in the 
correspondent “- protein” STD control experiments, run for each ligand in the same 
experimental conditions and in absence of the protein). 
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Figure 4.30. Differential Irradiation DEEP-STD NMR (2.25 ppm/0.60 ppm) spectra of (a) Ligand 
93, (b) Ligand 97, (c) Ligand 105, (d) Ligand 108 and (e) 3NPG in complex with CTB, at 2 s 
saturation time. In each panel, the reference spectrum (x1) is reported in black, and the 
difference spectra (x2) are reported in red (2.25 ppm) and green (0.60 ppm). Only the galactose 
spectral region is shown and the assignment of each peak is shown on top. 
4.3.4 DEEP-STD “on-resonance scanning” approach: towards picking up single “amino 
acid-ligand” interactions  
A way of getting more detailed information about the contacts and spatial proximity 
between ligands and protein protons is to acquire consecutive STD NMR experiments  
moving the irradiation frequency stepwise (increments of 0.1-0.2 ppm) around the 
irradiation frequency of interest (2.25 ppm in the case of 3NPG and the SCJ set). In 
Chapter 3, Section 3.2, we described this approach as “on-resonance scanning” as it 
consists of carrying out a set of STD NMR experiments at different on-resonance 
irradiation frequencies. 
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We “scanned” the irradiation frequencies from 1.45 ppm to 2.95 ppm (14 frequencies  
in total) and represented the STD intensities vs. irradiation frequency as a curve for each 
proton for Ligand 93, 97, 105, 108 and 3NPG (as a reference) in complex with CTB (Figure 
4.31). The furoate and benzyl protons were excluded from this analysis, as  the focus is 
here on the orientation of the thio-galactose moiety in the galactose binding subsite. 
The results could be gathered within two groups showing different behaviours: curves 
that were rather flat (within the experimental error, i.e. including noise) and those which 
showed one or more maxima. Interestingly, all the non-flat curves showed maxima at 
around 1.70 ppm and/or 2.22 ppm. We interpret the frequencies at which the maxima 
are observed as the central frequency of the protein protons closest to the ligands 
protons. The expected average chemical shift values of Glu51 and Gln56, the two 
residues identified as directly irradiated at 2.25 ppm according to the predictive 
program Shiftx2.ca (Chapter 3, Table 3.3), are 2.17 ppm and 1.92 ppm, respectively. 
These values are reasonably close to our observed maxima in the on-resonance scanning 
curves (1.70 ppm and 2.22 ppm), supporting our interpretation.  
Interestingly, in the on-resonance scanning of 3NPG, no maximum was observed at 1.70 
ppm, but a maximum at 2.60 ppm was detected for protons H2, H4 and H5 (Figure 
4.31e). Examining the crystal structure of the 3NPG/CTB complex (Figure 4.29c), it can 
be seen that Lys91 pointing towards the H2-H4 area of the sugar ring, which is a very 
good agreement with H2 having a maximum at 2.60 ppm but not at 2.22 ppm. According 
to the chemical shifts simulate with shiftx2, the Lys91 η protons resonate at around 2.95 
ppm (which is not far from 2.60 ppm where the maximum is experimentally observed).  
The Lys91 protons were not accounted as direct irradiated protons in the DEEP-STD 
NMR study, as they are more than 0.40 ppm away from the irradiation frequency of 2.25 
ppm. Still, the predicted chemical shifts should be regarded as an indication of the 
averaged chemical shift of each protein proton, while slight variations of temperature 
and pH can affect the validity of the prediction by some tenths of ppm. On the other 
hand, for protein signals with very broad linewidths (as it might be the case for a 65 kDa 
toroid-shaped protein, such as CTB), spurious saturation can be efficiently achieved, 
enlarging further the frequency range in which a given amino acid can be saturated. 
On the other hand, comparing the structure of 3NPG/CTB with the on-resonance 
scanning in Figure 4.31e, it can be observed that the ligand protons laying outside the 
155 | P a g e  
 
galactose binding subsite showed a relatively flat on-resonance scanning curve (namely, 
H1, Ha, Hb and Hcd). This reinforces our interpretation of the on-resonance scanning 
profile representing direct contacts between ligands protons and directly irradiated 
protein protons. Reasonably, those ligand protons which are too far from the directly 
irradiated protein protons, as to efficiently receive intermolecular NOE, will not show 
any maxima (corresponding to those protons with ΔDEEP-STDs close to zero, in the 
DEEP-STD NMR approach).  
 
Figure 4.31. On-resonance scanning of (a) Ligand 93, (b) Ligand 97, (c) Ligand 105, (d) Ligand 
108 and (e) 3NPG in complex with CTB. The maxima in STD% represents the ligand protons 
closest to given residue protons. 
Overall, comparing the on-resonance scanning profiles of the SCJ set and 3NPG indicates 
that the four small ligands fit, in slightly different orientations, in the galactose binding 
subsite, and none of them bind in the exact same orientation as 3NPG (Figure 4.31e). 
Ligand 105 seems to have the most similar orientation to 3NPG (Figure 4.31c), as 
expected given their similar structure.  
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To dissipate any concerns on the possibility of having direct ligand irradiations, the same 
on-resonance scanning experiments were run in the absence of the CTB. For our five 
ligands, the STD NMR difference spectra at each of the on-resonance scanning 
frequency did not show any signal, except for the STD signal of the methyl  group of the  
SCJ ligands, which resonates at around 2.20 ppm. The STD intensity of the methyl group 
in the blank experiments was 100% at 2.20 ppm, 2.22 ppm or 2.25 ppm, and it decrease 
down to 5% at 1.46 ppm and 2.94 ppm. What is more important for our approach, no 
STD signal was observed for any of the other ligand protons in the STD NMR experiments  
of the free ligands. Taking this into consideration, and the fact that the methyl group 
was excluded from the analysis, we can safely interpret the on-resonance scanning 
maxima as genuinely reporting on close interactions of single protein-ligand protons. 
Aiming to obtain more detailed information on the specific interactions of Glc56 and 
Glu51 to the SCJ set, we run DEEP-STD NMR experiments and determined the 
ΔDEEP-STD values of the ligand protons differentially irradiating at the frequencies of 
the two STD maxima observed in Figure 4.31 (1.70 ppm and 2.22 ppm), i.e., ΔDEEP-STD 
(1.70 ppm/0.60 ppm) and (2.22 ppm/0.60 ppm). For ease of analysis, we show their 
comparison on the same histogram (Figure 4.32). Positive ΔDEEP-STDs at both 
frequencies carry information on the relative distances between ligand protons and the 
single residues identified as resonating at each frequency ( i.e., Gln56 at 1.70 ppm and 
Glu51 at 2.22 ppm, in blue and green respectively in Figure 4.32). 
Thus, with DEEP-STD NMR providing differential epitope mappings reported on the 
ligands structures second (Figure 4.32), we gain access to a second layer of structural 
information, beyond the classical STD NMR epitope mapping, showing those ligand 
protons receiving more saturation when irradiating at different frequencies. Figure 4.32 
provides that “extra” layer of structural information reporting on ligand protons  
receiving more saturation when irradiating at 1.70 ppm (in green) or at 2.22 ppm (in 
blue). This allows us to identify which protons of the different ligands are pointing more 
towards Gln56 or Glu51, respectively, within the GM1 binding pocket of CTB.  
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Figure 4.32. DEEP-STD histograms (2.22 ppm/0.6 ppm vs. 1.70ppm/0.60ppm) of (a) Ligand 93, 
(b) Ligand 97, (c) Ligand 105 and (d) Ligand 108 in complex with CTB. For each irradiation 
frequency (2.22 ppm/0.60 ppm in blue and 1.70 ppm/0.60 ppm in green), the two strongest  
ΔDEEP-STD are shown in darker tones. These are additionally plotted on the ligands structures, 
where blue dots show protons receiving more saturation at 1.70 ppm and therefore pointing 
towards Gln56, and green dots show protons receiving more saturation at 2.22 ppm and 
therefore pointing towards Glu51. R ≡ furaote-benzyl group. 
In particular, Ligand 93 and 97 orient their H2,3 and H5 protons closer to Glu51 (green), 
and H4 and both H6 protons towards Gln56 (blue), as shown in Figure 4.32a,b. On the 
contrary, Ligand 105 orients H4 and H5 towards Glu51 (green) and H5 and H3 towards  
Gln56 (blue). Ligand 108 points H4 and H6 towards Gln56 (blue) and H3 and H5 towards 
Glu51 (green). 
It is important to highlight that the DEEP-STD NMR experiments at 2.25 ppm (fingerprint 
approach, Figure 4.29) already carried most of this information, i.e., that protons H3 to 
H6s of the thio-galactose moieties were in close distance to protein residues resonating 
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at around 2.25 ppm (namely, Glu51, Gln56 and possibly Lys91). In fact, this is due to the 
broad CTB signals, so that irradiating at 2.25 ppm becomes close enough to excite them, 
thus giving rise to a very different STD factor compared to the irradiation at 0.60 ppm.  
We consider that the on-resonance screening, albeit tedious, is a powerful expansion of 
the DEEP-STD NMR approach, which allows to identify the irradiation frequencies at 
which the STD values of each proton reach a maximum and giving finer details on the 
orientation of the ligands in the binding site.  
4.3.5 Competition experiments: zooming in on the sialic acid/PHF subsites  
The presence of a cluster of CTB residues resonating around 2.25 ppm in the galactose 
subsite, allowed us to apply DEEP-STD NMR to the thio-galactose moiety of the SCJ 
ligands. However, the same approach was not possible for the furoate-benzyl moiety, 
for which we could not identify frequencies where furoate and aromatic protons were 
responsive.  
Nevertheless, as the SCJ ligands occupy the galactose subsite with the thio-galactose 
moiety, the furoate-benzyl moiety must either occupy the adjacent sialic acid subsite or 
point towards the novel subsite (given the “small” size of the aglycon moiety).  
From our previous study (Section 4.2), we know that Ligand 33 occupies the novel 
subsite (for which the 3D model of the complex is available, Figure 4.19b). Thus, we 
resorted to STD NMR competition experiments between the SCJ ligands and Ligand 33, 
to find out whether the novel binding subsite is involved in accommodating these small 
ligands. The competitions were performed by the addition of the SCJ ligands to four 
samples containing the Ligand 33/CTB complex. As Ligand 33 has lower affinity than the 
small ligands (1.35 mM vs. 0.25-0.39 mM, respectively), the former would be displaced 
by any of the latter being able to occupy the novel binding subsite.  
The results of the competitions experiments showed that all the reporter signals from 
Ligand 33 (i.e. those that do not overlap with any signal coming from the SCJ ligands) 
retained their STD intensity upon addition of the SCJ ligands (Table 4.3). The lack of 
competition between them suggests that the SCJ ligands do not hinder the binding space 
of Ligand 33 and they most likely are oriented towards the sialic acid subsite. 
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  Ligand 93 Ligand 97 Ligand 105 Ligand 108 
δ 1H 
(ppm) 
Proton 
ID 
STD % 
before 
addition 
STD % 
after 
addition 
STD % 
before 
addition 
STD % 
after 
addition 
STD % 
before 
addition 
STD % 
after 
addition 
STD % 
before 
addition 
STD % 
after 
additio
n 
2.24 CH3 9.16 - 10.29 12.15 9.34 - 8.72 9.8 
3.48 H2'' 3.01 3.84 2.92 - 2.5 - 2.78 - 
3.79 H3'' 3.01 4.36 4.28 5.2 4.49 - 3.35 - 
4.23 H4''b 4.24 4.3 3.45 4.28 2.68 2.87 3.45 3.1 
4.41 H4''a 2.92 - - 3.88 2.1 2.38 2.12 3.62 
5.03 CH2(Bn) 3.96 - 4.54 - 3.77 6.2 3.66 - 
6.36 H3''' 9.52 8.98 11.13 12.63 10.29 9.25 9.43 10.7 
7.12 Hpara 9.16 - 10.21  - 9.24   - 9.01 -  
7.16 Hmeta 9.8 -  10.98  -  9.81  -  9.23  - 
7.21 Horto 9.43 -  11.31 -   9.56 -   9.38  - 
7.68 Htriazol 4.81 5.57 6.7 8.98 4.9 6.32 4.54 7.46 
Table 4.3. STD NMR competition experiments between Ligand 33 and the SCJ ligands. The STD 
intensities (%) of the furoate-benzyl moiety of Ligand 33 are given for each sample before and 
after the addition of the competitor (Ligand 93 to 108). No significant variation in the STD 
intensities of Ligand 33 was observed when adding any of the SCJ ligands. This shows that there 
is no competition between them and that the binding of the SCJ ligands to CTB does not occur 
at the novel binding subsite. 
4.3.6 Tr-NOESY/NOESY distance measurements: zooming in on the rotatable bonds  
Determining intra-ligand distances in the bound state by tr-NOESY build-up curves using 
the isolated spin-pair approximation is a powerful way to obtain structural information 
(see Materials and Methods, Sub-section 4.5.2). Running similar NOESY experiments on 
the free ligands in the absence of the receptor allows to assess whether there are 
conformational rearrangements upon binding.  
We focused on the protons at the glycosidic linkage, around the sulphur atom, 
determining for each ligand the CH2(S)-H1 and CH2(S)-Hfur’’ distances (carbon 
nomenclature is given in Figure 4.33). The intra-sugar-ring H1-H5 or H1-H2 NOEs were 
chosen as reference of the β- and α-protons respectively, as they correspond to fixed 
inter-proton distances. 
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Remarkably, the C1-S, S-C(S) and C(S)-Hfur’ bonds represent the centre of the molecules 
and the main source of flexibility as they constitute three rotatable bonds (red arrows 
in Figure 4.33). Thus, defining the distances between the protons surroundings these 
bonds is of specific interest to elucidate the bound conformation and to compare it with 
the free state. Excluding Ligand 97, in which the two CH(S) protons resonate at the same 
frequency, for the other three compounds it was possible to determine the distances of 
H1 and Hfur’’ from both the CH2(S) protons (Table 4.4).  
 
Figure 4.33. Carbon nomenclature for Ligands 93 and 105, which can be extended to Ligand 97 
and 105. The central rotatable bonds are indicated by red curly arrows. R ≡ benzyl group. 
The results shown on Table 4.4 can be summarised as follows:  
1) both β-compounds (Ligands 93 and 97) have shorter H(S)-H1 distances than the 
α-compounds;  
2) both thioethers (Ligands 93 and 105) have  similar short H(S)-Hfur’’ distances 
(and the same to both H(S)s); 
3) Ligand 93’s H(S)-H1 distances are comparable to its H(S)-Hfur’’ distances, while 
Ligand 105’s H(S)-H1 distances are larger than its H(S)-Hfur’’ distances; 
4) for the sulphones (Ligands 97 and 108), the distance H(S)-Hfur’’ is larger than for 
the thioethers (above 3.3 Ȧ vs. 2.0-2.2 Ȧ for the thioethers); 
5) Ligand 93, 97 and 105 show some (small) degree of conformational 
rearrangement upon binding;  
6) Ligand 108 seems to undergo a significant conformational rearrangement, as its 
H(S)2 cross peak to H1 and Hfur’’ disappear completely in the free state.  
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Reference (Ȧ) Distances (Ȧ) 
 
Distances (Ȧ) 
Ligand 93 H1-H5  H1-H(S)1  H1-H(S)2  Hfur’’-H(S)1  Hfur’’-H(S)2 
Bound 2.4  2.3 = 2.3 = 2.2 = 2.2 
Free 2.4  2.6 = 2.5 > 2.3 = 2.2 
          
Ligand 97 H1-H5  H1-H(S)s    Hfur’’-H(S)s   
Bound 2.4  1.9   < 3.6   
Free 2.4  1.9   < 3.1   
          
Ligand 105 H1-H2  H1-H(S)1  H1-H(S)2  Hfur’’-H(S)1  Hfur’’-H(S)2 
Bound 2.5  2.8 = 2.7 > 2.1 = 2.0 
Free 2.5  2.7 = 2.6 > 2.1 > 1.9 
          
Ligand 108 H1-H2  H1-H(S)1  H1-H(S)2  Hfur’’-H(S)1  Hfur’’-H(S)2 
Bound 2.5  2.9 = 3.0 < 3.3 = 3.2 
Free 2.5  2.8 < >4 < 3.7 < >4 
Table 4.4. Experimental conformation-defining distances of the SCJ ligands in the bound and 
free state as extracted from tr-NOESY and NOESY experiment, respectively. The reference 
distances used where measured on the galactose protons of 3NPG from the X-ray structure of 
the 3NPG/CTB complex (PDB ID: 1EEI88). Note that the proR and proS CH2(S) protons are not 
assigned, therefore they are simply referred to as H(S)1 and H(S)2.  
The conformational study by tr-NOESY and NOESY experiments allowed us to define 
distances around the sulphur, regarded as the central element of this class of ligands, 
and to investigate for conformational rearrangement upon binding.  In conclusion, as 
already argued by STD epitope mapping and DEEP-STD data, the four ligands behave 
very differently, and it is hard to find a consistent pattern across the SCJ set, confirming 
that the anomeric configuration and the presence or absence of the oxygens on the 
sulphur have a strong influence, especially on the central (very flexible) part of the 
ligands.  
4.3.7 Molecular docking: 3D molecular models for the complexes of CTB with SCJ ligands  
Although we demonstrated by STD NMR that the novel binding subsite is not involved 
in the molecular recognition of the SCJ ligands, and that the thio-galactose moieties 
162 | P a g e  
 
present different orientations in the galactose binding subsite, a 3D molecular model of 
the binding of each ligand to CTB is lacking.  
For the purposes of further three-finger ligands development, simply providing a 
qualitative model of the binding mode of the SCJ ligands validated by NMR experiments  
can be enough, as these ligands can be considered as simple intermediates. Therefore, 
we performed molecular docking of the four SCJ ligands on the “closed” CTB structure 
(the GM1/CTB XRD structure, PDB ID: 3CHB). 
For each ligand, the first 5 to 10 lowest energy solutions converged to a binding mode 
in which the thio-galactose moiety sits in the galactose binding subsite and the furoate-
benzyl group fit in the sialic acid binding subsite (Figure 4.34, docking tables are reported 
in Section A.6 of the Appendix). Remarkably, the galactose moiety of the four ligands 
did not converge to a single orientation, in good agreement with what we observed 
experimentally. On the contrary, the four benzyl groups precisely converged in the cleft 
accommodating the sialic acid of GM1 in the PDB ID: 3CHB (blue in Figure 4.34), where 
a π-stacking to Tyr12 can take place (Figure 4.36b). The “closed” conformation of the 
protein certainly introduces a bias, preventing the ligands to point towards the Ile58 and 
Lys34 residues, which are responsible of “opening” the novel subsite. However, as 
previously discussed, our experimental data showed that the novel subsite is not 
involved in the SCJ ligands binding mode, and the π-stacking to the Tyr12 appears to be 
a reasonable driving force to orient the benzyl group in the sialic acid subsite.  
A closer look to the galactose subsite shows the different orientations of the thio-
galactose moieties. The galactose moiety of lowest energy docking solutions of the α-
ligands (Ligands 105 and 108) precisely overlap with the galactose moiety of GM1 and 
3NPG, as observed in their XRD structure (Figure 4.35a). On the contrary, the galactose 
moiety of the lowest energy docking solutions of the β-ligands (Ligands 93 and 97) do 
not converge either between themselves, or with their α-analogues (Figure 4.35b).  
Disappointingly, the orientation of the thio-galactose moieties obtained by rigid docking 
do not match with our experimental findings, i.e., i) the CH2(S)-H1 and CH2(S)-Hfur’’ 
distances found by tr-NOESY experiments do not match with those obtained from 
docking, and ii) the single residue-ligand contacts between H3-H6 and Glu51 and Gln56 
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(suggested by the DEEP-STD on-resonance scanning data) do not lie within the range of 
distances measured in the best docking poses.  
 
Figure 4.34. Lowest energy docking solutions for Ligand 93 (grey), Ligand 97 (pink), Ligand 105 
(green) and Ligand 108 (violet) with CTB (“closed” conformation). The residues lining the 
galactose, sialic acid and novel binding subsites are enclosed in orange, blue and green surfaces, 
respectively. Relevant amino acids are labelled on top of the surfaces.  
 
Figure 4.35. Zoom on the galactose binding subsite for the lowest energy docking solutions for 
(a) Ligand 105 (green) and Ligand 108 (violet) superimposed to GM1 (turquoise) and 3NPG 
(orange); (b) Ligand 93 (grey), Ligand 97 (pink) superimposed to 3NPG only (orange) with CTB 
(“closed” conformation). 
On the other hand, it is reasonable to think that the orientation of the thio-galactose 
moiety might adjust by establishing favourable contacts to the amidic group of Asn14 
and/or the NH group of Trp88 present at the protein surface (turquoise in Figure 4.36a).  
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The rotatable bonds S-C(S) and C(S)-Cfur’ allow the methyl group on the furoate group 
to point towards the His13 (red sticks in Figure 4.36a). This can be justified by the 
presence of the Gln61 on the other side of the protein surface. The glutamine is rather 
hydrophilic and it hydrogen-bonds to a water molecule in the GM1 crystal structure 
(Figure 4.36a), therefore it could repel the methyl group, directing it towards the 
opposite histidine. Finally, the semi-rotatable bonds in between the furoate and the 
phenyl ring adjust to allow the best contact between the aromatic moiety and Tyr12 
(Figure 4.36b).  
 
Figure 4.36. Lowest energy docking solutions for the SCJ ligands on a semi-transparent surface 
of CTB to show the interactions with key lipophilic/hydrophilic residues.  (a) Only the sulphones 
(Ligand 97, pink and Ligand 108, violet) are included for simplicity, to show the sulphonic 
oxygens pointing towards Asn14 and Trp88 (in turquoise sticks), and the methyl on the furoate 
pointing parallel to His13 (red sticks), rather than towards Gln61 (turquoise sticks). (b) The four 
SCJ ligands are shown, zooming on the π-stacking interaction between the phenyl group of the 
ligands and Tyr12 (turquoise sticks). 
4.3.8 Implications of the study and future directions  
The 3D molecular models from docking solutions provided here for the binding of SCJ 
ligands to CTB should be taken as qualitative models of binding. Despite lacking 
quantitative agreement with the STD NMR and tr-NOESY data, they confirm the impact 
of the variations at the thio-glycosidic linkage (the α- or β- configuration and the 
oxidation state of the sulphur) on the orientation of the galactose in the galactose 
subsite. Interestingly, our models highlight the specificity of the phenyl group for the 
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sialic acid subsite. This structural element had been already reported by the research 
group of by Jimenez-Barbero for Ligand 7 (Figure 4.3), in which the phenyl group fitted 
nicely in the sialic acid subsite, being held in place by a π-stacking interaction with the 
underlying Tyr12, as shown by molecular docking128. The same finding was reported by 
Fan and co-workers in studying the interaction of CTB with 3NPG and its aromatic 
derivatives. In particular, the crystal structure of BAPG (a 3NPG derivative, in which the 
an amidic group with a benzyl group in α takes the place of the nitro group) shows the 
same π-stacking between the terminal phenyl ring and Tyr12 (PDB ID: 1FD7)88.  
In fact, our findings are of paramount importance for the design of three-finger ligands. 
The structures investigated exclude the possibility of decoration at the sulphoxide 
moiety, as the two oxygens are pointing towards the protein surface. However, our 
results clearly show that the furoate Cfur’’ could be decorated with a PHF-like fragment 
(“Ligand 33-like”) which would point towards the novel binding subsite. To this purpose, 
the α-ligands of the SCJ set could be the best choice, as they resemble 3NPG more 
closely, and most likely the α-thioether (Ligand 105) would do the job best, also 
considering that it has the lowest 𝐾𝐷. Even so, to explore the GM1 binding pocket even 
further it would be interesting to investigate three-finger analogues of the four SCJ 
ligands studied here. 
Once and again, the combination of NMR and molecular modelling has proved to be an 
excellent tool to elucidate the binding mode of flexible ligands, magnifying binding 
differences of ligands with similar chemical structures and providing quick answer. 
As a final remark, our CTB – SCJ ligands systems had a very good behaviour in terms of 
DEEP-STD NMR experiments, due to the presence of a cluster of residues in CTB 
resonating around 2.25 ppm (Glu51 and Gln56). The DEEP-STD NMR fingerprint 
approach was very useful to clarify the position and orientation of binding of the 
thio-galactose moieties, using 3NPG as a reference. Additionally, we explored the 
potentiality of DEEP-STD on-resonance scanning to detect single residue-ligand 
interactions by identifying the maxima in the STD % vs. irradiation frequency curves. It 
might be potentially useful to implement this latter approach to restrained docking 
calculations. 
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4.4 Conclusions  
By a combination of STD NMR, a novel Inter-Ligand (IL) STD NMR approach, docking 
calculations and molecular dynamics simulations, we describe a novel binding sub-site 
on the GM1 binding pocket of the CTB receptor, adjacent to the galactose and the sialic 
acid binding sites, showing specificity of the non-carbohydrate moieties of our ligands 
and hitherto unknown. Our polyhydroxyalkylfuroate binders, Ligands 30 and Ligand 33, 
do not bind in the proposed sialic acid subsite, as it was proposed in previous studies, 
but instead they show specificity for the novel groove through their non-carbohydrate 
polihydroxyfuroate moiety. Ligand 33 fits deeper than Ligand 30 and its binding is 
compatible with the binding of 3NPG in the adjacent galactose subsite (as observed by 
ILOE and IL-STD NMR).  
Despite the failed attempts of crystallization, the combination of STD NMR and tr-NOESY 
experiments with classic MD, HREMD and molecular docking resulted in the validation 
of a dynamic model based on 100 MD frames for each ligand, as confirmed by 
CORCEMA-ST. 
The presence of the new non-carbohydrate specific binding groove, accessible also 
when the adjacent subsites are occupied, is of paramount importance to pave the way 
to design future classes of CTB inhibitors based on the concept of three-finger 
compounds, with the prospective of increased affinity relative to the ligands studied 
here. The ternary complex of Ligand33/CTB/3NPG was a good system for the application 
and validation of the novel IL-STD methodology, introduced in Chapter 3, Section 3.4. 
This novel STD NMR approach allowed us to reproduce the information obtained by 
ILOE, and together with it could be a promising and time-efficient technique for 
knowledge-based drug design and to explore the orientation of binding sub-sites and 
bound fragments in known and unknown binding pockets. 
A thorough STD NMR analysis of “small Ligand 30 analogues” lacking the triazole-
polyhydroxy chain, the SCJ set, allowed to investigate the specificity of the thio-
galactose and furoate-benzoyl fragments, leading towards the design of three-finger 
ligands. We also provided 3D models of the binding obtained by molecular docking, 
showing qualitative agreement with STD NMR binding epitope mapping. 
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Figure 4.37. Schematic representation of a novel class of three-finger non-carbohydrate CTB 
inhibitors proposed by us, potentially able to occupy simultaneously the galactose, sialic acid 
and novel binding subsites (orange, blue and green fragments, respectively). The length and the 
flexibility of the X linker, should be investigated.  
Based on our 3D molecular models (Figures 4.19 and 4.34), we propose that the 
decoration of the SCJ ligands with a “Ligand 33-like” fragment at position Cfur’’ (the only 
CH of the furoate ring) could yield powerful three-finger ligands, with optimal affinity to 
the three binding subsites (Figure 4.37). The length and flexibility of the linker should be 
tuned to occupy the three subsites simultaneously, specifically and with the minimal loss 
of enthalpy. This could result into a novel approach to CTB inhibition, building on a 
promising class of non-carbohydrate, non-hydrolysable, innovative compounds. 
4.5 Materials and methods  
4.5.1 Chemicals, ligands and proteins  
Ligand 3-nitro-phenyl α-ᴅ-galactopyranoside, Cholera Toxin Subunit B, deuterium oxide 
(99.9% 2H), dimethyl sulphoxide-d6 (DMSO-d6), disodium hydrogen phosphate 
(Na2HPO4), potassium dihydrogen phosphate (KH2PO4), sodium chloride (NaCl) and 
potassium chloride (KCl) were purchased from Sigma Aldrich. The PHF ligands (Ligands 
20, 30 and 33) and the SCJ ligands (Ligand 93, 97, 98, 105, 108 and 109) were provided 
by our collaborators at University of Seville (research group of Prof. Inmaculada Robina). 
The synthesis of the PHF ligands has been described previously92, while the synthesis of 
the SCJ ligands is still unpublished. All the synthetic ligands were prepared in stock 
solutions 3% DMSO-d6 in D2O. 
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4.5.2 NMR measurements and processing  
All the STD NMR experiments were performed on samples of 1 mM ligand and 5 μM CTB 
in 10 mM PBS and 137 mM NaCl buffer pH 7.4 in D2O. As each pentamer contains 5 
equivalent binding sites, the protein:ligand ([P]:[L]) ratio obtained was 1:40. For the STD 
NMR competitions of the PHF ligands (Sub-section 4.2.2), the STD NMR experiment of 
the ligand under investigation (Ligand 30 and Ligand 33) in the presence of CTB was first 
performed (irradiation frequency 0.0 ppm, saturation time 2 s, delay between 
experiments of 5 s and 512 scans). Then the competitor ligand in equimolar 
concentration was freeze-dried and dissolved in the initial sample, and the same STD 
NMR experiment was subsequently carried out. For the IL-STD NMR experiments on the 
ternary complex 3NPG/CTB/Ligand 33 (Sub-section 4.2.6), STD NMR experiments at 2 s 
saturation time with a [P]:[L] of 1:40 (1 mM of each ligand and 5 μM CTB) were 
performed by irradiating at 0.60 ppm (off-ligand experiment) and 7.27 ppm (on-ligand 
experiment). As a control, the same couple of experiments in the same conditions were 
acquired on the binary complexes, 3NPG/CTB and Ligand 33/CTB. For the ILOE on the 
ternary complex 3NPG/CTB/Ligand 33 (Sub-section 4.2.3), transferred-NOESY (tr-
NOESY) experiments were performed with a [P]:[L] of 1:10 (1 mM of each ligand and 20 
μM CTB), with a mixing time of 1.2 s, a relaxation delay of 2 s and 160 scans. As a control, 
the same experiment was performed on 3NPG/CTB, Ligand 33/CTB and CTB alone under 
the same conditions. In addition, IL-STD NMR experiments were performed on the 
ternary complex with a [P] : [L] ratio of 1:40 under the same conditions as the STD NMR 
competition experiments. 
For the SCJ ligands (Ligands 93, 97, 98, 105, 108 and 109), STD NMR build-up curves 
were acquired with irradiation frequency 0.60 ppm, at 0.5 s, 1 s, 2 s, 3 s, 4 s and 5s, with 
a delay between experiment of 5 s and 256 scans (Sub-section 4.3.2). For the DEEP-STD 
NMR fingerprint approach and on-resonance scanning of Ligands 93, 97, 105 and 108 
(Sub-section 4.3.3-.4), a series of STD NMR experiments at 2 s saturation time and 32 
scans were performed at the following irradiation frequencies: 0.60 ppm, 1.464 ppm, 
1.70 ppm, 1.80 ppm, 1.90 ppm, 2.0 ppm, 2.1 ppm, 2.20 ppm, 2.222 ppm, 2.25 ppm, 2.30 
ppm, 2.40 ppm, 2.50 ppm, 2.60 ppm, 2.70 ppm and 2.94 ppm. For the STD NMR 
competitions of the SCJ ligands (Sub-section 4.3.5), STD NMR experiments of four 
sample containing 1 mM Ligand 33 and 5 μM CTB were firstly performed (irradiation 
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frequency 0.60 ppm, saturation time 2 s, relaxation delay between experiments of 5 s 
and 32 scans), then the competitor ligand in equimolar concentration was added and 
the same STD NMR experiment was repeated. For the distance determination of Ligands 
93, 97, 105 and 108 in the bound state (Sub-section 4.3.6), NOE build-up curves were 
acquired on the STD NMR samples (1 mM ligands and 5 μM CTB) running tr-NOESY 
experiments at 0.3 s, 0.4 s, 0.6 s and 0.8 s mixing time, delay between experiments 1.5 
s delay between experiments and 16 scans. To determine distances in the free state, the 
same NOESY experiments were run on samples containing 1 mM of each ligands, in the 
absence of the protein. All the NMR experiments were performed at 278 K.  
All the STD NMR experiments were acquired using an STD NMR pulse sequence that 
included 2.5 ms and 5 ms trim pulses, a spoil gradient (3 ms), and water suppression by 
excitation sculpting with gradients (stddiffesgp.3). Saturation was achieved applying a 
train of 50 ms Gaussian pulses (0.40 mW) on the f2 channel, at the required on-
resonance irradiation frequency (depending on the experiment) and 40 ppm (off-
resonance experiments). The broad protein signals were removed using a 40 ms spinlock 
(T1ρ) filter (stddiff.3). Tr-NOESY and NOESY experiments were performed using a phase-
sensitive pulse program with gradient pulses in the mixing time and a relaxation delay 
of 1.5 s or 2 s, with water suppression using the 3-9-19 scheme with gradients 
(noesyfpgpph19) when necessary. All the experiments were recorded at 1H frequency 
of 800.23 MHz on a Bruker Avance III spectrometer equipped with a 5-mmD probe TXI 
800 MHz H-C/N-D-05 Z BTO. 
To obtain the binding epitope mapping of the ligands, we used Origin 10.4.12 to 
mathematically fit the STD NMR build‐up curves to a mono‐exponential equation, from 
which the initial slopes were obtained. The binding epitope was obtained by dividing all 
the initial slopes by the one of a convenient proton of the sialic acid residue (depending 
on the ligand), to which an arbitrary value of 100% was assigned. DEEP‐STD NMR maps 
were calculated using the DEEP‐STD NMR equation87 (Equation 3.5): 
ΔDEEP− STD𝑖 = 
𝑆𝑇𝐷 𝑒𝑥𝑝1,𝑖
𝑆𝑇𝐷 𝑒𝑥𝑝2,𝑖
− 
1
𝑛
∑ (
𝑆𝑇𝐷 𝑒𝑥𝑝1,𝑖
𝑆𝑇𝐷 𝑒𝑥𝑝2,𝑖
)𝑛𝑖 . 
Intermolecular distances were calculated according to the initial rate approximation, 
which establishes that the evolution of the initial build‐up of NOE enhancements with 
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mixing time is approximately linear56. The longitudinal cross‐relaxation rate can 
therefore be determined from the initial slope of the build‐up curve (𝐼𝐼𝑆  as function of 
𝜏m), where the NOE enhancement (𝐼𝐼𝑆 ) is defined as the ratio between the intensity of 
the cross‐peak at a certain mixing time and the intensity of the diagonal peak at zero 
mixing time 139. In turn, the cross‐relaxation rate is proportional to the inverse sixth 
power of the inter‐nuclear distance (𝜎𝐼𝑆  is proportional to 𝑟𝐼𝑆
−6). The observed NOE 
intensities were normalised relatively to a known spin pair distance as indicated in the 
text. For distances in the bound state, the slopes were calculated on the 0.3 s, 0.4 s and 
0.6 s mixing time points (as at 0.8 s the line was not linear anymore); for the distances 
in the free state, the slopes were calculated on the 0.4 s, 0.6 s and 0.8 s mixing time 
points, due to the different correlation time of the ligands in the bound and free state.  
4.5.3 Molecular Docking and CORCEMA-ST validation  
All molecular modelling was performed with the module Glide within Schrödinger’s  
Maestro software suite140,76,141. For the docking of the PHF ligands, coordinates for the 
receptor were obtained from the Protein Data Bank (PDB ID: 3CHB) for the closed 
conformation and from a representative frame of our HREMD trajectory of the 
GM1/CTB complex for the open conformation. Where necessary, coordinates for 
missing atoms were added according to known protein chemistry and sidechain 
protonation was optimised for neutral pH. A short minimisation was run using the OPLS3 
force field, converging heavy atoms to a RMSD of 0.3 Å. The receptor grid was then 
calculated, using the centroid of GM1 as geometric centre of the rigid box and a length 
of 30 Å in order to encompass all subsites. Three dimensional structures of all ligands 
were generated using a conformational search, implementing Monte-Carlo torsional 
sampling, keeping only unique structures (RMSD > 0.5 Å) and eliminating all structure 
with an energy 21 kJ mol-1 greater than the lowest energy structure. All resulting 
structures were then minimised using conjugate gradient minimisation, converging on 
a threshold of 0.05 kJ mol-1 Å-1. For each ligand, the 10 lowest energy conformations  
were used to initiate docking. The docking consisted of further conformer generation, 
docking and then minimisation. Conformers were generated with 4x enhanced sampling 
and during docking, the non-bonded term of the potential energy function was softened 
for nonpolar ligand atoms (charge < |0.15|) by applying a scaling factor of 0.8. Finally, 
minimisation was performed using implicit solvent with a distance dependant dielectric 
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constant of 4. For the molecular docking of the SCJ set, a 20 Å was built using the 
coordinates of the receptor in the closed conformation from the Protein Data Bank (PDB 
ID: 3CHB), otherwise the same settings as for the PHF ligands were used.  
For CORCEMA-ST66, based on the experimental conditions, the concentration of ligand 
was 1 mM and the [P] : [L] ratio was kept fixed at 25:1. The cut-off distance around the 
binding pocket was 13 Å. kon was set to 1 × 10-8 M-1 and the irradiation frequency to the 
range -0.8 ppm to 0.8 ppm. The bound ligand correlation time (τ) was 65 ns for both 
ligands, whereas the free correlation time was 1.2 ns, 1 ns and 1 ns respectively for 
Ligand 30, Ligand 20 and Ligand 33 (these correlation time values are coming from a 
rough approximation based on the molecular weight of protein and ligands). The 
equilibrium constant used for Ligand 30 was 2000 M-1, 1000 M-1 for Ligand 20 and 1500 
M-1 for Ligand 33, with ρ leak of 0.25 s -1. For Ligand 30 and 33, CORCEMA-ST calculations 
were run in parallel on the High Performance Computing Unit, and then averaged to 
provide a representative build up curve for each ligand. The NOE R-factor was calculated 
on the averaged simulated data obtained, with the following equation: 
𝑁𝑂𝐸 𝑅 − 𝐹𝑎𝑐𝑡𝑜𝑟 =  √
∑ (𝑆𝑇𝐷
𝑘
𝑒𝑥𝑝
−𝑆𝑇𝐷𝑘
𝑐𝑎𝑙 )
2
𝑘
∑ (𝑆𝑇𝐷
𝑘
𝑒𝑥𝑝)
2
𝑘
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172 | P a g e  
 
Chapter 5  
Investigation of the structural elements of sialic acid 
recognition by the intramolecular trans-sialidase 
RgNanH from gut microbiota 
Parts of the findings from this Chapter are published as: 
Owen, D. C.*; Tailford, L. E.*; Monaco, S.; Šuligoj T.; Vaux, L.; Lallement, R.; Khedri, Z.; 
Yu, H.; Lecointe, K.; Walshaw, J.; Tribolo, S.; Horrex, M.; Bell, A.; Chen, X.; Taylor, G. L.;  
Varki, A.; Angulo, J.; Juge, N., Unravelling the specificity and mechanism of sialic acid 
recognition by the gut symbiont Ruminococcus gnavus. Nature Communications 2017, 
8, 2196. 
5.1 Introduction  
5.1.1 Gut microbiota: general features and human health  
The human body provides a suitable environment for microorganisms to colonise in 
numbers comparable to the number of the human cells in the body142. Most of these 
microorganisms resides in the gastrointestinal tract (GIT) where they are referred to as 
the gut microbiota143.  
These resident species comprise non-pathogenic bacteria, eukaryotic microorganisms, 
archea, viruses and bacteriophages; and the number of overall species is estimated 
around several hundred144. Among the bacteria, the dominating phyla are: 
Bacteroidetes, Firmicutes and Actinobacteria145. Many are commensals, i.e. they benefit 
from the nutrient-rich environment of the intestine while at the same time, improving 
the digestion by the host by fermenting otherwise non-digestible nutrients (humans  
produce about 17 classes of host enzymes in the GIT mostly targeting starch 
degradation, while the microbiota produces thousands of complementary hydrolytic 
enzymes with diverse specificities146). Other resident bacteria include opportunistic 
pathogens, which can cause diseases when the host resistance is lowered. Overall, the 
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presence of the microorganisms keeps the system in a state of “physiological 
inflammation”: this provides immune-defence and ensures a quick and adapted 
response to pathogens147.  
The microbiota ecosystem in the GIT evolves throughout the human life (Figure 5.1). The 
unborn child is sterile, or almost so, and receives the first microbiota at birth, with the 
delivery mode (caesarean section or vaginal delivery) being the most important factor 
affecting the initial microbiota composition144. The composition evolves along the first 
years of life both in diversity and richness: the feeding mode (breast- or formula-
feeding) is a crucial factor, and the introduction of solid food has a very strong effect on 
the gut microbiota evolution in the baby. Once the balance is reached, past the toddler 
age, there are many factors which can perturb it: antibiotic treatments, malnutrition, 
obesity and general health condition148.  
The role of the human gut microbiota is critical for the well-being of the host, through 
its contribution to polysaccharide digestion, immune system development, vitamin 
production and pathogen defence149. A dysbiosis of the gut microbiota is associated with 
numerous intestinal diseases including cancers, infections, and inflammatory bowel 
diseases 150, stressing the importance of understanding the mechanisms of host-microbe 
interactions, so to devise microbiota-targeted strategies to restore health.  
 
Figure 5.1. Dynamic composition of the gut microbiota and factors affecting it. The “cake 
representation”’ provides a global overview of the relative abundance of key phyla of the human 
microbiota composition in various stages of life, measured by either 16S RNA or metagenomic 
approaches. Figure from 151.  
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5.1.2 Mucin glycans and gut microbiota: role of the sialic acid and sialidases  
The microbiota composition varies longitudinally along the GIT but also transversally 
from the lumen to the mucosa152, with most of the gut bacteria residing in the colon, 
where they compete for dietary and host glycans153. 
The gradient and availability of glycans within discrete physical niches is among the 
several factors influencing the biogeography of symbiotic bacteria within the gut152. The 
mucus layer covering the GIT is at the interface between the gut microbiota and the 
host150. In the colon, the mucus layer is divided into an outer layer providing a habitat 
to commensal bacteria and an inner layer firmly attached to the epithelium and 
providing a protection from bacterial invasion150. Large highly glycosylated gel-forming 
mucin secreted by goblet cells are the main components of the intestinal mucus 
layers154. Importantly, the mucin oligosaccharides provide binding sites and nutrients to 
the bacteria which have adapted to the mucosal environment155. Commensal and 
pathogenic microbes have evolved a range of adhesins allowing their interaction with 
the mucus in the gut, reflecting the structural diversity of mucin glycans and their 
location156. Variations in mucosal carbohydrate availability lead to variations in the 
composition of the resident microbiota157.   
The glycan structures present in mucins are complex, consisting of core O-glycans 
elongated by diverse carbohydrate sequences. These are terminated by fucose and sialic 
acid such as N-acetylneuraminic acid (Neu5Ac) sugar residues, via α1–2/3/4 and α2–3/6 
linkages, respectively. Hence, these sugar residues are prominent targets for commensal 
and pathogenic bacteria158. The release of sialic acid by microbial sialidases allows the 
bacteria present in the mucosal environment to access free sial ic acid for catabolism, 
decrypt host ligands for adherence, participate in biofilm formation, modulate immune 
function by metabolic incorporation, and expose the underlying glycans for further 
degradation154,159,18.   
Based on their substrate specificity and mechanism, bacterial exo-sialidases can be 
divided into three classes: hydrolytic, trans-sialidases and intramolecular trans-
sialidases (IT-sialidases). Hydrolytic sialidases release free sialic acid (Figure 5.2a), trans-
sialidases transfer the cleaved sialic acid to other glycoconjugates, while IT-sialidases 
release 2,7-anhydro-sialic acid (Figure 5.2b)18. The capacity to carry out one or more of 
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these enzymatic reactions, together with the ability or not of catabolising sialic acid and 
its derivatives, has a large impact on the adaptation of the microorganisms to the 
mucosal environment160. 
 
Figure 5.2.  Structures of (a) sialic acid (NEu5Ac) and (b) 2,7-anhydro-sialic acid (2,7-anhydro-
Neu5Ac), with their atom nomenclature. The nomenclature is given for the carbons of Neu5Ac 
and it is applied to all the ligands. (c) Mechanism of action hydrolytic/trans-/IT-sialidases via a 
two-step double-displacement. The glycosylation step is the same for all three classes of 
sialidase, but for the deglycosylation step the incoming molecule can be water, another sugar 
or the internal oxygen atom, as indicated. Adapted from http://www.cazy.org27,18. 
All sialidases follow a catalytic mechanism of double inversion (so that the α-
configuration of Neu5Ac is retained) via the formation of a covalent intermediate, which 
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sees the Neu5Ac bound to the protein. A nucleophile tyrosine, a charge relay glutamate 
and an acid/base aspartate are the essential catalytic residues involved in the enzymatic 
reaction170, as schematised in Figure 5.2c. 
As often with carbohydrate-active enzymes, sialidases are modular proteins consisting 
of: 
 A catalytic domain, classified as a glycoside hydrolase family 33 (GH33).  
 Carbohydrate binding modules (CBMs) such as sialic acid specific CBM40159,161 
and broadly specific CBM32162.  
As defined by the Carbohydrate Active Enzymes Database, CAZy, http://www.cazy.org2 7 . 
The CAZy classification is based on protein sequences and structure similarities, so to 
help reflecting enzymatic structural features (better than if it was based only on 
substrate specificity), providing a framework to understand mechanistic properties 163.  
5.1.3 The intramolecular trans-sialidase from Ruminococcus gnavus (RgNanH)  
The biological system of interest in this section is RgNanH, an IT-sialidase from 
Ruminococcus gnavus. R. gnavus is a prominent member of the gut microbiota of the 
healthy human gut164 and one of the few commensal species of bacteria which have 
been studied for their ability to utilise intestinal mucin glycans 165,17. Besides, R. gnavus 
has been found to be highly over-represented in individuals affected by Inflammatory 
Bowel Disease68. As an IT-sialidase, RgNanH has high specificity for cleaving α2/3 sialic 
acid capping the mucin oligosaccharides18. The hydrolysis of the terminal sialic acid is 
followed by intramolecular transglycosylation at the C2 position of Neu5Ac, attacked by 
its O7-hydroxy group at the glycerol moiety. The product of the reaction is 2,7-anhydro-
Neu5Ac166.  
RgNanH is the third IT-sialidase to be characterised, after NanL from Macrobella 
decora167 and NanB from Streptococcus pneumoniae168, and the first from a gut 
commensal species [4]. Despite their low sequence similarity, all IT-sialidases share the 
canonical six-bladed β-propeller typical of sialidases (although the sequence homology 
across sialidases is also low)168. As an example, Figure 5.3 shows the structure of the IT-
sialidase from Streptococcus pneumoniae.  
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Figure 5.3. General structure of an IT-sialidase (here from Streptococcus pneumoniae PDB ID: 
2VW1169). CBM40 in blue and GH33 in a six-bladed β-propeller shape in green to orange 
(complexing Neu5Ac, in sticks).  
Interestingly, R. gnavus can grow on 2,7-anhydro-Neu5Ac as a sole carbon source111. 
This finding strengthens the proposed adaptation strategy of R. gnavus to the mucosal 
environment by releasing a molecule, 2,7-anhydro-Neu5Ac, which it can preferentially 
catabolise, while uncapping the mucin glycan chains. This allows R. gnavus to access this 
rich source of nutrient in the colonic mucus for its own benefit, providing a nutritional 
advantage over the competitors, which are usually Neu5Ac catabolisers18. At the same 
time, it opens the way for further degradation of the mucin glycan chain for the rest of 
the mucosal bacteria community.  
In this study, led by the research group of Nathalie Juge at the Quadram Institute 
Bioscience (QIB), we analysed both domains of RgNanH: the catalytic domain GH33, and 
the carbohydrate binding module CBM40. We used STD NMR spectroscopy to 
contribute to the characterization of the molecular recognition preferences of the two 
domains in solution against oligosaccharides terminating with sialic acid (or its 
derivatives). The purified recombinant domains, RgGH33 and RgCBM40 (wild-type and 
mutants produced in E. coli) were provided by Louise Tailford at QIB (Juge Group), who 
also provided the sialylated ligands including the enzymatically-synthesised 2,7-
anhydro-Neu5Ac.  
In the structural investigation of GH33, we used both traditional STD NMR (binding 
epitope mappings determination, STD NMR competition experiments and variable 
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temperature STD NMR experiments), and the new DEEP-STD NMR approach developed 
in the framework of this PhD thesis. This allowed us to elucidate on the relative affinity 
and specificity of 3’-sialyllactose (Neu5Acα3Lac  or 3’SL) and 6’-sialyllactose 
(Neu5Acα6Lac or 6’SL) and, in combination with molecular docking, to provide for the 
first time a 3D model of the Michaelis complex of an IT-sialidase. 
In the structural investigation of CBM40, we used traditional STD NMR binding epitope 
mappings to study a larger set of sialylated ligands, with the aim to understand the effect 
of ligands deletions and decorations relative to the native ligands 3’SL and 6’SL. Our 
NMR analysis fits in a much wider biological study, including X-Ray diffraction structures, 
glycan microarrays studies, microcalorimetry analyses, immunogold labelling and 
western blotting97.  
5.2 GH33 D282A structural studies 
To study the binding of sialoglycans to the catalytic domain of RgNanH, an inactive GH33 
was engineered at QIB, by substituting the acid/base aspartate in position 282 (D282) 
with an alanine to produce GH33 D282A.  
 
Figure 5.4. ΔDEEP-STD pattern for 2,7-anhydro-Neu5Ac in complex with GH33 WT87, blue bars, 
and with GH33 D282A, orange bars. The graph demonstrate that the effect of the mutation is 
negligible from the STD NMR spectroscopic point of view.  
Importantly, we repeated the differential irradiation DEEP-STD experiments on the 2,7-
anhydro-Neu5Ac/GH33 complex reported in reference 87, on the 2,7-anhydro-
Neu5Ac/GH33 D282A complex (Figure 5.4). The two ΔDEEP-STD patterns are very similar 
within the experimental error, showing that the effect of the mutation from aspartate 
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to alanine in position 282 is negligible from the STD NMR spectroscopic point of view. 
This also implies that the data reported in the present section are easily comparable 
with the data reported in Chapter 3, Section 3.3, and in reference 87.  
Also, as discussed at the end of this section and shown by molecular docking in Section 
A.9 of the Appendix, the mutation did not affect the binding mode of the ligands so that 
both, GH33 or GH33 D282A, can be used for binding analyses by STD NMR. 
5.2.1 STD NMR binding epitope mapping and variable temperature experiments: 
investigating relative affinities and kinetics of binding of 3’SL and 6’SL to GH33 D282A 
The interactions of 3’SL and 6’SL with GH33 D282A were analysed by STD NMR on 
samples containing each sialoglycan in the presence of the enzyme. Binding was 
detected for both oligosaccharides. Figure 5.5 shows the resulting STD NMR spectra of 
the two complexes, carried out with different irradiation frequencies (0.60 ppm and 6.55 
ppm).  
 
Figure 5.5. 50 M GH33 D282A in the presence of 1 mM of 3’SL (left panel) and 1 mM 6’SL (right 
panel), 285 K. (a) Reference spectra; (b) STD NMR spectra with on‐resonance irradiation at 6.55 
ppm; (c) STD NMR spectra with on‐resonance irradiation at 0.60 ppm.  Spectra were acquired at 
2 s saturation time. The magnification relative to the reference spectrum is give n for each 
difference spectrum. 
The observation of binding for 3’SL was in line with this ligand being the preferential 
substrate of GH3317, as the sialoglycan microarray analyses conducted with GH33 D282A 
also showed (34). However, the binding of 6’SL was not expected (it was not detected by 
microarrays).  Next, STD NMR build-up curves at two different frequencies were run for 
3’SL and 6’SL and binding epitopes were obtained for the two ligands upon saturation 
at different frequencies (Figure 5.6).  
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Figure 5.6. Binding epitope mappings of 3’SL and 6’SL as bound to GH33 D282A from STD NMR 
experiments with irradiation frequency at 0.60 ppm (a,b), or 6.55 ppm (c,d). Relative STD 
intensities are shown for each proton. Please note that, due to a slight “STD incremental effect” 
at 0.60 ppm irradiation frequency, the STD intensity of the methyl group is largely over‐scale; 
therefore, we preferred to normalise to the second strongest STD signal (H7 for 3’SL and H5 for 
6’SL). To graphically appreciate variations of the binding epitopes upon changing the saturation 
frequency, in (c) and (d) the numerical values of the relative STD intensities which decrease from 
0.60 ppm to 6.55 ppm are reported in light blue and those which increase are reported in red 
(unrelatedly to the colour of the dots).   
Traditional binding epitope mapping analysis is a very powerful tool in structural studies 
of ligands for which the structures of their complexes are unknown70b. In addition, 
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comparison of epitope maps acquired at different saturation frequencies can provide 
further insights into specific intermolecular contacts in ligand/protein complexes, as a 
preliminary step, before a DEEP-STD NMR analysis. 
By comparing the STD NMR data for 3’SL and 6’SL at 0.60 ppm (Figure 5.6a,b), the 
following considerations could be made:  
i) the sialic acid is the main recognition element and the STD pattern for this residue 
is similar for both oligosaccharides (except for the glycerol moiety which appeared 
to be more solvent exposed in 6’SL); 
ii) the binding epitope of 3’SL is “flatter” than 6’SL (lowest values being 52% and 28%, 
respectively), with 6’SL showing less contacts with the enzyme than 3’SL; 
iii) the absolute STD values are higher for 6’SL than for 3’SL (spectra in Figure 5.5). 
In Figure 5.6c,d, the epitopes of the same ligands at 6.55 ppm irradiation frequency are 
reported. A comparison of the binding epitopes at 0.60 ppm (Figure 5.6a,b) and at 6.55 
ppm (Figure 5.6c,d) revealed a further difference:  
iv) the pattern of values increasing or decreasing upon changing irradiation 
frequency differs slightly for the two ligands: for both, the CH3 and H3 protons  
receive more saturation at the irradiation frequency of 0.60 ppm and the g lycerol 
protons H8‐H9s receive more saturation at the irradiation frequency of 6.55 ppm. 
This point will be expanded in Sub‐section 5.2.2, where the DEEP‐STD NMR fingerprint 
approach is applied to these ligands. For comparison, the binding epitope mappings for 
the complex 2,7-anhydro-Neu5Ac/GH33 at 0.60 ppm and 6.55 ppm are reported in 
Section A.7 of the Appendix. 
From the NMR perspective, and as a first interpretation, we can consider that points i), 
ii) and iii) suggest differences in relative affinities and kinetics; while point iv) reports on 
interesting features about the mode and location of binding. To determine the relative 
affinity of 3’SL and 6’SL, variable temperature STD NMR experiments were performed, 
acquiring 2 s saturation time STD NMR experiments with protein saturation at 0.60 ppm 
and following the intensity of the best isolated STD signals. Variable temperature 
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experiments rely on the fact that the kinetics of exchange increases with temperature 
and that STD intensities depend heavily on kinetics66. Thus, we can associate the 
observation of increases in STD signals at increasing temperatures to strong interactions 
(in STD NMR standards), as they signal a slow kinetics (for which STDs are weak due to 
the poor accumulation of saturated ligand in the bulk free state) getting faster and hence 
becoming more “STD‐visible” upon heating the sample. This is what we observed for 
3’SL (Figure 5.7a).  
 
Figure 5.7. Variable temperature STD NMR experiments. STD intensities for 3‘SL, (a), and 6‘SL, 
(b), upon binding to GH33 D282A at increasing temperatures. Upon increases in temperature, 
the STD signals are increasing for 3‘SL and decreasing for 6‘SL. This strongly support that both 
ligands are located at different extremes of the kinetic window favourable for STD NMR 
observation (3’SL in the low kinetics range, and 6’SL in the high kinetics one).  
On the other hand, decreasing STD signals at increasing temperature reflect weak 
interactions, that is, a fast kinetics (favourable for STD NMR observation) getting even 
faster and less “STD‐visible”, due to the very short residence time in the bound state 
precluding significant transfer of saturation by intermolecular NOE66. This is what we 
observed for 6’SL (Figure 5.7b). 
Based on these data, we propose that the two ligands fall into two different kinetics 
windows: i) 3’SL binds to GH33 D282A with slow kinetics (higher affinity) and hence a 
long residence time in the bound state, compatible with the “flatter” binding epitope 
mapping observed, whereas ii) 6’SL binds with faster kinetics (shorter bound residence 
time), as the magnetisation spreads less homogeneously along the ligand.  
It is worth noting that this ranking of affinity was properly elucidated by the variable 
temperature STD NMR experiments, as the wrong conclusion could have been drawn if 
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the discussion had been focused on their respective STD intensities at a given 
temperature. As mentioned before, STD intensities were stronger, under similar 
experimental conditions, for 6’SL (Figure 5.5), which could have been misinterpreted as 
a sign of a higher affinity of this ligand for GH33. This is an important characteristic of 
STD NMR experiments: the comparison of intensities between different ligands, under 
similar experimental conditions, cannot be directly used to rank them in terms of 
affinities. The absolute intensity of an STD NMR signal can be low either for strong 
ligands or for weak ones, provided their kinetics of binding are placed in the extreme 
regions of the appropriate kinetics window for STD NMR observation66. 
5.2.2 DEEP-STD NMR fingerprint: probing the ligands orientation in the binding pocket  
While gathering experimental evidences to rank the ligands in terms of relative affinity 
was relatively straightforward, providing answers about their binding modes requires a 
more profound analysis. We resorted to our newly developed DEEP-STD NMR analysis 
and to STD NMR competition experiments. As outlined in Chapter 4, Sub-section 4.3.3, 
DEEP-STD NMR can be used to determine a fingerprint of the binding pocket, which can 
aid to discriminate whether two ligands bind in the same location and, if they do, 
whether their orientation in the bound state is comparable.  
In this study, the DEEP-STD factors (with differential frequencies 0.60 ppm/6.55 ppm, 
and 0.5 s saturation time) were calculated for 3’SL  and 6’SL with GH33 D282A and 
compared to the differential epitope map obtained for 2,7-anhydro-Neu5Ac and GH33 
in the same conditions. Their differential epitope maps are reported in Figure 5.8.  
For this analysis, the histogram representation is preferable to the differential epitope 
map onto the ligand structures, as it is the whole ΔDEEP-STD pattern (including values 
below a given threshold) that drives the data interpretation.  
A similar ΔDEEP-STD pattern was obtained for the Neu5Ac moiety of the three ligands, 
3’SL, 6’SL and 2,7-anhydro-Neu5Ac. Overall, this suggests that the three ligands occupy 
the same binding pocket, most likely with the same orientation of the Neu5Ac moiety, 
as they “respond” to the differential irradiations in an analogous way.  
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Figure 5.8. Differential Epitope Mapping (0.60 ppm/6.55 ppm) of 3’SL (a) and 6’SL (b), in complex 
with GH33 D282A, and of 2,7-anhydro-Neu5Ac (c) in complex with GH3387. Protons from the 
Neu5Ac moiety are shown in light blue, protons from the galactose moiety are shown in red, 
and protons from the glucose moiety are shown in green. 
On closer inspection, the main differences were found at the protons of the polyhydroxy 
chain (H7 to H9): this is compatible with the different geometry of both sialic acid rings 
at the non-reducing ends of 3’SL and 6’SL relative to 2,7-anhydro-Neu5Ac. The 
comparison between 3’SL and 2,7-anhydro-Neu5Ac is particularly interesting: we can 
look at them as the substrate and the product of the catalytic reaction, res pectively. 
During hydrolysis, the hydroxyl group at C7 attacks and covalently binds to C2, while the 
lactose is leaving. Arguably, the smaller |ΔDEEP-STD| values of protons H8 and H9s of 
3’SL, relative to those of H8 and H9s of 2,7-anhydro-Neu5Ac, may be reporting on the 
movement of the polyhydroxy chain further from the aromatic residues resonating at 
6.55 ppm (Tyr667, and Trp698), as the reaction takes place. 
The DEEP-STD factors for the H8-H9 of 6’SL are even more different from those of 2,7-
anhydro-Neu5Ac. For 6’SL, the ΔDEEP-STD of H8 is positive and the |ΔDEEP-STD| of H9 
are even smaller if compared to those of 3’SL and 2,7-anhydro-Neu5Ac. This suggests 
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that the polyhydroxy chain of 6’SL is oriented in a different way from the one of 3’SL 
(arguably pointing slightly further from the patch of aromatic residues). 
More remarkably, the DEEP-STD factors of the galactose and glucose moieties differ 
considerably among the two ligands, reporting on a divergent orientation of their 
respective lactose parts in the binding pocket. Particularly, homogeneously negative 
ΔDEEP-STD were observed for the galactose moiety of 3’SL, suggesting vicinity of this 
galactose ring to one or more aromatic residues (for 6’SL, significantly negative ΔDEEP-
STD are only observed for H5 and H6 of galactose and H2, H5 and H6 of glucose).  
The analysis of the DEEP-STD NMR fingerprints of the two ligands 3’SL and 6’SL against 
2,7-anyhydro-Neu5Ac gives us ground to propose that both ligands binds in the same 
binding pocket with different orientation of the lactose moiety. The diverse orientations  
were readily determined in the DEEP-STD maps in agreement with the different 
geometry of the glyosidic link. To further confirm that the binding takes place in the 
same binding site, we carried out STD NMR competition experiments. 
5.2.3 STD NMR competition experiments: validation of the DEEP-STD NMR data on the 
location of binding (and comparison of the two approaches)  
STD NMR competition is a traditional approach to probe if two or more ligands are 
binding in the same location on a given protein81,82. Here, we first assessed the 
competition between 3'SL and 6'SL by performing STD NMR experiments of GH33 D282A 
in the presence of a) 3'SL (1 mM), b) 6'SL (1 mM) and c) 3'SL (1 mM) + 6'SL (1 mM). In all 
cases, the STD intensities of 7 well‐isolated reporter signals were followed at 288 K, as 
shown in Figure 5.9. The STD intensities of the reporter signals of 3’SL were not 
significantly affected when 6’SL was present (Figure 5.9, left). In contrast, the STD 
intensities of the protons of 6'SL were considerably reduced in the presence of 3’SL 
(Figure 5.9, right). These findings support binding of the two ligands in the same site, 
with 3'SL having stronger binding affinity (it “displaces” 6'SL almost completely).  
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Figure 5.9. STD NMR competition experiments for 3’SL (left) and 6’SL (right). The samples 
containing the complexes 3’SL/GH33 D282A and 6’SL/GH33 D282A are compared with the 
sample containing both ligands 3’SL and 6’SL in the presence of GH33 D282A. The stars indicate 
overlapping of the signal of the two species in the sample containing both ligands. 3’SL displaces 
6’SL, but its binding is not affected by the presence of 6’SL.  
Another valuable application of  STD NMR competition is to identify the position of 
binding of ligands with unknown binding site by using the “spy approach”171. This was 
developed to investigate strong interactions above the limit of STD NMR detection (slow 
chemical exchange, i.e. 𝐾𝐷  below 10
‐7 M) and relies on the use of “STD‐visible” weak‐
binders (ideally of known affinity and for which a 3D structure in complex with the 
protein of interest is available) to monitor their displacement from the binding site in 
the presence of other potential high‐affinity ligands. Disappearance of the STD signals of 
the “spy” provides evidence that the tested ligands bind to the receptor more tightly and 
in the same binding pocket as the spy. 
Alternatively, the approach can be used with a strong‐binder of known 3D structure as 
an “inverted spy” to probe for interaction of the protein to weaker ligands. Fortuitously, 
while performing STD analysis of 3’SL/GH33 D282A on consecutive days, we found that 
2,7‐anhydro‐Neu5Ac could be used for this purpose (Figure 5.10).  
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Figure 5.10. STD NMR spectra at day 0 (a) and day 12 (b) of a sample containing 3’SL in the 
presence of GH33 D282A (2 s saturation time, 0.60 ppm irradiation frequency). Hydrolysis of 3 S´L 
to produce 2,7‐anhydro‐Neu5Ac was observed, and it led to a change in the pattern of STD 
signals. By overlapping the 1H 1D spectra recorded at the two time‐points (c), the hydrolysis was 
estimated to be around 30%. The signals 2,7‐anhydro‐Neu5Ac are labelled in (d) and starred in 
(b), where we see 2,7‐anhydro‐Neu5Ac competing with 3’SL. Due to non‐equimolar 
concentration of the two ligands, no quantification can be done, but we can conclude that the 
product displaced the substrate. 
Due to the residual activity of the catalytic mutant, new STD signals appeared in the STD 
difference spectrum, taking over the signals from 3’SL (Figure 5.10b). The new signals 
belonged to 2,7-anhydro-Neu5Ac, the product of the catalytic reaction. The enzymatic 
reaction was also evident in the 1H 1D spectrum, but less appreciably, due to the 
resulting set of crowded signals. The STD data showed that 2,7-anhydro-Neu5Ac 
displaces the substrate 3’SL from the enzyme binding pocket. This confirms that both 
ligands bind at the same site, with the product 2,7-anhydro-Neu5Ac binding more 
strongly than the substrate 3’SL to the GH33 D282A mutant.  
We then further studied the competition between 6’SL and 2,7-anhydro-Neu5Ac. As 
previously reported, GH33 does not hydrolyse α2/6 substrates; accordingly, GH33 
D282A did not show any activity towards 6’SL, and this sample remained stable over 
time. However, as shown in Figure 5.11, upon addition of an equimolar concentration 
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of 2,7-anhydro-Neu5Ac to the 6’SL/GH33 D282A sample, the signals corresponding to 
6’SL completely disappeared. 
Together findings from these STD NMR competitions demonstrated that: 
 3’SL and 6’SL compete for the same binding site (3’SL displace 6’SL, Figure 5.9); 
 3’SL and 2,7-anhydro-Neu5Ac compete for the same binding site (2,7-anhydro-
Neu5Ac displaces 3’SL, Figure 5.10); 
 6’SL and 2,7-anhydro-Neu5Ac compete for the same binding site (2,7-anhydro-
Neu5Ac displaces 6’SL, Figure 5.11). 
 
Figure 5.11. STD NMR competition experiment between 6’SL and 2,7‐anhydro‐Neu5Ac: off‐
resonance and STD NMR spectra prior addition, (a) and (b), and after addition, (c) and (d), of 
2,7‐anhydro‐Neu5Ac in the presence of GH33 D282A. The STD signals of 6’SL disappear 
completely when 2,7‐anhydro‐Neu5Ac is present, proving that they bind in the same binding 
pocket. The signals of 2,7‐anhydro‐Neu5Ac are labelled in (c). 
The combination of these STD NMR competition experiments supports the existence of 
a single binding pocket for these sialoglycans in GH33, as also suggested by the DEEP-
STD fingerprint approach (Sub-section 5.2.2). As both oligosaccharides are displaced by 
2,7-anhydro-Neu5Ac, and 3’SL displaces 6’SL, a ranking of affinities could be 
experimentally established with 2,7-anhydro-Neu5Ac > 3’SL > 6’SL. 
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It is worth stressing that the information obtained by STD NMR competition experiments  
offers more definitive answers on the location of binding, when compared to the DEEP-
STD NMR approach. This is so because similar DEEP-STD fingerprints may also be the 
result of ligands binding to two different binding sites that fortuitously showed similar 
geometrical distribution of residues contacting the ligands. The two approaches are 
therefore complementary: STD NMR competition experiments providing further 
evidence on the location of binding (with the starting point of a known 3D structure), 
while DEEP-STD NMR can provide information on the orientation of unknown ligands in 
known binding sites.  
5.2.4 Docking of 3’SL and 6’SL onto GH33: towards the model of the 3D structure in 
solution  
To provide a model of the structure in solution, we combined the STD NMR experimental 
information with molecular docking, using the crystal structure of 2,7-anhydro-Neu5Ac 
in complex with RgNanH GH33 (PDB ID: 4X4A17) as a starting point. First, the docking 
conditions were optimised to reproduce the complex of 2,7-anhydro-Neu5Ac in the 
GH33 binding as observed in the crystal structure17.  
 
Figure 5.12. Superimposition of the lowest energy convergent docking solutions for GH33 in 
complex with 3’SL, (a) 10 poses, and 6’SL, (b) 6 poses. 
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The coordinate of GH33 from the X-Ray structure with 2,7-anhydro-Neu5Ac (PDB ID: 
4X4A) were used to generate the receptor grid; then, 3'SL and 6'SL were docked. Both 
ligands converged to lowest energy solutions showing the Neu5Ac ring fitting deeply in 
the catalytic cavity (with glide gscore and glide emodel of circa -5.0 kcal/mol and -55 
kcal/mol, respectively, comparable for both ligands). For 3’SL, convergence of the first 
10 lowest poses was observed, whereas convergence of the first 6 poses was observed 
for 6’SL (Figure 5.12). The docking tables are reported in Section A.10 of the Appendix. 
The solutions with higher energies presented the ligands flipped by 180°, fitting the 
glucose in the catalytic cavity, instead. These solutions could safely be excluded based 
on the experimental STD NMR evidences showing that GH33 does mainly recognise the 
sialic acid residue (Figure 5.6).  
 
Figure 5.13. (a) 2,7-anhydro-Neu5Ac (in orange) from PDB ID: 4X4A, overlapped with the 
Neu5Ac rings of the best docking solutions for 3’SL (cyan) and 6’SL (purple). Only protein 
residues within 3 Å are shown and labelled. C8 and C9 are pointed by arrows. Protons are 
omitted for clarity (here and in the following molecular schemes). (b) ΔDEEP-STD for 2,7-
anhydro-Neu5Ac87 and the Neu5Ac rings of 3’SL and 6’SL, following the same colouring scheme 
as in (a) (adapted from Figure 5.8). 
In both 3’SL/GH33 and 6’SL/GH33 models, the Neu5Ac ring was found in a comparable 
orientation to 2,7-anhydro-Neu5Ac in the crystal structure. Interestingly, the glycerol 
moieties of the tri-saccharides were further away from the Tyr667 and Trp698 residues 
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(resonating at 6.55 ppm) than the polyhydroxy chain of 2,7-anhydro-Neu5Ac (whose 
hydroxyl on C7 is covalently bound to C2 because of the intramolecular trans -
glycosylation). In agreement with the DEEP-STD fingerprint data, H8 and H9s of 6’SL 
(purple in Figure 5.13) appear to point in the opposite direction relative to the same 
protons of 3’SL (cyan in Figure 5.13).  
It is worth noticing that the main difference between the binding of 3’SL and 6’SL is in 
the orientation of the lactose moiety. The α2/3 glycosidic linkage directs the galactose 
of 3’SL to a very efficient π-stacking with Trp698. Figures 5.14a and 5.15a provide two 
views of 3’SL π-stacking to Trp698 and shows how the galactose region encompassing 
C3, C4 and C5 point towards the tryptophan side chain (in magenta, resonating around 
6.55 ppm, as discussed in Chapter 3). This is in strong agreement with the DEEP-STD data 
reported with both figures (Figures 5.14a and 5.15a). 
 
Figure 5.14. Lowest energy docking solutions for 3’SL (a) and 6’SL (b) bound to GH33. For the 
purposes of comparability, both 3’SL and 6’SL are shown in (b). Top view of the galactose 
orientation relative to Trp698 (shown in magenta). The ΔDEEP-STD histograms (0.60 ppm/6.55 
ppm) of the galactose protons of both ligands (adapted from Figure 5.8) are shown at the 
bottom. Positions of ligands protons with negative ΔDEEP-STDs are pointed by arrows and 
labelled to show their close contact to the aromatic residue Trp698. 
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The glucose moiety of 3’SL is pointing more towards the solvent, again in accordance 
with low ΔDEEP-STDs as shown in Figure 5.15a: if the ligand protons are solvent exposed, 
they will not be strongly affected by differential irradiation frequencies, although the 
strong positive ΔDEEP-STD observed for the glucose-H4 of 3’SL remains to be 
investigated.  
For 6’SL, the larger flexibility of α2/6 glycosidic linkage makes the galactose ring to sit in 
an orientation rather perpendicular to the galactose of 3’SL and therefore to Trp698 
(Figure 5.15b). This results in galactose H5 and H6s protons pointing towards the 
tryptophan, while the rest of the galactose protons point to the other side of the binding 
pocket. This is in agreement with the DEEP-STD data reported below both figures 
(Figures 5.14b and 5.15b).  
 
Figure 5.15. Lowest energy docking solutions for 3’SL (a) and 6’SL (b) bound to GH33. For the 
purposes of comparability, both 3’SL and 6’SL are shown in (b). Side view of Trp698 (shown in 
magenta) relative to the galactose of 3’SL and the glucose of 6’SL. The ΔDEEP-STD histograms 
(0.60 ppm/6.55 ppm) of the glucose protons of both ligands (adapted from  Figure 5.8) are shown 
below each figure. Ligands protons with negative ΔDEEP-STDs are pointed by arrows and 
labelled to show their close contact to the aromatic residue Trp698. 
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The distinct bending of 6’SL imposed by its flexible glycosidic linkage brings its glucose 
ring closer to Trp698 than the adjacent galactose ring: glucose C2 and C6 point towards 
the tryptophan, as one would expect from the negative DEEP-STD factors observed for 
H2 and one of the H6s (Figure 5.14b). 
To further support that mutation of aspartate to alanine at position 282 did not affect 
the binding mode of the sialoglycans into the GH33 binding pocket, the mutant was 
reproduced computationally based on the crystal structure of GH3317 by mutating the 
single aspartate 282 residue to an alanine on Maestro Schrodinger (refer to Materials 
and Methods, Sub-section 5.5.3 for details). From this structure, a new grid was 
generated, with size and coordinates identical to the WT grid. The docking of 3’SL and 
6’SL was repeated in the newly obtained grid, and the resulting poses and clus tering 
perfectly matched those obtained for the wild type GH33. This result suggests that, 
whereas the D282A mutation partially inactivates the enzymatic activity, it does not 
appear to affect the binding mode of 3’SL and 6’SL in the catalytic cleft.  This  is something 
important regarding the studies of ligand binding to enzymes: binding in many cases can 
be considered a separate event from the enzymatic reaction, meaning that the presence 
or absence of catalytic residues might not impact significantly the binding modes of 
ligands. This explain why ligands of similar nature can bind in the same catalytic site with 
very different enzymatic outcomes (reaction or no reaction at all). For example, this 
situation was also described by NMR regarding the binding of ligands to the human 
blood group B galactosyltransferase (GTB): UDP-Gal and UDP-Glc sugar nucleotides bind 
equally well to the enzyme, whereas the reaction only takes place on the first one (the 
natural substrate). 
5.2.5 CORCEMA-ST simulations on 3’SL/GH33 and 6’SL/GH33: validating the 3D structures 
in solution 
To validate the 3D structures of the 3’SL/GH33 or 6’SL/GH33 complex in solution, 
CORCEMA-ST simulations were run for the lowest energy solutions from docking 
calculations of 3’SL and 6’SL. The simulated build-up curves were compared against the 
experimental ones obtained at an irradiation frequency of 0.60 ppm (Figure 5.16 and 
5.17). For both ligands, NOE R-factors lower than 0.30 were obtained, validating the 
docking solutions as good models for the complexes in solution.  
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It is worth noticing that, for 6’SL, the glucose moiety was excluded from the calculations, 
due to the high number of glucose overlapping proton signals in the NMR spectrum. 
Remarkably, the presence of overlapping protons does not have a major effect on the 
interpretation of DEEP-STD data, as the effect is cancelled by comparison of data sets in 
two conditions. Instead, proton overlapping brings to larger discrepancies when 
comparing the CORCEMA-ST simulated data with the experimental data: CORCEMA-ST 
predicts STD intensities for each single proton, while for overlapped protons we only 
appreciate the average of the STD intensities of the protons resonating at the same 
frequencies. In these situations, it is hard to fit the simulated data to the experimental 
one (for example, the NOE R-factor for 6’SL including the glucose was 0.35). 
 
Figure 5.16. Experimental STD NMR build-up curves, (a), and CORCEMA-ST simulated build-up 
curves, (b), for the 3’SL/GH33 complex. 
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Figure 5.17. Experimental STD NMR build-up curves, (a), and CORCEMA-ST simulated build-up 
curves, (b), for the 6’SL/GH33 complex. 
5.2.6 Some thermodynamics considerations  
The intramolecular trans-glycosylation reaction of RgNanH has been demonstrated to 
have a strict specificity for α2-3-linked sialic acid17,97. Therefore, the STD NMR findings 
supporting binding of both 3’SL and 6’SL to GH33 D282A was unexpected. In addition, 
STD NMR experiments (including variable temperature and competition experiments) 
demonstrated that the binding takes place with different affinities and with different 
kinetics: 3’SL inhibits the binding of 6’SL almost completely and binds with a 
considerably larger residence time in the bound state. 
According to our docking models, the two ligands would bind with rather similar binding 
modes, particularly at the main recognition element which is the sialic acid ring at the 
non-reducing end, and differing mainly at the orientation of the lactose moiety. 
Whereas for 3’SL a π-stacking with Trp698 is observed, the α2/6 glyosidic linkage of 6’SL 
directs its galactose ring further from the tryptophan. Trp698 has been proposed to be 
one of the key residues involved in the trans-sialidase reaction,  providing an 
hydrophobic environment that would repel water molecules from the catalytic cleft, and 
promote the closest nucleophilic hydroxyl (either from another sugar or from the 
substrate itself) to attack the covalent intermediate of the Neu5Ac bound to the 
nucleophilic tyrosine, therefore favouring an intramolecular reaction18. Trp698 has also 
196 | P a g e  
 
been associated to the strict specificity of trans-sialidases, and especially of the IT-
sialidases, for α2/3 sialoglycans. Our 3D models showed that the galactose ring is in a 
favourable position for π-stacking with Trp698 only in the case of the 3’SL, in contrast to 
6’SL. This could account for the lack of reaction with 6’SL, which is also recognised with 
much lower affinity. 
From a thermodynamic point of view, the higher affinity of 3’SL for the catalytic domain 
of RgNanH can be explained thermodynamically, as due to: 
i) Favourable enthalpy contribution coming from the π-stacking with Trp698 (only 
possible for 3’SL); 
ii) Unfavourable entropy contribution for 6’SL, due to the extra rotatable bond in the 
geometry of the α2/6 glycosidic bond.  
Additionally, the STD NMR competition experiments show that the presence of 6’SL 
does not interfere with the interaction between 3’SL and GH33 D282A, even when they 
are in equimolar concentrations. Therefore, although both ligands are present in the 
mucus layer of the mammalian intestine, the potentiality of GH33 to recognise and 
weakly bind α2/6 sialoglycans is expected not to affect the efficiency of hydrolysis of 
α2/3 sugars in physiological conditions. 
5.3 CBM40 structural studies  
As opposed as to the structural study on RgGH33 D282A, focused on solving the 3D 
model of the enzyme in complex with 3’SL and 6’SL, the study on CBM40 reported in the 
present section focuses on a much larger set of sialylated ligands. Here, the aim is to 
understand the effect of ligands deletions and decorations relative to the native ligands 
3’SL and 6’SL in the molecular recognition of the carbohydrate binding module 
RgCBM40. 
5.3.1 Binding tests and binding epitope mapping: investigating the broad specificity of 
CBM40  
In this study97, Neu5Ac, N-glycolylneuraminic acid (Neu5Gc), 2,7-anhydro-Neu5Ac, 
Neu5Acα3Lac (3’SL), Neu5Acα6Lac (6’SL), Neu5Acα3Gal (3’SGal), Neu5Acα6Gal (6’SGal), 
Neu5Acα3LacNAc (3’SLN), Neu5Acα6LacNAc (6’SLN), Neu5Gcα3Lac (3’SLGc), 
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Neu5Gcα6Lac (6’SLGc), Neu5Acα6GalαOC3H6N3 (Neu5Ac-STn), Neu5Gcα6GalαOC3H6N3 
(Neu5Gc-STn), and Neu5Acα3Gal3GalNAcαOC3H6N3 (STF) were tested as potential 
ligands for CBM40. The structures and atom nomenclature of Neu5Ac and 2,7-anhydro-
Neu5Ac are shown in Figure 5.2a,b, and those of the di- and trisaccharides are reported 
in Figure 5.18 and Figure 5.20, together with their binding epitopes.  
The set of sialylated ligands includes several elements of diversification, with the main 
motif being the α2/3 or α2/6 glycosidic linkage of sialic acid and its derivative to the rest 
of the molecule. Another essential element is the presence of the Neu5Gc as the non-
reducing end. Neu5Gc is a Neu5Ac derivative, where the methyl of the acetyl group is 
substituted with a glycolyl group. Also, the deletion of the reducing glucose is another 
element under investigation, such as the presence of acetamide groups in position C2 
of the reducing moieties. 
STD NMR experiments at 2 s saturation time were performed on all the sugars. Binding 
to CBM40 was detected for all the di- and trisaccharides, while the three 
monosaccharides, Neu5Ac, Neu5Gc and 2,7-anhydro-Neu5Ac did not show binding. For 
the 11 binders, STD NMR build-up curves were run, and their binding epitope mappings 
were obtained as described in Materials and Methods (Sub-section 5.5.2). The sialic acid 
ring was found to be the main recognition element across all ligands tested and the 
binding mode was not affected by the nature of the glycosidic linkage (α2/3 or α2/6) of 
the sialoglycan. 
Figure 5.18a shows the STD NMR spectra of 3’SL and 6’SL interacting with CBM40, and 
Figure 5.18b their corresponding binding epitope mappings. The binding epitopes of 3’SL 
and 6’SL from STD NMR were in good agreement with the crystal structures  that were 
solved in parallel to this work of the complex between RgCBM40 and 3’SL or 6’SL (Figure 
5.19, PDB ID: 6ER3 and 6ER497). In the crystal structures, the sialic acid shows the closest 
contacts to the protein surface while the lactose moiety is more solvent exposed, as also 
suggested from the low STD intensities observed for the galactose and glucose protons. 
The very strong STD intensity of the methyl group is in excellent agreement with the N-
acetyl group sitting deep in the hydrophobic pocket surrounded by the protein protons  
from the side chains of Ile95, Tyr116, and Tyr210 (Figure 5.19), about which we 
discussed in Chapter 3, Sub-section 3.2.2. The high intensity on H7 compared to the 
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much lower one on the adjacent H8 agrees with H7 facing the hydrophobic side chains, 
while H8, in trans-conformation to it, is pointing towards the solvent.  
 
Figure 5.18. STD NMR analysis of CBM40 binding to sialoglycans, (a) Reference (top, x1) and 
difference (bottom, x32) spectra of 3’SL and 6’SL, 2 s saturation time. The strongest signals from 
Neu5Ac protons are labelled in the difference spectra. (b) Binding epitope mapping from STD 
NMR of 3’SL and 6’SL. Legend indicates relative STD intensities normalised at H7: blue, 0–24%; 
yellow, 25–50%, red 51–100%; larger red dots indicate values over 100%. Figure from 97. 
The binding epitopes of the other oligosaccharides tested showed that there are no 
stark differences in the orientation of the sialic acid ring in the binding pocket of CBM40, 
within the STD NMR experimental error (Figure 5.20). The absence of the reducing 
glucose (for 3’SGal, 6’SGal, Neu5Ac-STn and Neu5Gc-STn) or the presence of decorations  
on the ligands (3’SLN and 6’SLN) did not significantly impact on the overall binding 
mode. 
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Figure 5.19. Close-up view of the crystal structures of CBM40 in complex with (a) 3’SL and (b) 
6’SL, PDB ID: 6ER3 and 6ER4, respectively. The Neu5Ac residue is shown in cyan and the 
galactose residue as black lines, for clarity the glucose residue i s not shown. Interacting CBM40 
residues are shown in green with black dashed lines indicating hydrogen bonding interactions. 
The semi-transparent surfaces indicate hydrophobic niche. Figure from 97. 
 
Figure 5.20.  Binding epitope mapping of (a) Neu5Gcα3Lac (3’SLGc), (b) Neu5Gcα6Lac (6’SLGc), 
(c) Neu5Acα3Gal (3’SGal), (d) Neu5Acα6Gal (6’SGal), (e) Neu5Acα3LacNAc (3’SLN), (f) 
Neu5Acα6LacNAc (6’SLN), (g) Neu5Acα6GalαOC3H6N3 (Neu5Ac-STn), (h) 
Neu5Gcα6GalαOC3H6N3 (Neu5Gc-STn), and (i) Neu5Acα3Gal3GalNAcαOC3H6N3 (STF) as bound 
to CBM40 from STD NMR experiments. Legend as in Figure 5.18. STD NMR spectra (2 s saturation 
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time) of the binding of 3’SLGc and Neu5Gcα2-6Lac 6’SLGc to CBM40 are shown as a 
representative example (reference spectra on top x1, difference spectra on bottom x64). Figure 
from 97. 
Interestingly, CBM40 also showed binding to Neu5Gc-ending oligosaccharides, albeit 
with a lower strength (overall lower STD signals in Figure 5.20a,b when compared to 
Figure5.18a).  
Again, sialic acid was the main recognition element of these sialoglycans, but the binding 
epitope mappings were slightly different to those observed for 3’SL and 6’SL. For the 
Neu5Gc-ending ligands, stronger STD intensities on H3s and lower ones on H6 were 
observed, suggesting a small reorientation of the ring around C3, which would expose 
C6, to fit the bulkier hydroxyl group on the acetamide moiety. 
5.3.2 Interpreting the different “STD incremental effect” of the methyl groups across the 
l igands  
All the Neu5Ac-containing oligosaccharide ligands of CBM40 showed an over-the-scale 
STD value of the acetamide methyl group. In Chapter 3, Sub-section 3.2.2, we analysed 
the “STD incremental effect” for the methyl group of Neu5Ac in the 6’SL/CBM40 
complex, and we used “on-resonance” scanning to explain this effect. We ascribed it to 
the combination of: 
i) the small size of the molecule (short τc), making spin diffusion inefficient; 
ii) the shallow binding pocket where only the methyl group of Neu5Ac is deeply 
buried in the hydrophobic niche; 
iii) the direct irradiation at the aliphatic side chain of Ile95 within the 
hydrophobic niche; 
iv) the fast kinetics of exchange, where the short bound residence time prevents 
the magnetisation to spread evenly from the methyl group, in very close contact 
with the protein protons, and the rest of the ligand protons, further from the 
protein surface (we will explain this point further at the end of this sub-section).  
As mentioned above, the binding epitopes of all ligand tested are similar within the 
experimental error (Figure 5.18 and 5.20), and the methyl group is always largely over-
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scale. For the Neu5Ac-containing ligands, the normalised STD initial slopes of the methyl 
group ranged from 450% to 1200% relative to H7 of the Neu5Ac. For the three Neu5Gc-
containing ligands, where the glycolic group replaces the methyl group (Figure 
5.20a,b,h), the normalised STD initial slope of the methylene group (-CH2-OH) was lower 
(167%, 106% and 108% for 3’SLGc, 6’SLGc and Neu5Gc-STn, respectively). These findings 
agree with the presence of the bulky hydroxyl of the glycolic group somehow hindering 
the interaction, bringing the CH2 further from the protein surface, when compared to 
the Neu5Ac ligands. 
One of our initial concerns was to exclude the possibility of direct irradiation on the 
methyl group. The analysis of the resulting binding epitopes provided further evidences 
that this is indeed the case. Firstly, the spectra of the 3’SLN and 6’SLN contain two 
methyl groups, one on the Neu5Ac and one on the lactosamine. Although their signals 
are only 0.01 ppm-0.05 ppm far from each other, the STD intensities of the lactosamine 
methyl group were in the same range as those of the rest of the molecule. Secondly, the 
H3 axial, which falls about 0.3 ppm high-field to the methyl group in analysis, does not 
show such a dramatic effect. Finally, because the methyl groups share the same 
chemical shift (between 1.70 and 1.80 ppm), normalised STD intensities ranging 
between 450% and 1200% indicate that the phenomenon is ligand-dependent and 
cannot simply be ascribed to a technical artefact. 
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Figure 5.21. STD initial slopes of CH3s normalised relative to H7 for the Neu5Ac-containing 
binders. The disaccharides show higher values, suggesting a shorter residence time in the 
binding pocket.  
Since direct irradiation was excluded, we investigated whether the different STD 
intensities across the Neu5Ac-containing ligands could provide information on the 
kinetics of binding. The size of the protein, the binding mode and the irradiation 
frequency, points i) to iii), are constant for all the STD NMR experiments; instead, the 
residence time, point iv), can be considered the variable factor. All the ligands interact 
with different affinities and, most likely, different kinetics of binding. According to iv), 
the faster the kinetics of interaction, the larger the gap between the STD value of the 
methyl group and that of the H7 (H7 was used as a reporter signal as it generally showed 
the second strongest STD signal across the set of ligands).  
To explain how the gap in STD intensities between the methyl groups and the H7 relates 
to the kinetics of the interaction, we can use an analogy to thermal diffusion. Let us 
imagine a bar of metal which is brought close to a flame or any other source of heat. 
The very extremity of the bar, the one closer to the flame, will be the first part to get 
hot, and the hottest one at any time point. Hence, the longer time the bar will spend 
close to the flame, the further the heat will diffuse and the hottest the rest of the bar 
will get (in a gradient-manner, but we will not get too formal about the mathematics of 
it). If we now imagine the magnetisation to be the heat, the protein surface to be the 
source of heath, and the ligands to be bar-like, we can translate the thermic diffusion 
analogy to explain the gap in STD intensities between the extremity of the ligands  and 
the rest of the molecule. In fact, as we know from the X-Ray structure in Figure 5.19, the 
methyl groups of the sialylated ligands (extremity of the bar) fits inside a hydrophobic 
pocket at a very close distance to Ile95 (source of heat). Therefore, the amount of 
saturation (heat) which will reach the rest of the molecule (the rest of the bar) depends  
on the residence time spent by the ligand in the binding pocket.  
As shown in Figure 5.21, the normalised values of the methyl protons group in two 
ranges: the trisaccharides with values around 500% and the disaccharides with values 
around 1200%. With the thermic diffusion analogy in mind, this pattern can be ascribed 
to a faster kinetics of binding for the disaccharides relative to the trisaccharides (albeit 
we do not have any thermodynamic data confirming this yet). 
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5.3.3 Discussion of the STD NMR data in comparison with the glycan microarray and ITC 
data 
In summary, our STD NMR study reports CBM40 as a low affinity and broadly-specific 
binder of sialoglycans containing Neu5Ac at the non-reducing end. Albeit the sialic acid 
moiety is the main recognition element, sialic acid monomers were not recognised and 
at least a second moiety was necessary for recognition. The main role of the 
carbohydrate binding module is believed to be concentrating the IT-sialidase to 
potential substrates containing sialic acid. Neu5Ac, Neu5Gc and 2,7-anhydro-Neu5Ac 
are not hydrolysable and, consistently with its biological role, CBM40 does not recognise 
them. Accordingly, the minimal recognised sugars are the sialylgalactosides (3’SGal, 
6’SGal, Neu5Ac-STn and Neu5Gc-STn).  
Our STD NMR findings are in agreement with the sialoglycan microarray screening and 
isothermal titration calorimetry (ITC) analyses 97, showing that CBM40 bound to terminal 
Neu5Ac and Neu5Gc attached to aglycons by α2/3 and α2/6 linkages, with a  preference 
for terminal Neu5Ac over Neu5Gc and for α2/3 over α2/6-linkages (34). However, 
although the microarray reported excellent binding also to 3’SLN but not to 6’SLN, both 
gave positive results in STD NMR experiments. The same was observed for 6’SLGc and 
Neu5Gc-STn (which gave STD signals but no binding on microarrays).  
STD NMR is very sensitive towards binding events but is not the optimal technique to 
quantify binding affinities. In (34), ITC data were provided for Neu5Ac, Neu5Gc, 3’SL, 
6’SL, 3’SLGc and 6’SLGc as bound to CBM40. While the ITC data were mostly in 
agreement with the STD NMR data, it is interesting to compare the outcome from the 
two techniques: whereas by STD NMR we could not detect significant differences in 
affinities between 3’SL and 6’SL, the two showed a 𝐾𝐷  of 0.56 mM and 1.41 mM, 
respectively. On the other hand, we did notice a lower STD intensity for the SLGc sugars 
relative to the SL sugars, and, in fact, the former ones have 𝐾𝐷s above 2 mM by ITC 
measurements. Noticeably, no STD signal could be observed at all for the 
monosaccharides, whose binding is estimated above 15 mM by ITC (i.e. beyond the 
detection limit in terms of kinetics for STD NMR). 
From a biological perspective, the role of CBM40 has been proposed to target the 
enzyme (and hence the bacteria) towards sialic acid rich regions of the GIT (34). Using 
immunogold labelling and western blotting on mucins of different origin, our 
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collaborators at the Quadram Bioscience Institute provided further evidences for 
CBM40 from R. gnavus  to be considered as a novel bacterial mucus adhesin97. 
Interactions between bacterial adhesins from gut commensals and mucin glycans are 
generally of low affinity172,173. This fits with the findings that CBM40 broadly and weakly 
recognises potential IT-sialidase substrates, with a slight preference for α2/3 over α2/6 
sugars. This specificity differs from other characterised CBM40s showing a net 
preference for the α2/3 sialoglycans, such as those from C. perfringens or M. 
decora174,167. It is interesting to pinpoint the lack of recognition of monosaccharides 
Neu5Ac, Neu5Gc or 2,7-anhydro-Neu5Ac (the product of the enzymatic reaction) by 
CBM40.  
5.4 Conclusions 
The work presented in this chapter is a thorough structural investigation on the 
molecular recognition processes involving the two domains of the intramolecular trans-
sialidase RgNanH from the gut commensal symbiont Ruminoccocus gnavus, i.e. the 
GH33 and CBM40 domains, by STD NMR spectroscopy and computational tools. The 
specificity and the mechanisms of molecular recognition were investigated with a focus 
on the features underpinning the ligand specificity of the proteins and their ability to 
discriminate between α2/3 and α2/6 sialoglycans. Noticeably, the 3D structures in 
solution for 3’SL and 6’SL bound to GH33 were provided and validated against STD and 
DEEP-STD NMR data. Our NMR-validated 3’SL/GH33 3D model represents the first 
Michaelis complex of an IT-sialidase to date.  
Arguably, the fact that some residual activity is retained in the inactive mutant makes it 
particularly difficult to crystallise the sialidases in the presence of the substrate, as in 
the long times of the crystallisation process the enzymatic reaction will take place to a 
significant extent, resulting in the complex of the protein with the enzymatic product. 
This was the case for the sialidases from V. cholera (PDB ID: 1W0P161) and for the IT-
sialidase from M. decora (PDB ID: 3SLI166), where crystallisation attempts with the 
enzyme in the presence of the substrate were not successful and only complexes with 
Neu5Ac or 2,7-anhydro-Neu5Ac are available. The catalytic trans-sialidase mutant from 
T. cruzi, on the other hand, was successfully crystallised with both 3’SL (PDB ID: 1S0I175) 
and 2,3-dehoxy-Neu5Ac (DANA) and lactose (PDB ID: 1MS0176). 
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The structural analysis in this chapter informs on how the RgNanH carbohydrate binding 
and catalytic domains bind to their ligands. For both domains, the Neu5Ac sialic acid 
moiety constitutes the main recognition element with comparable orientation in α2/3 
and α2/6 ligands, although differing in binding affinities and kinetics. The carbohydrate 
binding module, CBM40, can recognize a wide range of di- and trisaccharides containing 
sialic acid, with a slight preference for α2/3 ligands. Although both, 3’SL and 6’SL bind 
to GH33, this enzyme binds to 3’SL with higher affinity than to 6’SL,  in agreement with 
its substrate specificity. The product of the enzymatic reaction, 2,7-anhydro-Neu5Ac, 
which inhibits the catalytic domain GH33, does not bind to CBM40, nor do the other 
monosaccharides tested (including Neu5Ac and Neu5Gc).  
The STD NMR competition experiments showed that the presence of 6’SL does not 
interfere with the interaction between 3’SL and GH33, even when they are in equimolar 
concentrations. Therefore, the potentiality of GH33 to recognise and weakly bind α2/6 
sialoglycans is thought not to affect the efficiency of hydrolysis of α2/3 sugars in 
physiological conditions. 
The main information which we can depict from the STD NMR studies on the mechanism 
of action of RgNanH is: 
 CBM40 broadly recognises α2/3- and α2/6-sialoglycans with a slight preference 
for the former, so it concentrates the enzyme in sialic-acid rich regions 
(addressing α2/3 rich regions preferentially), accordingly to its adhesin nature;  
 GH33 has much higher affinity for 3’SL than for 6’SL, which still can bind 
transiently (he catalytic site is, in practice, inaccessible to 6’SL when 3’SL is 
present); 
 The higher affinity of 3’SL can be explained by the presence of a π-stacking of the 
galactose of 3’SL with the tryptophan at position 698 (which is  not possible with 
6’SL), confirming the significant role of this residue for the trans-sialidase activity 
and the α2/3 specificity; 
 2,7-anhydro-Neu5Ac has higher affinity for GH33 than 3’SL, thus it can inhibit the 
hydrolysis when enough of the product has been generated. 
From the NMR point of view, STD NMR has proven to be an optimal and versatile tool 
to unveil details of interactions of proteins with weak (e.g., CBM40 with the sialic acid 
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containing di- and trisaccharides), or relatively strong  ligands  (e.g., GH33 D282A with 
3’SL or 2,7-anhydro-Neu5Ac).  
On a parallel route to the biological study, the peculiar STD behaviour of the sialoglycan 
methyl group interacting with CBM40 inspired us to follow-up this analysis to rationalise 
this system and paved the way to the development of the DEEP-STD NMR approach. 
From there, the analysis of GH33 prompted the development of DEEP-STD NMR, given 
the presence of two opposite “patches” of aromatic and aliphatic residues (as described 
in Chapter 3, Section 3.3).  
In particular, the DEEP-STD fingerprint approach was introduced and implemented to 
answer fundamental questions regarding the recognition of the non-hydrolysable 6’SL 
by GH33. DEEP-STD NMR provided information at the atomic detail and allowed to 
discriminate between the two binding modes, in excellent agreement with the lowest 
energy solutions obtained by molecular docking of the two ligands.  
These results further supported the use of DEEP-STD NMR as a powerful technique to 
shed light on the specificity of protein-ligand interactions, to drive the generation of 
computational models and validate them, or precisely orienting unknown ligands in 
known binding sites.  
5.5 Materials and methods  
5.5.1 Chemicals and proteins  
Neu5Ac, deuterium oxide (99.9% 2H), sodium chloride and tris-(hydroxymethyl-d3)-
amino-d2-methane (Tris-d11, 98% 2H) were purchased by Sigma Aldrich. 3’SLGc, 6’SLGc, 
Neu5Ac-STn, Neu5Gc-STn and STF were synthesised by our collaborators following a 
published methodology177.  Neu5Gc, 3’SL, 6’SL, 3’SGal, 6’SGal, 3’SLacNAc, 6’SLacNAc, 
were from Carbosynth. Enzymatically synthesised 2,7-anhydro-Neu5Ac and 
recombinantly produced CBM40 and GH33 D282A were provided by our collaborators  
at QIB as described in Sub-section 3.5.1 (GH33 D282A was expressed similarly to GH33).  
5.5.2 NMR measurements and processing  
All the sugars were assigned on the bases of 1D 1H, 2D 1H,1H‐DQF‐COSY, 1H,1H‐TOCSY, 
1H,13C‐HSQC and 1H,1H‐NOESY experiments ran on samples of the free ligands in 
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unbuffered D2O, pH 7.0. For STD NMR experiments, all the samples consisted of 1 mM 
ligand and 50 μM GH33 D282A or CBM40 in a D2O pH 7.8 buffer solution containing 10 
mM Tris‐d11 and 100 mM NaCl (ligand : protein ratio 20 : 1). To obtain the binding epitope 
mappings of the ligands (Sections 5.2 and 5.3), the STD NMR experiments were carried 
out at different saturation times (0.5, 1, 2, 3, 4 and 5 s) with 1024 scans for CBM40 and 
512 scans for GH33. CBM40 experiments were carried out at 288 K, while GH33 D282A 
experiments were carried out variable temperature as specified in the text. A sequence 
that includes 2.5 ms trim pulses and 3 ms spoil gradient was used. Saturation was 
achieved applying a train of 50 ms Gaussian pulses (0.40 mW) on the f2 channel, at 0.60 
ppm and/or 6.55 ppm (on‐resonance experiments) and 40 ppm (off‐resonance 
experiments). The protein signal was removed using a 40 ms spinlock (T1ρ) filter. All the 
experiments were recorded at 1H frequency of 800.23 MHz on a Bruker Avance III 
spectrometer equipped with 5‐mmD probe TXI 800 MHz H‐C/N‐D‐05 Z BTO. 
The STD NMR build‐up curves were fitted mathematically to a mono‐exponential 
equation, from which the initial slopes were obtained70c. The binding epitope was 
obtained by dividing all the initial slopes by the one of a convenient proton of the sialic 
acid residue (depending on the ligand), to which an arbitrary value of 100% was 
assigned. 
DEEP‐STD factors were calculated using the DEEP‐STD equation87 (Equation 3.5):  
ΔDEEP− STD𝑖 = 
𝑆𝑇𝐷 𝑒𝑥𝑝1,𝑖
𝑆𝑇𝐷 𝑒𝑥𝑝2,𝑖
− 
1
𝑛
∑ (
𝑆𝑇𝐷 𝑒𝑥𝑝1,𝑖
𝑆𝑇𝐷 𝑒𝑥𝑝2,𝑖
)𝑛𝑖 . 
5.5.3 Docking calculations  
All molecular modelling was performed with the module Glide within Schrödinger’s  
Maestro software suite, version 11140,141,76. Coordinates for the receptor were obtained 
from the Protein Data Bank (PDB ID: 4X4A17). Where necessary, coordinates for missing 
atoms were added according to known protein chemistry and sidechain protonation was 
optimised for neutral pH. A short minimisation was run using the OPLS3 force field, 
converging heavy atoms to a RMSD of 0.3 Å. The receptor grid was then calculated, 
centring on the centroid of 2,7-anhydro-Neu5Ac and with a length of 30 Å (WT grid). 
Three dimensional structures of 3’SL and 6’SL were generated using a conformational 
search, implementing Monte-Carlo torsional sampling, keeping only unique structures  
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(RMSD > 0.5 A) and eliminating all structures with an energy 21 kJ mol -1 greater than the 
lowest energy structure. All resulting structures were then minimised using conjugate 
gradient minimisation. For each ligand, the lowest energy conformations were used to 
initiate a preliminary round of docking. The docking consisted of further conformer 
generation, docking and then minimisation. Ten conformers were generated with 4x 
enhanced sampling and during docking, the non-bonded term of the potential energy 
function was softened for non-polar ligand atoms (charge < |0.15|) by applying a scaling 
factor of 0.8. Finally, minimisation was performed using implicit solvent with a distance 
dependent dielectric constant of 4. In a second round of docking, the 5 most diverse 
poses of the first round of docking were exported and re-docked in the same conditions, 
generating about 50 poses. To determine if the mutation D282A does not affect the 
binding mode, the D282 of the minimised receptor was mutated to A282 and a new grid 
was generated (mutant grid) with the same feature as the first. The 3D builder toolbox 
was used to mutate the residue. A second round of docking was then repeated with the 
mutant grid and a similar set of poses was generated (reported in Section A.9 of the 
Appendix). 
5.5.3 CORCEMA-ST predictions 
For CORCEMA-ST66, the cut-off distance around the protons of the ligand in the binding 
pocket was 10 Å. The concentration of ligand and protein used was respectively 2 mM 
and 50 μM. 𝑘𝑜𝑛  was set to 1 × 10
-8 M-1 s-1. The bound ligand correlation time was 50 ns, 
whereas the free correlation time was 1 ns. The equilibrium constant used was 5000 M-
1 and 2000 M-1 for 3’SL and 6’SL respectively. The non-specific relaxation leakage term 
(𝜌 leak) used was 0.4 Hz, to account for the effect of traces of dissolved paramagnetic 
oxygen, and the irradiation frequency was set to the range 0.1 - 1.1 ppm to simulate the 
conditions of irradiation at 0.60 ppm. The NOE R-factor was calculated on the averaged 
simulated data obtained, with the following equation: 
𝑁𝑂𝐸 𝑅 − 𝐹𝑎𝑐𝑡𝑜𝑟 =  √
∑(𝑆𝑇𝐷 %𝑒𝑥𝑝− 𝑆𝑇𝐷 %𝑐𝑎𝑙𝑐)
2
∑(𝑆𝑇𝐷 %𝑒𝑥𝑝 )
2 . 
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Chapter 6  
General discussion, conclusions and future work 
6.1 Beyond the limits of l igand-based NMR approaches: DEEP-STD and IL-STD NMR 
(Chapter 3) 
The core result of this thesis is the implementation of two novel STD NMR approaches: 
DiffErential Epitope mapping STD NMR (DEEP-STD NMR) and Inter Ligand STD NMR (IL-
STD NMR). In our view, these go in the direction of overcoming the limits of ligand-based 
NMR techniques, which traditionally, and by definition, only allow the ligand to be 
observed, leaving its surrounding (the protein or ideally other fragments) outside the 
permitted perspective. 
In Chapter 3, we answered some of our initial fundamental questions, demonstrating 
that: 
1. the inhomogeneity of spin diffusion can be exploited to track the different 
pathways for direct and indirect saturation transfer by differential irradiation 
STD NMR, getting precious information on the architecture of the binding 
pocket, through observation of the ligand; 
2. the presence of protons from water affects the saturation transfer from polar 
amino acid side chains containing exchangeable protons, and this is a further 
source of information allowing to detect the presence of (slow) exchanging polar 
amino acids lining the binding site; 
3. by direct irradiation on the proton frequencies of one of the ligands in a multi -
ligand complex, we can observe both intra-molecular NOEs across the bound 
state and inter-ligand NOEs on STD NMR experiments, for systems containing 
two ligands bound to adjacent subsites. 
Based on this, we provided two standardised protocols which we named DiffErential 
EPitope mapping STD NMR (DEEP-STD NMR) and Inter-Ligand NMR (IL-NMR) to be 
applied to a wide range of protein-ligand systems (provided they are suitable for STD 
NMR observation). 
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Figure 6.1. Cartoon schematising the information obtained on protein-ligand interactions by 
traditional STD NMR and by the two approaches proposed by us (DEEP-STD NMR and IL-STD 
NMR). 
6.1.1 Conclusions on DEEP-STD NMR 
DEEP-STD NMR gives access to a layer of structural information previously inaccessible: 
the nature of the amino acid residues surrounding the ligand in the binding site and an 
assessment of the architecture of the binding site. Among the strengths of the approach 
are the robustness and technical simplicity of its implementation, which relies on 
differential protein irradiation or differential deuteration of the polar solvent. Given the 
amphiphilic nature of many protein-ligand interactions, the approach is advantageous 
both in fragment based drug discovery and in fundamental biological research.  
As a proof of concept, we have analysed high resolution crystal structures of published 
protein-ligand complexes (3NPG/CTB and 2,7-anhydro-Neu5Ac/GH33) to demonstrate 
that the DEEP-STD data have the potential to provide an extraordinary level of atomic 
detail, as we reported in Chapter 3, Section 3.3. 
Hence, we implemented DEEP-STD NMR on unknown interactions involving the same 
proteins (CTB and GH33) in complex with, respectively: 
i) a library of small thio-galactoside-furoate inhibitors (Chapter 4, Section 4.3); 
ii) the natural sialoglycans 3’SL and 6’SL (Chapter 5, Section 5.2). 
In both cases, we have shown that, when the 3D structure of the protein is known, the 
protocol allows, for the first time, information to be gained from STD NMR about the 
orientation of the ligand relative to the key residues of the receptor. We have also 
proved that we can use the ΔDEEP-STD patterns of the known complexes as finger-prints 
to locate and orient unknown ligands in known binding sites. In both studies i) and ii), 
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the DEEP-STD data was in very good agreement with the lowest energy docking 
solutions generated, aiding the validation of the quality of the computational models.  
During the course of these studies, we have shown that the technique is versatile 
enough to be developed further and modified. In Chapter 4, Section 4.3, we expanded 
the scenario from two to many irradiation frequencies, allowing changes in the STD NMR 
intensities of each proton at variable saturation frequencies (arguably corresponding to 
single protein residues in a known receptor) to be mapped, in what we called the “on-
resonance scanning” approach. 
For receptors of unknown 3D structure, DEEP-STD NMR can help evaluating the 
architecture of the binding site, orienting, for instance, aromatic and aliphatic patches 
in the pocket relative to each other. This can be a valuable aid to identify unknown 
binding sites in receptors of known 3D structure, based on the response of known 
ligands to differential irradiation and solvent conditions. 
6.1.2 Conclusions on IL-STD NMR 
IL-STD NMR relies on a similar concept to DEEP-STD NMR: it exploits differential 
irradiation conditions to elucidate the “environment of binding”, detecting secondary 
ligands surrounding the ligand of interest, and their orientation relative to it. In Chapter 
4, Section 4.2 we have shown that, in a ternary complex composed of one receptor and 
two or more ligands, changing irradiation frequencies from “on-resonance” of one of 
the ligands to “off-resonance” (protein irradiation only) gives information on the 
proximity of the ligands and of their binding subsites. This also allows to define the 
“contact regions” between the fragments, that is, their relative orientation. It is 
important to remark that this is the same information which we can obtain by tr-NOESY 
following the ILOE approach84, without the need of selecting appropriately the 
irradiation frequency, as we have to do in IL-STD. On the other hand, ideally, IL-STD can 
give the same information in a small fraction of the experimental time.  
6.1.3 Perspectives and future work 
Potentially, the combination of DEEP-STD and IL-STD NMR can be very fruitful in 
fragment based drug design contexts, allowing the ligands to be oriented in their own 
binding subsites and relative to each other.  
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We have demonstrated the potential of these approaches for relatively small ligands, 
which are more difficult to orient than larger ones. DEEP-STD NMR combined with the 
3D structure of the protein is expected to define the orientation of larger ligands in the 
bound state even more easily, a feature which could turn out really useful in structural 
biological studies (the DEEP-STD NMR study on the 3’SL and 6’SL in complex with GH33, 
reported in Chapter 5, Section 5.2, is already a good example of successful analysis of 
larger ligands). 
Currently, the binding of synthetic and natural fragments to an important ubiquitin-
protein ligase receptor is being investigated by us. The 3D structure of the receptor has 
been solved by X-ray crystallography, but the binding site is not known as of yet, making 
this a very challenging problem to approach by the combination of DEEP-STD NMR and 
computational tools. 
Further works undergoing in our group show very promising results in the application of 
DEEP-STD NMR to larger protein receptors (up until ~140 kDa). The magnitude of the 
ΔDEEP-STD (or ΔIL-STD) is smaller, but the information is still very clear to interpret. 
In fact, the potential of this technique is not limited by the size nor the nature of the 
receptors. Projects currently under investigation in our laboratory show that DEEP-STD 
NMR can successfully be applied to lipopolysaccharides and even to block co-polymer 
micelles, moving out of the biological realm. The compartmented nature of these 
macromolecules (a large aliphatic environment adjacent to a large carbohydrate 
environment in the case of lipopolysaccharide; and the large blocks of different 
monomers assembled in an ordered way in block co-polymer micelles) makes them a 
perfect target for this technique. 
The chance to apply DEEP-STD NMR to a wide number of diverse systems (and with 
promising results so far) is very important to strengthen the potential of the technique 
and our future perspectives include further methodological investigation on the effect 
of the modification of different parameters (including temperature, irradiation power, 
ligand concentration, etc.) on the DEEP-STD outcome. 
So far, the significance and the crucial importance of this methodological work is that by 
exploiting intrinsic inhomogeneity in spin diffusion, we can differentiate between 
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different environments surrounding the ligands under observation. This is done by 
simple means of one-dimensional NMR spectra, and without requiring isotopic labelling 
(in contrast to, for example, SOS-NMR178) nor protein assignment (in contrast to 
receptor-based techniques). On these premises, we envision that DEEP-STD NMR, and 
in a smaller measure IL-STD NMR, will become popular approaches to characterise a 
wide range of ligand-receptor interactions, in pharmaceutical as well as biological 
research labs. 
6.2 New avenues for cholera toxin inhibition (Chapter 4) 
We started to investigate the field of CTB inhibitor design with the aim to confirm (or 
not) the binding mode of a polyhydroxyalkylfuroate thio-galactose ligand (Ligand 30) 
received from our collaborators in the research group of Inmaculada Robina, from the 
University of Seville. Ligand 30 was qualitatively proposed to bind to the two well-known 
galactose and sialic acid subsites in the GM1 binding pocket of cholera toxin subunit92, 
but the outcome of the study has been much more resounding than that. 
In Section 4.2, we demonstrated the existence of a hitherto-unknown binding subsite in 
the GM1 binding pocket of CTB, by a combination of several NMR approaches, molecular 
docking and traditional and non-classical molecular dynamics (Figure 6.2). By means of 
CORCEMA-ST, we could successfully validate the quality of our 3D models of Ligand 20, 
Ligand 30 and Ligand 33 in solution and show the specificity of the novel binding subsite 
for the polyhydroxyalkylfurate-aromatic moiety of Ligand 30 and Ligand 33.   
The potential of the discovery is conspicuous, for two main reasons: 
 the polyhydroxyalkylfuroate ligands are very drug-like, with a reduced 
carbohydrate nature (limited to the presence of non-hydrolisable thio-galactose 
moiety to anchor the ligands to the galactose binding subsite); 
 the presence of an additional non-carbohydrate specific binding subsite paves 
the way for the design of three-finger ligands, which could occupy the three 
subsites at the same time, arguably increasing the affinity. 
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Figure 6.2. (a) The STD binding epitope mappings of Ligand 30 and 33 in complex with CTB92. 
The STD values from the initial slopes of each proton relative to the most intense one are ranked 
according to their intensity: blue dots for weak contacts (45%-64%), yellow dots for medium 
contacts (65%-84%) and red dots for strong contacts (85%-100%). The 𝐾𝐷  values for the 
interactions are reported below the structures. (b) Representative frames of the most populated 
clusters of Ligand 30 (pale yellow) and Ligand 33 (light red) with CTB in the “open” conformation. 
The residues forming the galactose binding subsite are shown as orange surface. The  residues 
constituting the sialic acid binding subsite are shown as blue surface. Ile58 and Lys34, which 
constitute the novel binding subsite, are shown as green surface and labelled.  
To further investigate the CTB binding pockets, in Section 4.3, we have investigated a 
small library of short analogues of Ligand 30, in which the thio-galactose is directly 
linked to the furoate-aromatic moiety, by means of different thio-glycosidic linkages 
(varying in anomeric configuration and oxidation state of the sulphur, in Figure 6.3a). 
This part of the study helped to discern and rank the specificities of the two moieties of 
the ligands (thio-galactose and furoate-aromatic), as the short size does not allow both 
the galactose and the novel subsite to be occupied, as for Ligand 30. 
The main result was that the specificity of the thio-galactose residue for the galactose 
subsite drives the interaction, anchoring the ligands in the galactose subsite. Being too 
small to reach the novel binding subsite, the furoate-aromatic moiety is directed 
towards the sialic acid subsite, where it forms a π-stacking with Tyr12 of CTB (Figure 
6.3b).  The presence of the π-stacking for all of the four ligands, despite the nature of 
the thio-glycosidic bond, suggests that the interaction is particularly favourable and the 
sialic acid subsite has good selectivity for aromatic moieties, as previously proposed128. 
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Figure 6.3. (a) The STD binding epitope mappings of the small analogues of Ligand 30 in complex 
with CTB. The STD values from the initial slopes of each protons relative to the most intense one 
are ranked according to their intensity, following the same legend as in Figure 6.2. The 𝐾𝐷  for 
the interactions is reported above the structures. (b) Lowest energy docking solutions for Ligand 
93 (grey), Ligand 97 (pink), Ligand 105 (green) and Ligand 108 (violet) with CTB  in the “closed” 
conformation. The surface colouring is the same as in Figure 6.2. 
The two main pieces of structural information that we obtained investigating Ligand 30, 
Ligand 33 and the small analogues of Ligand 30 are: 
 the proof that the polyhydroxyalkylfuroate moiety fits tightly in the novel binding 
subsite (provided a long enough linker); 
 the hint that the sialic acid subsite can be specifically occupied by an aromatic 
moiety  π-stacking with the underlying Tyr12. 
This gave us ground to propose a novel three-finger scaffold for CTB inhibition, shown 
in Figure 6.4. Albeit the sulphur has been shown to be unideal for decoration, based on 
the docking poses, the furoate can be an optimal candidate for adding an additional 
fragment.  
IL-STD NMR could be a valuable aid to assess the relative orientation of the fragments, 
directing the drug design process in a knowledge-based fashion. Once a novel library of 
three-finger ligands is synthetised by our collaborators at the University of Seville, 
combination of NMR and computational tools would again help elucidate the 3D 
structure, hopefully directing towards a high affinity and highly selective lead to 
progress towards an efficient CTB inhibitor. 
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Figure 6.4. Future work: schematic representation of a novel class of three-finger non-
carbohydrate CTB inhibitors proposed by us, potentially able to occupy the galactose, sialic acid 
and novel binding subsites simultaneously, through its orange, blue and green fragments, 
respectively. The length and the flexibility of the X linker, should be investigated.  
6.3 Towards the structural understanding of intramolecular trans-sialidases from 
gut microbiota (Chapter 5) 
In collaboration with the research group of Nathalie Juge from the Quadram Institute 
Bioscience, we undertook a thorough study of the two subdomains of the intramolecular 
trans-sialidase RgNanH, CBM40 and GH33 D282A, combining STD NMR and 
computational tools with the biological assays, glycan microarray and ITC data 
performed by our collaborators. We investigated the specificity and the mechanism of 
molecular recognition, with a stress on the ability of discriminating between α2/3 and 
α2/6 sialoglycans.  
By molecular docking, we provided the 3D molecular models of 3’SL and 6’SL as bound 
to GH33, which we validated against experimental STD and DEEP-STD data. This makes 
our 3D model of the 3’SL/GH33 the first Michaelis complex of an IT-sialidase to date (as 
the residual activity of the inactive mutants of sialidases makes crystallising the 
receptor-substrate complex challenging). 
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Figure 6.5. (a) The STD binding epitope mappings of 3’SL and 6’SL in complex with GH33, at 0.60 
ppm. The STD values from the initial slopes of each protons relative to the most intense one are 
ranked according to their intensity: blue dots for weak contacts (50%-70%), yellow dots for 
medium contacts (71%-90%), red dots for strong contacts (91%-100%) and purple dots for very 
strong contacts (>100%). (b) The lowest energy converging docking solutions for GH33 in 
complex with 3’SL, 10 poses, and 6’SL, 6 poses. 
For both subdomains, the sialic acid moiety is the main recognition element for both 
α2/3 and α2/6 sialoglycans. This seems to be accommodated in both binding sites with 
comparable orientation, despite the fact that the difference in the configuration of the 
glycosylic linkages results in different affinities and kinetics of binding for the two 
ligands. Expectedly, the catalytic domain GH33 shows higher affinity to its natural 
substrate 3’SL, than to 6’SL, to whom it still transiently binds. The “recruiting” 
carbohydrate binding module, CBM40, can recognize a wide range of di- and 
trisaccharides containing sialic acid (for all of which the binding epitope has been 
determined), although a slight preference for the α2/3 ligands is observed. 2,7-anhydro-
Neu5Ac, which inhibits the catalytic domain, does not bind to CBM40, nor do the other 
monosaccharides (Neu5Ac and Neu5Gc). 
This revealed the following structural aspects that can be correlated to the mechanism 
of action of RgNanH: 
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 CBM40 broadly recognises 3’- and 6’-sialoglycans with a slight preference for the 
former. This allow to concentrate the enzyme in sialic acid-rich regions of the 
mucin niches (addressing α2/3 rich regions preferentially), accordingly to its 
adhesin nature; 
 GH33 has much higher affinity for 3’SL than for 6’SL, which can still bind 
transiently; 
 the higher affinity of 3’SL can be explained by the presence of a π-stacking of the 
galactose of 3’SL with Trp698 (which is not possible in the case of 6’SL), 
confirming the significant role of this residue for the trans-sialidase activity and 
the α2/3 selectivity; 
 the catalytic site is, in practice, inaccessible to 6’SL when 3’SL is present; 
 2,7-anhydro-Neu5Ac has higher affinity for GH33 than 3’SL, thus it can inhibit the 
hydrolysis when enough of the product has been generated. 
With the 3D model of the substrate as a starting point, the future work aims at 
elucidating the mechanism through which GH33 carries out the enzymatic IT-sialidase 
reaction from a molecular point of view. GH33 has been proved to be an exceptional 
candidate for the application of DEEP-STD NMR, given its amphiphilic nature combining 
aliphatic and aromatic patches with a highly polar cluster of arginine. We are confident 
that performing mutagenesis on key residues thought to be responsible for the 
enzymatic behaviour of GH33, and analysing the GH33 mutants by combination of STD 
and DEEP-STD NMR, as well as computational tools, will give further insights in the 
understanding of a fascinating, as much as an unusual, reaction.  
From our point of view, providing the 3D structure of the 3’SL/GH33 complex in solution 
is a significant achievement. Hence, unravelling the actual mechanism of reaction on a 
solid experimental basis could be a milestone in the investigation of mucin degrader 
micro-organisms and a substantial step forward in the design of sialidase inhibitors, a 
class of drug with a huge potential.  
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A.1 Full spectra of the STD NMR competition experiments a) and b) 
 
Figure A.1. Appendix to Figure 4.11a,b in Sub-section 4.2.2 Full width reference spectra of the 
STD competition experiments of Ligand 30/CTB/3NPG (a) and Ligand 30/CTB/Ligand 33 (b). In 
red the spectra of the first binder alone and in black the spectra upon addition of the competitor. 
The assignment of 3NPG and Ligand 30 is given in (a) (except for the 3.0 ppm to 4.0 ppm region 
squared in black, assigned in the Figure 4.11a,b). The peaks of Ligand 33 perfectly overlap to 
those of Ligand 30, therefore in (b) the assignment is not repeated. 
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A.2 STD NMR experiment on the complex 3’SL/CTB 
 
Figure A.2. Appendix to Figure 4.11d in Sub-section 4.2.2. 25 M CTB in the presence of 1 mM 
of 3’SL, 278 K. The reference and the difference spectra are shown and labelled, the 
magnification of the difference spectra relative to the reference spectra is reported. Spectra are 
acquired at 2 s saturation time and 0.0 ppm saturation time. For the full assignment of 3’SL, see 
Table A.16. 
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A.3 Tr-NOESY control spectra (ILOE approach) 
 
Figure A.3. Appendix to Figure 4.12 in Sub-section 4.2.3. Full width tr-NOESY experiments 
(Mixing time 1.2 s). Top, Ligand 33/CTB/3NPG (ternary complex, in black) and 3NPG/CTB (binary 
complex, in red), as in Figure 4.12. Bottom, Ligand 33/CTB (binary complex): the spectral area 
containing the inter-ligand signal is empty when the protein is alone, confirming that this is due 
to the ligands. 
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Figure A.4. Appendix to Figure 4.12 in Sub-section 4.2.3. Full width tr-NOESY experiments 
(Mixing time 1.2 s). Top, Ligand 33/CTB/3NPG (ternary complex, in black) and 3NPG-CTB (binary 
complex, in red), as in Figure 4.12. Bottom, CTB alone: the spectral area containing the inter-
ligand signal is empty when the protein is alone, confirming that this is due to the ligands.  
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A.4 Assignment and STD NMR binding epitope mapping raw data for the SCJ set of 
l igands in complex with CTB 
   STD (%) Ligand 93 
Proton 
ID 
1H δ 
(ppm) 
13C δ 
(ppm) 
0.25 s 0.5 s 0.75 s 1 s 2 s 3 s 4 s 5 s 
CH3(fur) 2.22 13.3 2.41 5.51 8.39 10.5 16.6 19.6 21.19 21.82 
H2 3.248 68.68 1.92 3.92 7.32 8.98 14.63 18.13 19.22 19.6 
H3 3.245 73.45 1.92 3.92 7.32 8.98 14.63 18.13 19.22 19.6 
H4 3.277 78.36 1.69 4.54 7.46 8.39 13.4 15.36 16.13 16.77 
H6/6' 3.319 60.27 1.71 4.49 6.9 8.39 11.57 13.01 14.07 14.07 
CH2(S) 3.554 25.7 1.83 3.92 8.07 6.08 8.64 10.5 10.91 11.92 
H5 3.617 68.3 1.41 4.67 8.07 9.52 15.06 17.44 17.78 19.79 
CH2(S) 3.693 25.7 1.92 2.95 6.64 6.57 8.47 10.5 10.91 11.92 
H1 4.039 84.53 1.61 2.41 4.9 6.14 10.81 13.14 14.2 14.91 
CH2(Bn) 5.01 66.01 2.29 4.49 6.44 8.81 12.39 13.27 14.48 13.93 
H(fur) 6.279 108.1 1.71 4.54 7.32 9.34 17.1 21.19 22.91 23.83 
H para 7.1 127.9 2.14 4.49 7.83 9.8 16.44 20.99 22.47 23.83 
H meta 7.14 128.3 1.83 4.36 7.17 9.34 15.81 20.38 22.04 23.83 
H orto 7.187 127.9 2.1 4.11 6.51 8.89 15.36 19.22 21.4 22.04 
Table A.1. Appendix to Figure 4.28 in Sub-section 4.3.2. Ligand 93. 1H and 13C assignment and 
the raw STD (%) at increasing saturation times. Irradiation frequency 0.0 ppm, 278 K.  
   STD (%) Ligand 97 
Proton 
ID 
1H δ 
(ppm) 
13C δ 
(ppm) 
0.25 
s 
0.5 s 0.75 s 1 s 2 s 3 s 4 s 5 s 
CH3(fur) 2.23 13 6.44 14.48 20.58 25.76 36.6 40.75 42.37 42.79 
H2 3.408 72.2 5.96 12.51 18.31 23.36 31.31 35.2 36.25 36.25 
H3 3.408 72.2 5.96 12.51 18.31 23.36 31.31 35.2 36.25 36.25 
H6 3.446 60.8 6.14 12.63 18.67 22.25 28.12 31.71 31.93 31.93 
H6' 3.531 80.1 6.08 12.51 19.22 21.61 28.12 29.53 30.71 30.11 
CH2(S) 3.531 60.8 6.38 13.15 18.13 21.81 27.58 29.81 30.41 30.41 
H5 3.692 68.1 6.26 12.51 19.79 23.59 32.88 36.25 34.18 36.6 
H4 3.82 64.9 5.04 13.14 18.85 23.59 38.43 46.26 44.06 46.71 
H1 4.236 88.3 3.84 9.9 14.91 19.6 29.82 33.85 35.5 35.5 
CH2(Bn) 4.984 66.3 6.2 13.14 17.95 22.35 29.53 31.62 32.24 33.52 
H(fur) 6.607 112.9 5.79 12.63 19.6 25.51 41.15 48.1 51 52.2 
H para 7.085 128.15 5.9 13.14 20.58 25.76 39.57 45.37 47.17 48.57 
H meta 7.119 128.4 5.73 13.66 20.58 25.76 39.57 45.37 47.17 48.57 
H orto 7.168 127.8 5.62 12.88 19.79 24.74 38.43 44.06 46.26 47.63 
Table A.2. Appendix to Figure 4.28 in Sub-section 4.3.2. Ligand 97. 1H and 13C assignment and 
the raw STD (%) at increasing saturation times. Irradiation frequency 0.0 ppm, 278 K. 
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   STD (%) Ligand 98 
Proton 
ID 
1H δ 
(ppm) 
13C δ 
(ppm) 
0.25 s 0.5 s 0.75 s 1 s 2 s 3 s 4 s 5 s 
CH3(fur) 2.24 12.9 4.4 9.52 13.53 17.27 25.76 29.24 30.41 31.31 
H6 3.44 60.83 3.04 7.53 11.35 14.07 20.18 21.61 22.47 22.25 
H6' 3.541 60.83 3.32 6.57 9.61 13.14 16.13 16.77 17.61 17.95 
H5 3.545 80.2 3.32 6.57 9.61 13.14 16.13 16.77 17.61 17.95 
H2 3.682 66.27 3.01 6.57 10 13.66 20.99 23.59 26.27 26.27 
H3 3.682 64.4 3.01 6.57 10 13.66 20.99 23.59 26.27 26.27 
H4 3.829 87.9 4.11 7.91 14.77 17.27 25.26 28.12 29.1 29.82 
CH2(S) 4.14 44.09 3.13 6.2 6.9 8.98 13.93 14.34 15.36 15.36 
H1 4.19 90.7 2.58 5.79 8.14 10 15.21 17.61 17.78 17.78 
CH2(S) 4.21 44.09 2.58 5.79 8.14 10 15.21 17.61 17.78 17.78 
CH2(Bn) 5.105 66.3 3.8 7.32 10.7 13.53 18.67 19.41 20.99 20.58 
H(fur) 6.51 112.2 3.96 8.31 13.1 16.28 27.05 31.93 34.18 34.86 
H para 7.103 128.13 3.99 7.83 11.69 15.06 25.76 31.01 32.88 34.18 
H meta 7.14 128.39 3.38 7.53 11.69 15.51 25.76 31.01 32.88 34.18 
H orto 7.189 127.83 3.32 7.32 11.24 14.48 24.29 29.53 31.31 32.24 
Table A.3. Appendix to Figure 4.28 in Sub-section 4.3.2. Ligand 98. 1H and 13C assignment and 
the raw STD (%) at increasing saturation times. Irradiation frequency 0.0 ppm, 278 K.  
   STD (%) Ligand 105 
Proton 
ID 
1H δ 
(ppm) 
13C δ 
(ppm) 
0.25 s 0.5 s 0.75 s 1 s 2 s 3 s 4 s 5 s 
CH3(fur) 2.217 13 5.3 11.02 15.97 20.99 31.01 34.52 35.89 35.2 
H6 3.379 60.5 5.05 8.39 14.63 16.28 19.79 20.69 21.4 21.4 
H3 3.394 69.9 5.05 8.39 14.63 16.28 19.79 20.69 21.4 21.4 
H6 3.417 60.5 3.77 7.68 12.63 15.06 21.19 21.19 21.4 21.82 
CH2(S) 3.433 24.3 3.77 7.68 12.63 15.06 21.19 21.19 21.4 21.82 
CH2(S) 3.526 24.3 4.19 5.41 9.25 11.24 15.97 16.77 17.2 17.95 
H5 3.654 68.6 4.54 8.07 13.53 17.27 24.77 27.58 28.96 28.96 
H2 3.767 67.3 4.32 8.07 12.15 13.66 25.26 31.31 30.41 32.28 
H4 3.925 71.2 5.84 8.31 13.14 18.13 26.01 28.12 29.4 30.11 
CH2(Bn) 5.006 66.2 3.45 8.31 10.7 13.66 22.04 23.14 24.29 23.59 
H1 5.09 83.9 3.66 7.56 9.9 13.66 22.47 26.52 26.52 27.85 
H(fur) 6.27 107.2 3.99 9.25 15.06 18.85 29.82 35.55 37.32 37.69 
H para 7.107 128.14 2.87 7.39 11.57 14.48 23.83 30.41 30.71 33.2 
H meta 7.143 128.32 2.76 7.24 12.03 14.91 24.53 30.41 32.88 33.85 
H orto 7.182 128.32 3.07 7.39 11.69 14.2 24.77 30.41 32.56 33.2 
Table A.4. Appendix to Figure 4.28 in Sub-section 4.3.2. Ligand 105. 1H and 13C assignment and 
the raw STD (%) at increasing saturation times. Irradiation frequency 0.0 ppm, 278 K.  
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   STD (%) Ligand 108 
Proton 
ID 
1H δ 
(ppm) 
13C δ 
(ppm) 
0.25 s 0.5 s 0.75 s 1 s 2 s 3 s 4 s 5 s 
CH3(fur) 2.23 13.2 2.81 6.2 9.52 12.3 19.41 22.69 24.53 25.02 
H6 3.408 60.6 4.15 7.83 10.5 14.2 18.67 17.27 18.85 18.85 
H6' 3.492 60.6 4.49 8.89 12.27 15.06 19.22 18.13 19.99 19.99 
H4 3.574 77.9 3.59 7.53 11.13 13.27 18.85 21.19 21.19 21.19 
H5 3.764 67.6 2.48 6.44 9.71 13.27 20.58 23.83 24.77 26.01 
H3 3.764 70.3 2.48 6.44 9.71 13.27 20.58 23.82 24.77 26.01 
CH2(S) 4.12 44.6 2.68 4.36 7.1 8.14 12.15 13.86 13.4 13.52 
H2 4.064 67.3 3.07 5.31 10.5 11.27 19.99 23.83 24.77 25.01 
CH2(S) 4.126 44.6 2.68 4.4 7.1 8.39 11.92 12.35 13.01 11.35 
H1 4.468 92.3 3.35 2.89 6.77 9.71 15.21 17.61 19.22 19.41 
CH2(Bn) 5.006 66.3 2.12 5.68 7.99 10.09 14.77 16.44 16.6 17.1 
H(fur) 6.528 112.67 2.45 6.64 9.8 13.14 22.91 28.4 30.71 31.93 
H para 7.104 128.1 2.68 6.2 9.43 12.39 21.4 26.27 28.68 30.41 
H meta 7.14 128.37 2.68 5.9 9.16 12.03 20.78 26.27 28.68 30.41 
H orto 7.195 127.7 2.38 5.57 8.81 11.46 19.6 24.53 27.05 28.4 
Table A.5. Appendix to Figure 4.28 in Sub-section 4.3.2. Ligand 108. 1H and 13C assignment and 
the raw STD (%) at increasing saturation times. Irradiation frequency 0.0 ppm, 278 K.  
   STD (%) Ligand 109 
Proton 
ID 
1H δ 
(ppm) 
13C δ 
(ppm) 
0.25 s 0.5 s 0.75 s 1 s 2 s 3 s 4 s 5 s 
CH3(fur) 2.2 12.8 3.99 6.08 7.68 12.39 14.77 16.44 17.1 17.27 
H4 3.37 74.9 1.96 2.65 3.62 5.3 5.79 7.04 7.24 6.83 
H6/6' 3.422 60.8 3.59 4.32 5.57 7.99 8.64 9.25 9.34 8.89 
H5 3.735 67.9 3.73 5.73 7.1 12.51 13.93 13.53 15.06 13.93 
H3 3.945 76.7 3.29 4.49 4.76 10.81 10.7 11.8 13.01 11.8 
H2 4.05 66.6 3.79 4.28 4.76 10.19 10.5 14.2 14.07 14.34 
CH2(S) 4.309 51.5 0.75 1.45 1.85 2.6 3.22 4.49 4.11 4.95 
CH2(S) 4.43 51.5 - - - - - - - - 
CH2(Bn) 4.97 66.4 3.29 4.49 6.2 9.43 10.91 11.46 11.92 11.24 
H1 4.97 89.2 3.29 4.49 6.2 9.43 10.91 11.46 11.92 11.24 
H(fur) 6.53 113.27 4.28 6.2 8.31 15.66 20.39 23.14 23.83 23.59 
H para 7.066 128.11 3.32 4.76 6.83 11.46 15.06 17.1 17.95 17.44 
H meta 7.098 128.55 3.45 5.41 7.39 12.51 15.66 17.95 18.85 19.41 
H orto 7.14 127.7 3.1 5.1 6.7 12.03 15.66 17.1 18.13 18.31 
Table A.6. Appendix to Figure 4.28 in Sub-section 4.3.2. Ligand 109. 1H and 13C assignment and 
the raw STD (%) at increasing saturation times. Irradiation frequency 0.0 ppm, 278 K.  
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Normalised initial slopes %  
 
Ligand 93 Ligand 97 Ligand 98 Ligand 105 Ligand 108 Ligand 109 
H1 57 71 60 62 54 76 
H2 85 90 72 67 73 67 
H3 85 90 72 91 79 73 
H4 85 90 100 84 90 41 
H5 90 96 77 80 79 94 
H6 83 94 83 91 100 76 
H6' 
 
96 77 78 
  
CH2(S) 59 96 59 78 56 17 
CH2(S) 60   60 56 62 
 
H(fur) 90 91 91 86 77 100 
CH3 (fur) 100 100 99 100 73 89 
CH2(Bn) 87 93 82 70 65 76 
H orto 81 91 79 66 65 78 
H meta 84 95 84 66 71 81 
H para 90 95 84 65 73 76 
Table A.7. Appendix to Figure 4.28 in Sub-section 4.3.2. STD NMR binding epitope mapping of 
the SCJ set of ligands. Normalised initial slope values for the six SCJ ligands, obtained from the 
fitting of the raw data in the Tables A.1 to A.6. For each ligand, the epitope is normalised against 
the proton with the strongest initial slope, arbitrarily.  
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A.5 DEEP-STD finger-print raw data for the SCJ set of l igands in complex with CTB 
Proton STD %  0.60 ppm STD %  2.25 ppm 
Ratio STD 
2.25 ppm/0.60 ppm 
ΔDEEP-STD 
H1 13.79 19.99 1.45 0.05 
H2,H3 17.1 37.69 2.20 0.80 
H4 16.44 31.93 1.94 0.54 
H5 17.1 41.55 2.43 1.03 
H6/6' 15.36 29.24 1.90 0.50 
CH2(S) 14.07 15.66 1.11 -0.29 
CH2(S) 14.07 15.66 1.11 -0.29 
H(fur) 22.25 22.47 1.01 -0.39 
CH2(Bn) 16.6 16.44 0.99 -0.41 
H para 23.36 19.99 0.86 -0.55 
H meta 22.25 19.99 0.90 -0.51 
H orto 21.19 19.99 0.94 -0.46 
   STD average  
   1.40  
Table A.8. Appendix to Figure 4.29 in Sub-section 4.3.2. Ligand 93. DEEP-STD NMR using 
Differential Irradiation (2.25 ppm/0.60 ppm). Protons assignment is given in Table A.1. 
 
Proton STD %  0.60 ppm STD %  2.25 ppm 
Ratio STD 
2.25 ppm/0.60 ppm 
ΔDEEP-STD 
H1 29.53 35.89 1.22 -0.05 
H2,3 30.41 54.61 1.80 0.53 
H4 36.96 45.81 1.24 -0.03 
H5 33.52 53.55 1.60 0.33 
H6 28.68 43.21 1.51 0.24 
H6' 26.27 41.21 1.57 0.30 
CH2(S) 28.12 41.96 1.49 0.23 
H(fur) 41.55 42.37 1.02 -0.25 
CH2(Bn) 30.71 28.68 0.93 -0.33 
H para 40.53 38.06 0.94 -0.33 
H meta 40.53 38.06 0.94 -0.33 
H orto 40.53 38.06 0.94 -0.33 
   STD average  
   1.27  
Table A.9. Appendix to Figure 4.29 in Sub-section 4.3.2. Ligand 97. DEEP-STD NMR using 
Differential Irradiation (2.25 ppm/0.60 ppm). Protons assignment is given in Table A.2. 
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Proton STD %  0.60 ppm STD %  2.25 ppm 
Ratio STD 
2.25 ppm/0.60 ppm 
ΔDEEP-STD 
H1 26.52 30.41 1.15 -0.27 
H2 26.52 38.81 1.46 0.05 
H3 24.53 46.26 1.89 0.47 
H4 27.58 63.83 2.31 0.90 
H5 26.52 55.14 2.08 0.67 
H6 21.26 33.2 1.56 0.15 
H6 20.99 42.37 2.02 0.61 
CH2(S) 15.21 19.6 1.29 -0.12 
CH2(S) 14.63 17.6 1.20 -0.21 
H(fur) 34.18 34.52 1.01 -0.40 
CH2(Bn) 23.59 24.06 1.02 -0.39 
H para 21.4 19.99 0.93 -0.48 
H meta 27.05 25.02 0.92 -0.49 
H orto 27.05 25.02 0.92 -0.49 
   STD average  
   1.41  
Table A.10. Appendix to Figure 4.29 in Sub-section 4.3.2. Ligand 105. DEEP-STD NMR using 
Differential Irradiation (2.25 ppm/0.60 ppm). Protons assignment is given in Table A.4.  
 
Proton STD %  0.60 ppm STD %  2.25 ppm 
Ratio STD 
2.25 ppm/0.60 ppm 
ΔDEEP-STD 
H1 12.21 12.03 0.99 -0.42 
H2 19.22 26.52 1.38 -0.02 
H3 22.47 48.51 2.16 0.76 
H4 21.19 42.37 2.00 0.60 
H5 21.82 51 2.34 0.94 
H6 19.04 35.55 1.87 0.46 
H6' 19.04 35.55 1.87 0.46 
CH2(S) 10.09 11.46 1.14 -0.27 
CH2(S) 10.09 11.46 1.14 -0.27 
H(fur) 22.91 22.69 0.99 -0.41 
CH2(Bn) 11.57 12.27 1.06 -0.34 
H para 18.67 16.13 0.86 -0.54 
H meta 18.67 17.27 0.93 -0.48 
H orto 17.44 16.13 0.92 -0.48 
   STD average  
   1.40  
Table A.11. Appendix to Figure 4.29 in Sub-section 4.3.2. Ligand 108. DEEP-STD NMR using 
Differential Irradiation (2.25 ppm/0.60 ppm). Protons assignment is given in Table A.5.  
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A.6 Glide docking tables for the SCJ set of ligands in complex with CTB 
Title 
Potential Energy-
OPLS-2005 
Relative Potential Energy-
OPLS-2005 
docking score glide emodel 
SCJ-93 -10.465 2.398 -4.05 -47.621 
SCJ-93 -10.694 2.169 -4.05 -47.621 
SCJ-93 -12.753 0.11 -4.05 -47.621 
SCJ-93 -12.863 0 -4.05 -47.621 
SCJ-93 -10.465 2.398 -3.997 -48.631 
SCJ-93 -10.694 2.169 -3.997 -48.631 
SCJ-93 -12.753 0.11 -3.997 -48.631 
SCJ-93 -12.863 0 -3.997 -48.631 
SCJ-93 -10.465 2.398 -3.839 -47.479 
SCJ-93 -10.694 2.169 -3.839 -47.479 
SCJ-93 -12.753 0.11 -3.839 -47.479 
SCJ-93 -12.863 0 -3.839 -47.479 
SCJ-93 -10.465 2.398 -3.703 -46.58 
SCJ-93 -10.694 2.169 -3.703 -46.58 
SCJ-93 -12.753 0.11 -3.703 -46.58 
SCJ-93 -12.863 0 -3.703 -46.58 
SCJ-93 -10.465 2.398 -3.304 -44.163 
SCJ-93 -10.694 2.169 -3.304 -44.163 
SCJ-93 -12.863 0 -3.304 -44.163 
Table A.12. Appendix to Figure 4.34 in Sub-section 4.3.7. Glide docking tables for the poses 
obtained by molecular docking of Ligand 93 on CTB (protein structure from PDB ID: 3CHB). The 
docking poses are sorted according to their docking score. 
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Title 
Potential Energy-
OPLS-2005 
Relative Potential Energy-
OPLS-2005 
docking score glide emodel 
SCJ-97 -19.452 0.46 -4.05 -48.197 
SCJ-97 -19.592 0.32 -4.05 -48.197 
SCJ-97 -19.721 0.191 -4.05 -48.197 
SCJ-97 -19.912 0 -4.05 -48.197 
SCJ-97 -19.452 0.46 -4.037 -48.264 
SCJ-97 -19.592 0.32 -4.037 -48.264 
SCJ-97 -19.721 0.191 -4.037 -48.264 
SCJ-97 -19.912 0 -4.037 -48.264 
SCJ-97 -19.452 0.46 -4.007 -49.616 
SCJ-97 -19.592 0.32 -4.007 -49.616 
SCJ-97 -19.721 0.191 -4.007 -49.616 
SCJ-97 -19.912 0 -4.007 -49.616 
SCJ-97 -19.452 0.46 -3.972 -50.71 
SCJ-97 -19.592 0.32 -3.972 -50.71 
SCJ-97 -19.721 0.191 -3.972 -50.71 
SCJ-97 -19.912 0 -3.972 -50.71 
SCJ-97 -19.452 0.46 -3.513 -47.174 
SCJ-97 -19.592 0.32 -3.513 -47.174 
SCJ-97 -19.721 0.191 -3.513 -47.174 
SCJ-97 -19.912 0 -3.513 -47.174 
Table A.13. Appendix to Figure 4.34 in Sub-section 4.3.7. Glide docking tables for the poses 
obtained by molecular docking of Ligand 97 on CTB (protein structure from PDB ID: 3CHB). The 
docking poses are sorted according to their docking score. 
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Title 
Potential Energy-
OPLS-2005 
Relative Potential Energy-
OPLS-2005 
docking score glide emodel 
SCJ-105 -13.78 0.207 -4.114 -49.046 
SCJ-105 -13.787 0.2 -4.114 -49.046 
SCJ-105 -13.892 0.094 -4.114 -49.046 
SCJ-105 -13.986 0 -4.114 -49.046 
SCJ-105 -13.78 0.207 -4.095 -49.801 
SCJ-105 -13.787 0.2 -4.095 -49.801 
SCJ-105 -13.892 0.094 -4.095 -49.801 
SCJ-105 -13.986 0 -4.095 -49.801 
SCJ-105 -13.78 0.207 -4.075 -49.555 
SCJ-105 -13.787 0.2 -4.075 -49.555 
SCJ-105 -13.892 0.094 -4.075 -49.555 
SCJ-105 -13.986 0 -4.075 -49.555 
SCJ-105 -13.78 0.207 -3.975 -47.795 
SCJ-105 -13.787 0.2 -3.975 -47.795 
SCJ-105 -13.892 0.094 -3.975 -47.795 
SCJ-105 -13.986 0 -3.975 -47.795 
SCJ-105 -13.78 0.207 -3.682 -46.168 
SCJ-105 -13.787 0.2 -3.682 -46.168 
SCJ-105 -13.892 0.094 -3.682 -46.168 
SCJ-105 -13.986 0 -3.682 -46.168 
Table A.14. Appendix to Figure 4.34 in Sub-section 4.3.7. Glide docking tables for the poses 
obtained by molecular docking of Ligand 105 on CTB (protein structure from PDB ID: 3CHB). The 
docking poses are sorted according to their docking score. 
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Title 
Potential Energy-
OPLS-2005 
Relative Potential Energy-
OPLS-2005 
docking score glide emodel 
SCJ-108 -23.929 0.143 -4.664 -55.287 
SCJ-108 -24.019 0.053 -4.664 -55.287 
SCJ-108 -24.071 0.001 -4.664 -55.287 
SCJ-108 -24.072 0 -4.664 -55.287 
SCJ-108 -23.929 0.143 -4.413 -53.432 
SCJ-108 -24.019 0.053 -4.413 -53.432 
SCJ-108 -24.071 0.001 -4.413 -53.432 
SCJ-108 -24.072 0 -4.413 -53.432 
SCJ-108 -23.929 0.143 -4.371 -52.992 
SCJ-108 -24.019 0.053 -4.371 -52.992 
SCJ-108 -24.071 0.001 -4.371 -52.992 
SCJ-108 -24.072 0 -4.371 -52.992 
SCJ-108 -23.929 0.143 -4.309 -52.898 
SCJ-108 -24.019 0.053 -4.309 -52.898 
SCJ-108 -24.071 0.001 -4.309 -52.898 
SCJ-108 -24.072 0 -4.309 -52.898 
SCJ-108 -23.929 0.143 -4.094 -53.746 
SCJ-108 -24.019 0.053 -4.094 -53.746 
SCJ-108 -24.071 0.001 -4.094 -53.746 
SCJ-108 -24.072 0 -4.094 -53.746 
Table A.15. Appendix to Figure 4.34 in Sub-section 4.3.7. Glide docking tables for the poses 
obtained by molecular docking of Ligand 108 on CTB (protein structure from PDB ID: 3CHB). The 
docking poses are sorted according to their docking score. 
A.7 Binding epitope mapping of 2,7-anhydro-Neu5Ac in complex with GH33 
 
Figure A.5. Appendix to Sub-section 5.2.1 Binding epitope mapping of 2,7-anhydro-Neu5Ac as 
bound to GH33 from STD NMR experiments at the irradiation frequency of 0.60 ppm (left) and 
6.55 ppm (right). Relative STD intensities normalised at H4 are shown for each atom (please note 
that for Neu5Ac and its derivative the pseudo-anomeric carbon is numbered C2). 
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A.8 Assignment and STD NMR binding epitope mapping raw data for 3’SL and 6’SL 
in complex with GH33 D282A at two different irradiation frequencies  
   
 STD (%) 3’SL, 0.60 ppm 
Proton 
ID 
Spin 
system 
1H δ 
(ppm) 
13C δ 
(ppm) 
0.5 s 1 s 2 s 3 s 4 s 5 s 
H3a Neu5Ac 1.669 39.37 1.79 2.98 3.84 4.03 4.07 4.07 
CH3 Neu5Ac 1.898 21.68 1.21 2.55 4.32 5.3 5.84 5.89 
H3e Neu5Ac 2.627 39.37 1.15 2.04 2.98 3.16 3.19 3.19 
H2 βGlc 3.150 73.79 0.32 0.81 1.87 2.63 2.95 3.01 
H2 Gal 3.443 69.22 0.45 1.02 2.25 2.92 3.35 3.48 
H2 αGlc 3.446 70.86 0.45 1.02 2.25 2.92 3.35 3.48 
H5 βGlc 3.462 67.88 0.44 1.03 2.22 2.84 3.21 3.29 
H8 Neu5Ac 3.472 74.58 0.47 1.1 2.04 2.63 2.73 2.81 
H6 Neu5Ac 3.498 72.62 0.57 1.29 2.22 2.73 2.92 3.01 
H3 βGlc 3.507 74.09 0.49 1.11 1.91 2.36 2.51 2.58 
H9 Neu5Ac 3.512 62.39 0.41 1.04 1.52 1.96 2.08 2.08 
H4 βGlc 3.536 78.01 0.54 1.26 1.89 2.53 2.61 2.73 
H4 αGlc 3.538 77.97 0.54 1.26 1.89 2.53 2.61 2.73 
H4 Neu5Ac 3.551 68.23 0.45 1.09 1.83 2.34 2.53 2.63 
H5 Gal 3.579 74.95 0.42 1.12 1.73 2.25 2.32 2.35 
H6 Gal 3.590 60.8 0.44 1.08 1.43 1.76 1.76 1.78 
H6' Gal 3.630 " 0.42 1.18 1.49 1.76 1.76 1.78 
H6 αGlc 3.690 59.8 0.4 0.78 1.52 1.87 2.04 2.04 
H6 βGlc 3.700 59.66 0.57 1.28 2.43 3.13 3.38 3.45 
H3 αGlc 3.705 71.5 0.57 1.28 2.43 3.13 3.42 3.48 
H5 Neu5Ac 3.723 51.49 0.63 1.16 1.71 2.08 2.25 2.27 
H9' Neu5Ac 3.744 62.39 0.49 0.93 1.54 1.83 1.87 1.91 
H6' βGlc 3.760 59.66 0.53 1.21 1.88 2.430 2.480 2.55 
H7 Neu5Ac 3.776 71.58 0.59 1.15 1.83 2.41 2.55 2.63 
H5 αGlc 3.810 69.87 - - - - - - 
H4 Gal 3.826 66.95 0.38 0.98 1.63 1.96 2.12 2.16 
H6' αGlc 3.830 59.8 0.33 0.84 1.12 1.48 1.64 1.65 
H3 Gal 3.985 75.13 0.48 1.06 1.87 2.27 2.43 2.49 
Table A.16. Appendix to Figure 5.5a in Sub-section 5.2.1 3’SL, 0.60 ppm. 1H and 13C assignment 
and the raw STD (%) at increasing saturation times. Experiments acquired at 285 K.  
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 STD (%) 6’SL, 0.60 ppm 
Proton 
ID 
Spin 
system 
1H δ 
(ppm) 
13C δ 
(ppm) 
0.5 s 1 s 2 s 3 s 4 s 5 s 
H3a Neu5Ac 1.664 40.00 5.41 8.89 11.69 12.51 12.88 12.88 
CH3 Neu5Ac 1.951 22.2 7.76 14.34 22.25 26.27 27.85 28.4 
H3e Neu5Ac 2.636 40.00 4.54 7.99 10.7 11.69 11.92 11.92 
H2 βGlc 3.231 73.67 0.97 2.53 4.67 6.26 6.83 7.04 
H2 Gal 3.454 70.66 1.87 4.07 7.39 9.25 10.29 10.49 
H8 Neu5Ac 3.487 68.24 2.59 5.05 8.55 10.39 11.02 11.24 
H2 αGlc 3.520 71.09 1.78 3.99 5.84 6.9 6.97 7.17 
H6 Gal 3.523 63.53 1.21 2.92 4.54 5.84 6.39 6.43 
H5 βGlc 3.536 74.58 1.35 3.01 4.72 5.73 6.02 6.04 
H4 βGlc 3.542 79.52 1.68 3.48 5.51 6.51 6.89 6.97 
H4 αGlc 3.550 79.53 1.68 3.48 5.51 6.51 6.89 6.97 
H9 Neu5Ac 3.560 62.54 1.99 4.07 6.51 7.68 8.14 8.22 
H3 βGlc 3.575 74.5 2.16 4.28 6.97 8.39 9.16 9.16 
H4 Neu5Ac 3.578 68.25 2.16 4.28 6.97 8.39 9.16 9.16 
H3 Gal 3.586 72.1 2.22 3.88 7.24 8.72 9.25 9.25 
H6 Neu5Ac 3.644 72.33 3.42 6.83 11.02 13.41 14.07 14.34 
H6 βGlc 3.717 60.2 0.78 1.81 2.55 3.22 3.29 3.29 
H5 Gal 3.733 73.83 2.01 3.69 5.46 6.64 6.97 7.17 
H3 αGlc 3.764 71.47 2.36 4.95 7.99 9.34 10.58 11.05 
H6 αGlc 3.764 59.9 2.36 4.95 7.99 9.34 10.58 11.05 
H5 Neu5Ac 3.787 51.6 3.78 7.46 11.92 14.07 15.21 15.66 
H9' Neu5Ac 3.800 62.54 2.22 4.28 6.32 7.32 7.61 7.99 
H5 αGlc 3.81 71.75 3.01 5.05 7.76 9.430 9.710 9.71 
H4 Gal 3.856 68.46 2.92 5.79 9.25 10.91 11.35 11.35 
H6' βGlc 3.866 60.2 1.03 2.38 3.32 3.59 3.96 3.96 
H7 Neu5Ac 3.876 69.84 1.03 2.38 3.32 3.59 3.96 3.96 
H6' αGlc 3.878 59.9 1.03 2.38 3.32 3.59 3.96 3.96 
H6' Gal 3.900 63.53 2.08 4.19 6.51 6.38 7.24 7.24 
H1 Gal 4.345 103.12 1.52 3.16 4.95 6.02 6.32 6.57 
H1 βGlc 4.585 95.62 0.85 2.02 3.04 3.96 4.39 4.58 
H1 αGlc 5.145 91.65 0.86 2.45 4.45 5.84 6.69 7.1 
Table A.17. Appendix to Figure 5.5b in Sub-section 5.2.1 6’SL, 0.60 ppm. 1H and 13C assignment 
and the raw STD (%) at increasing saturation times. Experiments acquired at 298 K.  
 
 
 
 
 
236 | P a g e  
 
  STD (%) 3’SL, 6.55 ppm 
Proton ID 
Spin 
system 
0.5 s 1 s 2 s 3 s 4 s 5 s 
H3a Neu5Ac 0.28 0.62 1.01 1.15 1.19 1.19 
CH3 Neu5Ac - 0.49 1.29 1.92 2.18 2.18 
H3e Neu5Ac 0.27 0.7 1.07 1.16 1.21 1.21 
H2 βGlc 0.23 0.59 1.29 1.89 2.01 2.04 
H2 Gal 0.23 0.72 1.46 1.94 2.41 2.45 
H2 αGlc 0.23 0.72 1.46 1.94 2.41 2.45 
H5 βGlc 0.26 0.78 1.52 1.87 2.25 2.25 
H8 Neu5Ac 0.29 0.73 1.37 1.73 1.92 2.02 
H6 Neu5Ac 0.3 0.71 1.25 1.61 1.78 1.87 
H3 βGlc 0.32 0.65 1.19 1.52 1.64 1.74 
H9 Neu5Ac 0.29 0.66 1.13 1.45 1.46 1.49 
H4 βGlc 0.21 0.65 1.18 1.35 1.67 1.74 
H4 αGlc 0.21 0.65 1.18 1.35 1.67 1.74 
H4 Neu5Ac 0.29 0.69 1.23 1.52 1.73 1.81 
H5 Gal 0.31 0.64 1.1 1.29 1.42 1.51 
H6 Gal 0.33 0.67 1.03 1.18 1.23 1.26 
H6' Gal 0.4 0.75 1.19 1.38 1.45 1.48 
H6 αGlc 0.35 0.78 1.24 1.33 1.49 1.55 
H6 βGlc 0.26 0.74 1.45 1.55 1.68 1.85 
H3 αGlc 0.26 0.74 1.45 1.55 1.68 1.85 
H5 Neu5Ac 0.25 0.72 1.29 1.54 1.79 1.94 
H9' Neu5Ac 0.34 0.66 1.16 1.23 1.38 1.39 
H6' βGlc 0.38 0.72 1.39 1.610 1.740 1.88 
H7 Neu5Ac 0.42 0.75 1.59 1.66 1.71 1.79 
H5 αGlc - - - - - - 
H4 Gal 0.38 0.78 1.38 1.71 1.83 1.86 
H6' αGlc 0.41 0.73 1.12 1.48 1.52 1.54 
H3 Gal 0.43 0.85 1.58 1.83 2.08 2.08 
Table A.18. Appendix to Figure 5.5c in Sub-section 5.2.1 3’SL, 6.55 ppm. Raw STD (%) at 
increasing saturation times. Experiments acquired at 285 K. 
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  STD (%) 6’SL, 6.55 ppm 
Proton ID 
Spin 
system 
0.5 s 1 s 2 s 3 s 4 s 5 s 
H3a Neu5Ac 2.12 4.15 6.51 7.04 7.46 7.46 
CH3 Neu5Ac 2.34 6.26 12.51 15.66 17.1 17.44 
H3e Neu5Ac 2.21 4.45 6.77 7.46 7.68 7.75 
H2 βGlc 1.1 2.41 4.58 5.9 6.57 6.89 
H2 Gal 1.19 2.81 5.73 7.24 8.22 8.47 
H8 Neu5Ac 1.48 3.38 6.38 7.83 8.47 8.64 
H2 αGlc 2.08 3.88 5.84 6.57 6.83 6.97 
H6 Gal 1.24 2.48 4.28 5.15 5.57 5.79 
H5 βGlc 1.22 2.53 4.15 5 5.35 5.35 
H4 βGlc 1.28 2.68 4.54 5.51 5.84 5.89 
H4 αGlc 1.28 2.68 4.54 5.51 5.84 5.89 
H9 Neu5Ac 1.41 2.98 5.15 6.21 6.7 6.81 
H3 βGlc 1.51 3.16 5.46 6.57 7.11 7.39 
H4 Neu5Ac 1.51 3.16 5.46 6.57 7.11 7.39 
H3 Gal 1.29 2.84 5.35 6.64 7.39 7.39 
H6 Neu5Ac 1.79 4.15 7.68 9.43 10.29 10.39 
H6 βGlc 0.71 1.48 2.18 2.61 2.81 2.87 
H5 Gal 1.98 3.73 6.52 6.26 6.64 6.77 
H3 αGlc 1.49 3.32 6.26 7.68 8.31 8.55 
H6 αGlc 1.49 3.32 6.26 7.68 8.31 8.55 
H5 Neu5Ac 1.71 4.15 7.91 9.89 10.7 10.81 
H9' Neu5Ac 1.48 3.16 5.15 6.02 6.32 6.44 
H5 αGlc 1.68 3.73 6.19 7.610 7.990 8.07 
H4 Gal 1.33 3.29 6.21 7.68 8.39 8.47 
H6' βGlc 0.81 1.48 2.53 3.04 3.19 3.84 
H7 Neu5Ac 0.81 1.48 2.53 3.04 3.19 3.84 
H6' αGlc 0.81 1.48 2.53 3.04 3.19 3.84 
H6' Gal 2.27 4.24 6.14 6.97 7.53 7.53 
H1 Gal 1.3 2.6 4.4 5.29 5.68 5.68 
H1 βGlc 0.79 1.98 3.42 3.99 4.58 4.62 
H1 αGlc 1.15 2.11 4.67 6.08 6.57 6.89 
Table A.19. Appendix to Figure 5.5d in Sub-section 5.2.1 6’SL, 6.55 ppm. Raw STD (%) at 
increasing saturation times. Experiments acquired at 298 K. 
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A.9 Docking of 3’SL and 6’SL on GH33 D282A as compared to GH33 WT  
 
Figure A.6. Appendix to Sub-section 5.2.4.  The lowest energy converging docking solutions for 
(a) 3’SL as bound to GH33 WT (cyan) and to GH33 D282A (orange); and (b) 6’SL as bound to 
GH33 WT (purple) and to GH33 D282A (green). The grey surface encloses the mutant grid only, 
and the Ala282 is shown in red. 
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A.10 Glide docking tables for 3’SL and 6’SL in complex with GH33 WT and GH33 
D282A 
 GH33 WT  GH33 D282A 
Title glide gscore glide emodel  glide gscore glide emodel 
3'SL_lowest -4.851 -55.108  -5.714 -69.097 
3'SL_lowest -4.599 -52.153  -5.678 -62.32 
3'SL_lowest -4.378 -51.585  -5.555 -67.041 
3'SL_lowest -4.358 -49.368  -5.523 -65.15 
3'SL_lowest -4.336 -48.47  -5.471 -63.716 
3'SL_lowest -4.212 -46.64  -5.461 -63.415 
3'SL_lowest -4.165 -51.572  -5.456 -67.82 
3'SL_lowest -4.129 -50.611  -5.43 -59.581 
3'SL_lowest -4.091 -48.006  -5.404 -67.586 
3'SL_lowest -4.048 -48.877  -5.342 -61.495 
3'SL_lowest -4.027 -50.191  -5.297 -66.962 
3'SL_lowest -3.916 -49.995  -5.159 -62.441 
3'SL_lowest -3.622 -52.849  -5.149 -66.088 
3'SL_lowest -3.597 -51.321  -5.139 -58.56 
3'SL_lowest -3.579 -47.157  -5.113 -63.42 
3'SL_lowest -3.52 -47.799  -5.11 -60.602 
3'SL_lowest -3.435 -49.426  -5.107 -61.548 
3'SL_lowest -3.432 -47.374  -5.099 -58.338 
3'SL_lowest -3.421 -49.284  -5.073 -65.733 
3'SL_lowest -3.409 -47.612  -5.06 -63.575 
3'SL_lowest -3.387 -51.591  -5.012 -60.545 
3'SL_lowest -3.357 -48.439  -4.987 -61.824 
3'SL_lowest -3.351 -48.784  -4.904 -61.937 
3'SL_lowest -3.349 -49.877  -4.883 -64.155 
3'SL_lowest -3.341 -43.892  -4.871 -65.052 
Table A.20. Appendix to Sub-section 5.2.4. Glide gscore and glide emodel tables for the the first 
25 poses obtained by molecular docking of 3’SL on GH33 WT and GH33 D282A (protein structure 
from PDB ID: 4X4A). The docking poses are sorted according to their gscore. 
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 GH33 WT  GH33 D282A 
Title glide gscore glide emodel  glide gscore glide emodel 
6'SL_lowest -5.473 -66.403  -5.444 -67.843 
6'SL_lowest -5.305 -62.096  -5.325 -70.796 
6'SL_lowest -5.06 -59.18  -5.286 -68.337 
6'SL_lowest -4.862 -59.249  -5.254 -68.351 
6'SL_lowest -4.815 -58.049  -5.226 -69.916 
6'SL_lowest -4.792 -56.344  -5.21 -69.48 
6'SL_lowest -4.064 -60.326  -5.207 -68.591 
6'SL_lowest -4.038 -57.426  -5.197 -67.927 
6'SL_lowest -3.874 -55.414  -5.071 -64.32 
6'SL_lowest -3.847 -51.886  -5.027 -66.51 
6'SL_lowest -3.648 -51.936  -4.871 -59.65 
6'SL_lowest -3.636 -53.673  -4.863 -64.773 
6'SL_lowest -3.426 -50.999  -4.406 -59.468 
6'SL_lowest -3.414 -51.824  -4.375 -58.224 
6'SL_lowest -3.386 -52.367  -4.316 -54.875 
6'SL_lowest -3.384 -49.545  -4.3 -60.301 
6'SL_lowest -3.353 -46.825  -4.003 -48.866 
6'SL_lowest -3.322 -46.886  -3.925 -53.695 
6'SL_lowest -3.223 -49.529  -3.817 -56.252 
6'SL_lowest -3.219 -49.444  -3.78 -53.083 
6'SL_lowest -3.119 -45.753  -3.751 -53.553 
6'SL_lowest -3.113 -43.44  -3.732 -52.327 
6'SL_lowest -3.081 -48.839  -3.691 -52.815 
6'SL_lowest -3.046 -47.699  -3.689 -53.024 
6'SL_lowest -2.938 -46.854  -3.638 -51.038 
Table A.21. Appendix to Sub-section 5.2.4. Glide gscore and glide emodel tables for the first 25 
poses obtained by molecular docking of 6’SL on GH33 WT and GH33 D282A (protein structure 
from PDB ID: 4X4A). The docking poses are sorted according to their gscore. 
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A.11 Assignment and STD NMR binding epitope mapping raw data for the 
sialoglycans in complex with CBM40 
  STD (%) 3’SL 
Proton ID 
Spin 
system 
0.5 s 1 s 2 s 3 s 4 s 5 s 
H3a Neu5Ac 4.72 7.17 8.98 9.82 10.6 10.91 
CH3 Neu5Ac 29.24 44.93 57.9 60.85 62.6 62.6 
H3e Neu5Ac 4.03 7.17 9.52 10.21 10.81 10.91 
H2 βGlc / / 1.03 1.11 1.81 1.81 
H2 Gal 1.41 1.71 2.71 2.92 3.16 3.59 
H2 αGlc " " " " " " 
H5 βGlc 4.32 7.53 10.7 12.15 12.88 12.88 
H8 Neu5Ac 5.51 9.52 14.34 15.97 16.93 16.93 
H6 Neu5Ac 4.03 6.51 9.61 11.46 12.51 12.88 
H3 βGlc 2.73 4.32 7.04 8.31 8.64 8.64 
H9 Neu5Ac 2.9 4.24 6.92 7.53 8.07 8.98 
H4 βGlc 1.33 2.55 4.39 5.9 6.26 6.32 
H4 αGlc " " " " " " 
H4 Neu5Ac 1.33 3.13 5.05 6.08 6.44 6.57 
H5 Gal 0.73 0.9 1.54 1.57 1.98 1.98 
H6 Gal 0.73 0.9 1.48 2.08 2.14 2.14 
H6' Gal 0.73 0.9 1.71 2.61 2.76 2.76 
H6 αGlc 1.01 1.21 1.71 2.04 2.06 2.06 
H6 βGlc 2.16 4.03 7.68 9.25 10.09 10.09 
H3 αGlc " " " " " " 
H5 Neu5Ac 3.25 5.57 9.99 12.88 13.42 13.93 
H9' Neu5Ac 2.79 5.35 8.14 9.71 10.09 10.6 
H6' βGlc 1.96 3.01 4.07 4.89 4.95 5.25 
H7 Neu5Ac 2.38 4.99 6.97 9.89 10.81 11.35 
H5 αGlc 1.28 1.63 2.48 2.61 2.61 2.61 
H4 Gal 0.87 1.26 1.76 2.18 2.60 2.65 
H6' αGlc 0.92 1.26 1.76 1.98 1.98 1.98 
H3 Gal 1.23 1.88 3.04 3.73 3.99 3.99 
Table A.22. Appendix to Figure 5.20 in Sub-section 5.3.1 3’SL. Raw STD (%) at increasing 
saturation times. See Table A.16 for assignment. Experiments acquired at 293 K.  
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  STD (%) 6’SL 
Proton ID 
Spin 
system 
0.5 s 1 s 2 s 3 s 4 s 5 s 
H3a Neu5Ac 8.64 13.01 17.61 18.85 20.78 20.99 
CH3 Neu5Ac 53.55 71.07 77.59 77.59 77.59 77.59 
H3e Neu5Ac 8.64 13.43 18.49 19.99 20.78 20.99 
H2 βGlc 1.01 2.02 3.92 4.76 5.1 5.41 
H2 Gal 1.01 2.02 2.68 3.38 4.81 4.81 
H8 Neu5Ac 14.34 23.83 30.11 31.01 31.92 32.56 
H2 αGlc 1.53 2.98 3.32 4.03 4.58 5.2 
H6 Gal 1.53 2.98 3.32 4.03 4.58 5.2 
H5 βGlc 1.34 2.36 2.48 3.52 3.92 4.2 
H4 βGlc 3.66 5.41 9.71 10.19 10.49 11.13 
H4 αGlc " " " " " " 
H9 Neu5Ac 4.24 7.32 11.57 12.63 13.39 13.66 
H3 βGlc 2.87 5.01 7.99 8.89 9.24 9.34 
H4 Neu5Ac " " " " " " 
H3 Gal 1.46 2.98 4.95 6.02 6.9 7.17 
H6 Neu5Ac 7.61 14.77 23.59 27.31 28.11 28.68 
H6 βGlc 1.34 1.98 2.41 3.01 3.52 3.62 
H5 Gal 1.28 2.73 3.55 3.66 4.4 4.72 
H3 αGlc 3.73 6.9 10.01 12.27 12.63 13.4 
H6 αGlc / / / / / / 
H5 Neu5Ac 4.4 8.64 13.27 14.77 15.81 15.97 
H9' Neu5Ac 5.46 9.9 15.66 17.95 18.84 18.84 
H7 Neu5Ac 3.28 6.09 7.97 10.01 11.81 12.36 
H4 Gal 1.01 1.81 3.01 3.96 4.11 4.36 
H6' βGlc 1.43 2.02 3.25 3.45 3.59 3.77 
H5 αGlc 1.43 2.02 3.25 3.45 3.59 3.77 
H6' αGlc 1.43 2.87 4.07 5.68 5.46 5.46 
H6' Gal 1.43 2.87 4.07 5.68 5.46 5.46 
H1 Gal 0.83 1.45 2.1 2.81 3.45 3.69 
Table A.23. Appendix to Figure 5.20 in Sub-section 5.3.1 6’SL. Raw STD (%) at increasing 
saturation times. See Table A.17 for assignment. Experiments acquired at 293 K.  
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    STD (%) 3’SLGc 
Proton 
ID 
Spin 
system 
1H δ 
(ppm) 
13C δ 
(ppm) 
0.5 s 1 s 2 s 3 s 4 s 5 s 
H3a Neu5Gc 1.672 39.39 2.29 3.29 3.88 4.62 4.89 4.89 
H3e Neu5Gc 2.583 39.39 1.78 2.7 3.55 3.99 4.24 4.07 
H2 βGlc 3.090 73.29 - 0.52 0.72 0.95 1.05 1.15 
H2 Gal 3.387 69.11 - 0.59 0.81 1.73 1.79 1.85 
H2 αGlc 3.387 70.83 - 0.59 0.81 1.73 1.79 1.85 
H8 Neu5Gc 3.397 67.63 1.35 2.7 4.32 5.20 5.57 5.68 
H5 βGlc 3.402 74.51 0.41 1.57 2.95 3.25 3.59 3.84 
H3 βGlc 3.441 74.05 0.58 1.3 1.69 2.34 2.58 2.58 
H9 Neu5Gc 3.449 62.18 0.58 1.3 1.69 2.34 2.58 2.58 
H4 αGlc 3.485 77.88 0.45 0.61 0.71 1.12 1.18 1.26 
H4 βGlc 3.494 77.88 0.45 0.61 0.71 1.12 1.18 1.26 
H7 Neu5Gc 3.520 75.07 0.38 0.67 0.82 1.29 1.34 1.39 
H6 Gal 3.541 60.68 0.67 1.03 1.29 1.93 2.09 2.13 
H6 Neu5Gc 3.561 72.23 0.47 0.96 1.63 2.43 2.53 2.53 
H4 Neu5Gc 3.590 67.72 0.96 2.25 3.66 4.36 4.86 5.15 
H6 βGlc 3.630 59.66 0.72 1.43 1.58 1.71 2.04 2.14 
H5 αGlc 3.635 71.01 0.41 0.72 0.77 1.18 1.24 1.27 
H9′ Neu5Gc 3.677 62.18 0.72 1.51 1.89 2.18 2.35 2.41 
H6 αGlc 3.694 59.45 0.44 0.98 1.35 1.54 1.54 1.54 
H5 Gal 3.697 71.55 0.63 1.53 2.16 2.68 2.92 2.95 
H5 Neu5Gc 3.754 51.09 1.04 1.73 2.87 4.32 4.40 4.54 
H4 Gal 3.756 67.12 0.51 1.16 1.71 1.78 1.94 2.14 
H3 αGlc 3.757 69.87 0.51 1.16 1.71 1.78 1.94 2.14 
H6' βGlc 3.772 59.66 0.51 1.16 1.71 1.78 1.94 2.14 
CH2 Neu5Gc 3.926 60.68 1.92 3.77 6.26 7.53 7.87 8.07 
H6' Gal 3.926 60.68 1.92 3.77 6.26 7.53 7.87 8.07 
H3 Gal 3.936 75.11 0.33 0.64 0.78 1.03 1.06 1.06 
Table A.24. Appendix to Figure 5.20 in Sub-section 5.3.1 3’SLGc. 1H and 13C assignment and the 
raw STD (%) at increasing saturation times. Experiments acquired at 293 K. 
 
 
 
 
 
 
 
 
244 | P a g e  
 
    STD (%) 6’SLGc 
Proton 
ID 
Spin 
system 
1H δ 
(ppm) 
13C δ 
(ppm) 
0.5 s 1 s 2 s 3 s 4 s 5 s 
H3a Neu5Gc 1.571 39.90 2.1 3.1 3.73 4.19 4.19 4.19 
H3e Neu5Gc 2.530 39.90 1.31 2.2 2.81 2.78 3.19 3.35 
H2 βGlc 3.122 73.40 - 0.36 0.66 0.83 1.03 1.04 
H2 Gal 3.341 70.48 0.3 0.47 0.82 1.02 1.12 1.37 
H8 Neu5Gc 3.369 67.94 1.31 2.2 4.28 5.11 5.41 5.62 
H6 Gal 3.403 63.44 0.26 0.43 0.60 0.72 0.78 0.83 
H2 αGlc 3.421 70.70 0.26 0.43 0.6 0.72 0.78 0.83 
H5 βGlc 3.435 72.14 - 0.43 0.61 0.71 0.71 0.77 
H9 Neu5Gc 3.443 62.28 0.44 0.61 1.01 1.13 1.19 1.24 
H4 αGlc 3.446 79.33 0.34 0.51 0.72 0.92 1.08 1.11 
H4 βGlc 3.446 79.33 0.34 0.51 0.72 0.92 1.08 1.11 
H3 βGlc 3.460 72.14 0.33 0.43 0.76 0.86 0.98 0.98 
H3 Gal 3.467 72.12 0.51 0.6 0.65 0.76 0.85 0.85 
H4 Neu5Gc 3.563 67.79 0.63 1.49 2.27 2.87 3.16 3.45 
H6 βGlc 3.601 59.88 / / / / / / 
H5 Gal 3.628 73.27 0.41 0.59 0.82 0.93 0.98 1.12 
H3 αGlc 3.650 71.81 0.48 0.73 1.37 1.79 2.08 2.08 
H6 Neu5Gc 3.651 71.70 0.48 0.73 1.37 1.79 2.08 2.08 
H6 αGlc 3.669 59.82 0.32 0.64 1.03 1.15 1.48 1.48 
H6' αGlc 3.669 59.82 0.32 0.64 1.03 1.15 1.480 1.48 
H9′ Neu5Gc 3.683 62.28 0.45 0.69 1.11 1.38 1.580 1.68 
H7 Neu5Gc 3.710 71.70 0.52 0.91 1.55 1.76 1.980 2.14 
H4 Gal 3.741 68.28 0.31 0.41 0.79 0.88 0.91 1.01 
H6' βGlc 3.758 59.88 0.51 0.73 1.480 1.73 1.83 1.9 
H5 Neu5Gc 3.761 51.18 0.51 0.73 1.480 1.73 1.83 1.90 
H5 αGlc 3.764 69.90 0.51 0.73 1.480 1.73 1.830 1.90 
H6' Gal 3.801 63.44 0.6 0.54 0.880 0.95 1.040 1.04 
CH2 Neu5Gc 3.926 60.57 1.39 2.22 4.32 5.05 5.200 5.30 
Table A.25. Appendix to Figure 5.20 in Sub-section 5.3.1 6’SLGc. 1H and 13C assignment and the 
raw STD (%) at increasing saturation times. Experiments acquired at 293 K.  
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    STD (%) 3’SGal 
Proton 
ID 
Spin 
system 
1H δ 
(ppm) 
13C δ 
(ppm) 
0.5 s 1 s 2 s 3 s 4 s 5 s 
H3 Neu5Ac 1.571 39.90 2.45 3.66 4.32 4.36 4.67 4.72 
CH3 Neu5Ac 1.789 21.75 26.52 40.75 51 54.08 55.14 55.14 
H3 Neu5Ac 2.519 39.90 1.52 2.95 3.48 3.92 4.03 4.12 
H2 βGal 3.288 69.83 0 0 0 0.00 1.09 1.23 
H7 Neu5Ac 3.359 67.62 1.92 4.54 7.39 8.81 9.16 9.16 
H6 Neu5Ac 3.381 72.45 1.45 2.9 5.46 6.32 6.83 7.24 
H6 βGal 3.396 62.10 1.01 2.12 3.66 3.77 4.24 4.76 
H4 Neu5Ac 3.443 67.98 1.25 1.71 3.10 3.84 4.19 4.19 
H5 βGal 3.452 74.59 0.81 1.43 2.02 3.16 3.25 3.57 
H9 Neu5Ac 3.479 60.66 0.56 0.75 1.58 1.87 1.87 2.18 
H6 αGal 3.479 60.66 0 0.41 0.81 0.85 0.92 1.02 
H2 αGal 3.607 66.56 0.78 1.12 2.18 2.95 3.22 3.22 
H5 Neu5Ac 3.616 51.10 0.78 1.31 2.55 3.22 3.59 3.69 
H6' βGal 3.633 62.10 0.78 1.39 2.31 2.84 2.98 3.19 
H8 Neu5Ac 3.649 71.38 0.78 1.39 2.12 2.36 2.53 2.58 
H4 βGal 3.707 67.26 0.6 0.77 1.08 1.12 1.41 1.43 
H4 αGal 3.778 67.34 0.5 0.77 1.08 1.11 1.15 1.17 
H5 αGal 3.835 70.13 0.7 0.92 1.08 1.15 1.21 1.21 
H3 βGal 3.849 75.61 0.9 1.04 1.45 1.58 1.61 1.88 
Table A.26. Appendix to Figure 5.20 in Sub-section 5.3.1 3’SGal. 1H and 13C assignment and the 
raw STD (%) at increasing saturation times. Experiments acquired at 293 K.  
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    STD (%) 6’SGal 
Proton 
ID 
Spin 
system 
1H δ 
(ppm) 
13C δ 
(ppm) 
0.5 s 1 s 2 s 3 s 4 s 5 s 
H3 Neu5Ac 1.471 39.94 3.19 5.05 5.84 6.38 6.77 6.77 
CH3 Neu5Ac 1.795 21.59 29.24 44.49 55.14 57.34 57.9 57.9 
H3 Neu5Ac 2.488 39.94 2.04 3.01 4.19 4.36 4.49 4.54 
H2 βGal 3.233 71.5 / / / / / / 
H5 βGal 3.336 67.90 2.1 4.67 7.83 8.81 9.34 9.34 
H9' Neu5Ac 3.346 63.43 1.9 3.55 6.19 7.09 7.53 7.53 
H3 βGal 3.394 72.21 0.98 1.41 1.94 2.45 2.55 2.55 
H6 βGal 3.395 62.12 1.52 1.88 3.01 3.25 3.45 3.76 
H4 Neu5Ac 3.417 67.98 1.29 2.27 4.28 4.03 5.05 5.51 
H6 Neu5Ac 3.495 72.33 1.42 2.55 4.19 5.25 5.96 6.02 
H2 αGal 3.538 68.00 0.3 0.66 0.98 1.12 1.12 1.12 
H5 αGal 3.543 72.52 0.3 0.66 0.98 1.12 1.12 1.12 
H5 Neu5Ac 3.598 51.59 0.94 2.12 3.92 4.89 5.41 5.46 
H3 αGal 3.617 68.66 0.8 1.24 2.27 2.48 2.69 2.93 
H6' βGal 3.641 62.12 0.91 1.54 2.41 2.55 2.62 2.62 
H9' Neu5Ac 3.651 63.43 0.5 1.16 2.20 2.27 2.68 2.78 
H8 Neu5Ac 3.651 71.37 0.5 1.16 2.20 2.27 2.68 2.78 
H6/6' αGal 3.687 63.36 0.4 0.67 0.90 0.90 0.90 0.90 
H4 βGal 3.687 68.44 0.4 0.67 0.90 0.90 0.90 0.90 
Table A.27. Appendix to Figure 5.20 in Sub-section 5.3.1 6’SGal. 1H and 13C assignment and the 
raw STD (%) at increasing saturation times. Experiments acquired at 293 K.  
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    STD (%) 3’SLN 
Proton 
ID 
Spin 
system 
1H δ 
(ppm) 
13C δ 
(ppm) 
0.5 s 1 s 2 s 3 s 4 s 5 s 
H3 Neu5Ac 1.573 39.20 7.1 10.81 16.13 16.77 18.31 19.04 
CH3 Neu5Ac 1.796 21.6 40.35 56.78 65.73 65.73 65.73 65.73 
CH3 βGlcNAc 1.806 21.6 7.91 9.25 11.57 13.53 14.34 14.48 
CH3 
αGlcNA
c 1.813 21.6 / / / / / / 
H3 Neu5Ac 2.524 39.20 8.31 12.88 16.13 18.31 20.18 21.61 
H2 Gal 3.341 69.17 1.78 3.22 4.49 6.51 7.46 8.35 
H8 Neu5Ac 3.359 67.69 11.24 12.88 18.85 22.04 22.91 23.59 
H3 βGlc 3.362 74.52 7.61 10.19 13.83 17.1 18.31 19.54 
H6 Neu5Ac 3.392 72.62 6.14 9.07 11.46 14.63 16.93 18.01 
H9 Neu5Ac 3.406 62.20 7.32 12.03 16.13 19.6 19.99 20.78 
H4 Neu5Ac 3.446 68.10 4.54 7.68 13.53 14.77 15.81 15.81 
H5 βGlcNAc 3.450 72.12 2.48 4.32 7.76 9.16 9.52 9.91 
H2 βGlcNAc 3.495 54.66 0.92 1.41 2.16 2.78 2.87 3.25 
H6 Gal 3.496 60.82 " " " " " " 
H6' Gal 3.496 60.82 " " " " " " 
H4 βGlcNAc 3.516 77.86 1.11 1.74 2.48 2.84 3.22 3.22 
H4 
αGlcNA
c 3.520 78.04 " " " " " " 
H3 
αGlcNA
c 3.527 69.88 1.68 2.29 2.41 2.59 2.95 2.95 
H6 βGlcNAc 3.615 59.58 3.92 7.11 12.27 13.93 14.48 15.36 
H5 Neu5Ac 3.624 51.19 4.45 7.61 13.27 15.06 15.66 15.97 
H9' Neu5Ac 3.638 62.20 5.41 9.61 16.44 17.44 17.81 17.95 
H6/6' 
αGlcNA
c 3.664 59.38 1.83 4.15 
7.76 
10.01 10.81 
11.13 
H2 
αGlcNA
c 3.668 53.55 " " 
" 
" 
" " 
H7 Neu5Ac 3.668 68.82 2.45 4.81 7.83 8.14 10.01 1.29 
H4 Gal 3.722 67.05 1.94 3.55 5.01 5.84 6.14 6.83 
H6' βGlcNAc 3.742 59.58 1.94 2.71 2.95 3.11 3.38 3.38 
H5 
αGlcNA
c 3.742 69.94 " " " " " " 
H3 Gal 3.894 75.11 2.22 4.98 5.79 7.39 7.76 8.55 
Table A.28. Appendix to Figure 5.20 in Sub-section 5.3.1 3’SLN. 1H and 13C assignment and the 
raw STD (%) at increasing saturation times. Experiments acquired at 293 K.  
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    STD (%) 6’SLN 
Proton 
ID 
Spin 
system 
1H δ 
(ppm) 
13C δ 
(ppm) 
0.5 s 1 s 2 s 3 s 4 s 5 s 
H3e Neu5Ac 1.511 39.62 5.15 8.22 11.13 11.35 12.15 12.27 
CH3 Neu5Ac 1.806 21.65 32.24 49.05 60.81 62.6 62.6 62.6 
CH3 
αGlcNA
c 1.824 21.65 / / / / / / 
CH3 βGlcNAc 1.844 21.73 1.63 2.84 4.45 5.21 5.57 5.89 
H3a Neu5Ac 2.443 39.62 5.57 7.68 11.54 11.57 11.69 12.03 
H6 Gal 3.309 63.05 0.57 1.48 2.63 2.98 2.98 2.98 
H2 Gal 3.324 70.30 0.98 1.64 3.16 3.73 3.89 3.99 
H8 Neu5Ac 3.340 68.12 6.64 11.46 16.13 17.78 19.79 20.38 
H5 βGlcNAc 3.404 74.09 2.87 5.25 7.99 8.81 8.89 9.43 
H4 βGlcNAc 3.415 80.46 3.32 6.38 9.52 10.91 11.57 12.39 
H9 Neu5Ac 3.416 62.28 " " " " " " 
H4 Neu5Ac 3.428 67.89 3.32 5.79 8.89 10.09 10.99 11.46 
H3 βGlcNAc 3.428 67.89 " " " " " " 
H4 
αGlcNA
c 3.447 80.58 0.69 1.18 2.04 2.11 2.14 2.58 
H3 Gal 3.458 72.12 0.69 1.29 2.36 2.41 2.52 2.87 
H6 Neu5Ac 3.486 72.30 3.73 6.83 11.81 13.79 14.48 15.97 
H2 βGlcNAc 3.516 55.50 0.99 1.09 2.22 2.92 2.98 3.32 
H5 Neu5Ac 3.601 51.54 4.49 6.32 12.15 15.06 15.36 16.93 
H6 βGlcNAc 3.606 60.00 1.45 3.13 4.86 6.14 6.77 6.97 
H3 
αGlcNA
c 3.611 73.34 " " 
" 
" 
" 
" 
H9' Neu5Ac 3.656 62.28 2.58 4.76 7.24 8.64 8.67 9.16 
H6/H6' 
αGlcNA
c 3.656 59.79 1.39 2.53 
3.92 4.67 4.81 4.86 
H5 Gal 3.679 71.42 1.98 4.45 6.19 7.53 8.07 8.64 
H4 Gal 3.705 68.60 0.37 0.72 1.31 1.63 1.73 1.88 
H2 
αGlcNA
c 3.712 53.12 0.76 0.92 
1.63 
2.18 2.41 2.48 
H7 Neu5Ac 3.715 69.17 " " " " " " 
H6' βGlcNAc 3.745 60.00 1.08 1.28 2.34 2.45 2.71 3.22 
H5 
αGlcNA
c 3.757 69.66 1.08 1.08 
1.45 1.55 1.98 2.10 
H6' Gal 3.782 63.05 0.98 1.66 2.22 2.55 2.84 3.22 
H1 Gal 4.228 103.30 0.77 1.61 1.74 1.79 1.88 1.96 
Table A.29. Appendix to Figure 5.20 in Sub-section 5.3.1 6’SLN. 1H and 13C assignment and the 
raw STD (%) at increasing saturation times. Experiments acquired at 293 K.  
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    STD (%) Neu5Ac-STn 
Proton 
ID 
Spin 
system 
1H δ 
(ppm) 
13C δ 
(ppm) 
0.5 s 1 s 2 s 3 s 4 s 5 s 
H3e Neu5Ac 1.393 39.88 2.95 4.28 5.57 5.68 5.96 5.960 
CH2 Chain 1.661 27.64 1.18 1.74 2.2 2.24 2.45 2.290 
CH3 Neu5Ac 1.736 21.51 19.99 31.01 41.15 44.49 44.93 44.930 
CH3 GalNAc 1.744 21.51 3.01 4.45 6.02 7.17 6.38 6.64 
H3a Neu5Ac 2.434 39.88 1.79 3.07 3.92 4.11 4.24 4.24 
CH2(N3) Chain 3.136 47.66 0.57 0.66 0.71 0.74 0.74 0.740 
CH2(N3) Chain 3.204 47.66 0.46 0.6 0.76 0.89 0.99 1.010 
CH2(O) Chain 3.214 64.66 0.46 0.6 0.76 0.89 0.99 1.010 
H8 Neu5Ac 3.282 67.80 1.98 4.32 7.17 9.16 9.61 9.610 
H6 GalNAc 3.301 63.48 0.56 0.87 1.02 1.11 1.35 1.35 
H9 Neu5Ac 3.336 62.12 0.94 1.6 2.68 3.35 3.55 3.66 
H4 Neu5Ac 3.350 67.88 1.260 1.9 3.01 4.36 4.45 4.55 
H6 Neu5Ac 3.717 72.26 0.62 0.9 1.3 1.54 1.63 1.68 
CH2(O) Chain 3.515 64.66 0.72 1.04 1.11 1.23 1.35 1.41 
H5 Neu5Ac 3.539 51.44 1.09 1.68 2.9 3.92 4.11 4.44 
H9' Neu5Ac 3.584 62.12 0.66 0.98 1.63 1.98 2.12 2.18 
H7 Neu5Ac 3.593 71.55 0.85 1.85 2.14 2.27 2.41 2.48 
H6' GalNAc 3.627 63.48 0.66 0.78 0.86 0.91 0.94 0.94 
H3 GalNAc 3.634 66.98 0.66 0.78 0.86 0.91 0.94 0.94 
H4 GalNAc 3.696 68.11 0.38 0.54 0.72 0.77 0.77 0.770 
H5 GalNAc 3.757 69.14 0.49 0.98 1.07 1.2 1.24 1.24 
H2 GalNAc 3.840 49.30 0.49 0.68 0.79 0.95 0.99 0.99 
Table A.30. Appendix to Figure 5.20 in Sub-section 5.3.1 Neu5Ac-STn. 1H and 13C assignment 
and the raw STD (%) at increasing saturation times. Experiments acquired at 293 K. 
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    STD (%) Neu5Gc-STn 
Proton 
ID 
Spin 
system 
1H δ 
(ppm) 
13C δ 
(ppm) 
0.5 s 1 s 2 s 3 s 4 s 5 s 
H3a Neu5Gc 1.41 39.88 2.48 4.58 5.25 5.3 5.62 5.620 
CH2 Chain 1.617 27.64 1.48 2.41 2.63 2.78 2.95 2.950 
CH3 GalNAc 1.742 21.51 0.43 0.97 1.66 2.02 2.12 2.220 
H3e Neu5Gc 2.451 39.88 1.71 2.48 2.92 3.29 3.31 3.32 
CH2(N3) Chain 3.143 47.66 0.62 0.78 0.86 0.910 0.99 0.99 
CH2(N3) Chain 3.193 47.66 0.55 0.63 0.71 0.880 0.88 0.88 
CH2(O) Chain 3.214 64.66 0.55 0.63 0.71 0.880 0.88 0.88 
H8 Neu5Gc 3.270 67.56 1.29 2.92 5.25 6.260 6.83 6.83 
H6 GalNAc 3.310 63.63 0.52 0.84 0.99 1.15 1.3 1.330 
H9 Neu5Gc 3.337 62.12 0.81 1.16 1.69 1.830 1.87 2.1 
H4 Neu5Gc 3.466 67.57 1.52 2.22 2.84 4.240 4.58 4.76 
CH2(O) Chain 3.513 64.66 - - - - - - 
H6 Neu5Gc 3.534 71.82 1.05 1.57 2.29 2.650 2.76 2.87 
H9' Neu5Gc 3.577 62.12 0.78 0.94 1.19 1.420 1.78 1.78 
H7 Neu5Gc 3.599 71.47 0.5 1.21 1.52 1.79 2.14 2.28 
H3 GalNAc 3.627 67.05 0.52 0.85 1.68 2.36 2.38 2.38 
H5 Neu5Gc 3.630 51.10 0.52 0.85 1.68 2.36 2.38 2.38 
H6' GalNAc 3.638 63.63 - - - - - - 
H4 GalNAc 3.696 68.11 0.24 0.54 0.72 0.84 0.86 0.86 
H5 GalNAc 3.757 69.14 0.49 0.81 1.33 1.42 1.52 1.52 
CH2 Neu5Gc 3.815 60.57 1.64 3.07 4.81 5.57 5.73 6.020 
H2 GalNAc 3.836 53.29 0.6 0.72 1.28 1.41 1.57 2.57 
Table A.31. Appendix to Figure 5.20 in Sub-section 5.3.1 Neu5Gc-STn. 1H and 13C assignment 
and the raw STD (%) at increasing saturation times. Experiments acquired at 293 K.  
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    STD (%) STF 
Proton 
ID 
Spin 
system 
1H δ 
(ppm) 
13C δ 
(ppm) 
0.5 s 1 s 2 s 3 s 4 s 5 s 
H3a Neu5Ac 1.498 39.18 2.84 3.99 5.55 5.73 5.79 6.380 
CH2 Chain 1.606 27.64 0.51 0.85 0.95 1.04 1.09 1.12 
CH3 αGlcNAc 1.727 21.51 8.98 14.34 19.22 20.99 21.19 21.19 
CH3 Neu5Ac 1.727 21.51 8.98 14.34 19.22 20.99 21.19 21.19 
H3e Neu5Ac 2.434 39.88 2.34 3.59 4.86 5.620 5.68 5.790 
CH2(N3) Chain 3.153 47.66 0.44 0.48 0.52 0.560 0.58 0.58 
CH2(N3) Chain 3.198 47.66 0.38 0.61 0.65 0.670 0.71 0.71 
CH2(O) Chain 3.235 64.39 0.27 0.61 0.92 1.05 1.15 1.210 
H2 Gal 3.246 68.72 0.27 0.61 0.92 1.05 1.15 1.210 
H8 Neu5Ac 3.294 67.60 1.83 3.96 6.26 7.240 8.22 8.22 
H6 Neu5Ac 3.315 72.30 1.83 3.96 6.26 7.240 8.22 8.22 
H9 Neu5Ac 3.338 62.02 0.75 1.6 2.41 2.680 2.92 3.01 
H5 Gal 3.345 74.51 0.75 1.6 2.41 2.680 2.92 3.01 
H4 Neu5Ac 3.376 68.07 0.56 2.55 3.8 4.32 5.2 5.41 
H6/6' Gal 3.410 60.69 0.43 0.69 0.75 0.790 0.790 0.790 
H6/6' αGlcNAc 3.450 60.68 0.43 0.69 0.75 0.790 0.790 0.790 
CH2(O) Chain 3.518 64.39 0.67 1.35 1.35 1.44 1.52 1.73 
H5 Neu5Ac 3.552 51.20 0.78 1.74 2.91 3.42 3.96 4.52 
H9' Neu5Ac 3.556 62.02 0.78 1.74 2.91 3.42 3.96 4.520 
H7 Neu5Ac 3.590 71.52 0.57 1.49 2.2 2.65 3.22 3.680 
H4 Gal 3.636 67.02 0.38 0.7 1.21 1.26 1.46 1.740 
H5 αGlcNAc 3.705 70.19 0.29 0.59 0.7 0.78 0.81 1.06 
H3 αGlcNAc 3.752 76.96 0.44 0.7 0.75 0.780 0.92 1.07 
H3 Gal 3.781 75.33 0.44 0.9 1.51 1.940 2.14 2.49 
H4 αGlcNAc 3.959 68.37 0.55 0.79 0.97 1.160 1.16 1.210 
Table A.32. Appendix to Figure 5.20 in Sub-section 5.3.1 STF. 1H and 13C assignment and the 
raw STD (%) at increasing saturation times. Experiments acquired at 293 K. 
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